
<html lang="en"     class="pb-page"  data-request-id="6f5d8ba4-b517-418c-9c45-0f49812e6ced"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;issue:issue:10.1021/jmcmar.2017.60.issue-16;ctype:string:Journal Content;article:article:10.1021/acs.jmedchem.7b00484;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Inhibitory Kappa B Kinase α (IKKα) Inhibitors That Recapitulate Their Selectivity in Cells against Isoform-Related Biomarkers" /></meta><meta name="dc.Creator" content="Nahoum G.  Anthony" /></meta><meta name="dc.Creator" content="Jessica  Baiget" /></meta><meta name="dc.Creator" content="Giacomo  Berretta" /></meta><meta name="dc.Creator" content="Marie  Boyd" /></meta><meta name="dc.Creator" content="David  Breen" /></meta><meta name="dc.Creator" content="Joanne  Edwards" /></meta><meta name="dc.Creator" content="Carly  Gamble" /></meta><meta name="dc.Creator" content="Alexander I.  Gray" /></meta><meta name="dc.Creator" content="Alan L.  Harvey" /></meta><meta name="dc.Creator" content="Sophia  Hatziieremia" /></meta><meta name="dc.Creator" content="Ka Ho  Ho" /></meta><meta name="dc.Creator" content="Judith K.  Huggan" /></meta><meta name="dc.Creator" content="Stuart  Lang" /></meta><meta name="dc.Creator" content="Sabin  Llona-Minguez" /></meta><meta name="dc.Creator" content="Jia Lin  Luo" /></meta><meta name="dc.Creator" content="Kathryn  McIntosh" /></meta><meta name="dc.Creator" content="Andrew  Paul" /></meta><meta name="dc.Creator" content="Robin J.  Plevin" /></meta><meta name="dc.Creator" content="Murray N.  Robertson" /></meta><meta name="dc.Creator" content="Rebecca  Scott" /></meta><meta name="dc.Creator" content="Colin J.  Suckling" /></meta><meta name="dc.Creator" content="Oliver B.  Sutcliffe" /></meta><meta name="dc.Creator" content="Louise C.  Young" /></meta><meta name="dc.Creator" content="Simon P.  Mackay" /></meta><meta name="dc.Description" content="IKKβ plays a central role in the canonical NF-kB pathway, which has been extensively characterized. The role of IKKα in the noncanonical NF-kB pathway, and indeed in the canonical pathway as a comp..." /></meta><meta name="Description" content="IKKβ plays a central role in the canonical NF-kB pathway, which has been extensively characterized. The role of IKKα in the noncanonical NF-kB pathway, and indeed in the canonical pathway as a comp..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="August 15, 2017" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.7b00484" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2017 American Chemical Society" /></meta><meta name="citation_fulltext_world_readable" content=""/></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b00484" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.7b00484" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b00484" /></link>
        
    
    

<title>Inhibitory Kappa B Kinase α (IKKα) Inhibitors That Recapitulate Their Selectivity in Cells against Isoform-Related Biomarkers | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.7b00484" /></meta><meta property="og:title" content="Inhibitory Kappa B Kinase α (IKKα) Inhibitors That Recapitulate Their Selectivity in Cells against Isoform-Related Biomarkers" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-16/acs.jmedchem.7b00484/20170818/images/large/jm-2017-004846_0021.jpeg" /></meta><meta property="og:description" content="IKKβ plays a central role in the canonical NF-kB pathway, which has been extensively characterized. The role of IKKα in the noncanonical NF-kB pathway, and indeed in the canonical pathway as a complex with IKKβ, is less well understood. One major reason for this is the absence of chemical tools designed as selective inhibitors for IKKα over IKKβ. Herein, we report for the first time a series of novel, potent, and selective inhibitors of IKKα. We demonstrate effective target engagement and selectivity with IKKα in U2OS cells through inhibition of IKKα-driven p100 phosphorylation in the noncanonical NF-kB pathway without affecting IKKβ-dependent IKappa-Bα loss in the canonical pathway. These compounds represent the first chemical tools that can be used to further characterize the role of IKKα in cellular signaling, to dissect this from IKKβ and to validate it in its own right as a target in inflammatory diseases." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.7b00484"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.7b00484">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.7b00484&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.7b00484&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.7b00484&amp;href=/doi/10.1021/acs.jmedchem.7b00484" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2017</span><span class="cit-fg-volume">, 60</span><span class="cit-fg-issue">, 16</span><span class="cit-fg-pageRange">, 7043-7066</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/60/16" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.7b00598" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.7b00724" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Inhibitory Kappa B Kinase α (IKKα) Inhibitors That Recapitulate Their Selectivity in Cells against Isoform-Related Biomarkers</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Nahoum+G.++Anthony">Nahoum G. Anthony</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jessica++Baiget">Jessica Baiget</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Giacomo++Berretta">Giacomo Berretta</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Marie++Boyd">Marie Boyd</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=David++Breen">David Breen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Joanne++Edwards">Joanne Edwards</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Carly++Gamble">Carly Gamble</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Alexander+I.++Gray">Alexander I. Gray</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Alan+L.++Harvey">Alan L. Harvey</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sophia++Hatziieremia">Sophia Hatziieremia</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ka+Ho++Ho">Ka Ho Ho</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Judith+K.++Huggan">Judith K. Huggan</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Stuart++Lang">Stuart Lang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sabin++Llona-Minguez">Sabin Llona-Minguez</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0003-3187-722X" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jia+Lin++Luo">Jia Lin Luo</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kathryn++McIntosh">Kathryn McIntosh</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Andrew++Paul">Andrew Paul</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Robin+J.++Plevin">Robin J. Plevin</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Murray+N.++Robertson">Murray N. Robertson</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0001-9543-7667" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Rebecca++Scott">Rebecca Scott</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Colin+J.++Suckling">Colin J. Suckling</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Oliver+B.++Sutcliffe">Oliver B. Sutcliffe</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0003-3781-7754" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Louise+C.++Young">Louise C. Young</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Simon+P.++Mackay">Simon P. Mackay</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0001-8000-6557" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, 161 Cathedral Street, Glasgow G4 0NR, Scotland, United Kingdom</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">WestCHEM Department of Pure and Applied Chemistry, University of Strathclyde, 295 Cathedral Street, Glasgow G1 1XL, Scotland, United Kingdom</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">Wolfson Wohl Cancer Research Centre, Institute of Cancer Sciences, University of Glasgow, Garscube Estate, Switchback Road, Glasgow G61 1QH, Scotland, United Kingdom</span></div><div class="corresp-info"><strong>*</strong>Phone: +44(0)141 548 2866. Fax: +44(0)141 552 2562. E-mail: <a href="/cdn-cgi/l/email-protection#4e3d2723212060232f2d252f370e3d3a3c2f3a26602f2d603b25"><span class="__cf_email__" data-cfemail="5a293337353474373b39313b231a292e283b2e32743b39742f31">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b00484&amp;href=/doi/10.1021%2Facs.jmedchem.7b00484" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2017</span></span><span class="cit-volume">, 60</span><span class="cit-issue">, 16</span><span class="cit-pageRange">, 7043–7066</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">July 24, 2017</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>6 May 2017</li><li><span class="item_label"><b>Published</b> online</span>15 August 2017</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 24 August 2017</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.7b00484" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00484</a></div><div class="article_header-article-copyright"><strong>Copyright © 2017 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/page/rightslinkno.jsp">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"><a href="/page/policy/authorchoice/index.html"><img src="/pb-assets/images/programsLogos/OA_Icons_Ac-1612971054130.svg" alt="ACS AuthorChoice" /></img><span>ACS AuthorChoice</span></a><span class="article_header-cc-by text">with CC-BY<a href="/page/policy/authorchoice_ccby_termsofuse.html" title="License">license</a></span></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.7b00484"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">3217</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">13</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.7b00484" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Inhibitory Kappa B Kinase α (IKKα) Inhibitors That Recapitulate Their Selectivity in Cells against Isoform-Related Biomarkers&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Nahoum&quot;,&quot;last_name&quot;:&quot;G. Anthony&quot;},{&quot;first_name&quot;:&quot;Jessica&quot;,&quot;last_name&quot;:&quot;Baiget&quot;},{&quot;first_name&quot;:&quot;Giacomo&quot;,&quot;last_name&quot;:&quot;Berretta&quot;},{&quot;first_name&quot;:&quot;Marie&quot;,&quot;last_name&quot;:&quot;Boyd&quot;},{&quot;first_name&quot;:&quot;David&quot;,&quot;last_name&quot;:&quot;Breen&quot;},{&quot;first_name&quot;:&quot;Joanne&quot;,&quot;last_name&quot;:&quot;Edwards&quot;},{&quot;first_name&quot;:&quot;Carly&quot;,&quot;last_name&quot;:&quot;Gamble&quot;},{&quot;first_name&quot;:&quot;Alexander&quot;,&quot;last_name&quot;:&quot;I. Gray&quot;},{&quot;first_name&quot;:&quot;Alan&quot;,&quot;last_name&quot;:&quot;L. Harvey&quot;},{&quot;first_name&quot;:&quot;Sophia&quot;,&quot;last_name&quot;:&quot;Hatziieremia&quot;},{&quot;first_name&quot;:&quot;Ka&quot;,&quot;last_name&quot;:&quot;Ho Ho&quot;},{&quot;first_name&quot;:&quot;Judith&quot;,&quot;last_name&quot;:&quot;K. Huggan&quot;},{&quot;first_name&quot;:&quot;Stuart&quot;,&quot;last_name&quot;:&quot;Lang&quot;},{&quot;first_name&quot;:&quot;Sabin&quot;,&quot;last_name&quot;:&quot;Llona-Minguez&quot;},{&quot;first_name&quot;:&quot;Jia&quot;,&quot;last_name&quot;:&quot;Lin Luo&quot;},{&quot;first_name&quot;:&quot;Kathryn&quot;,&quot;last_name&quot;:&quot;McIntosh&quot;},{&quot;first_name&quot;:&quot;Andrew&quot;,&quot;last_name&quot;:&quot;Paul&quot;},{&quot;first_name&quot;:&quot;Robin&quot;,&quot;last_name&quot;:&quot;J. Plevin&quot;},{&quot;first_name&quot;:&quot;Murray&quot;,&quot;last_name&quot;:&quot;N. Robertson&quot;},{&quot;first_name&quot;:&quot;Rebecca&quot;,&quot;last_name&quot;:&quot;Scott&quot;},{&quot;first_name&quot;:&quot;Colin&quot;,&quot;last_name&quot;:&quot;J. Suckling&quot;},{&quot;first_name&quot;:&quot;Oliver&quot;,&quot;last_name&quot;:&quot;B. Sutcliffe&quot;},{&quot;first_name&quot;:&quot;Louise&quot;,&quot;last_name&quot;:&quot;C. Young&quot;},{&quot;first_name&quot;:&quot;Simon&quot;,&quot;last_name&quot;:&quot;P. Mackay&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2017&quot;,&quot;month&quot;:&quot;08&quot;,&quot;day&quot;:&quot;15&quot;,&quot;issue&quot;:&quot;16&quot;,&quot;volume&quot;:&quot;60&quot;,&quot;pages&quot;:&quot;7043-7066&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.7b00484&quot;},&quot;abstract&quot;:&quot;IKKβ plays a central role in the canonical NF-kB pathway, which has been extensively characterized. The role of IKKα in the noncanonical NF-kB pathway, and indeed in the canonical pathway as a complex with IKKβ, is less well understood. One major reason for this is the absence of chemical tools designed as selective inhibitors for IKKα over IKKβ. Herein, we report for the first time a series of novel, potent, and selective inhibitors of IKKα. We demonstrate effective target engagement and selectivity with IKKα in U2OS cells through inhibition of IKKα-driven p100 phosphorylation in the noncanonical NF-kB pathway without affecting IKKβ-dependent IKappa-Bα loss in the canonical pathway. These compounds represent the first chemical tools that can be used to further characterize the role of IKKα in cellular signaling, to dissect this from IKKβ and to validate it in its own right as a target in inflammatory diseases.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b00484&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00484" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b00484&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00484" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b00484&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00484" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b00484&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00484&amp;href=/doi/10.1021/acs.jmedchem.7b00484" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.7b00484" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.7b00484" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (9 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00484&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.7b00484%26sid%3Dliteratum%253Aachs%26pmid%3D28737909%26genre%3Darticle%26aulast%3DAnthony%26date%3D2017%26atitle%3DInhibitory%2BKappa%2BB%2BKinase%2B%25CE%25B1%2B%2528IKK%25CE%25B1%2529%2BInhibitors%2BThat%2BRecapitulate%2BTheir%2BSelectivity%2Bin%2BCells%2Bagainst%2BIsoform-Related%2BBiomarkers%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D60%26issue%3D16%26spage%3D7043%26epage%3D7066%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (9)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291011" title="High-performance liquid chromatography">High-performance liquid chromatography</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291316" title="Mixtures">Mixtures</a>,</li><li><a href="/action/doSearch?ConceptID=292017" title="Solvents">Solvents</a>,</li><li><a href="/action/doSearch?ConceptID=292317" title="Ethyl groups">Ethyl groups</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/60/16" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-16/jmcmar.2017.60.issue-16/20170824/jmcmar.2017.60.issue-16.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-16/acs.jmedchem.7b00484/20170818/images/medium/jm-2017-004846_0021.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-16/acs.jmedchem.7b00484/20170818/images/large/jm-2017-004846_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00484&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">IKKβ plays a central role in the canonical NF-kB pathway, which has been extensively characterized. The role of IKKα in the noncanonical NF-kB pathway, and indeed in the canonical pathway as a complex with IKKβ, is less well understood. One major reason for this is the absence of chemical tools designed as selective inhibitors for IKKα over IKKβ. Herein, we report for the first time a series of novel, potent, and selective inhibitors of IKKα. We demonstrate effective target engagement and selectivity with IKKα in U2OS cells through inhibition of IKKα-driven p100 phosphorylation in the noncanonical NF-kB pathway without affecting IKKβ-dependent IKappa-Bα loss in the canonical pathway. These compounds represent the first chemical tools that can be used to further characterize the role of IKKα in cellular signaling, to dissect this from IKKβ and to validate it in its own right as a target in inflammatory diseases.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_03561" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_03561" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Nuclear factor-κB (NF-κB) transcription factors are central coordinators of the innate and adaptive immune response and play key roles in cancer development and progression.<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1, 2)</a> NF-κBs also have a major role in controlling the ability of both preneoplastic and malignant cells to resist apoptosis and support tumor angiogenesis and invasiveness.<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1, 2)</a> The signaling pathways that mediate the activation of the different NF-κB complexes are therefore attractive targets for new chemotherapeutic interventions.</div><div class="NLM_p">The NF-κB pathways, which are regulated by the inhibitory κB kinases (IKKs), are elevated when homeostasis is disrupted. This is represented by an increase in constitutive IKKα/β activity leading to enhanced NF-κB expression and subsequent nuclear localization. The IKKs are upstream regulators of the NF-κBs, which exist as either homo- or heterodimers bound to inhibitory kappa Bs (IκB’s).<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1, 2)</a> The activation of these IKK complexes dictates the phosphorylation, targeted ubiquitination, and proteolytic removal of IκBs in the canonical pathway and the phosphorylation and processing of high molecular weight NF-κB proteins (p100) in the noncanonical pathway.<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1, 2)</a> This in turn allows NF-κB complexes to translocate to the nucleus and bind specific promoter regions of their targeted genes. Studies<a onclick="showRef(event, 'ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref3 ref4">(3, 4)</a> have indicated that IKKα and IKKβ play key but divergent roles in the regulation of global NF-κB signaling and many aspects of cellular transcription. IKKβ controls the canonical pathway via activation of p65 RelA–p50 heterodimers,<a onclick="showRef(event, 'ref5 ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref5 ref6 ref7">(5-7)</a> and its inhibition leads to a reduction in pro-inflammatory gene expression in several cell types. This is relevant to cancer because several pro-inflammatory species associated with tumor development and progression are encoded by genes regulated through the IKKβ-NF-κB axis.<a onclick="showRef(event, 'ref3 ref4 ref6'); return false;" href="javascript:void(0);" class="ref ref3 ref4 ref6">(3, 4, 6)</a> IKKα has been shown to have a minor role in the canonical pathway<a onclick="showRef(event, 'ref4 ref6'); return false;" href="javascript:void(0);" class="ref ref4 ref6">(4, 6)</a> but is pivotal in the noncanonical pathway, catalyzing the phosphorylation and proteolytic processing of p100 NF-κB2 which in turn liberates distinct NF-κB p52/RelB dimers and initiates transcription of a specific subset of genes. IKKα and IKKβ have specific cellular functions,<a onclick="showRef(event, 'ref3 ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref3 ref8 ref9">(3, 8, 9)</a> and the selective inhibition of one isoform over the other may provide a useful and novel therapeutic strategy in cancer and inflammatory diseases.</div><div class="NLM_p">Over the past 15 years, many inhibitors of IKKβ have been reported,<a onclick="showRef(event, 'ref10 ref11 ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref10 ref11 ref12 ref13">(10-13)</a> primarily toward developing clinical agents to treat inflammatory conditions such as asthma. However, recent studies suggest there may be significant toxicity and side effects associated with IKKβ inhibition, including the development of inflammatory skin disease and sensitization of colonic epithelium to a range of insults.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> In addition, IKKβ knockout mice display severe liver dysfunction.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> Intestinal and liver toxicity have also been an issue in several clinical trials of IKKβ inhibitors which may further limit their clinical applications. Some IKKα inhibitors have been described in the patent literature but with little detail regarding activity and specificity.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> Asamitsu et al.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> reported that the natural product, noraristeromycin (NAM), inhibits IκBα phosphorylation and degradation upon TNFα stimulation and prevents p65 phosphorylation through selective IKKα inhibition. However, the pharmacodynamic readouts used were reporters for both IKKβ and IKKα activity in cells and do not focus on specific biomarkers of the IKKα-controlled noncanonical pathway such as p100 phosphorylation and subsequent processing to p52.</div><div class="NLM_p last">Given the growing evidence that IKKα has an important role in a number of cancers,<a onclick="showRef(event, 'ref18 ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref18 ref19 ref20">(18-20)</a> selective IKKα inhibitors are required in order to fully understand and validate its role in cancer development and progression, particularly in prostate,<a onclick="showRef(event, 'ref19 ref21'); return false;" href="javascript:void(0);" class="ref ref19 ref21">(19, 21)</a> breast,<a onclick="showRef(event, 'ref22 ref23 ref24'); return false;" href="javascript:void(0);" class="ref ref22 ref23 ref24">(22-24)</a> and pancreatic<a onclick="showRef(event, 'ref25 ref26 ref27'); return false;" href="javascript:void(0);" class="ref ref25 ref26 ref27">(25-27)</a> cancers. Herein we describe the design, synthesis, and evaluation of a series of 4-substituted 2-amino-5-cyanopyrrolo[2,3-<i>d</i>]pyrimidines as part of our program to develop isoform selective IKKα inhibitors. We present a comparison of the kinase domains of IKKα and IKKβ based on molecular dynamics simulations to explore differences in conformational flexibility that would enable small molecule inhibitors to discriminate between the two isoforms. Finally, we report the first example of IKKα-selective compounds that recapitulate activity in cells against isoform-related pharmacodynamic readouts.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_48523" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_48523" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Strategy for Discriminating between IKKα and IKKβ</h3><div class="NLM_p">To date, no group has been able to successfully crystallize IKKα and report a high resolution structure of sufficient detail to guide structure-based inhibitor design. To explore differences between the two IKK isoforms, we built a homology model of the IKKα kinase domain based on the crystal structure ofIKKβ (chain B, residues 1–309, PDB entry <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4KIK">4KIK</a>),<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> keeping the inhibitor (KSA700 in the pdb file) and water molecules found within 6 Å of the protein–inhibitor complex (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>). Both IKK kinase domains were solvated and then subjected to extended molecular dynamics, with an average structure generated for the last 21 ns (IKKα) or 26 ns (IKKβ) and subsequently minimized.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-16/acs.jmedchem.7b00484/20170818/images/medium/jm-2017-004846_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-16/acs.jmedchem.7b00484/20170818/images/large/jm-2017-004846_0001.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Sequence alignment for the kinase domains of IKKα and IKKβ (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4KIK">4KIK</a>_chainB) showing 61% of identical residues (colored in turquoise), a further 14% similar residues (polar for polar, hydrophobic for hydrophobic; in light blue), and 25% nonsimilar residues (white).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-16/acs.jmedchem.7b00484/20170818/images/large/jm-2017-004846_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00484&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">When superimposing the presimulated structures of both IKK isoforms, it was striking to see that regions making up the ATP-binding pocket were essentially identical (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>, left). However, analysis of descriptors of motion extracted from their MD trajectories such as residual fluctuation revealed dynamic differences between the two isoforms that could potentially be exploited in an inhibitor design program.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-16/acs.jmedchem.7b00484/20170818/images/medium/jm-2017-004846_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-16/acs.jmedchem.7b00484/20170818/images/large/jm-2017-004846_0002.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (left) Minimized average structure of IKKβ highlighting residues that are identical to (turquoise), similar to (light blue), or different from (white) IKKα. The ATP analogue marks the ATP binding site and is surrounded by turquoise residues. (right) Residual fluctuations of IKKα (black line) and IKKβ (blue line) arising during the MD simulations. Several areas were found to be more flexible in IKKα (red underline).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-16/acs.jmedchem.7b00484/20170818/images/large/jm-2017-004846_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00484&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Residual fluctuations obtained from the MD trajectories highlighted areas of the IKKs that acted differently during the simulations (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>, right). Overall, the two isoforms behaved very similarly but IKKα appeared more flexible in several key areas around the ATP binding site, particularly at the G-loop (residues 22–27) above the site entrance and the loop located just adjacent to the hinge (residues 155–159 in IKKα (VGGKI) and residues 156–160 in IKKβ (GEQRL)). Two residues could account for the differences observed with the G-loop: Pro52 and Gln48 in IKKβ (Thr52 and Leu48 in IKKα) induce a tension at the tip of the first α-helix through proline’s intrinsic structure and the engagement of the glutamine side chain in a reciprocal H-bond dimer arrangement with the side chain amide of Asn28 (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>). This asparagine is located at the end of the G-loop, and its interaction with Gln48 restrained the G-loop movement by more than 1 Å in IKKβ when compared with IKKα. A different dynamic behavior was observed with IKKα, as the equivalent residues do not impose restraints on the G-loop movements: Thr52 has no rigid turn restriction like Pro52 in IKKβ, and the side chain of Leu48 seeks a hydrophobic environment and will not engage in H-bond formation with Asn28, leaving the side chain of this latter residue free to make interactions in the ATP binding site of IKKα (in contrast to being sequestered by Gln48 as in IKKβ) (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>). The other significant difference was related to the VGGKI loop (residues 155–159) in IKKα (residues GEQRL: 156–160 in IKKβ). In this case, one residue is responsible for the change observed in residual fluctuation: Lys158 in IKKα is replaced by Arg159 in IKKβ. The slightly longer arginine side chain and its bifurcate H-bonding capacity forms a reciprocal H-bond dimer with the side chain carboxylate of Asp128 in IKKβ that was maintained throughout the simulation, while the equivalent lysine in IKKα never engaged in a strong interaction with the equivalent Asp127 in IKKα (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>). This interaction in IKKβ is responsible for tethering the 156–160 loop to α-helix 3 (Asp128 is located in the middle of this helix), thus reducing its flexibility compared with IKKα.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-16/acs.jmedchem.7b00484/20170818/images/medium/jm-2017-004846_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-16/acs.jmedchem.7b00484/20170818/images/large/jm-2017-004846_0003.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Superimposition of IKKα (white) and IKKβ (blue) highlighting the differences near/in the ATP binding site (marked by the staurosporine analogue as a stick model) between the two isoforms. The expanded area shows equivalent residues in IKKα (Asn28, Leu48, and Thr52) and IKKβ (Asn28, Gln48, and Pro52) engaged in different interactions/structural effects, resulting in Asn28 being available to interact with putative ligands in the binding pocket of IKKα but not IKKβ.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-16/acs.jmedchem.7b00484/20170818/images/large/jm-2017-004846_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00484&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-16/acs.jmedchem.7b00484/20170818/images/medium/jm-2017-004846_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-16/acs.jmedchem.7b00484/20170818/images/large/jm-2017-004846_0004.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. (left) Loop conformation located below the active site in IKKα (white) and IKKβ (blue) and its relationship with α-helix 3 residue Asp127 (IKKα)/Asp128 (IKKβ). In IKKβ, Arg159 makes a reciprocal hydrogen bond dimer interaction with Asp128, whereas in IKKα Lys158 has no close interactions with Asp127. (right) Side chain amine nitrogen (Lys158 (IKKα)/Arg159 (IKKβ)) to side chain acid oxygen (Asp127 (IKKα)/Asp128 (IKKβ)) distance throughout the equilibrated phase of the simulation.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-16/acs.jmedchem.7b00484/20170818/images/large/jm-2017-004846_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00484&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">With respect to putative inhibitor binding, the implications for isoform selectivity of these two sets of differences in the ATP site are 2-fold: first, it should be possible to design small molecules that target the free Asn28 side chain amide presented at the back of the IKKα pocket that is otherwise engaged in IKKβ (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>), and second, because the ATP binding pocket has greater flexibility in IKKα, it has the potential to accommodate larger substituents, particularly below the G-loop.</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Initial Hit Identification</h3><div class="NLM_p">To identify hits that could be developed to exploit the differences between the two isoforms, we screened our in-house compound library compiled of fragments designed to target the common hinge-binding motif found in protein kinases. Using a DELFIA kinase assay kit with minor modifications<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> to measure IKKα and IKKβ inhibitory activity, we identified 2-amino-4-chloro-5-cyanopyrrolo[2,3-<i>d</i>]pyrimidine <b>4</b> as our primary hit (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). On the basis of the assumption that the 2-aminopyrrolo[2,3-<i>d</i>]pyrimidine core of compound <b>4</b> was binding at the hinge of IKKα, we varied substitution at the 4-position widely. Differences in bulk and polar functionality were incorporated to exploit the greater flexibility in the IKKα ATP binding site and the position of the Asn28 side chain at the back of the pocket.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Biochemical Inhibitory Data for the <i>N</i><sup>4</sup>-Substituted 2-Amino-5-cyanopyrrolo[2,3-<i>d</i>]pyrimidines<a class="ref internalNav" href="#tbl1-fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-16/acs.jmedchem.7b00484/20170818/images/medium/jm-2017-004846_0015.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-16/acs.jmedchem.7b00484/20170818/images/medium/jm-2017-004846_0016.gif" alt="" id="fx2" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-16/acs.jmedchem.7b00484/20170818/images/medium/jm-2017-004846_0017.gif" alt="" id="GRAPHIC-d49e616-autogenerated" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl1-fn1"><div class="footnote" id="tbl1-fn1"><sup>Table a</sup><p class="last"><i>K</i><sub>i</sub> values are expressed in μM units and are the result of three independent experiments.</p></div></div><div></div></div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> Chemistry</h3><div class="NLM_p">The general route used to prepare <i>N</i><sup>4</sup>-substituted 2-amino-5-cyanopyrrolo[2,3-<i>d</i>]pyrimidines for assessment began with the preparation of <b>1</b> using a published procedure.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a><b>1</b> was then protected as either its diacetyl derivative <b>2</b> or pivaloyl derivative <b>3</b>, which were subsequently converted to the aryl chlorides <b>4</b> and <b>5</b> (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>) and used to prepare an initial series of compounds (<b>4</b>–<b>31</b>) (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>) by nucleophilic aromatic substitution with a range of primary and secondary amines. The second series of aryl cross coupled compounds exploring the 4-phenyl 2-amino-5-cyanopyrrolo[2,3-<i>d</i>]pyrimidines was prepared by Suzuki–Miyaura couplings (<b>43</b>–<b>62</b>) with <b>5</b>. In general, the use of the <i>N</i>-pivalamide <b>5</b> gave higher yields of the final compounds compared to the unprotected form <b>4</b>.</div><figure id="sch1" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-16/acs.jmedchem.7b00484/20170818/images/medium/jm-2017-004846_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-16/acs.jmedchem.7b00484/20170818/images/large/jm-2017-004846_0011.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-16/acs.jmedchem.7b00484/20170818/images/large/jm-2017-004846_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00484&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Ac<sub>2</sub>O, DMF, 150 °C, 4 h; (b) PivCl, pyridine, 85 °C; (c) POCl<sub>3</sub>, DMA; (d) amine, Et<sub>3</sub>N, 1,4-dioxane 200 °C (μW) 20 min; (e) amine, Et<sub>3</sub>N, <i>n</i>-BuOH, reflux, 16 h then KOH, EtOH, 80 °C, 20 h; (f) boronic acid/ester, Pd(dppf)Cl<sub>2</sub>, KOAc, H<sub>2</sub>O/dioxane, 110 °C 16 h.</p></p></figure><div class="NLM_p">To explore polar functionality further in the <i>N</i><sup>4</sup>-substituted 2-amino-5-cyanopyrrolo[2,3-<i>d</i>]pyrimidines, a series of amino alcohol derivatives (<b>23</b>–<b>31</b>) was prepared as analogues of <b>16</b>. Compounds <b>23</b>–<b>29</b> were prepared from commercially available amines using the procedure detailed in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. To incorporate 4-substituents with more than one hydroxyl group in the cyclopentane ring as in the putative IKKα selective inhibitor NAM,<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> we prepared the diol <b>30</b> and triol <b>31</b>.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> The synthesis of <b>30</b> began with bromination<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> of cyclopentene <b>32</b> to produce the unstable halide <b>33</b>, which was immediately treated with <i>N</i>,<i>N</i>-dibenzylamine. The resulting allylic amine <b>34</b> underwent <i>syn</i>-dihydroxylation to afford the diol <b>35</b><a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> with excellent diastereoselectivity, which was then protected as the dibenzoate <b>36</b>. The amine was subsequently deprotected by hydrogenation to yield <b>37</b>, which was coupled with <b>5</b>. Global deprotection gave the desired final product <b>30</b> (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>).</div><figure id="sch2" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-16/acs.jmedchem.7b00484/20170818/images/medium/jm-2017-004846_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-16/acs.jmedchem.7b00484/20170818/images/large/jm-2017-004846_0012.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-16/acs.jmedchem.7b00484/20170818/images/large/jm-2017-004846_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00484&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) NBS, (PhCO<sub>2</sub>)<sub>2</sub>, CCl<sub>4</sub>, 90 °C, 1 h; (b) NH(Bn)<sub>2</sub>, CCl<sub>4</sub>, rt, 12 h, 70%; (c) OsO<sub>4</sub>, NMO, acetone/H<sub>2</sub>O, rt, 4 h, 71%, 96:4 dr; (d) BzCl, pyridine, 0 °C to rt, 24 h, 84%; (e) H<sub>2</sub> (1 atm), Pd(OH)<sub>2</sub>, rt, 16 h, 98% (f) <b>5</b>, Et<sub>3</sub>N, <i>n</i>-BuOH, reflux, 16 h then KOH, EtOH 80 °C, 20 h, 42%.</p></p></figure><div class="NLM_p">To prepare the triol <b>31</b>, the allyl acetate <b>38</b> was reacted with sodium di-<i>tert</i>-butyl iminodicarbonate<a onclick="showRef(event, 'ref34 ref35'); return false;" href="javascript:void(0);" class="ref ref34 ref35">(34, 35)</a> to produce <b>39</b>, which was oxidized to the <i>syn</i>-diol <b>40</b> followed by benzoate protection of the hydroxyl functionalities to give <b>41</b> and removal of the BOC groups under acidic conditions to yield the amine <b>42</b>. This was then coupled with <b>5</b> followed by basic hydrolysis to remove the protecting groups to give the desired final product <b>31</b> (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>).</div><figure id="sch3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-16/acs.jmedchem.7b00484/20170818/images/medium/jm-2017-004846_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-16/acs.jmedchem.7b00484/20170818/images/large/jm-2017-004846_0013.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-16/acs.jmedchem.7b00484/20170818/images/large/jm-2017-004846_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00484&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Pd(PPh<sub>3</sub>)<sub>4</sub>, PPh<sub>3</sub>, NaH, NH(BOC)<sub>2</sub>, THF/DMF, 50 °C 24 h, 42%; (b) OsO<sub>4</sub>, NMO, acetone/H<sub>2</sub>O, rt, 24 h, 89%; (c) BzCl, pyridine, 0 °C to rt, 17 h, 74%; (d) 4 N HCl in 1,4-dioxane, 0 °C to rt, 16 h, 76%; (e) <b>7</b>, Et<sub>3</sub>N, nBuOH, reflux, 16 h then KOH, EtOH 80 °C, 20 h, 33%.</p></p></figure><div class="NLM_p">An obvious progression from this series was to replace the bulky saturated ring with a phenyl ring bearing a selection of polar <i>o</i>-, <i>m</i>-, or <i>p</i>-substituents. This series was prepared by reacting <b>5</b> with a variety of boronic acids or esters under Suzuki–Miyaura coupling conditions to afford the products <b>43</b>–<b>62</b> (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>; <a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>).</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Biochemical Inhibitory Data for the 4-Phenyl 2-Amino-5-cyanopyrrolo[2,3-<i>d</i>]pyrimidine Series<a class="ref internalNav" href="#tbl2-fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-16/acs.jmedchem.7b00484/20170818/images/medium/jm-2017-004846_0018.gif" alt="" id="fx3" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-16/acs.jmedchem.7b00484/20170818/images/medium/jm-2017-004846_0024.gif" alt="" id="fx100" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl2-fn1"><div class="footnote" id="tbl2-fn1"><sup>Table a</sup><p class="last"><i>K</i><sub>i</sub> values are expressed in μM units and are the result of three independent experiments.</p></div></div><div></div></div><div class="NLM_p">To assess the importance of the 2-amino and 5-cyano groups for activity and selectivity, we purchased (<b>63</b>) or prepared compounds (<b>64</b>–<b>71</b>) without either or both substituents (<a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>, <a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>).</div><figure id="sch4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-16/acs.jmedchem.7b00484/20170818/images/medium/jm-2017-004846_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-16/acs.jmedchem.7b00484/20170818/images/large/jm-2017-004846_0014.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 4. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-16/acs.jmedchem.7b00484/20170818/images/large/jm-2017-004846_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00484&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) alkylamine, Et<sub>3</sub>N, 1,4-dioxane 200 °C (μW) 20 min; (b) boronic acid/ester, Pd(dppf)Cl<sub>2</sub>, KOAc, H<sub>2</sub>O/dioxane, 110 °C, 16 h.</p></p></figure><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Biochemical Inhibitory Data for the 4-Substituted Pyrrolo[2,3-<i>d</i>]pyrimidines With and Without the 2-Amino and/or 5-Cyano groups<a class="ref internalNav" href="#tbl3-fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-16/acs.jmedchem.7b00484/20170818/images/medium/jm-2017-004846_0019.gif" alt="" id="fx4" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-16/acs.jmedchem.7b00484/20170818/images/medium/jm-2017-004846_0020.gif" alt="" id="fx5" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl3-fn1"><div class="footnote" id="tbl3-fn1"><sup>Table a</sup><p class="last"><i>K</i><sub>i</sub> values are expressed in μM units and are the result of three independent experiments.</p></div></div><div></div></div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> Structure–Activity Relationship Studies</h3><div class="NLM_p">In the <i>N</i><sup>4</sup>-substituted series (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>) several compounds had similar <i>K</i><sub>i</sub> values against IKKα compared to the initial hit <b>4</b>. For example, compounds with aliphatic substituents retained potency and selectivity against IKKα and had the potential to be improved through further derivatization. Inhibitory activity for the secondary amines (<b>7</b>, <b>8</b>, and <b>9</b>) suggests the presence of a restricted lipophilic pocket in IKKα, which could be responsible for a 5-fold increase in potency from the methylamine analogue <b>7</b> to the cyclohexylamine derivative <b>9</b>. However, the inactivity of the compound with the bulkier cyclohexylmethylamino group (<b>10</b>) suggested that this lipophilic pocket was limited in size. In contrast, the more planar phenyl and benzyl analogues (<b>11</b> and <b>14</b>) were found to be less active than <b>9</b>, and the insertion of polar substituents in the <i>para</i> position of the aniline group produced no significant improvement in activity (<b>12</b> and <b>13</b>). Conversely, the insertion of polar groups in more flexible side chains was tolerated (<b>16</b>), which suggested the presence of a polar region adjacent to the lipophilic pocket.</div><div class="NLM_p">Although compounds with a piperidyl side chain (<b>17</b> and <b>18</b>) were found to be active, other tertiary amines at position 4 were not tolerated (<b>19</b>–<b>22</b>), which could be due to additional heteroatoms not being accepted in a lipophilic area of the binding directly proximal to position 4 of the pyrrolo[2,3-<i>d</i>]pyrimidine scaffold. By contrast, the activity of <b>16</b> suggested that a flexible ethyl chain is able to direct the heteroatom away from this lipophilic region and possibly engage an adjacent polar region more effectively.</div><div class="NLM_p">Removal of the hydrogen bond donor (HBD) from the 4-amino substituent by replacing the secondary cyclohexylamino group in <b>9</b> with the tertiary <i>N</i>-methylcyclohexylamine (<b>10</b>) abrogated activity. However, the activity of piperidyl analogue <b>17</b> suggests that a HBD at the 4-position is not an absolute requirement for inhibition of IKKα. The inactivity of compound <b>10</b> can be explained by rotation of the <i>N</i>-methyl (and hence the cyclohexyl group) substituent orthogonal to the pyrrolo[2,3-<i>d</i>]pyrimidine moiety to reduce steric clash with the 5-cyano substituent and generate a conformation that is no longer compatible with the binding site.</div><div class="NLM_p">On the basis of the activity of the 4-hydroxyethylamino derivative <b>16</b>, we prepared a second series of amino alcohol derivatives (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). Extending the alkyl chain of <b>16</b> from ethyl to propyl was detrimental to activity (<b>23</b>), whereas the cyclic analogues produced more interesting results. The (<i>R</i>)-pyrrolidin-3-ol enantiomer <b>25</b> was active and selective against IKKα, whereas the (<i>S</i>)-enantiomer <b>24</b> was inactive, suggesting the directionality of the hydroxyl group had a major influence on activity and selectivity. On the other hand, the (<i>R</i>)- and (<i>S</i>)-pyrrolidin-2-yl methanol enantiomers <b>26</b> and <b>27</b> shared the same activity and selectivity against IKKα, implying that free rotation around the methyl alcohol is sufficient to allow equivalent interactions.</div><div class="NLM_p">The <i>trans</i>-aminocyclohexanol derivative <b>28</b> was also active and selective against IKKα, but the cyclohexylamino ethyl alcohol <b>29</b>, designed as a hybrid of compounds <b>8</b> and <b>16</b>, proved to be inactive. Like compound <b>10</b>, this is probably due to the aliphatic ring and the ethyl chain being twisted 90° away from the nitrile axis to adopt a more energetically favored conformation that is incompatible with the binding site. The diol <b>30</b> was active and selective but did not offer significant improvement. The triol <b>31</b>, prepared as an analogue of NAM, proved to be as active as <b>30</b> but less selective. Overall, no significant improvement in binding or selectivity was gained by the introduction of more than one hydroxyl group in this series of secondary cyclic amine derivatives.</div><div class="NLM_p">The direct attachment of an aromatic ring to position 4 of the pyrrolo[2,3-<i>d</i>]pyrimidine scaffold exemplified by compound <b>43</b> retained the potency and selectivity of the original hit <b>4</b> (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). In general, compounds with <i>para</i> substituents in the phenyl ring had better activity against IKKα and produced our first nanomolar IKKα inhibitors in <b>47</b> and <b>48</b>. Although activity against IKKβ was evident for these two compounds, their higher potency for IKKα ensured significant isoform selectivity was maintained. Compounds with <i>meta</i> substituents were low micromolar inhibitors of IKKα (for example <b>53</b>, <b>56</b>, and <b>57</b>) but were equipotent against IKKβ, apart from <b>55</b>, which was inactive against both isoforms. As with compounds <b>10</b> and <b>28</b>, the inactivity of the <i>ortho</i>-substituted derivatives in this series can be attributed to enforced conformational rotation of the phenyl ring to a more orthogonal relationship with the pyrrolo[2,3-<i>d</i>]pyrimidine scaffold, which introduces steric clashes in the binding site. This is less pronounced with an <i>o</i>-fluoro substituent and, consequently, <b>59</b> had similar potency to the unsubstituted 4-phenyl derivative <b>43</b>.</div><div class="NLM_p">Compound <b>48</b> (proprietary code SU909), with a <i>para</i>-primary sulfonamide, represents the most potent IKKα inhibitor reported to date that has significant selectivity over IKKβ, although a limited kinase profile using 40 kinases representative of the kinome identified off-target effects (>80% inhibitory activity) with other kinases albeit at 10 μM (Aurora A, CaMK1, CHK2, CK1, GSK3, MEK1, and PKC: <a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>).</div><figure id="fig5" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-16/acs.jmedchem.7b00484/20170818/images/medium/jm-2017-004846_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-16/acs.jmedchem.7b00484/20170818/images/large/jm-2017-004846_0005.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Percent residual activity of 40 kinases challenged with compound <b>48</b> at 10 μM.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-16/acs.jmedchem.7b00484/20170818/images/large/jm-2017-004846_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00484&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To explore the role of the primary sulfonamide, the 4-methyl sulfone analogue <b>49</b> and the secondary sulfonamides <b>50</b> and <b>51</b> were prepared. Notably, <b>49</b> and <b>50</b> had reduced potency against IKKα, but both were more active against IKKβ, reversing the isoform selectivity for the first time in this series. Similarly, when the orientation of the sulfonamide with respect to the phenyl ring (<b>52</b>) was reversed, a reduction in potency against IKKα occurred but an improvement against IKKβ was again evident, inverting isoform selectivity.</div><div class="NLM_p">The absence of a 5-cyano group in <b>48</b> (compound <b>64</b>) reduced activity against IKKα more than 30-fold (<a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>), although there was a slight improvement against IKKβ. Compound <b>65</b>, which lacked both the 5-cyano and the 2-amino substituent, had lower activity against both isoforms. Compound <b>66</b>, without the 2-amino group but with the 5-cyano, attenuated IKKβ activity but did not re-establish the potency against IKKα seen for <b>48</b>. The importance of the 5-cyano group for activity against IKKα was further demonstrated by preparing analogues of selected active <i>N</i><sup>4</sup>-substituted exemplars from <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>: removal of the 5-cyano substituent produced inactive compounds against both isoforms (<b>67</b>–<b>69</b>), and its replacement with other electron-withdrawing substituents such as a trifluoromethyl (<b>70</b>) or a carboxamide (<b>71</b>) moiety also attenuated all IKKα inhibitory activity (<a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>, <a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>). Furthermore, compound <b>63</b>, which represents the original hit compound (<b>4</b>) without the 5-cyano group, was also inactive against IKKα (<a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>).</div><div class="NLM_p last">Overall, our SAR data suggest that the 5-cyano substituent is essential for IKKα activity in this series of compounds but must be combined with a 2-amino group to promote selectivity. To enhance potency for IKKα, a 4-phenyl group bearing a specific polar <i>para</i>-substituent appears to be crucial.</div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Docking Studies</h3><div class="NLM_p">To explain the general SAR profile observed with our series and to relate these to the differences between the two IKK isoforms that our MD studies had revealed, we performed docking studies using GOLD.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> A limited flexibility was enabled in the side chains of specific residues that had shown significant fluctuation in the MD trajectories, namely Asn28, Val29, and Lys44. In the co-crystal structure of IKKβ<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> that had formed the basis of our simulations, the staurosporine analogue interacts though H-bonds with the backbone groups of GK+1 (Glu97) and GK+3 (Cys99) in the conserved hinge region. Initially, no attempt was made to direct the ligands to interact specifically with the hinge region in our docking simulations; the only requirement was to occupy the ATP binding site. This first docking study was performed to find a common binding mode that could explain the IKKα inhibitory activity and selectivity reported for exemplars from our two series. To explore this, compounds bearing different hydrophobic substituents were selected for their similar potency and selectivity (e.g., <b>4</b>, <b>9</b>, and <b>43</b>). The poses where the 2-aminopyrrolo[2,3-<i>d</i>]pyrimidine scaffold interacted with the hinge region by H-bonds were studied in detail and compared to similar hinge-binding protein kinase inhibitors.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> For example, aminopurines are known to adopt two different binding modes in interactions with the hinge region of CDK2 via three hydrogen bonds.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> However, in similar poses for our compounds in IKKα, the analogous triplet of hydrogen bonds was poorly supported by the IKKα hinge region in terms of bond distances and bond angles. Not surprisingly, similar poses were found when the same compounds were docked with IKKβ, which is due to the high isoform homology and subtle differences in topography in this hinge region of the ATP binding site. These poses could not account for the selectivity reported in our assays and suggested that this was not the binding mode responsible for conveying such discriminatory activity between the isoforms. However, a binding mode where the 2-aminopyrrolo[2,3-<i>d</i>]pyrimidine scaffold interacted with the back pocket of the IKKα active site explained the potency and selectivity displayed by our compounds more effectively. Parts A–C of <a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a> illustrate how compounds <b>4</b>, <b>9</b>, and <b>43</b> were predicted to interact with IKKα, specifically targeting the carboxylate group of Glu61, the ammonium group of Lys44 and, most significantly, the side chain carbonyl group of Asn28 via four H-bonds. In IKKβ, because Asn28 is involved in a dimeric H-bond interaction with Gln48 revealed by our simulations (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>), which also changes the position of Glu61, the triple H-bond interaction observed in IKKα is lost. We therefore propose that the aminopyrrolo[2,3-<i>d</i>]pyrimidine scaffold is anchored to the back of the ATP site specifically targeting Asn28 in IKKα, which accounts for the observed selectivity. In this orientation, the importance of the 5-cyano group when binding with IKKα can also be explained. Examination of the trajectory from an MD simulation of <b>47</b> revealed a water molecule present for the majority of the run that formed a three-centered hydrogen bond bridge between the nitrile, the side chain carboxylate of Asp102, and the backbone NH of the same residue (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>D). Overall, binding to IKKα appears to be facilitated through four centers on the 2-amino-5-cyanopyrrolo[2,3-<i>d</i>]pyrimidine scaffold with four residues in the ATP binding site: Glu61, Lys44, Asn28, and Asp102. A similar binding orientation with IKKβ is less likely because the two of the equivalent sites are less accessible (Asn28 and Glu61), and this would account for the lack of activity in this isoform.</div><figure id="fig6" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-16/acs.jmedchem.7b00484/20170818/images/medium/jm-2017-004846_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-16/acs.jmedchem.7b00484/20170818/images/large/jm-2017-004846_0006.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Docked poses of <b>4</b>, <b>9</b>, <b>43</b>, and <b>47</b> (A–D, respectively) binding to the back of the ATP pocket in IKKα, where the 2-aminopyrrolo[2,3-<i>d</i>]pyrimidine motif forms H-bonds (shown in green) with the side chain carboxylate of Glu61, the side chain ammonium group of Lys44, and the side chain carbonyl group of Asn28. No equivalent poses were identified when these compounds were docked with IKKβ. (D) An MD simulation of <b>47</b> revealed an additional interaction with a molecule of water that formed an H-bond bridging interaction between the 5-cyano group, the side chain of Asp102, and the backbone NH of the same residue.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-16/acs.jmedchem.7b00484/20170818/images/large/jm-2017-004846_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00484&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Although the poses described for compounds <b>4</b>, <b>9</b>, and <b>43</b> showed no interaction with the hinge region, the equivalent poses for the nanomolar inhibitors <b>47</b> and <b>48</b> had significant H-bond interactions with the GK+3 residue via their <i>p</i>-hydroxymethyl and <i>p</i>-sulfonamide substituents (<a class="ref internalNav" href="#fig6" aria-label="Figures 6">Figures 6</a>D and <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>). The equivalent binding pose in IKKβ did not feature the hydrogen bonds HB1 and HB2 due to local structural differences observed between the kinase isoforms and could explain the lower affinity of <b>48</b> for IKKβ. Interestingly, the presence of the methyl group in the secondary sulfonamide <b>50</b> compromised its ability to form an H-bond with the HBA carbonyl group of GK+3 because of a steric clash with the hinge region, thus reducing affinity for IKKα. The sulfonyl group could still interact with the NH of GK+3, which explains why <b>50</b> and the sulfone <b>49</b> both have similar potency against IKKα.</div><figure id="fig7" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-16/acs.jmedchem.7b00484/20170818/images/medium/jm-2017-004846_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-16/acs.jmedchem.7b00484/20170818/images/large/jm-2017-004846_0007.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. (left) Docked pose of <b>48</b>. As before, the 2-aminopyrrolo[2,3-<i>d</i>]pyrimidine moiety engages with the back of the ATP pocket in IKKα and the sulfonamide group generates additional H-bonds with the main chain carbonyl and NH of GK+3 that produce nanomolar activity. (right) Schematic representation of the proposed binding mode in the IKKα-ATP binding site showing key interactions for compound <b>48</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-16/acs.jmedchem.7b00484/20170818/images/large/jm-2017-004846_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00484&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The reason for both <b>49</b> and <b>50</b> also having greater inhibitory activity against IKKβ that reverses isoform selectivity is because the polar side chain of Asn28 in IKKβ rotates out of the back pocket to H-bond with Gln48 (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>). When <b>49</b> and <b>50</b> were docked in the IKKβ structure, they commonly adopted a flipped pose, where the 2-aminopyrrolo[2,3-<i>d</i>]pyrimidine engaged with the GK+1 and +3 residues at the hinge through H-bonding, while the sulfonyl oxygen and the 5-cyano group H-bonded with K44 in the back pocket (<a class="ref internalNav" href="#fig8" aria-label="Figure 8">Figure 8</a>). Binding to IKKβ by <b>49</b> and <b>50</b> in this orientation is facilitated by moving the polar Asn28 from the immediate vicinity, creating a cleft that can more easily accommodate the hydrophobic methyl moiety of <b>49</b> and <b>50</b>. A similar reversal of selectivity was seen with <b>64</b>, which lacks the 5-cyano substituent of <b>48</b>. The drop in potency against IKKα can be attributed to the absence of a water-bridging H-bond interaction with Asp102 but also to the removal of the conformationally restraining effect of the 5-cyano group on the adjacent 4-phenyl ring which would normally optimize alignment of the <i>p</i>-sulfonamide H-bonding interaction with GK+3 in the hinge. The enhanced affinity for IKKβ by <b>64</b> can again be explained by the adoption of a flipped pose when binding to this isoform, which is enabled by a more flexible <i>p</i>-sulfonamide that can H-bond more effectively with Lys44. Just as importantly, this flexibility allows the HBD of the sulfonamide group to access the less accessible Glu41 at the back of IKKβ pocket.</div><figure id="fig8" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-16/acs.jmedchem.7b00484/20170818/images/medium/jm-2017-004846_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-16/acs.jmedchem.7b00484/20170818/images/large/jm-2017-004846_0008.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. (left) Docked pose of <b>50</b> in IKKβ. Unlike IKKα, the aminopyrrolo[2,3-<i>d</i>]pyrimidine moiety has flipped and H-bonds to GK+1 and GK+3. The rotation of Asn28 out of the pocket to H-bond with Glu48 allows the sulfonyl group to H-bond to Lys44 and accommodates the lipophilic methyl group in the cleft opened up by this rotation. (right) Schematic representation of the proposed binding mode in the IKKβ-ATP binding site showing key interactions for compound <b>50</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-16/acs.jmedchem.7b00484/20170818/images/large/jm-2017-004846_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00484&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">In summary, in line with our SAR data and the hypothesis derived from our MD simulation studies, we suggest that nanomolar potency against IKKα with selectivity over IKKβ can be accomplished by having molecules that can bind to the hinge region of the ATP binding site and to the Asn28 residue at the back of the pocket that is available in IKKα but not in IKKβ (<a class="ref internalNav" href="#fig8" aria-label="Figure 8">Figure 8</a>). Furthermore, inhibitory potency against IKKα can be enhanced when compounds can form H-bonding interactions with the three residues in the back pocket (Glu41, Lys44, Asn28) and the GK+3 and Asp102 residues in the hinge.</div></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Demonstrating IKKα Activity and Selectivity Is Recapitulated in Cells</h3><div class="NLM_p">The objective of the cell-based assessment was to characterize whether the two most active compounds against IKKα (<b>47</b> and <b>48</b>) recapitulated their activity in a cellular environment. IKKα but not IKKβ plays a role in the regulation of the noncanonical NF-κB cascade which initially involves phosphorylation of p100, followed by p100 processing to p52 to regulate a number of genes that contribute to and promote cellular growth.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> More recent studies have shown that overactivation of the noncanonical NF-κB pathway in a variety of cellular settings, e.g., prostate<a onclick="showRef(event, 'ref19 ref21'); return false;" href="javascript:void(0);" class="ref ref19 ref21">(19, 21)</a> and pancreas,<a onclick="showRef(event, 'ref25 ref26 ref27'); return false;" href="javascript:void(0);" class="ref ref25 ref26 ref27">(25-27)</a> is inherently associated with cell survival and proliferation. The U2OS osteosarcoma cell line is representative of these proliferative characteristics and is dependent on constitutively activated IKKα signaling;<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> it was therefore selected as the system to demonstrate perturbation of IKKα activity in the cellular environment.</div><div class="NLM_p">Pretreatment of U2OS cells with increasing concentration of <b>48</b> and <b>47</b> resulted in concentration-dependent inhibition of FCS-stimulated phosphorylation of p100 (<a class="ref internalNav" href="#fig9" aria-label="Figures 9">Figures 9</a>a and <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a>a). The IC<sub>50</sub> values for <b>48</b> and <b>47</b> were calculated as 8.8 and 13.9 μM, respectively. Two IKKβ-dependent readouts were selected to assess selectivity over IKKβ. First, TNFα stimulates IκBα degradation through activation of IKKβ and if IKKβ is inhibited, then a band corresponding to the IκBα protein should be evident by Western analysis. Second, IKKβ phosphorylates p65 on Ser536, which can also be assessed by Western blot analysis. Only at the highest concentration (100 μM) of <b>48</b> was IκBα degradation and p65 (Ser536) phosphorylation inhibited (<a class="ref internalNav" href="#fig9" aria-label="Figure 9">Figure 9</a>b). Even at this high concentration, these effects were not apparent following pretreatment with <b>47</b> (<a class="ref internalNav" href="#fig10" aria-label="Figure 10">Figure 10</a>b).</div><figure id="fig9" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-16/acs.jmedchem.7b00484/20170818/images/medium/jm-2017-004846_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-16/acs.jmedchem.7b00484/20170818/images/large/jm-2017-004846_0009.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Effect of compound <b>48</b> on (a) FCS-stimulated noncanonical and (b) TNF-α-induced canonical NF-kB activation in U2OS cells. Cells were pretreated with <b>48</b> 1 h prior to stimulation with FCS (10%) for 4 h or TNF-α (10 ng/mL) for 30 min. Whole cell lysate were prepared, separated by SDS-PAGE, and assessed for (a) inhibition of p100 phosphorylation (Ser866/870) and (b) IkB-α and p-p65 (Ser536) status. (c) Blots were quantified, and the IC<sub>50</sub> value for inhibition of p100 phosphorylation was determined (<b>48</b> IC<sub>50</sub> = 5.8 μM). The results are representative of three independent experiments.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-16/acs.jmedchem.7b00484/20170818/images/large/jm-2017-004846_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00484&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig10" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-16/acs.jmedchem.7b00484/20170818/images/medium/jm-2017-004846_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-16/acs.jmedchem.7b00484/20170818/images/large/jm-2017-004846_0010.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Effect of compound <b>47</b> on (a) FCS-stimulated noncanonical and (b) TNF-α-induced canonical NF-kB activation in U2OS cells. Cells were pretreated with <b>47</b> 1 h prior to stimulation with FCS (10%) for 4 h or TNF-α (10 ng/mL) for 30 min. Whole cell lysate were prepared, separated by SDS-PAGE, and assessed for (a) inhibition of p100 phosphorylation (Ser866/870) and (b) IkB-α and p-p65 (Ser536) status. (c) Blots were quantified, and the IC<sub>50</sub> value for inhibition of p-p100 was determined (<b>47</b> IC<sub>50</sub> = 19.1 μM). The results are representative of three independent experiments.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-16/acs.jmedchem.7b00484/20170818/images/large/jm-2017-004846_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00484&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To provide further evidence for cellular activity, mouse embryonic fibroblasts lacking the IKKβ kinase subunit were utilized to investigate the potency of both compounds against agonist-stimulated IKKα-regulated NF-κB transcriptional activation. Cells were infected with an adenovirus encoding an NF-κB-luciferase promoter gene. NF-κB transcriptional activity driven by IKKα was stimulated specifically using IL-1β,<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> and the ability of the compounds to inhibit this response was assessed. At maximal concentrations of 50–100 μM, <b>48</b> abolished transcriptional activity compared to <b>47</b> which inhibited activity by approximately 81% (% stim: Il-1β+DMSO = 100%, <b>48</b>+Il-1β = −40.9 ± 4.6%, <b>47</b>+IL-1β = 18.79 ± 7.2%, both **<i>P</i> < 0.01) (<a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>). Both <b>47</b> and <b>48</b> demonstrated concentration-dependent inhibitory effects on FCS-induced phosphorylation of p100 by IKKα. As IKKα plays a lesser role in the canonical NF-κB cascade,<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> particularly the rapid and transient stimulated degradation of IκBα, selective IKKα inhibitors should not affect TNF-α induced IκBα degradation and p65 phosphorylation. Compound <b>47</b> did not affect either agonist stimulated IκBα degradation or p65 phosphorylation, while <b>48</b> only had a small effect on both markers at the highest concentration tested (100 μM). Taken together, these data demonstrate that <b>47</b> and <b>48</b> are the first examples of IKKα-selective compounds that inhibit agonist-stimulated NF-κB signaling of the noncanonical pathway at much lower concentrations than the canonical pathway.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Il-1β-Stimulated NF-κB Transcriptional Activation in IKKα<sup>–/–</sup> MEFs<a class="ref internalNav" href="#tbl4-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="center" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">treatment</th><th class="colsep0 rowsep0" align="center">% stimulation</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center">IL-1β + DMSO</td><td class="colsep0 rowsep0" align="center">100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center">Il-1β+<b>47</b> (100 μM)</td><td class="colsep0 rowsep0" align="center">–40.9 ± 4.6**</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center">Il-1β+<b>48</b> (100 μM)</td><td class="colsep0 rowsep0" align="center">18.79 ± 7.2**</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl4-fn1"><div class="footnote" id="tbl4-fn1"><sup>a</sup><p class="last">IKKβ<sup>–/–</sup> MEFs infected with Adv.NF-kB.luc were grown to near confluency and rendered quiescent by serum deprivation for 24 h. Cells were then pre-treated for 1 h with increasing concentrations of compounds <b>48</b> or <b>47</b> prior to stimulation with IL-1β (10 ng/mL) for a further 6 h. Cells were assayed for NF-κB-linked luciferase reporter activity, as outlined in the methods section. Values (RLUs) were collated and converted to percentage stimulation (of positive control = IL-1β + DMSO). Each value represents the mean ± SEM from at least four independent experiments, and data was quantified using one way ANOVA, with Dunnett’s post-test. *<i>P</i> < 0.05. 88<i>P</i> < 0.01 compared to IL-1β+DMSO alone.</p></div></div></div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i13">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_40013" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_40013" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">There are many reported inhibitors of IKKβ, primarily because it was considered a viable target in inflammatory disease. Designing inhibitors of IKKα that are selective over IKKβ has to this date not been reported despite the former isoform now being recognized as a potential target in a number of cancers. One reason for this is the high sequence-homology in the ATP-binding site of the two isoforms and the absence of any high-resolution crystal structure of IKKα to guide structure-based inhibitor design.</div><div class="NLM_p">By employing molecular dynamics simulations on a homology model of IKKα based on IKKβ, we identified key dynamic differences at the ATP-binding site and exploited these to design the first selective inhibitors of IKKα. Our compounds demonstrated target engagement with IKKα-related pharmacodynamic markers and nonengagement with IKKβ markers in cells. These compounds therefore represent the first chemical tools that can be used to further characterize the role of IKKα in cellular signaling, to dissect this from the very similar IKKβ isoform and to validate IKKα in its own right as a target in cancers, such as prostate, breast, and pancreatic cancer.</div><div class="NLM_p last">The discovery of a 2-aminopyrrolo[2,3-<i>d</i>]pyrimidine chemical series also provides valuable information with respect to SAR for IKKα inhibitory activity. Substituents at position 4 of the pyrrolo[2,3-<i>d</i>]pyrimidine scaffold allowed for diversification, with IKKα selectivity achievable through the introduction of groups that specifically target residues in its binding site. However, further significant improvements in activity through aliphatic 4-amino substituents appear to be unlikely. Modifying the 4-phenyl substituent offers a more promising route toward generating compounds with improved activity and selectivity. Using this strategy, we are currently developing more potent IKKα-inhibitors that display functional outputs in a number of cell lines, all of which will be reported in due course.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i14">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_88848" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_88848" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> IKKα Homology Model</h3><div class="NLM_p">Building a homology model of IKKα: the kinase domain of IKKβ (chain B, residues 1–309, PDB entry <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4KIK">4KIK</a>.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> was used as a template to build the kinase domain of IKKα, keeping the inhibitor (KSA700 in the pdb file) and waters found within 6 Å of the protein–inhibitor complex. The residue alignment (Figure Mod1) and homology building were performed using Discovery Studio 3.1 (Accelrys Inc., San Diego, USA) after missing residues D174, Q175, and G176 were added in an extended conformation.</div><div class="NLM_p last">Both IKK kinase domains were subjected to molecular dynamics using the AMBER12 simulation software. The inhibitor present (residue name KSA700) was kept and parametrized using antechamber and charges calculated and fitted using the AM1-BCC scheme. The two systems were placed in a periodic octahedral box and solvated with TIP3P water with outer edges 6 Å in each direction from the closest solute atom. The systems were then neutralized and physiological salt conditions applied (∼150 mM) by adding 24 Cl<sup>–</sup> and 29 Na<sup>+</sup> ions to the IKKα system and 24 Cl<sup>–</sup> and 30 Na<sup>+</sup> ions to the IKKβ system. The AMBER ff12SB was applied to all protein atoms, while gaff was used for the ligand. Parameters for the phosphoserine residues were taken from Craft and Legge.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> Before the MD production phase, minimization and equilibration (to reach 310 K) were performed in two stages as described.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> The NPT ensemble was used at 310 K until the systems had stabilized for at least 20 ns (50 and 100 ns simulation time for IKKβ and IKKα, respectively). All MD steps used the SHAKE algorithm<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> with a 2 fs time-step and a 10 Å cutoff for long-range electrostatic interactions. An average structure was generated (using ptraj within the AMBER suite) for the last 21 ns (IKKα) or 26 ns (IKKβ) and subsequently minimized in three steps, with the solvent, ions, and hydrogen atoms initially minimized while the protein and inhibitor were restrained by 100 kcal mol<sup>–1</sup> Å<sup>–2</sup>. The restraint was then removed from the protein side chain atoms, and finally the whole system was allowed to minimize until a derivative of 0.1 kcal mol<sup>–1</sup> Å<sup>–2</sup> was achieved. These structures were then utilized for further docking studies with the GOLD software.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> General Experimental</h3><div class="NLM_p">Solvents (reagent grade or better) were purchased from Sigma-Aldrich or Fischer Scientific. Anhydrous solvents where purchased from Sigma-Aldrich. Deuterated solvents were purchased from Sigma-Aldrich. Chemicals (95% purity or above) were purchased from Acros Organics, Alfa Aesar, Apollo, Fluorochem, or Sigma-Aldrich. Solvents and chemicals were used as received without further purification or treatment.</div><div class="NLM_p">Oxygen- or moisture-sensitive reactions were carried out under a nitrogen atmosphere.</div><div class="NLM_p">Microwave reactions were performed with a Biotage Initiator system. High absorbance was selected for polar solvents and normal absorbance was selected for nonpolar solvents.</div><div class="NLM_p">The progress of the reactions was monitored on Merck 60F254 TLC plates. Spots were visualized by irradiation with ultraviolet light (254/366 nm) or KMnO<sub>4</sub>, ninhydrin, or phosphomolibdic acid (PMA) TLC stains.</div><div class="NLM_p">Column chromatography was performed with a Biotage SP4 system; cartridge size and eluent specified in the corresponding experiments (% is referring to the most polar solvent in the mixture), using silica gel as the stationary phase (particle size 0.040–0.063 mm, Merck or Fisher Scientific).</div><div class="NLM_p">Specific rotations were measured in a PerkinElmer polarimeter 341 apparatus at 20 °C and a wavelength of 589 nm (sodium D line) in DMSO UV spectrophotometric analysis grade.</div><div class="NLM_p"><sup>1</sup>H and <sup>13</sup>C NMR data were recorded on either a JEOL ECX-400 (400 MHz) or Bruker Avance3/DPX400 (400 MHz) spectrometers at 400.0 and 100.6 MHz, respectively. Chemical shifts (δ) are expressed in parts per million (ppm) coupling constants (<i>J</i>) are in hertz (Hz). Chemical shifts (δ) are reported relative to TMS (δ = 0 ppm) and/or referenced to the solvent in which they were measured. All measurements were carried out at 298 K (except when stated). Abbreviations used in the description of NMR data are as follows: app, apparent; s, singlet; bs, broad singlet; d, doublet; t, triplet; q, quartet; p, pentuplet; m, multiplet.</div><div class="NLM_p">HR-MS was conducted using a Thermo Scientific Exactive Orbitrap mass analyzer. LR-MS was conducted using a ThermoQuest Finnigan LCQ Duo instrument. GC-MS was conducted using a ThermoQuest Finnigan Polaris Q instrument.</div><div class="NLM_p">Final compounds tested in the kinase inhibition assay possessed a purity of ≥95% by HPLC analysis (unless stated otherwise) conducted using an Agilent Technologies 1220 series system (methods A, B, C, and D). Column: Agilent Eclipse XDB C18 4.6 mm ID × 250 mm (5 μm) 80 Å. Flow rate: 1 mL/min. Detector: 254 nm. Sample volume: 10 μL. Mobile phase: (method A) 15% MeCN in H<sub>2</sub>O (3 min), 15–90% MeCN in H<sub>2</sub>O (12 min) followed by equilibration/blank run; (method B) 5% MeCN in H<sub>2</sub>O (3 min), 5–100% MeCN in H<sub>2</sub>O (14 min), 100% MeCN in H<sub>2</sub>O (5 min), 100–5% MeCN in H<sub>2</sub>O (5 min), 5% MeCN in H<sub>2</sub>O (5 min) followed by blank run; (method C) 5% MeCN + 5 mM NH<sub>4</sub>Ac in H<sub>2</sub>O + 5 mM NH<sub>4</sub>Ac (3 min), 5–100% MeCN + 5 mM NH<sub>4</sub>Ac in H<sub>2</sub>O + 5 mM NH<sub>4</sub>Ac (14 min), 100% MeCN + 5 mM NH<sub>4</sub>Ac in H<sub>2</sub>O + 5 mM NH<sub>4</sub>Ac (5 min), 100–5% MeCN in H<sub>2</sub>O (5 min), 5% MeCN + 5 mM NH<sub>4</sub>Ac in H<sub>2</sub>O + 5 mM NH<sub>4</sub>Ac (5 min) followed by blank run. Method D was conducted in a Dionex UltiMate 3000 LC system. Column: ACE 3 C8 3 mm ID × 50 mm. Mobile phase: 5–95% MeCN + 0.1% HCO<sub>2</sub>H in H<sub>2</sub>O + 0.1% HCO<sub>2</sub>H (24 min), 95–5% MeCN + 0.1% HCO<sub>2</sub>H in H<sub>2</sub>O + 0.1% HCO<sub>2</sub>H (1 min), 5% MeCN + 0.1% HCO<sub>2</sub>H in H<sub>2</sub>O + 0.1% HCO<sub>2</sub>H (5 min). Flow rate: 0.4 mL/min. Detector: 254 nm. Sample volume: 10 μL.</div><div id="sec5_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i17" class="anchor-spacer"></div><h4 class="article-section__title" id="_i17"> 2-Amino-4-oxo-4,7-dihydro-3<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidine-5-carbonitrile (<b>1</b>)</h4><div class="NLM_p last">Methyl formate (18.0 mL, 17.48 g, 291.4 mmol) in toluene (8 mL) was added at 0 °C to a stirred suspension of NaOMe (14.30 g, 264.9 mmol) in toluene (200 mL). This was followed by dropwise addition of chloroacetonitrile (16.8 mL, 20.00 g, 264.9 mmol) in toluene (60 mL) over 1 h. The reaction mixture was stirred for 3 h followed by addition of H<sub>2</sub>O (150 mL). The organic layer was separated, and the aqueous layer was acidified to pH 5 using 6 M HCl and subsequently extracted with EtOAc (3 × 100 mL). The organic layers were combined and dried over MgSO<sub>4</sub> and concentrated in vacuo (40 °C, 70 mbar). The dark residue was suspended in H<sub>2</sub>O (60 mL) and added to a solution of NaOAc (16.39 g, 199.8 mmol) and 2,6-diaminopyrimidin-4(3<i>H</i>)-one (12.00 g, 95.2 mmol) in H<sub>2</sub>O (200 mL) (previously stirred at 100 °C until complete dissolution). The reaction was refluxed for 16 h. After cooling to room temperature, the suspension was filtered and washed with H<sub>2</sub>O (2 × 20 mL), acetone (2 × 10 mL), and Et<sub>2</sub>O (2 × 40 mL) to yield <b>1</b> (10.11 g, 60%) as a light-tan solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 6.37 (bs, 2H), 7.58 (s, 1H), 10.70 (bs, 1H), 11.95 (bs, 1H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 86.0, 99.2, 116.3, 128.2, 158.0, 152.1, 154.2. 3</div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i18" class="anchor-spacer"></div><h4 class="article-section__title" id="_i18"> <i>N</i>-(7-Acetyl-5-cyano-4-oxo-4,7-dihydro-3<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-2- yl)acetamide (<b>2</b>)</h4><div class="NLM_p last">A suspension of <b>1</b> (1.18 g, 6.74 mmol) in acetic anhydride (18 mL) and dry DMF (10 mL) was heated at 150 °C for 4 h. Solvents were evaporated in vacuo, and the residue was triturated with Et<sub>2</sub>O (2 × 10 mL) to yield <b>2</b> (1.65 g, 95%) as a brown solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 2.22 (s, 3H), 2.86 (s, 3H), 8.41 (s, 1H), 11.73 (bs, 1H), 12.20 (bs, 1H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 24.5, 26.0, 90.5, 105.1, 114.2, 129.8, 148.9, 149.3, 155.7, 168.5, 174.4.</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19"> <i>N</i>-(5-Cyano-4-oxo-4,7-dihydro-3<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-2-yl)pivalamide (<b>3</b>)</h4><div class="NLM_p last"><b>1</b> (7.33 g, 28.30 mmol) was stirred in dry pyridine (60 mL) at 60 °C for 1 h. Upon formation of a homogeneous suspension, the mixture was cooled to 0 °C and treated dropwise with pivaloyl chloride (10.5 mL, 10.23 g, 84.87 mmol). The suspension was then stirred at 85 °C for 2 h. After cooling to room temperature, the resulting suspension was neutralized with 33% ammonia in H<sub>2</sub>O and left to stand at 4 °C for 16 h. The suspension was filtered off, washed with H<sub>2</sub>O (10 mL), dried, and then triturated with Et<sub>2</sub>O (2 × 10 mL) to afford <b>3</b> (6.97 g, 64%) as a pale-brown solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 1.25 (s, 9H), 7.93 (s, 1H), 11.00 (bs, 1H), 12.11 (bs, 1H) and 12.65 (bs, 1H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 27.0, 40.7, 86.9, 103.7, 115.9, 130.9, 149.1, 149.1, 156.4, 181.7.</div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> 2-Amino-4-chloro-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidine-5-carbonitrile (<b>4</b>)</h4><div class="NLM_p last">POCl<sub>3</sub> (5.2 mL, 8.57 g, 55.9 mmol) was added dropwise to a suspension of <b>2</b> (1.61 g, 6.21 mmol) and <i>N</i>,<i>N</i>-dimethylaniline (1.2 mL, 1.13 g, 9.32 mmol) in dry MeCN (10 mL). The reaction mixture was heated at 100 °C for 6 h. After cooling to room temperature, the mixture was placed in an ice bath and neutralized with saturated aqueous Na<sub>2</sub>CO<sub>3</sub>. The suspension was filtered off, washed with H<sub>2</sub>O (10 mL), dried, and then triturated with Et<sub>2</sub>O (2 × 10 mL) to afford <b>6</b> (1.44 g) as a brown solid. Chromatographic purification (manual column, solvent system: MeOH/EtOAc; gradient 0% 50 mL, 0–25% 200 mL, 25% 100 mL) yielded a pure analytical sample of <b>6</b>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 6.95 (bs, 2H), 8.11 (s, 1H), 12.52 (bs, 1H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 83.5, 106.5, 115.4, 134.5, 151.5, 155.0, 160.8. HRMS (ESI) calculated for for C<sub>7</sub>H<sub>5</sub>N<sub>5</sub>Cl [M + H]<sup>+</sup> 194.0228, found 194.0229. HPLC <i>t</i><sub>R</sub> = 5.56 min (method D).</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> <i>N</i>-(4-Chloro-5-cyano-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-2-yl)pivalamide (<b>5</b>)</h4><div class="NLM_p last">A suspension of <b>3</b> (6.82 g, 26.31 mmol), <i>N</i>,<i>N</i>-dimethylaniline (14 mL, 13.39 g, 110.48 mmol), and triethylbenzylammonium chloride (2.93 g, 13.15 mmol) in dry MeCN (100 mL) was treated dropwise with POCl<sub>3</sub> (24.5 mL, 40.33 g, 263.05 mmol). The reaction mixture was refluxed for 1 h, allowed to cool down, and concentrated in vacuo. The resulting dark oil was cautiously treated with ice and was set to pH = 5 using 33% ammonia in H<sub>2</sub>O. The aqueous layer was extracted with EtOAc (4 × 100 mL), and the combined organic layers were dried over MgSO<sub>4</sub> and concentrated in vacuo. The residue was triturated with Et<sub>2</sub>O (3 × 30 mL), MeOH (2 × 20 mL), and Et<sub>2</sub>O (2 × 20 mL) to give <b>5</b> (2.56 g, 35%) as a light-tan solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 1.22 (s, 9H), 8.50 (s, 1H), 10.27 (bs, 1H), 13.35 (bs, 1H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 27.4, 40.3, 84.1, 111.8, 115.1, 138.2, 151.4, 153.5, 153.8, 176.5.</div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> 2,4-Diamino-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidine-5-carbonitrile (<b>6</b>)</h4><div class="NLM_p last">Pyrimidine-2,4,6-triamine (800 mg, 6.39 mmol) was added to a solution of NaOAc (1.10 g, 13.43 mmol) in distilled water (20 mL) and stirred at 50 °C until near total dissolution. A solution of 2-chloro-3-oxopropanenitrile (794 mg, 7.67 mmol) in H<sub>2</sub>O (10 mL) was added dropwise over 1 h to the reaction mixture, then stirred 16 h at 50 °C, and subsequently, the mixture was refluxed for 1 h. After cooling to room temperature, the reaction was cooled to 0 °C for 2 h. The obtained black solid was boiled in MeOH (4 mL) and washed with hot MeOH (2 × 4 mL). The remaining solid was refluxed in H<sub>2</sub>O (5 mL) and washed with hot H<sub>2</sub>O (5 mL) to yield <b>34</b> (91 mg, 8%) as a dark solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 5.89 (bs, 2H), 6.17 (bs, 2H), 7.68 (s, 1H), 11.82 (bs, 1H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 82.5, 94.6, 117.4, 129.4, 154.3, 157.8, 161.7. HRMS (ESI) calculated for for C<sub>7</sub>H<sub>5</sub>N<sub>6</sub> [M – H]<sup>−</sup> 173.0581, found 173.0581.</div></div><div id="sec5_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> 2-Amino-4-(methylamino)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidine-5-carbonitrile (<b>7</b>) (Procedure A*)</h4><div class="NLM_p last"><b>5</b> (100 mg, 0.52 mmol), methylamine (8 M solution in EtOH) (53 mg, 0.20 mL, 1.70 mmol), and <i>N</i>,<i>N</i>-dimethylaniline (94 mg, 0.1 mL, 0.77 mmol) were suspended in dry 1,4-dioxane (2 mL) and heated for 20 min at 200 °C in the microwave reactor. After cooling to room temperature, the reaction mixture was suspended in MeOH, adsorbed on silica gel, and concentrated in vacuo*. Chromatographic purification (Biotage SP4, 10 g cartridge, solvent system: MeOH/EtOAc; gradient 0% 4CV, 0–5% 10CV, 5% 4CV) yielded <b>7</b> (20 mg, 21%) as a pale-cream solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 2.92 (d, <i>J</i> = 4.6 Hz, 3H), 5.94 (bs, 2H), 6.05 (q, <i>J</i> = 4.6 Hz, 1H), 7.67 (s, 1H), 11.73 (bs, 1H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 28.3, 82.3, 94.8, 117.4, 129.1, 153.6, 157.3, 161.5. HRMS (ESI) calculated for for C<sub>8</sub>H<sub>9</sub>N<sub>6</sub> [M + H]<sup>+</sup> 189.0883, found 189.0883. HPLC <i>t</i><sub>R</sub> = 4.09 min (method A).</div></div><div id="sec5_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> 2-Amino-4-((cyclopropylmethyl)amino)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidine-5-carbonitrile (<b>8</b>) (Procedure B)</h4><div class="NLM_p last"><b>5</b> (0.109 g, 0.39 mmol) and cyclopropanemethylamine (0.105 mL, 1.21 mmol) in 1,4-dioxane (2 mL, anhydrous) in a microwave vial was heated to 200 °C for 20 min. The resulting solution was then diluted with EtOH (6 mL) and KOH (2 pellets) was added and the reaction mixture was heated to 90 °C for 20 h. The reaction mixture was then concentrated under reduced pressure, the residue was suspended in water, and the mixture was pH adjusted to pH 5.5, extracted into EtOAc, dried over MgSO<sub>4</sub>, and concentrated under reduced pressure. The resulting solid was triturated with Et<sub>2</sub>O and filtered to afford the title compound as an off-white solid (0.032 g, 0.14 mmol, 36%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 0.29 (m, 2H), 0.44 (m, 2H), 1.16 (m, 1H), 3.32 (m, 2H), 5.90 (t, <i>J</i> = 5.4 Hz, 1H), 5.96 (s, 2H), 7.69 (s, 1H), 11.82 (br s, 1H). HRMS (ESI) calculated for C<sub>11</sub>H<sub>13</sub>N<sub>6</sub> 229.1194, found 229.1196.</div></div><div id="sec5_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> 2-Amino-4-(cyclohexylamino)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidine-5-carbonitrile (<b>9</b>)</h4><div class="NLM_p last">Prepared according to procedure A. Chromatographic purification (Biotage SP4, 10 g cartridge, solvent system: MeOH/EtOAc; gradient 0% 4CV, 0–2% 12CV) yielded <b>11</b> (35 mg, 26%) as a pale-cream solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 1.22–1.28 (m, 1H), 1.30–1.37 (m, 4H), 1.54–1.57 (m, 1H), 1.67–1.70 (m, 2H), 1.91–1.93 (m, 2H), 4.01–4.08 (m, 1H), 5.32 (d, <i>J</i> = 8.0 Hz, 1H), 5.92 (bs, 2H), 7.66 (s, 1H), 11.80 (bs, 1H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 24.8, 25.7, 32.8, 48.3, 81.8, 94.6, 117.7, 128.7, 153.6, 156.0, 161.6. HRMS (ESI) calculated for for C<sub>13</sub>H<sub>17</sub>N<sub>6</sub> [M + H]<sup>+</sup> 257.1509, found 257.1504. HPLC <i>t</i><sub>R</sub> = 11.09 min (method A).</div></div><div id="sec5_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> 2-Amino-4-(cyclohexylmethylamino)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidine-5-carbonitrile (<b>10</b>)</h4><div class="NLM_p last">Prepared according to procedure A. Chromatographic purification (Biotage SP4, 10 g cartridge, solvent system: EtOAc/Hex; gradient 25% 4CV, 25–100% 10CV, 100% 6CV) yielded <b>9</b> (27 mg, 19%) as a pale-cream solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 0.91–1.01 (m, 2H), 1.13–1.23 (m, 3H), 1.54–1.65 (m, 2H), 1.68–1.74 (m, 4H), 3.32 (m, 2H), 5.75 (t, <i>J</i> = 5.7 Hz, 1H), 5.94 (bs, 2H), 7.68 (s, 1H), 11.82 (bs, 1H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 26.0, 26.7, 31.0, 38.0, 46.4, 82.0, 94.8, 117.6, 128.9, 153.6, 157.0, 161.6. HRMS (ESI) calculated for for C<sub>14</sub>H<sub>17</sub>N<sub>6</sub> [M – H]<sup>−</sup> 269.1520, found 269.1519. HPLC <i>t</i><sub>R</sub> = 11.83 min (method A).</div></div><div id="sec5_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> 2-Amino-4-(phenylamino)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidine-5-carbonitrile (<b>11</b>)</h4><div class="NLM_p last">Prepared according to procedure A. Chromatographic purification (Biotage SP4, 10 g cartridge, solvent system: EtOAc/Hex; gradient 25% 4CV, 25–100% 10CV, 100% 6CV) yielded <b>11</b> (37 mg, 29%) as a pale-yellow solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 6.20 (bs, 2H), 7.00–7.04 (m, 1H), 7.30–7.33 (m, 2H), 7.68–7.70 (m, 2H), 7.68–7.70 (m, 1H), 8.03 (bs, 1H), 11.86 (bs, 1H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 82.8, 96.0, 117.3, 120.8, 122.8, 129.2, 130.3, 140.5, 154.5, 154.6, 161.2. HRMS (ESI) calculated for for C<sub>13</sub>H<sub>9</sub>N<sub>6</sub> [M – H]<sup>−</sup> 249.0894, found 249.0891. HPLC <i>t</i><sub>R</sub> = 9.85 min (method A).</div></div><div id="sec5_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> 4-((2-Amino-5-cyano-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl)amino)benzoic acid (<b>12</b>)</h4><div class="NLM_p last"><b>5</b> (0.103 g, 0.37 mmol) and methyl-4-aminobenzoate (0.166 g, 1.1 mmol) in 1,4-dioxane (2 mL, anhydrous) in a 2–5 mL microwave vial was heated to 200 °C for 20 min. Ethanol (4 mL) was added to the reaction mixture and KOH (1 pellet) was added and the mixture heated to 80 °C for 24 h. The reaction mixture was concentrated under reduced pressure, water was added, and the mixture was pH adjusted to pH 5 with acid. The resulting white precipitate was filtered under reduced pressure and dried in an oven to afford the title compound as a white solid (0.0135 g, 0.05 mmol, 13%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 6.33 (br s, 2H), 7.88 (m, 5H), 8.57 (s, 1H), 12.08 (br s, 1H), 12.61 (br s, 1H). HRMS (ESI) calculated for C<sub>14</sub>H<sub>11</sub>O<sub>2</sub>N<sub>6</sub> 295.0938, found 295.0938.</div></div><div id="sec5_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> 4-((2-Amino-5-cyano-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl)amino)benzenesulfonamide (<b>13</b>)</h4><div class="NLM_p last">Prepared according to procedure B. The remaining solid was triturated with cold H<sub>2</sub>O (2 × 2 mL), filtered, dried, and then triturated with Et<sub>2</sub>O (2 × 3 mL) to yield <b>13</b> as an off-white solid (0.0096 g, 0.03 mmol, 8%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 6.63 (br s, 2H), 7.55 (br s, 2H), 7.80 (m, 4H), 8.13 (s, 1H), 12.38 (br s, 1H). HRMS (ESI) calculated for C<sub>13</sub>H<sub>12</sub>O<sub>2</sub>N<sub>7</sub>S 330.0768, found 330.0768.</div></div><div id="sec5_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> 2-Amino-4-(benzylamino)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidine-5-carbonitrile (<b>14</b>)</h4><div class="NLM_p last">Prepared according to procedure A. Chromatographic purification (Biotage SP4, 10 g cartridge, solvent system: EtOAc/Hex; gradient 80% 4CV, 80–100% 4CV, 100% 13 4C,; then MeOH/EtOAc, gradien: 0–10% 4CV) yielded <b>14</b> (53 mg, 39%) as a light-tan solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 4.69 (d, <i>J</i> = 5.9 Hz, 1H), 5.96 (bs, 2H), 6.48 (t, <i>J</i> = 5.9 Hz, 1H), 7.23–7.38 (m, 5H), 7.71 (s, 1H), 11.85 (bs, 1H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 43.7, 82.2, 94.6, 117.4, 127.2, 127.9, 128.89, 129.4, 140.7, 153.9, 156.6, 161.5. HRMS (ESI) calculated for C<sub>14</sub>H<sub>11</sub>N<sub>6</sub> [M – H]<sup>−</sup> 263.10507, found 263.10489. HPLC <i>t</i><sub>R</sub> = 10.05 min (method A).</div></div><div id="sec5_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> 2-Amino-4-(2-morpholinoethylamino)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidine-5-carbonitrile (<b>15</b>)</h4><div class="NLM_p last">Prepared according to procedure A. Chromatographic purification (Biotage SP4, 10 g cartridge, solvent system: MeOH/EtOAc; gradient 0% 4CV, 0–10% 12CV, 10% 6CV) yielded <b>15</b> (23 mg, 31%) as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 2.42–2.46 (m, 4H), 2.54–2.57 (m, 2H), 3.50–3.54 (m, 2H), 3.61–3.63 (m, 4H), 5.98 (bs, 2H), 6.17 (t, <i>J</i> = 4.7 Hz, 1H), 7.69 (s, 1H), 11.82 (bs, 1H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 36.9, 53.5, 56.7, 66.8, 82.1, 94.8, 117.4, 128.9, 153.6, 156.5, 161.7. HRMS (ESI) calculated for C<sub>13</sub>H<sub>16</sub>ON<sub>7</sub> [ M– H]<sup>−</sup> 286.1422, found 286.1421. HPLC <i>t</i><sub>R</sub> = 3.25 min (method B).</div></div><div id="sec5_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> 2-Amino-4-(2-hydroxyethylamino)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidine-5-carbonitrile (<b>16</b>)</h4><div class="NLM_p last">Prepared according to procedure A. Chromatographic purification (Biotage SP4, 10 g cartridge, solvent system: MeOH/EtOAc; gradient 0% 6CV, 0–10% 12CV, 10% 6CV) yielded <b>16</b> (16 mg, 24%) as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 3.52–3.58 (m, 4H), 4.86 (t, <i>J</i> = 4.6 Hz, 1H), 5.89 (t, <i>J</i> = 5.1 Hz, 1H), 5.97 (bs, 2H), 7.29 (s, 1H), 11.83 (bs, 1H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 42.9, 60.2, 82.0, 94.6, 117.3, 129.0, 153.5, 156.7, 161.3. HRMS (ESI) calculated for C<sub>9</sub>H<sub>10</sub>ON<sub>6</sub> [M + H]<sup>+</sup> 219.0989, found 219.0987. HPLC <i>t</i><sub>R</sub> = 2.79 min (method A).</div></div><div id="sec5_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> 2-Amino-4-(piperidin-1-yl)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidine-5-carbonitrile (<b>17</b>)</h4><div class="NLM_p last">Prepared according to procedure B. The remaining solid was triturated with cold H<sub>2</sub>O (2 × 2 mL), filtered, dried, and then triturated with Et<sub>2</sub>O (2 × 3 mL) to yield <b>17</b> (43 mg, 49%) as a pale-yellow solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 1.62–1.65 (m, 6H), 3.52–3.57 (m, 4H), 6.02 (bs, 2H), 7.83 (s, 1H), 11.95 (bs, 1H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 24.7, 26.00, 49.2, 84.1, 95.9, 118.2, 131.1, 155.6, 159.8, 160.6. HRMS (ESI) calculated for C<sub>12</sub>H<sub>16</sub>N<sub>6</sub> [M + H]<sup>+</sup> 243.1353, found 243.1349. HPLC <i>t</i><sub>R</sub> = 9.63 min (method A).</div></div><div id="sec5_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> 1-(2-Amino-5-cyano-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl)piperidine-4-sulfonamide (<b>18</b>)</h4><div class="NLM_p last"><b>5</b> (105 mg, 0.38 mmol), piperidine-4-sulfonic acid amide hydrochloride (139 mg, 0.85 mmol) and triethylamine (0.16 mL, 1.15 mmol) in 1,4-dioxane (2.5 mL) was degassed under nitrogen prior to being irradiated with microwaves at 200 °C for 20 min. Once cooled to room temperature, the reaction mixture was diluted with EtOH (8 mL) and KOH (2 pellets) were added and the reaction mixture was heated to 90 °C for 22 h. The reaction mixture was then concentrated under reduced pressure, water was added, and the mixture was adjusted to pH 5.5 with 1 M HCl. This was then extracted into EtOAc, and the organics were dried over MgSO<sub>4</sub>, filtered, and concentrated under reduced pressure. The crude material was then purified by column chromatography (using 100% hexane–100% EtOAc as eluent) to afford the title compound <b>18</b> as a white solid (26.1 mg, 0.08 mmol, 21%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 1.73 (m, 2H), 2.09 (d, <i>J</i> = 8.4 Hz, 2H), 3.00 (t, <i>J</i> = 9.4 Hz, 2H), 3.11 (m, 1H), 4.32 (d, <i>J</i> = 10.4 Hz, 2H), 6.06 (br s, 2H), 6.80 (br s, 2H), 7.85 (s, 1H), 11.99 (br s, 1H). HRMS (ESI) calculated for C<sub>12</sub>H<sub>14</sub>O<sub>2</sub>N<sub>7</sub>S 320.0935, found 320.0938.</div></div><div id="sec5_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> 2-Amino-4-morpholino-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidine-5-carbonitrile (<b>19</b>)</h4><div class="NLM_p last">Prepared according to procedure A. Chromatographic purification (Biotage SP4, 10 g cartridge, solvent system: MeOH/EtOAc; gradient 0% 4CV, 0–2% 10CV) yielded <b>21</b> (40 mg, 32%) as a pale-cream solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 3.53–3.55 (m, 4H), 3.73–3.75 (m, 4H), 6.13 (bs, 2H), 7.88 (s, 1H), 11.78 (bs, 1H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 49.0, 66.5, 83.7, 96.2, 118.3, 131.5, 155.7, 159.8, 160.7. HRMS (ESI) calculated for C<sub>11</sub>H<sub>11</sub>ON<sub>6</sub> [M – H]<sup>−</sup> 243.0999, found 243.0997. HPLC <i>t</i><sub>R</sub> = 6.84 min (method A).</div></div><div id="sec5_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> 2-Amino-4-(4-methylpiperazin-1-yl)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidine-5-carbonitrile (<b>20</b>)</h4><div class="NLM_p last">Prepared according to procedure B. The remaining solid was triturated with cold H<sub>2</sub>O (2 × 2 mL), filtered, dried, and then triturated with Et<sub>2</sub>O (2 × 3 mL) to yield <b>20</b> (63 mg, 68%) as a pale-yellow solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 2.23 (s, 3H), 2.45 (app t, <i>J</i> = 4.8 Hz, 4H), 3.55 (app t, <i>J</i> = 4.8 Hz, 4H), 6.09 (bs, 2H), 7.86 (s, 1H), 11.96 (bs, 1H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 27.5, 48.0, 54.9, 83.8, 95.9, 118.1, 131.3, 155.6, 159.5, 160.5. HRMS (ESI) calculated for C<sub>12</sub>H<sub>14</sub>N<sub>7</sub> [M – H]<sup>−</sup> 256.1316, found 256.1317. HPLC <i>t</i><sub>R</sub> = 1.75 min (method C).</div></div><div id="sec5_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> 2-Amino-4-(4-phenylpiperazin-1-yl)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidine-5-carbonitrile (<b>21</b>)</h4><div class="NLM_p last">Prepared according to procedure B. The remaining solid was triturated with cold H<sub>2</sub>O (2 × 2 mL), filtered, dried, and then triturated with Et<sub>2</sub>O (2 × 3 mL) to yield <b>21</b> (83 mg, 85%) as a pale-yellow solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 3.29 (app t, <i>J</i> = 4.8 Hz, 4H), 3.71 (app t, <i>J</i> = 4.8 Hz, 4H), 6.06 (bs, 2H), 6.79–6.83 (m, 1H), 6.99–7.01 (m, 2H), 7.22–7.24 (m, 2H), 7.87 (s, 1H), 12.04 (bs, 1H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 48.3, 48.7, 83.2, 96.7, 116.1, 118.7, 119.7, 129.6, 132.9, 151.5, 156.5, 159.7, 160.5. HRMS (ESI) calculated for C<sub>17</sub>H<sub>18</sub>N<sub>7</sub> [M + H]<sup>+</sup> 320.1618, found 320.1614. HPLC <i>t</i><sub>R</sub> = 11.09 min (method A).</div></div><div id="sec5_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> 2-Amino-4-(4-(2-hydroxyethyl)piperazin-1-yl)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidine-5-carbonitrile (<b>22</b>)</h4><div class="NLM_p last">Prepared according to procedure B. The remaining solid was suspended in MeOH, adsorbed on silica gel, and concentrated in vacuo. Chromatographic purification (Biotage SP4, 10 g cartridge, solvent system: 5% NH<sub>4</sub>OH in MeOH/EtOAc; gradient 10% 4CV, 10–25% 10CV, 25% 4CV) yielded product X (51 mg, 40%,) a gum which was triturated with acetone (2 × 1 mL) to afford <b>22</b> (72 mg, 70%) as a pale-yellow solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 2.46 (app t, <i>J</i> = 6.2 Hz, 2H), 2.56–2.58 (m, 4H), 3.53–3.58 (m, 6H), 4.42 (bs, 1H), 6.04 (bs, 2H), 7.84 (s, 1H), 11.94 (bs, 1H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 47.6, 52.9, 58.5, 60.2, 83.3, 95.3, 117.6, 130.7, 155.1, 158.9, 160.0. HRMS (ESI) calculated for C<sub>13</sub>H<sub>16</sub>ON<sub>7</sub> [M – H]<sup>−</sup> 286.1422, found 286.1422. HPLC <i>t</i><sub>R</sub> = 7.24 min (method C).</div></div><div id="sec5_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> 2-Amino-4-(3-hydroxypropylamino)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidine-5-carbonitrile (<b>23</b>)</h4><div class="NLM_p last">Prepared according to procedure B. The remaining solid was triturated with cold H<sub>2</sub>O (2 × 2 mL), filtered, dried, and then triturated with Et<sub>2</sub>O (2 × 3 mL) to yield <b>23</b> (62 mg, 74%) as a pale-cream solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 1.70–1.76 (m, 2H), 3.48–3.55 (m, 4H), 4.66 (t, <i>J</i> = 4.3 Hz, 1H), 5.95 (bs, 2H), 6.08 (t, <i>J</i> = 5.1 Hz, 1H), 7.68 (s, 1H), 11.82 (bs, 1H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 32.6, 38.5, 59.6, 82.2, 94.7, 117.3, 129.1, 153.6, 156.8, 161.5. HRMS (ESI) calculated for C<sub>10</sub>H<sub>12</sub>NO [M – H]<sup>−</sup> 231.1000, found 231.1001. HPLC <i>t</i><sub>R</sub> = 3.66 min (method A).</div></div><div id="sec5_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> (<i>R</i>)-2-Amino-4-(3-hydroxypyrrolidin-1-yl)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidine-5-carbonitrile (<b>24</b>)</h4><div class="NLM_p last"><b>5</b> (100 mg, 0.36 mmol), (3<i>R</i>)-3-hydroxypyrrolidine (0.2 mL, 2.48 mmol), and TEA (0.15 mL, 1.13 mmol) in dioxane (2.5 mL) was heated in the microwave at 200 °C for 20 min. The reaction mixture was then diluted with EtOH (8 mL) and KOH (2 pellets) added and heated at 90 °C for 24 h. The reaction mixture was concentrated at reduced pressure, water (5 mL) added, acidified to pH 5.7 (3 M HCl), and extracted with EtOAc (10 mL × 3). The organic fractions were combined, dried over anhydrous MgSO<sub>4</sub>, filtered, and concentrated under reduced pressure to give the crude product. The crude was triturated with Et<sub>2</sub>O to afforded <b>24</b> (28 mg, 0.11 mmol, 33%). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): d 1.85–1.94 (m, 1H), 1.94–2.04 (m, 1H), 3.56–3.64 (m, 1H), 3.70–3.85 (m, 3H), 4.39 (s, 1H), 4.99 (br s, 1H), 5.81 (s, 2H), 7.79 (s, 1H), 11.88 (br s, 1H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>): d 33.0, 46.7, 57.3, 68.7, 83.4, 93.7, 118.6, 130.9, 154.7, 155.5, 159.8. HRMS: calculated for C<sub>11</sub>H<sub>13</sub>ON<sub>6</sub> 245.1145 [M + H]<sup>+</sup>, found 245.1143.</div></div><div id="sec5_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> (<i>R</i>)-2-Amino-4-(3-hydroxypyrrolidin-1-yl)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidine-5-carbonitrile (<b>25</b>)</h4><div class="NLM_p last">Prepared according to procedure A. Chromatographic purification (Biotage SP4, 10 g cartridge, solvent system: MeOH/EtOAc; gradient 0% 6CV, 0–10% 12CV, 10% 6CV) yielded <b>25</b> (10 mg, 13%) as a light-brown solid; [α]<sub>D</sub><sup>20</sup> −21.5o (<i>c</i> = 0.37, DMSO). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 1.85–1.92 (m, 1H), 1.94–2.03 (m, 1H), 3.58–3.61 (m, 1H), 3.70–3.83 (m, 3H), 4.36–4.41 (m, 1H), 5.01 (d, <i>J</i> = 3.4 Hz, 1H), 5.84 (bs, 2H), 7.80 (s, 1H), 11.84 (bs, 1H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 33.6, 47.3, 57.9, 69.3, 84.0, 94.3, 119.2, 131.5, 155.3, 156.0, 160.4. HRMS (ESI) calculated forC<sub>11</sub>H<sub>11</sub>ON<sub>6</sub> [M – H]<sup>−</sup> 243.1000, found 243.1001. HPLC <i>t</i><sub>R</sub> = 7.85 min (method C).</div></div><div id="sec5_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> (<i>R</i>)-2-Amino-4-(2-(hydroximethyl)pyrrolidin-1-yl)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidine-5-carbonitrile (<b>26</b>)</h4><div class="NLM_p last">Prepared according to procedure B. The residue was suspended in MeOH, adsorbed on silica gel, and concentrated in vacuo. Chromatographic purification (Biotage SP4, 10 g cartridge, solvent system: MeOH/DCM; gradient 0% 4CV, 0–5% 4CV, 5% 4CV, 5–10% 4CV, 10% 4CV) yielded <b>26</b> (62 mg, 67%) as fluffy off-white solid; [α]<sub>D</sub><sup>20</sup> −96.3o (<i>c</i> = 0.55, DMSO). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 1.83–1.89 (m, 1H), 1.90–1.96 (m, 2H), 2.02–2.10 (m, 1H), 3.52–3.63 (m, 2H), 3.70–3.76 (m, 1H), 3.86–3.91 (m, 1H), 4.46–4.51 (m, 1H), 4.77 (t, <i>J</i> = 5.0 Hz, 1H), 5.81 (bs, 2H), 7.81 (d, <i>J</i> = 1.0 Hz, 1H), 11.89 (bs, 1H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 24.6, 27.5, 51.1, 60.4, 62.3, 84.3, 94.5, 119.3, 131.6, 155.4, 156.2, 160.2. HRMS (ESI) calculated forC<sub>12</sub>H<sub>15</sub>ON<sub>6</sub> [M + H]<sup>+</sup> 259.1302, found 259.1299. HPLC <i>t</i><sub>R</sub> = 7.26 min (method A).</div></div><div id="sec5_27" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> (<i>S</i>)-2-Amino-4-(2-(hydroximethyl)pyrrolidin-1-yl)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidine-5-carbonitrile (<b>27</b>)</h4><div class="NLM_p last">Prepared according to procedure B. The residue was suspended in MeOH, adsorbed on silica gel, and concentrated in vacuo. Chromatographic purification (Biotage SP4, 10 g cartridge, solvent system: MeOH/DCM; gradient 0% 4CV, 0–5% 4CV, 5% 4CV, 5–10% 4CV, 10% 4CV) yielded <b>27</b> (68 mg, 73%) as fluffy off-white solid; [α]<sub>D</sub><sup>20</sup> −93.8o (<i>c</i> = 0.54, DMSO). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 1.83–1.89 (m, 1H), 1.90–1.96 (m, 2H), 2.02–2.10 (m, 1H), 3.52–3.63 (m, 2H), 3.70–3.76 (m, 1H), 3.86–3.91 (m, 1H), 4.46–4.51 (m, 1H), 4.77 (t, <i>J</i> = 5.0 Hz, 1H), 5.81 (bs, 2H), 7.81 (d, <i>J</i> = 1.0 Hz, 1H), 11.89 (bs, 1H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 24.6, 27.5, 51.1, 60.4, 62.3, 84.3, 94.5, 119.3, 131.6, 155.4, 156.2, 160.2. HRMS (ESI) calculated for C<sub>12</sub>H<sub>15</sub>ON<sub>6</sub> [M + H]<sup>+</sup> 259.1302, found 259.1298. HPLC <i>t</i><sub>R</sub> = 7.26 min (method A).</div></div><div id="sec5_28" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> 2-Amino-4-((1<i>R</i>,4<i>R</i>)-4-hydroxycyclohexylamino)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidine-5-carbonitrile (<b>28</b>)</h4><div class="NLM_p last">Prepared according to procedure B. The remaining solid was suspended in MeOH, adsorbed on silica gel, and concentrated in vacuo. Chromatographic purification (Biotage SP4, 10 g cartridge, solvent system: MeOH/EtOAc; gradient 0% 6CV, 0–15% 16CV, 15% 8CV) yielded a beige solid which was triturated with MeOH (0.5 mL) to yield <b>28</b> (32 mg, 35%) as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 1.26–1.34 (m, 2H), 1.41–1.52 (m, 2H), 1.83–1.88 (m, 2H), 1.92–1.98 (m, 2H), 3.41–3.49 (m, 1H), 3.97–4.08 (m, 1H), 6.67 (bs, 1H), 7.31 (bs, 2H), 7.85 (s, 1H), 12.68 (bs 1H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 30.2, 34.2, 49.5, 68.4, 84.3, 94.6, 116.2, 130.5, 147.1, 158.0, 160.4. HRMS (ESI) calculated for C<sub>13</sub>H<sub>15</sub>ON<sub>6</sub> [M + H]<sup>+</sup> 271.1313, found 271.1316. HPLC <i>t</i><sub>R</sub> = 6.54 min (method A).</div></div><div id="sec5_29" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> 2-Amino-4-(cyclohexyl(2-hydroxyethyl)amino)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidine-5-carbonitrile (<b>29</b>)</h4><div class="NLM_p last">Prepared according to procedure B. The remaining solid was suspended in MeOH, adsorbed on silica gel, and concentrated in vacuo. Chromatographic purification (Biotage SP4, 10 g cartridge, solvent system: MeOH/DCM; gradient 0% 4CV, 0–5% 4CV, 5% 4CV, 5–10% 4CV, 10% 4CV) yielded <b>29</b> (51 mg, 40%) as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 1.05–1.14 (m, 1H), 1.36–1.45 (m, 2H), 1.53–1.61 (m, 3H), 1.71–1.77 (m, 4H), 3.44–3.48 (m, 2H), 3.54–3.49 (m, 1H), 4.16–4.21 (m, 1H), 4.55 (t, <i>J</i> = 5.4 Hz, 1H), 5.91 (bs, 2H), 7.84 (s, 1H), 11.95 (bs, 1H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 25.4, 25.7, 31.1, 44.9, 58.9, 60.5, 84.2, 95.4, 118.2, 131.5, 155.8, 158.7, 160.1. HRMS (ESI) calculated forC<sub>15</sub>H<sub>19</sub>ON<sub>6</sub> [M – H]<sup>−</sup> 299.1626, found 299.1628. HPLC <i>t</i><sub>R</sub> = 9.46 min (method A).</div></div><div id="sec5_30" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> 2-Amino-4-((1<i>RS</i>,2<i>SR</i>,3<i>RS</i>)-2,3-dihydroxycyclopentylamino)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidine-5-carbonitrile (<b>30</b>)</h4><div class="NLM_p last"><b>5</b> (80 mg, 0.29 mmol), <b>37</b> (70 mg, 0.35 mmol), and Et<sub>3</sub>N (0.04 mL, 29 mg, 0.29 mmol) were suspended in <i>n</i>-BuOH (4 mL) and refluxed for 16 h. After cooling to room temperature, EtOH (4 mL) and KOH (3 pellets) were added and the reaction mixture was heated at 80 °C for 20 h. The mixture was neutralized using 6 M HCl and subsequently concentrated in vacuo. The remaining solid was suspended in MeOH, adsorbed on silica gel, and concentrated in vacuo. Chromatographic purification (Biotage SP4, 50g cartridge, solvent system: MeOH/CHCl<sub>3</sub>; gradient 0% 4CV, 0–15% 14CV, 15% 4CV) yielded <b>30</b> (33 mg, 42%) as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 1.29–1.38 (m, 1H), 1.47–1.55 (m, 1H), 1.87–1.96 (m, 1H), 2.18–2.27 (m, 1H), 3.72–3.75 (m, 1H), 3.89–3.93 (m, 1H), 4.28–4.36 (m, 1H), 4.39 (d, <i>J</i> = 3.3 Hz, 1H), 4.94 (d, <i>J</i> = 5.5 Hz, 1H), 5.66 (d, <i>J</i> = 7.1 Hz, 1H), 5.99 (bs, 2H), 7.69 (s, 1H), 11.83 (bs, 1H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 27.0, 28.8, 55.4, 70.6, 77.8, 81.5, 94.2, 116.9, 128.4, 153.0, 156.5, 160.8. HRMS (ESI) calculated for C<sub>12</sub>H<sub>13</sub>O<sub>2</sub>N<sub>6</sub> [M + H]<sup>+</sup> 273.1105, found 273.1107. HPLC <i>t</i><sub>R</sub> = 4.47 min (method A).</div></div><div id="sec5_31" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> 2-Amino-4-((1<i>R</i>,2<i>S</i>,3<i>R</i>,4<i>S</i>)-2,3,4-trihydroxycyclopentylamino)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidine-5-carbonitrile (<b>31</b>)</h4><div class="NLM_p last"><b>5</b> (70 mg, 0.25 mmol), <b>42</b> (146 mg, 0.30 mmol), and Et<sub>3</sub>N (0.08 mL, 61 mg, 0.60 mmol) were suspended in <i>n</i>-BuOH (4 mL) and refluxed for 16 h. After cooling to room temperature, EtOH (4 mL) and KOH (3 pellets) were added and the reaction mixture was heated at 80 °C for 20 h. The mixture was neutralized using 6 M HCl and subsequently concentrated in vacuo. The remaining solid was suspended in MeOH, adsorbed on silica gel, and concentrated in vacuo. Chromatographic purification (Biotage SP4, 10 g cartridge, solvent system: 5% NH<sub>4</sub>OH in MeOH/CHCl<sub>3</sub>; gradient 2% 6CV, 2–15% 12CV, 10% 15CV) yielded a beige solid which was further triturated with MeOH (0.2 mL) and Et<sub>2</sub>O (2 mL) to yield <b>31</b> (24 mg, 33%) as a white solid; [α]<sub>D</sub><sup>20</sup> −25.7° (<i>c</i> = 0.12, DMSO). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 1.23–1.29 (m, 1H), 2.5–2.551 (m, 1H), 3.67–3.68 (m, 1H), 3.80–3.81 (m, 1H), 3.91–3.93 (m, 1H), 4.30–4.36 (m, 1H), 4.58 (d, <i>J</i> = 3.6 Hz, 1H), 4.91 (bs, 1H), 4.92 (bs, 1H), 5.70 (d, <i>J</i> = 7.5 Hz, 1H), 5.99 (bs, 2H), 7.69 (s, 1H), 11.83 (bs, 1H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 37.8, 55.2, 74.6, 76.8, 77.6, 94.1, 117.0, 128.5, 129.5, 153.1, 156.2, 160.9. HRMS (ESI) calculated forC<sub>12</sub>H<sub>15</sub>O<sub>3</sub>N<sub>6</sub> [M + H]<sup>+</sup> 291.1200, found 291.1189. HPLC <i>t</i><sub>R</sub> = 6.40 min (method B).</div></div><div id="sec5_32" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> 3-(<i>N</i>,<i>N</i>-Dibenzylamino)cyclopent-1-ene (<b>34</b>)</h4><div class="NLM_p last">A mixture of cyclopentene (12.3 mL, 9.18 g, 0.135 mol), NBS (6.01 g, 33.71 mmol), and benzoyl peroxide (70%, 163 mg, 0.67 mmol) in CCl<sub>4</sub> (21 mL) was heated at reflux for 1 h. The reaction mixture was cooled to 0 °C, filtered through a pad of Celite (eluent CCl<sub>4</sub>), and solvent and cyclopentene were distilled off in vacuo. The residue was dissolved in CCl<sub>4</sub> (30 mL), cooled to 0 °C, and <i>N</i>,<i>N</i>-dibenzylamine (16.2 mL, 16.60 g, 84.28 mmol) was added to the crude solution of bromide <b>33</b>. The mixture then warmed to room temperature and stirred for 30 min. The reaction mixture was then filtered, heated to 40 °C, and stirred at this temperature for 1 h, then filtered and stirred at room temperature for 16 h. The mixture was then filtered and concentrated in vacuo. Chromatographic purification (Biotage SP4, 100 g cartridge, solvent system: 10% Et<sub>2</sub>O in Hex/Hex; gradient 0% 4CV, 0–10% 10CV) yielded <b>34</b> (6.23 g, 70%) as a colorless oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ: 1.78–1.93 (m, 2H), 2.22–2.29 (m, 1H), 2.34–2.41 (m, 1H), 3.43 (d, <i>J</i> = 13.8 Hz, 2H), 3.64 (d, <i>J</i> = 13.8 Hz, 2H), 4.03–4.05 (m, 1H), 5.75–5.76 (m, 1H), 5.86–5.89 (m, 1H), 7.19–7.23 (m, 2H), 7.27–7.31 (m, 4H), 7.37–7.39 (m, 4H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ: 23.4, 31.9, 54.5, 66.1, 126.8, 128.3, 128.8, 132.1, 133.3, 140.8.</div></div><div id="sec5_33" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> (1<i>RS</i>,2<i>SR</i>,3<i>RS</i>)-3-(Dibenzylamino)cyclopentane-1,2-diol (<b>35</b>)</h4><div class="NLM_p last">A solution of OsO<sub>4</sub> in H<sub>2</sub>O (4% w/v, 0.32 mL, 13 mg, 0.05 mmol) was added to a stirred solution of <b>51</b> (1.31 g, 4.98 mmol) and NMO (1.33 g, 14.94 mmol) in acetone/H<sub>2</sub>O (4:1, 35 mL), and the resultant mixture was stirred at room temperature for 4 h. Saturated aq Na<sub>2</sub>SO<sub>3</sub> (5 mL) was then added, and the solution was stirred for an additional 30 min. Acetone was evaporated in vacuo, H<sub>2</sub>O (10 mL) was added, and the aqueous layer was extracted with DCM (3 × 20 mL). The organic layer was adsorbed on silica gel and concentrated in vacuo. Chromatographic purification (Biotage SP4, 50 g cartridge, solvent system: EtOAc/Hex; gradient 10% 4CV, 10–20% 6CV, 20% 4CV, 20–60% 6CV; 60% 6CV) yielded <b>35</b> (1.06 g, 72%) as a white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ: 1.52–1.75 (m, 2H), 1.83–1.96 (m, 2H), 2.28 (bs, 1H), 2.37 (bs, 1H), 3.27 (app q, <i>J</i> = 8.4 Hz, 1H), 3.57 (d, <i>J</i> = 13.9 Hz, 2H), 3.78 (d, <i>J</i> = 13.9 Hz, 2H), 3.92 (app dd, <i>J</i> = 8.2, 5.2 Hz, 1H), 3.99–4.05 (m, 1H), 7.21–7.25 (m, 2H), 7.29–7.32 (m, 4H), 7.35–7.37 (m, 4H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ: 19.6, 29.0, 55.0, 65.1, 71.1, 74.6, 127.1, 128.4, 128.7, 139.9. HRMS (ESI) calculated for C<sub>19</sub>H<sub>24</sub>O<sub>2</sub>N [M + H]<sup>+</sup> 298.1802, found 298.1798.</div></div><div id="sec5_34" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> (1<i>RS</i>,2<i>SR</i>,3<i>RS</i>)-3-(Dibenzylamino)cyclopentane-1,2-diyl-dibenzoate (<b>36</b>)</h4><div class="NLM_p last">Benzoyl chloride (1.62 mL, 1.96 g, 13.92 mmol) was added dropwise to a stirred solution of <b>35</b> (1.03 g, 3.48 mmol) in dry pyridine (30 mL) at 0 °C, left to warm to room temperature, and stirred for 1 day. Pyridine was evaporated in vacuo, and the residue was suspended in Et<sub>2</sub>O (40 mL), cooled to 0 °C, followed by addition of saturated aqueous NaHCO<sub>3</sub> (10 mL). The organic layer was then washed with saturated aqueous NaHCO<sub>3</sub> (3 × 20 mL) and subsequently adsorbed on silica gel and concentrated in vacuo. Chromatographic purification (Biotage SP4, 50 g cartridge, solvent system: 10% Et<sub>2</sub>O in Hex/Hex; gradient 0% 3CV, 0–10% 3CV, 10% 4CV, 10–20% 4CV, 20% 4CV, 20–40% 6CV) yielded <b>36</b> (1.45 g, 84%) as a white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ: 1.75–1.84 (m, 1H), 1.88–1.96 (m, 1H), 2.01–2.10 (m, 1H), 2.18–2.26 (m, 1H), 3.67 (d, <i>J</i> = 13.8 Hz, 2H), 3.77 (d, <i>J</i> = 13.8 Hz, 2H), 3.78–3.86 (m, 1H), 5.54 (dt, <i>J</i> = 5.0, 4.6 Hz, 1H), 5.67 (dd, <i>J</i> = 8.0, 5.0 Hz, 1H), 7.20–7.40 (m, 14 H), 7.49 (m, 1H), 7.55 (m, 1H), 7.76 (dd, <i>J</i> = 8.4, 1.3 Hz, 2H), 7.94 (dd, <i>J</i> = 8.4, 1.3 Hz, 2H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ: 20.7, 27.6, 54.7, 62.2, 73.3, 74.0, 126.9, 128.3, 128.3, 128.4, 128.7, 129.6, 129.8, 130.1, 130.2, 132.9, 133.0, 139.7, 165.7, 165.9. HRMS (ESI) calculated for C<sub>33</sub>H<sub>32</sub>O<sub>4</sub>N [M + H]<sup>+</sup> 506.2326, found 506.2321.</div></div><div id="sec5_35" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> (1<i>RS</i>,2<i>SR</i>,3<i>RS</i>)-3-Aminocyclopentane-1,2-diyl dibenzoate (<b>37</b>)</h4><div class="NLM_p last">Pd(OH)<sub>2</sub>/C (20% w/w, 700 mg) was added to a vigorously stirred solution of <b>36</b> (1.42 g, 2.81 mmol) in EtOH/EtOAc (5:1, 60 mL), and the resultant suspension was stirred at room temperature under H<sub>2</sub> (1 atm) for 16 h. The suspension was filtered through a Celite pad (eluent MeOH) and concentrated in vacuo. The residue was triturated with Et<sub>2</sub>O (2 × 20 mL) to give <b>37</b> (908 mg, 98%) as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 1.73–1.82 (m, 1H), 1.93–2.02 (m, 1H), 2.32–2.43 (m, 2H), 3.93 (app dt, <i>J</i> = 8.0, 7.6 Hz, 1H), 5.49 (dd, <i>J</i> = 7.5, 5.1 Hz, 1H), 5.59–5.63 (m, 1H), 7.42–7.49 (m, 4H), 7.61–7.66 (m, 2H), 7.86–7.89 (m, 2H), 8.38 (bs, 2H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 25.2, 27.7, 53.4, 73.2, 76.6, 129.1, 129.2, 129.6, 129.7, 129.8, 129.9, 134.1, 134.1, 165.4, 165.5. HRMS (ESI) calculated for C<sub>19</sub>H<sub>20</sub>O<sub>4</sub>N [M + H]<sup>+</sup> 326.1387, found 326.1382.</div></div><div id="sec5_36" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> Di-<i>tert</i>-butyl-[(1<i>R</i>,4<i>S</i>)-4-hydroxycyclopent-2-en-1-yl]imidodicarbonate (<b>39</b>)</h4><div class="NLM_p last">A suspension of sodium di-<i>tert</i>-butyl-iminodicarboxylate, previously prepared by reaction of di-<i>tert</i>-butyl-iminodicarboxylate (1.195 g, 5.50 mmol) with NaH (60% suspension in mineral oil) (132 mg, 5.50 mmol) in dry THF (18 mL), was cannulated to a room temperature solution of (1<i>R</i>,4<i>S</i>)-4-hydroxycyclopent-2-enyl acetate (521 mg, 3.67 mmol), PPh<sub>3</sub> (144 mg, 0.55 mmol), and Pd(PPh<sub>3</sub>)<sub>4</sub> (636 mg, 0.55 mmol) in dry THF/DMF (1:1) (16 mL). The reaction mixture was heated at 50 °C for 1 day, then diluted with MeOH (10 mL) and dry loaded on to silica. Chromatographic purification (Biotage SP4, 50 g cartridge, solvent system: EtOAc/Hex; gradient 0% 4CV, 0–20% 10CV, 20% 6CV) yielded <b>39</b> (463 mg, 42%) as a colorless oil that solidifies upon standing to afford a white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ: 1.48 (s, 18H), 1.83 (dt, <i>J</i> = 15.1, 2.3 Hz, 1H), 2.68 (ddd, <i>J</i> = 15.1, 9.3, 7.9 Hz, 1H), 3.20 (bs, 1H), 4.57–4.61 (m, 1H), 5.09 (app dq, <i>J</i> = 9.3, 2.3 Hz, 1H), 5.74 (dd, <i>J</i> = 5.4, 2.3 Hz, 1H), 6.04 (dt, <i>J</i> = 5.4, 2.3 Hz, 1H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ: 28.1, 38.9, 60.3, 75.8, 82.9, 131.5, 136.9, 153.4.</div></div><div id="sec5_37" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> Di-<i>tert</i>-butyl-[(1<i>R</i>,2<i>S</i>,3<i>R</i>,4<i>S</i>)-2,3,4-trihydroxycyclopentyl] imidodicarbonate (<b>40</b>)</h4><div class="NLM_p last">A solution of OsO<sub>4</sub> in H<sub>2</sub>O (4% w/v, 0.06 mL, 3 mg, 0.01 mmol) was added to a solution of <b>39</b> (120 mg, 0.40 mmol) and NMO (141 mg, 1.20 mmol) in a 4:1 mixture acetone/H<sub>2</sub>O (10 mL). The solution was stirred at room temperature for 1 day. Saturated aqueous Na<sub>2</sub>SO<sub>3</sub> (5 mL) was added, and the reaction mixture was stirred for 30 min. Acetone was removed in vacuo, and the aqueous layer was extracted with EtOAc (4 × 20 mL). The organic layer was adsorbed on silica gel and concentrated in vacuo. Chromatographic purification (Biotage SP4, 10 g cartridge, solvent system: EtOAc/DCM; gradient 20% 6CV, 20–80% 8CV, 80% 8CV) yielded <b>40</b> (71 mg, 53%) as a colorless oil that solidifies upon standing to afford a white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ: 1.49 (s, 18H), 1.79–1.85 (m, 1H), 2.53–2.62 (m, 1H), 2.91 (bs, 3H), 3.98–3.99 (m, 1H), 4.01–4.04 (m, 1H), 4.39–4.45 (m, 1H), 4.55–4.58 (m, 1H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ: 28.0, 34.1, 61.9, 74.9, 75.1, 77.3, 83.6, 153.7. HRMS (ESI) calculated for C<sub>15</sub>H<sub>27</sub>O<sub>7</sub>NNa [M + Na]<sup>+</sup> 356.1680, found 356.1682.</div></div><div id="sec5_38" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> (1<i>S</i>,2<i>R</i>,3<i>S</i>,4<i>R</i>)-4-(Bis(<i>tert</i>-butoxycarbonyl)amino)cyclopentane-1,2,3-triyl tribenzoate (<b>41</b>)</h4><div class="NLM_p last">Benzoyl chloride (0.33 mL, 397 mg, 2.83 mmol) was added dropwise to a stirred solution of <b>40</b> (235 mg, 0.71 mmol) in dry pyridine (6 mL) at 0 °C and left to warn to room temperature and stirred for 1 day. Pyridine was evaporated in vacuo, and the residue was partitioned between Et<sub>2</sub>O (40 mL) and saturated aqueous NaHCO<sub>3</sub> (10 mL). The organic layer was separated and washed with saturated aqueous NaHCO<sub>3</sub> (3 × 20 mL) and subsequently adsorbed on silica gel and concentrated in vacuo. Chromatographic purification (Biotage SP4, 50 g cartridge, solvent system: Et<sub>2</sub>O/Hex; gradient 0% 6CV, 0–20% 10CV, 20% 6CV) yielded <b>41</b> (338 mg, 74%) as a colorless oil that solidified upon standing to afford a white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ: 1.51 (s, 18H), 2.21–2.29 (m, 1H), 2.75–2.82 (m, 1H), 5.00–5.07 (m, 1H), 5.58–5.64 (m, 1H), 5.98–6.05 (m, 2H), 7.29–7.34 (m, 4H), 7.41–7.51 (m, 3H), 7.54–7.63 (m, 2H), 7.90–7.93 (m, 4H), 8.08–8.13 (m, 2H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ: 28.1, 30.3, 58.3, 73.7, 74.3, 75.6, 83.3, 128.3, 128.4, 128.5, 129.4, 129.4, 129.6, 129.7, 129.8, 129.9, 133.1, 133.1, 133.2, 152.5, 165.3, 165.4, 166.0. HRMS (ESI) calculated for C<sub>36</sub>H<sub>39</sub>O<sub>10</sub>NNa [M + Na]<sup>+</sup> 668.2463, found 668.2463.</div></div><div id="sec5_39" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> (1<i>S</i>,2<i>R</i>,3<i>S</i>,4<i>R</i>)-4-Aminocyclopentane-1,2,3-triyl-tribenzoate Hydrochloride (<b>42</b>)</h4><div class="NLM_p last"><b>41</b> (297 mg, 0.46 mmol) was placed in an oven-dry round-bottom flask, purged with N<sub>2</sub>, cooled to 0 °C, and subsequently treated with 4 M HCl in 1,4-dioxane (10 mL). The mixture was left to warm to room temperature, stirred for 16 h, and concentrated in vacuo. The residue was triturated with Et<sub>2</sub>O (5 × 1 mL) to yield <b>42</b> (168 mg, 76%) as a white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ: 2.01–2.09 (m, 1H), 2.97–3.04 (m, 1H), 4.07–4.14 (m, 1H), 5.51–5.56 (m, 1H), 5.73–5.76 (m, 1H), 5.82–5.83 (m, 1H), 7.43–7.49 (m, 4H), 7.55–7.59 (m, 2H), 7.63–7.73 (m, 3H), 7.87–7.92 (m, 4H), 8.03–8.05 (m, 2H), 8.66 (bs, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ: 31.6, 51.6, 73.6, 74.6, 74.8, 129.0, 129.1, 129.2, 129.2, 129.3, 129.4, 129.8, 129.9, 129.9, 134.2, 164.9, 165.2, 165.4. HRMS (ESI) calculated forC<sub>26</sub>H<sub>24</sub>O<sub>6</sub>N [M + H]<sup>+</sup> 446.1598, found 446.1599.</div></div><div id="sec5_40" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> 2-Amino-4-phenyl-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidine-5-carbonitrile (<b>43</b>)</h4><div class="NLM_p last"><b>5</b> (96 mg 0.35 mmol), phenyl boronic acid (73 mg, 0.60 mmol), and Pd(PPh<sub>3</sub>)<sub>4</sub> (0.041 g, 0.047 mmol) were suspended in a mixture of IPA/H<sub>2</sub>O (3:1.5 mL) and degassed. <i>t</i>-Butylamine (0.19 mL, 1.81 mmol) was added, and the mixture was irradiated at 160 °C for 40 min. The resulting solution was diluted with EtOH (8 mL) and KOH (2 pellets) were added and the mixture was heated to 90 °C for 20 h. The reaction mixture was then concentrated under reduced pressure, and the resulting mixture was suspended in water, pH adjusted to pH 5.3, extracted into EtOAc (2 × 100 mL), and dried over MgSO<sub>4</sub>. The resulting solid was purified by column chromatography (100% hexane–100% ethyl acetate) and triturated with diethyl ether to afford the title compound <b>43</b> as a light-brown solid (4.9 mg, 0.0208 mmol, 6.0%). <sup>1</sup>H NMR (400 Hz, DMSO-<i>d</i><sub>6</sub>): δ 6.63 (br s, 2H), 7.54–7.55 (m, 3H), 7.78–7.80 (m, 2H), 8.12 (s, 1H), 12.40 (br s, 1H). HRMS (ESI) calculated for C<sub>13</sub>H<sub>9</sub>N<sub>5</sub> [M + H]<sup>+</sup> 236.0931, found 236.0930.</div></div><div id="sec5_41" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> 2-Amino-4-(4-hydroxyphenyl)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimdine-5-carbonitrile (<b>44</b>)</h4><div class="NLM_p last"><b>5</b> (115 mg, 0.42 mmol), 4-hydroxyphenyl boronic acid (92 mg, 0.67 mmol), and Pd(PPh<sub>3</sub>)<sub>4</sub> (49 mg, 0.042 mmol) were suspended in a mixture of IPA/H<sub>2</sub>O (3:1.5 mL) and degassed. <i>t</i>-Butylamine (0.18 mL, 1.71 mmol) was added, and the mixture was irradiated at 160 °C for 40 min. The reaction mixture was then concentrated under reduced pressure, and the resulting solid was triturated with methanol, filtered, and dried. EtOH (9 mL) was added KOH (2 pellets) and the mixture heated to 90 °C for 48 h. The reaction mixture was concentrated under reduced pressure, water was added, and the mixture was pH adjusted to pH 6 and extracted into EtOAc. The organic layer was dried over MgSO<sub>4</sub> and concentrated under reduced pressure to afford the title compound <b>44</b> as a brown solid 10.1 mg, 0.040 mmol, 67%). <sup>1</sup>H NMR (400 Hz, DMSO-<i>d</i><sub>6</sub>): δ 6.51 (br s, 2H), 6.89 (d, 2H, <i>J</i> = 8.4 Hz), 7.67 (d, 2H, <i>J</i> = 8.8 Hz), 8.08 (s, 1H), 9.90 (s, 1H), 12.28 (br s, 1H). HRMS (ESI) calculated for C<sub>13</sub>H<sub>9</sub>N<sub>5</sub>O 252.0880 [M + H]<sup>+</sup>, found 252.0880. HPLC: <i>t</i><sub>R</sub> = 8.62 min (70.46%).</div></div><div id="sec5_42" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> 2-Amino-4-(4-fluorophenyl)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidine-5-carbonitrile 9<b>45</b>)</h4><div class="NLM_p last"><b>5</b> (100 mg 0.31 mmol), Pd-118 (20 mg, 0.03 mmol), <i>t</i>-butylamine (160 μL, 1.55 mmol), and 4-fluorophenylboronic acid (69 mg, 0.5 mmol) were suspended in a 2:1 mixture <i>i</i>-PrOH/H<sub>2</sub>O (4.5 mL) and were irradiated with microwaves at 160 °C for 40 min. Once cooled to room temperature, the reaction mixture was concentrated under reduced pressure. To this was added EtOH (5 mL) and KOH (2 pellets), and the reaction mixture was refluxed at 90 °C for 20 h. The mixture was then concentrated under reduced pressure, and the crude material was then suspended in H<sub>2</sub>O and adjusted to pH 5 with 1 M HCl. The solution was then extracted with EtOAc (2 × 50 mL); the organic layer was adsorbed on silica gel and concentrated under reduced pressure. Chromatographic purification (EtOAc/Hex: 50% 4CV, 50–75% 6CV, 75% 4CV, 75–100% 7CV, 100% 6CV) yielded a beige solid that was triturated with Et<sub>2</sub>O to afford the title compound <b>45</b> as a beige solid (13 mg, 0.05 mmol, 17%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 6.62 (s, 2H), 7.36 (t, <i>J</i> = 8.3 Hz, 2H), 7.83 (t, <i>J</i> = 7.7 Hz, 2H), 8.12 (s, 1H), 12.36 (s, 1H). HRMS: calculated for C<sub>13</sub>H<sub>9</sub>N<sub>5</sub>F [M + H]<sup>+</sup> 254.0837, found 254.0831.</div></div><div id="sec5_43" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59"> 4-(2-Amino-5-cyano-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimdin-4-yl)benzamide (<b>46</b>)</h4><div class="NLM_p last"><b>5</b> (101 mg, 0.36 mmol), 4-aminocarbonyl phenylboronic acid (96 mg, 0.58 mmol), and Pd(PPh<sub>3</sub>)<sub>4</sub> (40 mg, 0.035 mmol) were suspended in a mixture of IPA/H<sub>2</sub>O (3:1.5 mL) and degassed. <i>t</i>-Butylamine (0.20 mL, 1.90 mmol) was added, and the mixture was irradiated at 160 °C for 40 min. The resulting solution was diluted with EtOH (6 mL) and KOH (2 pellets) were added and the mixture was heated to 90 °C for 30 h. The reaction mixture was then concentrated under reduced pressure, and the resulting mixture was suspended in water, pH adjusted to pH 5.2, extracted into EtOAc (2 × 100 mL), and dried over MgSO<sub>4</sub>. The mixture was then concentrated under reduced pressure, triturated with diethyl ether and methanol, and filtered. The solid and filtrate were combined and purified by column chromatography (100% hexane–100% ethyl acetate). The isolated compound was triturated with diethyl ether, filtered under reduced pressure, and dried to afford the title compound <b>46</b> as an off-white solid (6 mg, 0.022 mmol, 5.9%). <sup>1</sup>H NMR (400 Hz, DMSO-<i>d</i><sub>6</sub>): δ 6.68 (s, 2H), 7.51 (br s, 1H), 7.85 (d, 2H, <i>J</i> = 9.2 Hz), 8.40 (d, 2H, <i>J</i> = 10.4 Hz), 8.14 (br s, 1H), 8.16 (s, 1H), 12.40 (br s, 1H). HRMS (ESI) calculated for C<sub>14</sub>H<sub>8</sub>N<sub>6</sub>O [M + H]<sup>+</sup> 277.0843, found 277.0844. HPLC: <i>t</i><sub>R</sub> = 7.94 min (method A) (76.01%).</div></div><div id="sec5_44" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60"> 2-Amino-4-(4-hydroxymethyl)phenyl-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidine-5-carbonitrile (<b>47</b>)</h4><div class="NLM_p last"><b>5</b> (103 mg, 0.37 mmol), 4-hydroxymethyl)phenyl boronic acid (99 mg, 0.65 mmol), and Pd-118 (47 mg, 0.072 mmol) were suspended in a mixture of IPA/H<sub>2</sub>O (3:1.5 mL) and degassed. <i>t</i>-Butylamine (0.20 mL, 1.90 mmol) was added, and the mixture was irradiated at 160 °C for 40 min. The resulting solution was diluted with EtOH (8 mL) and KOH (2 pellets) were added and the mixture was heated to 90 °C for 20 h. The reaction mixture was then concentrated under reduced pressure, and the resulting mixture was suspended in water, pH adjusted to pH 5.3, extracted into EtOAc (2 × 100 mL), and dried over MgSO<sub>4</sub>. The resulting solid was purified by column chromatography (100% hexane–100% ethyl acetate) to afford the title compound <b>47</b> as an off-white solid (28.5 mg, 0.108 mmol, 29%). <sup>1</sup>H NMR (400 Hz, DMSO-<i>d</i><sub>6</sub>): δ 4.61 (d, 2H, <i>J</i> = 5.6 Hz), 5.34 (t, 1H, <i>J</i> = 5.8 Hz), 6.60 (br s, 2H), 7.47 (d, 2H, <i>J</i> = 7.6 Hz), 7.77 (d, 2H, <i>J</i> = 8.0 Hz), 8.11 (s, 1H), 12.34 (br s, 1H). HRMS (ESI) calculated for C<sub>14</sub>H<sub>11</sub>N<sub>5</sub>O [M + H]<sup>+</sup> 264.0891, found 264.0891. HPLC: <i>t</i><sub>R</sub> = 8.45 min (method A) (94.35%).</div></div><div id="sec5_45" class="NLM_sec NLM_sec_level_3"><div id="ac_i61" class="anchor-spacer"></div><h4 class="article-section__title" id="_i61"> 4-(2-Amino-5-cyano-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl)benzenesulfonamide (<b>48</b>)</h4><div class="NLM_p last"><b>5</b> (100.6 mg, 0.36 mmol), 4-sulphamoylbenzene boronic acid (124 mg 0.62 mmol), Pd-118 (43 mg 0.066 mmol) were suspended in a mixture of IPA/H<sub>2</sub>O (3:1.5 mL) and degassed. <i>t</i>-Butylamine (0.195 mL, 1.86 mmol) was added and the mixture was irradiated at 160 °C for 40 min. The resulting solution was diluted with EtOH (6 mL) and KOH (2 pellets) were added and the mixture was heated to 90 °C for 20 h. The reaction mixture was then concentrated under reduced pressure and the resulting mixture was suspended in water, pH adjusted to pH 5.5, extracted into EtOAc (2 × 100 mL) and dried over MgSO<sub>4</sub>. The resulting solid was purified by column chromatography (100% hexane–100% ethyl acetate) and triturated with diethyl ether to afford the title compound <b>48</b> as an off-white solid (19.1 mg, 0.0608 mmol, 17%). <sup>1</sup>H NMR (400 Hz, DMSO-<i>d</i><sub>6</sub>): δ 6.70 (br s, 2H), 7.54 (br s, 2H), 7.97 (br s, 4H), 8.17 (s, 1H), 12.45 (br s, 1H). HRMS (ESI) calculated for C<sub>13</sub>H<sub>8</sub>N<sub>6</sub>O<sub>2</sub>S [M + H]<sup>+</sup> 313.0513, found 313.0517. HPLC: <i>t</i><sub>R</sub> = 8.33 min (method A) (94.29%).</div></div><div id="sec5_46" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62"> 2-Amino-4-(4-(methylsulfonyl)phenyl)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidine-5-carbonitrile (<b>49</b>)</h4><div class="NLM_p last"><b>5</b> (104 mg, 0.38 mmol), (4-methylsulfonyl)benzene boronic acid (128 mg, 0.64 mmol), and Pd-118 (25 mg, 0.038 mmol) were suspended in a mixture of IPA/H<sub>2</sub>O (3:1.5 mL) and degassed. <i>t</i>-Butylamine (0.22 mL, 2.09 mmol) was added, and the mixture was irradiated at 160 °C for 40 min. The resulting solution was diluted with EtOH (8 mL) and KOH (2 pellets) were added and the mixture was heated to 90 °C for 22 h. The reaction mixture was then concentrated under reduced pressure, and the resulting mixture was suspended in water, pH adjusted to pH 5.7, extracted into EtOAc (2 × 100 mL), and dried over MgSO<sub>4</sub>. The resulting solid was purified by column chromatography (100% hexane–100% ethyl acetate), triturated with diethyl ether, filtered, and dried to afford the title compound <b>49</b> as a pale-yellow solid (54.8 mg, 0.175 mmol, 47%). <sup>1</sup>H NMR (500 Hz, DMSO-<i>d</i><sub>6</sub>): δ 3.30 (br s, 3H), 6.67 (br s, 2H), 8.03 (d, 2H, <i>J</i> = 8.5 Hz), 8.09 (d, 2H, <i>J</i> = 8.5 Hz), 8.17 (s, 1H), 12.45 (br s, 1H). HRMS (ESI) calculated for C<sub>14</sub>H<sub>10</sub>N<sub>5</sub>O<sub>2</sub>S [M + H]<sup>+</sup> 312.0561, found 312.0564. HPLC: <i>t</i><sub>R</sub> = 8.97 min (method A).</div></div><div id="sec5_47" class="NLM_sec NLM_sec_level_3"><div id="ac_i63" class="anchor-spacer"></div><h4 class="article-section__title" id="_i63"> <i>N</i>-(4-(2-Amino-5-cyano-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl)phenyl)methanesulfonamide (<b>50</b>)</h4><div class="NLM_p last"><b>5</b> (0.103 g, 0.37 mmol), 4-(methylsulfonyl)aminobenzene boronic acid (0.121 g, 0.56 mmol), Pd-118 (0.027 g, 0.041 mmol) were suspended in a mixture of IPA/H<sub>2</sub>O (3:1.5 mL) and degassed. <i>t</i>-Butylamine (0.20 mL, 1.90 mmol) was added, and the mixture was irradiated at 160 °C for 40 min. The resulting solution was diluted with EtOH (8 mL) and KOH (2 pellets) were added and the mixture was heated to 90 °C for 22 h. The reaction mixture was then concentrated under reduced pressure, and the resulting mixture was suspended in water, pH adjusted to pH 5.7, extracted into EtOAc (2 × 100 mL), and dried over MgSO<sub>4</sub>. The resulting solid was purified by column chromatography (100% hexane–100% ethyl acetate), triturated with diethyl ether, filtered, and dried to afford the title compound <b>50</b> as a pale-yellow solid (0.0399 g, 0.122 mmol, 32.7%). <sup>1</sup>H NMR (400 Hz, DMSO-<i>d</i><sub>6</sub>): δ 3.08 (s, 3H), 6.55 (br s, 2H), 7.34 (d, 2H, <i>J</i> = 8.8 Hz), 7.78 (d, 2H, <i>J</i> = 8.4 Hz), 8.10 (s, 1H), 10.08 (br s, 1H), 12.33 (br s, 1H). HRMS (ESI) calculated for C<sub>14</sub>H<sub>11</sub>N<sub>6</sub>O<sub>2</sub>S [M + H]<sup>+</sup> 327.0670, found 327.0673. HPLC: <i>t</i><sub>R</sub> = 8.92 min (method A) (85.80%).</div></div><div id="sec5_48" class="NLM_sec NLM_sec_level_3"><div id="ac_i64" class="anchor-spacer"></div><h4 class="article-section__title" id="_i64"> 4-(2-Amino-5-cyano-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl)-<i>N</i>-(<i>p</i>-tolyl)benzenesulfonamide (<b>51</b>)</h4><div class="NLM_p last"><b>5</b> (100 mg, 0.36 mmol), 4-(<i>N</i>-<i>p</i>-tolylsulfamoyl)phenylboronic acid (168 mg, 0.58 mmol), and Pd-118 (23 mg, 0.03 mmol) in IPA/H<sub>2</sub>O (3:1.5 mL) was degassed with nitrogen. <i>t</i>-Butylamine (0.19 mL, 1.8 mmol) was added, and the mixture was heated in the microwave at 160 °C for 40 min. The reaction mixture was then diluted with EtOH (4 mL), KOH (2 pellets) added and heated at 90 °C for 24 h. The reaction mixture was concentrated under reduced pressure, and the resulting mixture was suspended in water (5 mL), acidified to pH 5.7 (3 M HCl) and extracted with EtOAc (10 mL × 3). The organic fractions were combined, dried over anhydrous MgSO<sub>4</sub>, filtered and concentrated under reduced pressure to give the crude product. Purification by flash column chromatography (silica gel with EtOAc (75–100%) in hexane afforded the title compound <b>51</b> as an off-white solid (0.005 g, 0.01 mmol, 3%). <sup>1</sup>H NMR (400 Hz, DMSO-<i>d</i><sub>6</sub>): 2.18 (s, 3H), 6.69 (br s, 2H), 6.98 (d, 2H, <i>J</i> = 8.4 Hz), 7.03 (d, 2H, <i>J</i> = 8.4 Hz), 7.84 (d, 2H, <i>J</i> = 8.4 Hz), 7.88 (d, 2H, <i>J</i> = 8.4 Hz), 8.14 (s, 1H), 10.20 (s, 1H), 12.43 (br s, 1H). HRMS: calculated for C<sub>20</sub>H<sub>15</sub>O<sub>2</sub>N<sub>6</sub>S [M + H]<sup>+</sup> 403.0983, found 403.0986.</div></div><div id="sec5_49" class="NLM_sec NLM_sec_level_3"><div id="ac_i65" class="anchor-spacer"></div><h4 class="article-section__title" id="_i65"> 4-(2-Amino-5-cyano-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl)-<i>N</i>-methylbenzenesulfonamide (<b>52</b>)</h4><div class="NLM_p last"><b>5</b> (115 mg, 0.42 mmol), 4-((methylamino)sulphonyl)benzene boronic acid (134 mg 0.62 mmol), and Pd-118 (32 mg, 0.049 mmol) were suspended in a mixture of IPA/H<sub>2</sub>O (3:1.5 mL) and degassed. <i>t</i>-Butylamine (0.22 mL, 2.09 mmol) was added, and the mixture was irradiated at 160 °C for 40 min. The resulting solution was diluted with EtOH (8 mL) and KOH (2 pellets) were added and the mixture was heated to 90 °C for 22 h. The reaction mixture was then concentrated under reduced pressure, and the resulting mixture was suspended in water, pH adjusted to pH 5.5, extracted into EtOAc (2 × 100 mL), and dried over MgSO<sub>4</sub>. The resulting solid was purified by column chromatography (100% hexane–100% ethyl acetate), triturated with diethyl ether, filtered, and dried to afford the title compound <b>52</b> as a pale-yellow solid (47.2 mg, 0.144 mmol, 35%). <sup>1</sup>H NMR (400 Hz, DMSO-<i>d</i><sub>6</sub>): δ 2.46 (d, 3H, <i>J</i> = 4.8 Hz), 6.71 (br s, 2H), 7.60 (q, 1H, <i>J</i> = 4.9 Hz), 7.92 (d, 2H, <i>J</i> = 8.0 Hz), 7.98 (d, 2H, <i>J</i> = 8.4 Hz), 8.16 (s, 1H), 12.45 (br s, 1H). HRMS (ESI) calculated for C<sub>14</sub>H<sub>11</sub>N<sub>6</sub>O<sub>2</sub>S [M + H]<sup>+</sup> 327.0670, found 327.0674. HPLC: <i>t</i><sub>R</sub> = 9.24 min (method A) (82.18%).</div></div><div id="sec5_50" class="NLM_sec NLM_sec_level_3"><div id="ac_i66" class="anchor-spacer"></div><h4 class="article-section__title" id="_i66"> 2-Amino-4-(3-hydroyphenyl)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidine-5-carbonitrile (<b>53</b>)</h4><div class="NLM_p last"><b>5</b> (113 mg, 0.41 mmol), 3-hydroxyphenyl boronic acid (95 mg, 0.69 mmol), and Pd-118 (33 mg 0.051 mmol) were suspended in a mixture of IPA/H<sub>2</sub>O (3:1.5 mL) and degassed. <i>t</i>-Butylamine (0.22 mL, 2.09 mmol) was added, and the mixture was irradiated at 160 °C for 40 min. The resulting solution was diluted with EtOH (8 mL) and KOH (2 pellets) were added and the mixture was heated to 90 °C for 22 h. The reaction mixture was then concentrated under reduced pressure, and the resulting mixture was suspended in water, pH adjusted to pH 5.5, extracted into EtOAc (2 × 100 mL), and dried over MgSO<sub>4</sub>. The resulting solid was purified by column chromatography (100% hexane–100% ethyl acetate) to afford the title compound <b>53</b> as an off-white solid (12 mg, 0.048 mmol, 11.7%). <sup>1</sup>H NMR (400 Hz, DMSO-<i>d</i><sub>6</sub>): δ 6.58 (br s, 2H), 6.91 (d, 1H, <i>J</i> = 8.0 Hz), 7.15–7.19 (m, 2H), 7.31 (t, 1H, <i>J</i> = 7.6 Hz), 8.09 (s, 1H), 9.62 (s, 1H), 12.33 (br s, 1H). HRMS (ESI) calculated for C<sub>13</sub>H<sub>7</sub>N<sub>5</sub>O [M + H]<sup>+</sup> 250.0734, found 250.0737. HPLC: <i>t</i><sub>R</sub> = 8.75 min (method A).</div></div><div id="sec5_51" class="NLM_sec NLM_sec_level_3"><div id="ac_i67" class="anchor-spacer"></div><h4 class="article-section__title" id="_i67"> 2-Amino-4-(3-fluorophenyl)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidine-5-carbonitrile (<b>54</b>)</h4><div class="NLM_p last"><b>5</b> (104 mg, 0.38 mmol), 3-fluorobenzene boronic acid (85 mg, 0.61 mmol), and Pd(PPh<sub>3</sub>)<sub>4</sub> (45 mg, 0.039 mmol) were suspended in a mixture of IPA/H<sub>2</sub>O (3:1.5 mL) and degassed. <i>t</i>-Butylamine (0.16 mL, 1.52 mmol) was added, and the mixture was irradiated at 160 °C for 40 min. The reaction mixture was then concentrated under reduced pressure, and the resulting solid was triturated with methanol, filtered, and dried to give the intermediate compound as an off-white solid (28.3 mg, 0.084 mmol, 22%). To EtOH (10 mL) was added KOH (2 pellets) and the mixture heated to 90 °C for 20 h. The reaction mixture was then concentrated under reduced pressure and suspended in water. The mixture was then pH adjusted to pH 5.8 and extracted into EtOAc (2 × 100 mL), dried over MgSO<sub>4</sub>, and concentrated under reduced pressure. The resulting solid was triturated with diethyl ether, filtered, and dried to afford the title compound <b>54</b> as an off-white solid (12.2 mg, 0.048 mmol, 58%). <sup>1</sup>H NMR (400 Hz, DMSO-<i>d</i><sub>6</sub>): δ 6.67 (br s, 2H), 7.39 (t, 1H, <i>J</i> = 7.5 Hz), 7.55–7.63 (m, 3H), 8.15 (s, 1H), 12.40 (br s, 1H). HRMS (ESI) calculated for C<sub>13</sub>H<sub>8</sub>N<sub>5</sub>F [M + H]<sup>+</sup> 254.0837, found 254.0833. HPLC: <i>t</i><sub>R</sub> = 10.42 min (method A) (90.05%).</div></div><div id="sec5_52" class="NLM_sec NLM_sec_level_3"><div id="ac_i68" class="anchor-spacer"></div><h4 class="article-section__title" id="_i68"> 3-(2-Amino-5-cyano-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimdin-4-yl)benzamide (<b>55</b>)</h4><div class="NLM_p last"><b>5</b> (112 mg, 0.40 mmol), 3-(aminocarbonyl)phenyl boronic acid (108 mg, 0.65 mmol), and Pd-118 (37 mg, 0.056 mmol) were suspended in a mixture of IPA/H<sub>2</sub>O (3:1.5 mL) and degassed. <i>t</i>-Butylamine (0.21 mL, 2.0 mmol) was added, and the mixture was irradiated at 160 °C for 40 min. The resulting solution was diluted with EtOH (8 mL) and KOH (2 pellets) were added and the mixture was heated to 90 °C for 24 h. The reaction mixture was then concentrated under reduced pressure, and the resulting mixture was suspended in water, pH adjusted to pH 5.5, extracted into EtOAc (2 × 100 mL), and dried over MgSO<sub>4</sub>. The resulting solid was purified by column chromatography (100% hexane–100% ethyl acetate–5% methanol/ethyl acetate) to afford the title compound <b>55</b> as a yellow solid (34.2 mg, 0.123 mmol, 30%).<sup>1</sup>H NMR (400 Hz, DMSO-<i>d</i><sub>6</sub>): δ 6.67 (br s, 2H), 7.45 (br s, 1H), 7.61 (t, 1H, <i>J</i> = 7.6 Hz), 7.91 (d, 1H, <i>J</i> = 7.6 Hz), 8.01–8.05 (m, 2H), 8.14 (s, 1H), 8.30 (br s, 1H), 12.45 (br s, 1H). HRMS (ESI) calculated for C<sub>14</sub>H<sub>9</sub>N<sub>5</sub>O [M + H]<sup>+</sup> 277.0843, found 277.0846. HPLC: <i>t</i><sub>R</sub> = 8.17 min (method A) (46.30%).</div></div><div id="sec5_53" class="NLM_sec NLM_sec_level_3"><div id="ac_i69" class="anchor-spacer"></div><h4 class="article-section__title" id="_i69"> 2-Amino-4-(3-(hydroxymethyl)phenyl)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidine-5-carbonitrile (<b>56</b>)</h4><div class="NLM_p last"><b>5</b> (103 mg, 0.37 mmol), 3-(hydroxymethyl)phenyl boronic acid (94 mg, 0.62 mmol), and Pd-118 (53 mg, 0.081 mmol) were suspended in a mixture of IPA/H<sub>2</sub>O (3:1.5 mL) and degassed. <i>t</i>-Butylamine (0.20 mL, 1.90 mmol) was added, and the mixture was irradiated at 160 °C for 40 min. The resulting solution was diluted with EtOH (8 mL) and KOH (2 pellets) were added and the mixture was heated to 90 °C for 20 h. The reaction mixture was then concentrated under reduced pressure, and the resulting mixture was suspended in water, pH adjusted to pH 5.5, extracted into EtOAc (2 × 100 mL), and dried over MgSO<sub>4</sub>. The resulting solid was purified by column chromatography (100% hexane–100% ethyl acetate), triturated with diethyl ether, filtered, and dried to afford the title compound <b>56</b> as a yellow solid (30.5 mg g, 0.115 mmol, 31%). <sup>1</sup>H NMR (400 Hz, DMSO-<i>d</i><sub>6</sub>): δ 4.60 (d, 2H, <i>J</i> = 4.4 Hz), 5.28 (t, 1H, <i>J</i> = 5.2 Hz), 6.60 (br s, 2H), 7.49 (br s, 2H), 7.65–7.66 (m, 1H), 7.74 (s, 1H), 8.11 (s, 1H), 12.20 (br s, 1H). HRMS (ESI) calculated for C<sub>14</sub>H<sub>9</sub>N<sub>5</sub>O [M + H]<sup>+</sup> 264.0891, found 264.0894. HPLC: <i>t</i><sub>R</sub> = 8.62 min (method A).</div></div><div id="sec5_54" class="NLM_sec NLM_sec_level_3"><div id="ac_i70" class="anchor-spacer"></div><h4 class="article-section__title" id="_i70"> 3-(2-Amino-5-cyano-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl)benzenesulfonamide (<b>57</b>)</h4><div class="NLM_p last"><b>5</b> (102 mg g, 0.37 mmol), 3-(aminosulphonyl)benzene boronic acid (122 mg, 0.61 mmol), and Pd-118 (24 mg, 0.037 mmol) were suspended in a mixture of IPA/H<sub>2</sub>O (3:1.5 mL) and degassed. <i>t</i>-Butylamine (0.20 mL, 1.90 mmol) was added, and the mixture was irradiated at 160 °C for 40 min. The resulting solution was diluted with EtOH (8 mL) and KOH (2 pellets) were added, and the mixture was heated to 90 °C for 24 h. The reaction mixture was then concentrated under reduced pressure, and the resulting mixture was suspended in water, pH adjusted to pH 5.7, extracted into EtOAc (2 × 100 mL), and dried over MgSO<sub>4</sub>. The resulting solid was purified by column chromatography (100% hexane–100% ethyl acetate) to afford the title compound <b>57</b> as a pale solid (43.2 mg, 0.138 mmol, 38%). <sup>1</sup>H NMR (400 Hz, DMSO-<i>d</i><sub>6</sub>): δ 6.74 (br s, 2H), 7.44 (br s, 2H), 7.74 (t, 1H, <i>J</i> = 7.8 Hz), 8.00 (t, 2H, <i>J</i> = 7.2 Hz), 8.17 (s, 1H), 8.23 (br s, 1H), 12.45 (br s, 1H). HRMS (ESI) calculated for C<sub>13</sub>H<sub>9</sub>N<sub>6</sub>S [M + H]<sup>+</sup> 313.0513, found 313.0516. HPLC: <i>t</i><sub>R</sub> = 8.44 min (method A) (93.47%).</div></div><div id="sec5_55" class="NLM_sec NLM_sec_level_3"><div id="ac_i71" class="anchor-spacer"></div><h4 class="article-section__title" id="_i71"> 2-Amino-4-(2-hydroxyphenyl)-7<i>7H</i>-pyrrolo[2,3-<i>d</i>]pyrimidine-5-carbonitrile (<b>58</b>)</h4><div class="NLM_p last"><b>5</b> (117 mg, 0.36 mmol), 2-hydroxybenzene boronic acid (94 mg, 0.68 mmol), and Pd-118 (26 mg, 0.040 mmol) were suspended in a mixture of IPA/H<sub>2</sub>O (3:1.5 mL) and degassed. <i>t</i>-Butylamine (0.20 mL, 1.90 mmol) was added, and the mixture was irradiated at 160 °C for 40 min. The resulting solution was diluted with EtOH (8 mL) and KOH (2 pellets) were added and the mixture was heated to 90 °C for 24 h. The reaction mixture was then concentrated under reduced pressure, and the resulting mixture was suspended in water, pH adjusted to pH 5.3, extracted into EtOAc (2 × 100 mL), and dried over MgSO<sub>4</sub>. The mixture was then concentrated under reduced pressure, triturated with diethyl ether, and purified by column chromatography (100% hexane–100% ethyl acetate). The resulting solid was triturated with diethyl ether, filtered under reduced pressure, and dried to afford the title compound <b>58</b> as a bright-yellow solid (30.7 mg, 0.122 mmol, 34%). <sup>1</sup>H NMR (400 Hz, DMSO-<i>d</i><sub>6</sub>): δ 6.99 (t, 1H, <i>J</i> = 7.5 Hz), 7.07 (d, 1H, <i>J</i> = 8.0 Hz), 7.46 (d of t, 1H, <i>J</i> = 1.5, 7.0 Hz), 7.56 (d of d, 1H, <i>J</i> = 2.0, 1.5 Hz), 8.36 (s, 1H). HRMS (ESI) calculated for C<sub>15</sub>H<sub>10</sub>N<sub>2</sub>O<sub>2</sub> [M + H]<sup>+</sup> 250.0737, found 250.0735. HPLC: <i>t</i><sub>R</sub> = 10.11 min (method A).</div></div><div id="sec5_56" class="NLM_sec NLM_sec_level_3"><div id="ac_i72" class="anchor-spacer"></div><h4 class="article-section__title" id="_i72"> 2-Amino-4-(2-fluorophenyl)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidine-5-carbonitrile (<b>59</b>)</h4><div class="NLM_p last"><b>5</b> (100 mg, 0.31 mmol), Pd-118 (20 mg, 0.03 mmol), <i>t</i>-butylamine (160 μL, 1.55 mmol), and 2-fluorophenylboronic acid (69 mg, 0.5 mmol) were suspended in a 2:1 mixture <i>i</i>-PrOH/H<sub>2</sub>O (4.5 mL) and were irradiated with microwaves at 160 °C for 40 min. Once cooled to room temperature, the reaction mixture was concentrated under reduced pressure. To this was added EtOH (5 mL) and KOH (2 pellets) and the reaction mixture was refluxed t at 90 °C for 20 h. The mixture was then concentrated under reduced pressure, and the crude material was then suspended in H<sub>2</sub>O and adjusted to pH 5 with 1 M HCl. The solution was then extracted with EtOAc (2 × 50 mL); the organic layer was adsorbed on silica gel and concentrated under reduced pressure. Chromatographic purification (EtOAc/Hex: 50% 4CV, 50–75% 6CV, 75% 4CV, 75–100% 7CV, 100% 6CV) yielded a beige solid that was triturated with Et<sub>2</sub>O to afford the title compound <b>59</b> and as a beige solid (16 mg g, 0.06 mmol, 20%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 6.68 (s, 2H), 7.35 (t, <i>J</i> = 8.3 Hz, 2H), 7.58 (t, <i>J</i> = 7.7 Hz, 2H), 8.06 (s, 1H), 12.34 (s, 1H). HRMS (ESI) calculated for C<sub>13</sub>H<sub>9</sub>N<sub>5</sub>F [M + H]<sup>+</sup> 254.0837 found 254.0831.</div></div><div id="sec5_57" class="NLM_sec NLM_sec_level_3"><div id="ac_i73" class="anchor-spacer"></div><h4 class="article-section__title" id="_i73"> 2-(2-Amino-5-cyano-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl)benzamide (<b>60</b>)</h4><div class="NLM_p last"><b>5</b> (104 mg, 0.32 mmol), 2-(aminocarbonyl)benzne boronic acid (87 mg, 0.53 mmol), and Pd-118 (21 mg, 0.032 mmol) were suspended in a mixture of IPA/H<sub>2</sub>O (3:1.5 mL) and degassed. <i>t</i>-Butylamine (0.18 mL, 1.71 mmol) was added, and the mixture was irradiated at 160 °C for 40 min. The resulting solution was diluted with EtOH (8 mL) and KOH (2 pellets) were added and the mixture was heated to 90 °C for 24 h. The reaction mixture was then concentrated under reduced pressure, and the resulting mixture was suspended in water, pH adjusted to pH 5.3, extracted into EtOAc (2 × 100 mL), and dried over MgSO<sub>4</sub>. The mixture was then concentrated under reduced pressure, triturated with methanol, and purified by column chromatography (100% hexane–10% methanol/ethyl acetate). The resulting solid was recrystallized from dichloromethane and diethyl ether and dried to afford the title compound <b>60</b> as a bright-yellow solid (3.5 mg, 0.0126 mmol, 3.9%). <sup>1</sup>H NMR (400 Hz, DMSO-<i>d</i><sub>6</sub>): δ 6.48 (br s, 2H), 7.23 (s, 1H), 7.40–7.42 (m, 1H), 7.51–7.60 (m, 2H), 7.71 (d, 1H, <i>J</i> = 2.2 Hz), 7.73 (br s, 1H), 7.96 (s, 1H), 12.20 (br s, 1H). HRMS (ESI) calculated for C<sub>14</sub>H<sub>9</sub>N<sub>6</sub>O [M + H]<sup>+</sup> 277.0843, found 277.0851. HPLC: <i>t</i><sub>R</sub> = 7.86 min (method A) (88.64%).</div></div><div id="sec5_58" class="NLM_sec NLM_sec_level_3"><div id="ac_i74" class="anchor-spacer"></div><h4 class="article-section__title" id="_i74"> 2-Amino-4-(2-(hydroxymethyl)phenyl)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidine-5-carbonitrile (<b>61</b>)</h4><div class="NLM_p last"><b>5</b> (110 mg, 0.40 mmol), 2-hydroxymethylbenzne boronic acid (133 mg, 0.87 mmol), and Pd-118 (31 mg, 0.048 mmol) were suspended in a mixture of IPA/H<sub>2</sub>O (3:1.5 mL) and degassed. <i>t</i>-Butylamine (0.21 mL, 2.0 mmol) was added, and the mixture was irradiated at 160 °C for 40 min. Organics were combined and concentrated under reduced pressure. The resulting solid was triturated with diethyl ether, filtered, and dried to afford the title compound <b>61</b> as an off-white solid (51 mg g, 0.193 mmol, 49%). <sup>1</sup>H NMR (400 Hz, DMSO-<i>d</i><sub>6</sub>): δ 4.55 (d, 2H, <i>J</i> = 5.6 Hz), 5.09 (t, 1H, <i>J</i> = 5.8 Hz), 6.64 (br s, 2H), 7.37–7.41 (m, 2H), 7.48 (d of t, 1H, <i>J</i> = 2.0, 7.2 Hz), 7.61 (d, 1H, <i>J</i> = 7.6 Hz), 8.05 (s, 1H), 12.31 (br s, 1H). HRMS (ESI) calculated for C<sub>14</sub>H<sub>10</sub>N<sub>5</sub>O [M + H]<sup>+</sup> 264.0891, found 264.0891.</div></div><div id="sec5_59" class="NLM_sec NLM_sec_level_3"><div id="ac_i75" class="anchor-spacer"></div><h4 class="article-section__title" id="_i75"> 2-(2-Amino-5-cyano-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl)benzenesulfonamide (<b>62</b>)</h4><div class="NLM_p last"><b>5</b> (130 mg, 0.405 mmol), 2-(sulfamoylphenyl)boronic acid (130 mg, 0.65 mmol), and Pd-118 (28 mg, 0.043 mmol) was suspended in a mixture of IPA/H<sub>2</sub>O (3 mL:1.5 mL), and the mixture was degassed under nitrogen. <i>t</i>-Butylamine (0.25 mL, 2.4 mmol) was added, and the reaction mixture was degassed under nitrogen. The reaction mixture was irradiated with microwaves at 160 °C for 40 min. Once cooled to room temperature, the mixture was diluted with EtOH (8 mL) and KOH (2 pellets) added. The reaction mixture was heated to 95 °C for 20 h. The reaction mixture was then concentrated under reduced pressure. The residue was suspended in water, and the mixture was pH adjusted to pH 5.5 and extracted with ethyl acetate and concentrated under reduced pressure. The resulting solid was triturated with diethyl ether and filtered off. Further purification was required, and this was carried out using HPLC to afford the title compound <b>62</b> (6.8 mg). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 6.82 (br s, 2H), 7.16 (br s, 2H), 7.62 (m, 1H), 7.73 (m, 2H), 8.04 (m, 1H), 8.06 (d, <i>J</i> = 5.0 Hz, 1H), 12.39 (br s, 1H). HRMS (ESI) calculated for C<sub>13</sub>H<sub>11</sub>N<sub>6</sub>O<sub>2</sub>S [M + H]<sup>+</sup> 315.0659, found 315.0656.</div></div><div id="sec5_60" class="NLM_sec NLM_sec_level_3"><div id="ac_i76" class="anchor-spacer"></div><h4 class="article-section__title" id="_i76"> 4-(2-Amino-7<i>H</i>-pyrrol[2,3-<i>d</i>]pyrimidin-4-yl)benzenesulfonamide (<b>64</b>)</h4><div class="NLM_p last">4-Chloro-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimdin-2-amine (70 mg, 0.42 mmol), 4-sulphamoylbenzne boronic acid (133 mg, 0.66 mmol), and Pd-118 (37 mg, 0.057 mmol) were suspended in a mixture of IPA/H<sub>2</sub>O (3:1.5 mL) and degassed. <i>t</i>-Butylamine (0.22 mL, 2.09 mmol) was added, and the mixture was irradiated at 160 °C for 40 min. Once cooled to room temperature the reaction mixture was diluted with ethyl acetate and concentrated under reduced pressure. The resulting solid was purified by column chromatography (100% hexane–100% ethyl acetate), triturated with diethyl ether, filtered, and dried to afford the title compound <b>64</b> as a pale-yellow solid (23.7 mg, 0.082 mmol, 20%). <sup>1</sup>H NMR (400 Hz, DMSO-<i>d</i><sub>6</sub>): δ 6.23 (br s, 2H), 6.61 (d, 1H, <i>J</i> = 2.0 Hz), 7.17 (d, 1H, <i>J</i> = 2.8 Hz), 7.48 (br s, 2H), 7.98 (d, 2H, <i>J</i> = 8.4 Hz), 8.2 (d, 2H, <i>J</i> = 8.4 Hz), 11.36 (br s, 1H). HRMS (ESI) calculated for C<sub>12</sub>H<sub>11</sub>N<sub>5</sub>O<sub>2</sub>S [M + H]<sup>+</sup> 290.0706, found 290.0703. HPLC: <i>t</i><sub>R</sub> = 8.45 min (method A).</div></div><div id="sec5_61" class="NLM_sec NLM_sec_level_3"><div id="ac_i77" class="anchor-spacer"></div><h4 class="article-section__title" id="_i77"> 4-(7<i>H</i>-Pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl)benzenesulfonamide (<b>65</b>)</h4><div class="NLM_p last">6-Chloro-7-deazapurine (233 mg, 1.45 mmol), 4-sulfamoylbenzene boronic acid (408 mg, 2.03 mmol), and 2-amino-2-methylpropane (0.61 mL, 5.80 mmol) were dissolved in 2-propanol (7.5 mL) and water (3.75 mL), and the solution degassed with argon. Dichloro[1,1′ bis(di-<i>tert</i>-butylphosphino)]ferrocene palladium(II) (94.4 mg, 0.145 mmol) was added, and the mixture was heated at 160 °C for 40 min in a microwave. The reaction mixture was concentrated under reduced pressure and purified by flash column chromatography (silica gel with EtOAc (100%)–50% MeOH/EtOAc) to give the crude product. Trituration of the crude product with DCM/MeOH (9:1) gave the title compound <b>65</b> as a yellow solid (155 mg, 0.57 mmol, 39%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): 6.95 (d, 1H, <i>J</i> = 2.0 Hz), 7.52 (s, 2H), 7.27 (dd, 1H, <i>J</i> = 2.8, 2.0 Hz), 8.04 (d, 2H, <i>J</i> = 8.4 Hz), 8.37 (d, 2H, <i>J</i> = 8.4 Hz), 8.89 (s, 1H), 12.41 (br s, 1H). HRMS (ESI) calculated for C<sub>12</sub>H<sub>10</sub>N<sub>4</sub>O<sub>2</sub>S [M + H]<sup>+</sup> 275.0603, found 275.0597.</div></div><div id="sec5_62" class="NLM_sec NLM_sec_level_3"><div id="ac_i78" class="anchor-spacer"></div><h4 class="article-section__title" id="_i78"> 4-(5-Cyano-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl)benzenesulfonamide (<b>66</b>)</h4><div class="NLM_p last">4-Chloro-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidine-5-carbonitrile (95 mg, 0.53 mmol), 4-sulfamoylphenylboronic acid (171 mg, 0.85 mmol), and Pd-118 (35 mg, 0.05) was suspended in a mixture of IPA/H<sub>2</sub>O (3 mL:1.5 mL), and the mixture was degassed under nitrogen. <i>t</i>-Butylamine (0.28 mL, 2.7 mmol) was added, and the reaction mixture was degassed under nitrogen. The reaction mixture was irradiated with microwaves at 160 °C for 1 h. The reaction mixture was cooled to room temperature, and the crude material was suspended in methanol, adsorbed onto silica gel, and concentrated under reduced pressure. Purification was achieved using column chromatography (100% hexane–50/50 hexane/ethyl acetate–100% ethyl acetate) to afford the title compound <b>66</b> as a beige solid (76 mg, 0.25 mmol, 48%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.58 (s, 2H), 8.03 (d, <i>J</i> = 8.0 Hz, 2H), 8.08 (d, <i>J</i> = 8.3 Hz, 2H), 8.73 (s, 1H), 9.06 (s, 1H), 13.52 (s, 1H). HRMS (ESI) calculated for C<sub>13</sub>H<sub>10</sub>O<sub>2</sub>N<sub>5</sub>S [M + H]<sup>+</sup> 300.0550, found 300.0546.</div></div><div id="sec5_63" class="NLM_sec NLM_sec_level_3"><div id="ac_i79" class="anchor-spacer"></div><h4 class="article-section__title" id="_i79"> 4-(Piperidin-1-yl)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-2-amine (<b>67</b>)</h4><div class="NLM_p last">4-Chloro-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-2-amine (80 mg, 4.76 mmol), NEt<sub>3</sub> (0.2 mL, 1.43 mmol), and piperidine (0.15 mL, 1.52 mmol) was suspended in 1,4-dioxane (2.5 mL), which was degassed under nitrogen. The reaction mixture was irradiated with microwaves at 200 °C for 20 min. The resulting mixture was diluted with EtOAc (10 mL) and concentrated under reduced pressure. Purification by column chromatography (100% EtOAc–10% MeOH/EtOAc) followed by trituration with diethyl ether and filtration afforded the title compound <b>67</b> as a white solid (8 mg, 0.04 mmol, 0.8%).<sup>1</sup>H NMR (400 Hz, DMSO-<i>d</i><sub>6</sub>): δ 1.56 (m, 4H), 1.64 (m, 2H), 3.75 (t, <i>J</i> = 5.0 Hz, 4H), 5.49 (br s, 2H), 6.31 (dd, <i>J</i> = 2.0, 3.5 Hz, 1H), 6.72 9dd, <i>J</i> = 2.5, 3.5 Hz, 1H), 10.80 (br s, 2H). HRMS (ESI) calculated for C<sub>11</sub>H<sub>16</sub>N<sub>5</sub> [M + H]<sup>+</sup> 218.1400, found 218.1398.</div></div><div id="sec5_64" class="NLM_sec NLM_sec_level_3"><div id="ac_i80" class="anchor-spacer"></div><h4 class="article-section__title" id="_i80"> <i>N</i><sup>4</sup>-Cyclohexyl-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidine-2,4-diamine (<b>68</b>)</h4><div class="NLM_p last">To 2-amino-3<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4(7<i>H</i>)-one (110 mg, 0.73 mmol), BOP (44 mg, 1.00 mmol), and DBU (0.22 mL, 1.47 mmol) in DMF/DMSO (1:1, 4 mL) was added cyclohexylamine (0.25 mL, 2.19 mmol) at room temperature. The reaction mixture was stirred at room temperature for 4 d then heated to 60 °C for 2 h. The reaction mixture was cooled to room temperature and concentrated under reduced pressure. The resulting residue was triturated with water and extracted into EtOAc. The organic layer was concentrated under reduced pressure to afford the title compound <b>68</b> as an yellow solid (50 mg, 0.22 mmol, 30%). <sup>1</sup>H NMR (400 Hz, DMSO-<i>d</i><sub>6</sub>): δ 1.14 (m, 1H), 1.35 (m, 4H), 1.63 (m, 2H), 1.76 (m, 2H), 1.90 (m, 2H), 6.49 (br s, 2H), 6.63 (s, 1H), 6.85 (s, 1H), 7.36 (br s, 1H), 11.71 (br s, 1H). LRMS (ESI): calculated for C<sub>12</sub>H<sub>17</sub>N<sub>5</sub> [M + H]<sup>+</sup> 232.29, found 232.27.</div></div><div id="sec5_65" class="NLM_sec NLM_sec_level_3"><div id="ac_i81" class="anchor-spacer"></div><h4 class="article-section__title" id="_i81"> (1<i>R</i>,4<i>R</i>)-4-(2-Amino-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-ylamino)cyclohexanol (<b>69</b>)</h4><div class="NLM_p last">Prepared according to procedure B using 4-chloro-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-2-amine. Chromatographic purification (Biotage SP4, 10 g cartridge, solvent system: MeOH/DCM; gradient 5% 4CV, 0–20% 10CV, 20% 4CV) yielded <b>69</b> (94 mg, 64%) as a fluffy white solid; mp 178–180 °C (d). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 1.20–1.36 (m, 4H), 1.84–1.90 (m, 4H), 3.37–3.44 (m, 1H), 3.91–4.01 (m, 1H), 4.54 (d, <i>J</i> = 4.4 Hz, 1H), 5.38 (bs, 2H), 6.31–6.32 (m, 1H), 6.59–6.60 (m, 1H), 6.63 (bs, 1H), 10.57 (bs, 1H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 31.4, 35.0, 48.0, 69.1, 96.5, 99.4, 117.0, 153.2, 156.6, 160.3. HRMS (ESI) calculated for C<sub>12</sub>H<sub>18</sub>ON<sub>5</sub> [M + H]<sup>+</sup> 248.1506, found 248.1504. HPLC <i>t</i><sub>R</sub> = 7.40 min (method C).</div></div><div id="sec5_66" class="NLM_sec NLM_sec_level_3"><div id="ac_i82" class="anchor-spacer"></div><h4 class="article-section__title" id="_i82"> <i>N</i><sup>4</sup>-Cyclohexyl-5-(trifluoromethyl)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidine-2,4-diamine (<b>70</b>)</h4><div class="NLM_p last">Prepared according to procedure A using 4-chloro-5-(trifluoromethyl)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-2-amine (100 mg, 0.42 mmol). Chromatographic purification (Biotage SP4, 10 g cartridge, solvent system: EtOAc/Hex; gradient 15% 4CV; 15–75% 10CV; 75% 6CV) yielded a brown oil. The oil was dissolved in Et2O (1 mL) and poured dropwise into Hex (6 mL). The precipitate was filtered off to yield <b>70</b> (30 mg, 24%) as a light-brown solid; mp 202–204 °C (d). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 1.11–1.20 (m, 3H), 1.25–1.37 (m, 2H), 1.58–1.62 (m, 1H), 1.70–1.74 (m, 2H), 1.88–1.91 (m, 2H), 3.70–3.80 (m, 1H), 6.91 (d, <i>J</i> = 7.3 Hz, 1H), 7.09 (bs, 2H), 7.99 (s, 1H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 25.3, 25.9, 33.1, 49.0, 59.3, 100.0, 105.5, 121.8, 123.9, 147.6, 151.6. HRMS (ESI) calculated for C<sub>13</sub>H<sub>16</sub>N<sub>5</sub>F<sub>3</sub> [M – H]<sup>−</sup> 298.1285, found 298.1283. HPLC <i>t</i><sub>R</sub> = 10.76 min (method A).</div></div><div id="sec5_67" class="NLM_sec NLM_sec_level_3"><div id="ac_i83" class="anchor-spacer"></div><h4 class="article-section__title" id="_i83"> 2-Amino-4-((1<i>R</i>,4<i>R</i>)-4-hydroxycyclohexylamino)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidine-5-carboxamide (<b>71</b>)</h4><div class="NLM_p last"><b>5</b> (100 mg, 0.56 mmol) and <i>trans</i>-4-aminocyclohexanol (124 mg, 1.08 mmol) were suspended in <i>n</i>-BuOH (4 mL) and refluxed for 16 h. After cooling to room temperature H<sub>2</sub>O (2 mL) and KOH (2 pellets) were added and the reaction mixture was heated for 40 min at 150 °C in the microwave oven. The mixture was neutralized using 6 M HCl and concentrated in vacuo. The residue was triturated with H<sub>2</sub>O (4 mL) and dried in vacuo. The remaining solid was then triturated with Et<sub>2</sub>O (2 × 10 mL) and dried in vacuo to afford <b>71</b> (91 mg, 87% yield) as a beige solid; mp >300 °C (d). FTIR (neat): 3441.8, 3352.4, 3130.0, 2938.5, 2854.5, 1628.5, 1593.6, 1507.5, 1451.01, 1417.06 cm<sup>–1</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 1.18–1.32 (m, 4H), 1.83–1.85 (m, 2H), 1.95–1.98 (m, 2H), 3.43–3.53 (m, 1H), 3.88–3.96 (m, 1H), 4.54 (d, <i>J</i> = 2.6 Hz, 1H), 5.56 (bs, 2H), 7.00 (bs, 1H), 7.50 (s, 1H), 7.65 (bs, 1H), 9.37 (d, <i>J</i> = 7.7 Hz, 1H), 11.16 (bs, 1H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 30.7, 33.9, 47.4, 68.4, 95.0, 111.1, 122.1, 154.0, 157.0, 161.1, 168.0. HRMS (ESI) calculated for C<sub>13</sub>H<sub>19</sub>O<sub>2</sub>N<sub>6</sub> [M + H]<sup>+</sup> 291.1564, found 291.1563. HPLC <i>t</i><sub>R</sub> = 6.64 min (method C).</div></div></div><div id="sec5_68" class="NLM_sec NLM_sec_level_2"><div id="ac_i84" class="anchor-spacer"></div><h3 class="article-section__title" id="_i84"> IKK Assays</h3><div class="NLM_p">IKKα and IKKβ inhibitory activity was determined using a dissociation enhanced ligand fluorescent immunoassay (DELFIA) based on the protocol of HTScan IKKβ kinase assay (Cell Signaling Technology, USA).</div><div class="NLM_p">Recombinant IKKα or IKKβ, 37 nM (Millipore, Dundee, UK), was incubated with IκB-α (Ser32) (New England Biolabs, Hitchin, UK), biotinylated peptide substrate (0.375 μM), and 40 μM ATP in assay buffer (40 mM Tris-HCl (pH 7.5), 20 mM MgCl<sub>2</sub>, EDTA 1 mM, DTT 2 mM, and BSA 0.01 mg/mL) in a V-well 96-well plate in the presence and absence of test compound. The assay plate was incubated for 60 min at 30 °C, after which the kinase reaction was quenched by the addition of 50 mM EDTA, pH 8. The resulting mixture was transferred to a streptavidin-coated 96-well plate (PerkinElmer, Beaconsfield, UK) and incubated for 1 h at 30 °C to immobilize the substrate peptide. After three washes with wash buffer (0.01 M phosphate buffered saline (PBS), 0.05% Tween-20, pH 7.4), a primary antibody against the phosphorylated substrate (phospho-IκB-α) (Ser32/36) (5A5) mouse mAb (New England Biolabs, Hitchin, UK) (1:1000 dilution with 1% bovine serum albumin (BSA) in wash buffer) was added and incubated at 37 °C for 2 h.</div><div class="NLM_p last">After a further three washes, a secondary europiated antibody (Eu–N1 labeled antimouse IgG, (PerkinElmer, Beaconsfield, UK) diluted 1:500 in 1% BSA/wash buffer) was added and incubated at 30 °C for 30 min. After a further five washes, DELFIA enhancement solution (PerkinElmer, Beaconsfield UK) was added and allowed to incubate for 10 min at room temperature, protected from light, to facilitate the chemifluorescent detection. The relative fluorescence units (RFU) signal were measured on a Wallac Victor 1420 multilabel counter (PerkinElmer, Beaconsfield, UK) in time-resolved fluorescence mode. The counter was set at an excitation wavelength of 340 nm with a 400 μs delay before detecting emitted light at 615 nm. The apparent <i>K</i><sub>i</sub> of the phosphorylated substrate was calculated for each compound using the Cheng–Prusoff equation.</div></div><div id="sec5_69" class="NLM_sec NLM_sec_level_2"><div id="ac_i85" class="anchor-spacer"></div><h3 class="article-section__title" id="_i85"> Cell Culture</h3><div class="NLM_p last">U2OS cells were cultured with McCoy’s 5A modified medium and MEF were cultured with DEME medium containing 10% (v/v) FCS and medium was changed every 2 d thereafter until cells became confluent. Cells were incubated at 37 °C in humidified air with 5% CO<sub>2</sub> and rendered quiescent by serum deprivation for 24 h prior to stimulation in serum-free medium.</div></div><div id="sec5_70" class="NLM_sec NLM_sec_level_2"><div id="ac_i86" class="anchor-spacer"></div><h3 class="article-section__title" id="_i86"> Western Blot Analysis</h3><div class="NLM_p last">Whole cell lysates were prepared from U2OS and status of IκBα, p65, p-p65 (Ser536), and p-p100 (Ser 866/870) assessed by Western blotting as described in Mackenzie et al. (2007).<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a></div></div><div id="sec5_71" class="NLM_sec NLM_sec_level_2"><div id="ac_i87" class="anchor-spacer"></div><h3 class="article-section__title" id="_i87"> NFκB Transcriptional Activity Assays</h3><div class="NLM_p last">An adenoviral vector encoding NFκB-luciferase (Adv.NFκB-Luc) was purchased from Vector Biolabs (University of Pennsylvania, Philadelphia, US). Large-scale production of high titer recombinant adenovirus was performed by routine methods.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> IKKβ knockout mouse embryonic fibroblasts (MEFs; kindly provided by Prof. I. Verma, UCSD, USA) were counted when approximately 60–70% confluent in T75 cm<sup>2</sup> flasks and infected with adenovirus up to 300 pfu/cell<sup>–1</sup> for 24 h in 10% DMEM. Cells were then lifted from the flasks and plated into 96-well clear bottom, black luciferase plates and allowed to settle for 24 h before serum starved overnight. Cells were then stimulated with the appropriate agonists for the indicated times and reactions terminated by addition of lysis buffer containing 0.2 mM luciferin substrate. Relative light units (RLU) were measured using a Trilux microbeta counter (luminometer).</div></div><div id="sec5_72" class="NLM_sec NLM_sec_level_2"><div id="ac_i88" class="anchor-spacer"></div><h3 class="article-section__title" id="_i88"> Kinase Profiling</h3><div class="NLM_p last">Kinase profiling of compound <b>48</b> was outsourced to Millipore, specifically the Kinase Profiler Customer Service for single concentration studies using duplicate assay points.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i89"><a href="/doi/suppl/10.1021/acs.jmedchem.7b00484">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_85280" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_85280" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.7b00484" class="ext-link">10.1021/acs.jmedchem.7b00484</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">IKKα homology model (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00484/suppl_file/jm7b00484_si_001.pdb" class="ext-link">PDB</a>)</p></li><li><p class="inline">IKKα with compound <b>4</b>(<a href="/doi/suppl/10.1021/acs.jmedchem.7b00484/suppl_file/jm7b00484_si_002.pdb" class="ext-link">PDB</a>)</p></li><li><p class="inline">IKKα with compound <b>9</b>(<a href="/doi/suppl/10.1021/acs.jmedchem.7b00484/suppl_file/jm7b00484_si_003.pdb" class="ext-link">PDB</a>)</p></li><li><p class="inline">IKKα with compound <b>43</b>(<a href="/doi/suppl/10.1021/acs.jmedchem.7b00484/suppl_file/jm7b00484_si_004.pdb" class="ext-link">PDB</a>)</p></li><li><p class="inline">IKKα with compound <b>47</b>(<a href="/doi/suppl/10.1021/acs.jmedchem.7b00484/suppl_file/jm7b00484_si_005.pdb" class="ext-link">PDB</a>)</p></li><li><p class="inline">IKKα with compound <b>48</b>(<a href="/doi/suppl/10.1021/acs.jmedchem.7b00484/suppl_file/jm7b00484_si_006.pdb" class="ext-link">PDB</a>)</p></li><li><p class="inline">IKKα with compound <b>50</b>(<a href="/doi/suppl/10.1021/acs.jmedchem.7b00484/suppl_file/jm7b00484_si_007.pdb" class="ext-link">PDB</a>)</p></li><li><p class="inline">Molecular formula strings with associated IKK biochemical inhibitory data in SMILES format (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00484/suppl_file/jm7b00484_si_008.csv" class="ext-link">CSV</a>)</p></li><li><p class="inline">The inhibitory kinome profile for compound <b>48</b> against 40 kinases (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00484/suppl_file/jm7b00484_si_009.xls" class="ext-link">XLS</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00484/suppl_file/jm7b00484_si_001.pdb">jm7b00484_si_001.pdb (191.46 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00484/suppl_file/jm7b00484_si_002.pdb">jm7b00484_si_002.pdb (390.49 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00484/suppl_file/jm7b00484_si_003.pdb">jm7b00484_si_003.pdb (392.31 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00484/suppl_file/jm7b00484_si_004.pdb">jm7b00484_si_004.pdb (391.5 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00484/suppl_file/jm7b00484_si_005.pdb">jm7b00484_si_005.pdb (397.85 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00484/suppl_file/jm7b00484_si_006.pdb">jm7b00484_si_006.pdb (392.0 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00484/suppl_file/jm7b00484_si_007.pdb">jm7b00484_si_007.pdb (387.97 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00484/suppl_file/jm7b00484_si_008.csv">jm7b00484_si_008.csv (4.29 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00484/suppl_file/jm7b00484_si_009.xls">jm7b00484_si_009.xls (28.5 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.7b00484" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_12081" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_12081" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Simon P. Mackay</span> - <span class="hlFld-Affiliation affiliation">Strathclyde Institute
of Pharmacy and Biomedical Sciences, University
of Strathclyde, 161 Cathedral Street, Glasgow G4 0NR, Scotland, United
Kingdom</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-8000-6557" title="Orcid link">http://orcid.org/0000-0001-8000-6557</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#62110b0f0d0c4c0f030109031b2211161003160a4c03014c1709"><span class="__cf_email__" data-cfemail="73001a1e1c1d5d1e121018120a3300070112071b5d12105d0618">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nahoum G. Anthony</span> - <span class="hlFld-Affiliation affiliation">Strathclyde Institute
of Pharmacy and Biomedical Sciences, University
of Strathclyde, 161 Cathedral Street, Glasgow G4 0NR, Scotland, United
Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jessica Baiget</span> - <span class="hlFld-Affiliation affiliation">Strathclyde Institute
of Pharmacy and Biomedical Sciences, University
of Strathclyde, 161 Cathedral Street, Glasgow G4 0NR, Scotland, United
Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Giacomo Berretta</span> - <span class="hlFld-Affiliation affiliation">Strathclyde Institute
of Pharmacy and Biomedical Sciences, University
of Strathclyde, 161 Cathedral Street, Glasgow G4 0NR, Scotland, United
Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Marie Boyd</span> - <span class="hlFld-Affiliation affiliation">Strathclyde Institute
of Pharmacy and Biomedical Sciences, University
of Strathclyde, 161 Cathedral Street, Glasgow G4 0NR, Scotland, United
Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">David Breen</span> - <span class="hlFld-Affiliation affiliation">WestCHEM Department of Pure and Applied Chemistry, University of Strathclyde, 295 Cathedral Street, Glasgow G1 1XL, Scotland, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Joanne Edwards</span> - <span class="hlFld-Affiliation affiliation">Wolfson Wohl Cancer Research Centre, Institute
of Cancer Sciences, University of Glasgow, Garscube Estate, Switchback Road, Glasgow G61 1QH, Scotland, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Carly Gamble</span> - <span class="hlFld-Affiliation affiliation">Strathclyde Institute
of Pharmacy and Biomedical Sciences, University
of Strathclyde, 161 Cathedral Street, Glasgow G4 0NR, Scotland, United
Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alexander I. Gray</span> - <span class="hlFld-Affiliation affiliation">Strathclyde Institute
of Pharmacy and Biomedical Sciences, University
of Strathclyde, 161 Cathedral Street, Glasgow G4 0NR, Scotland, United
Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alan L. Harvey</span> - <span class="hlFld-Affiliation affiliation">Strathclyde Institute
of Pharmacy and Biomedical Sciences, University
of Strathclyde, 161 Cathedral Street, Glasgow G4 0NR, Scotland, United
Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sophia Hatziieremia</span> - <span class="hlFld-Affiliation affiliation">Strathclyde Institute
of Pharmacy and Biomedical Sciences, University
of Strathclyde, 161 Cathedral Street, Glasgow G4 0NR, Scotland, United
Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ka Ho Ho</span> - <span class="hlFld-Affiliation affiliation">Strathclyde Institute
of Pharmacy and Biomedical Sciences, University
of Strathclyde, 161 Cathedral Street, Glasgow G4 0NR, Scotland, United
Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Judith K. Huggan</span> - <span class="hlFld-Affiliation affiliation">Strathclyde Institute
of Pharmacy and Biomedical Sciences, University
of Strathclyde, 161 Cathedral Street, Glasgow G4 0NR, Scotland, United
Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stuart Lang</span> - <span class="hlFld-Affiliation affiliation">WestCHEM Department of Pure and Applied Chemistry, University of Strathclyde, 295 Cathedral Street, Glasgow G1 1XL, Scotland, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sabin Llona-Minguez</span> - <span class="hlFld-Affiliation affiliation">Strathclyde Institute
of Pharmacy and Biomedical Sciences, University
of Strathclyde, 161 Cathedral Street, Glasgow G4 0NR, Scotland, United
Kingdom</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-3187-722X" title="Orcid link">http://orcid.org/0000-0003-3187-722X</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jia Lin Luo</span> - <span class="hlFld-Affiliation affiliation">Strathclyde Institute
of Pharmacy and Biomedical Sciences, University
of Strathclyde, 161 Cathedral Street, Glasgow G4 0NR, Scotland, United
Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kathryn McIntosh</span> - <span class="hlFld-Affiliation affiliation">Strathclyde Institute
of Pharmacy and Biomedical Sciences, University
of Strathclyde, 161 Cathedral Street, Glasgow G4 0NR, Scotland, United
Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Andrew Paul</span> - <span class="hlFld-Affiliation affiliation">Strathclyde Institute
of Pharmacy and Biomedical Sciences, University
of Strathclyde, 161 Cathedral Street, Glasgow G4 0NR, Scotland, United
Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Robin J. Plevin</span> - <span class="hlFld-Affiliation affiliation">Strathclyde Institute
of Pharmacy and Biomedical Sciences, University
of Strathclyde, 161 Cathedral Street, Glasgow G4 0NR, Scotland, United
Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Murray N. Robertson</span> - <span class="hlFld-Affiliation affiliation">Strathclyde Institute
of Pharmacy and Biomedical Sciences, University
of Strathclyde, 161 Cathedral Street, Glasgow G4 0NR, Scotland, United
Kingdom</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-9543-7667" title="Orcid link">http://orcid.org/0000-0001-9543-7667</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rebecca Scott</span> - <span class="hlFld-Affiliation affiliation">Strathclyde Institute
of Pharmacy and Biomedical Sciences, University
of Strathclyde, 161 Cathedral Street, Glasgow G4 0NR, Scotland, United
Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Colin J. Suckling</span> - <span class="hlFld-Affiliation affiliation">WestCHEM Department of Pure and Applied Chemistry, University of Strathclyde, 295 Cathedral Street, Glasgow G1 1XL, Scotland, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Oliver B. Sutcliffe</span> - <span class="hlFld-Affiliation affiliation">Strathclyde Institute
of Pharmacy and Biomedical Sciences, University
of Strathclyde, 161 Cathedral Street, Glasgow G4 0NR, Scotland, United
Kingdom</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-3781-7754" title="Orcid link">http://orcid.org/0000-0003-3781-7754</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Louise C. Young</span> - <span class="hlFld-Affiliation affiliation">Strathclyde Institute
of Pharmacy and Biomedical Sciences, University
of Strathclyde, 161 Cathedral Street, Glasgow G4 0NR, Scotland, United
Kingdom</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d49e6703-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i90">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_01270" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_01270" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Financial support was provided by Cancer Research UK through grant no. C7599/A9336 and Prostate Cancer UK, grant no. PG12-27</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i91" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i91"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i92" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i92"> Abbreviations Used</h2><tr><td class="NLM_term">CDK2</td><td class="NLM_def"><p class="first last">cyclin dependent kinase 2</p></td></tr><tr><td class="NLM_term">DELFIA</td><td class="NLM_def"><p class="first last">dissociation-enhanced lanthanide fluorescence immunoassay</p></td></tr><tr><td class="NLM_term">FCS</td><td class="NLM_def"><p class="first last">fecal calf serum</p></td></tr><tr><td class="NLM_term">GK</td><td class="NLM_def"><p class="first last">gatekeeper</p></td></tr><tr><td class="NLM_term">G-loop</td><td class="NLM_def"><p class="first last">glycine-rich loop</p></td></tr><tr><td class="NLM_term">IkBα</td><td class="NLM_def"><p class="first last">inhibitory kappa B α</p></td></tr><tr><td class="NLM_term">IKK</td><td class="NLM_def"><p class="first last">inhibitory kappa B kinase</p></td></tr><tr><td class="NLM_term">IL-1β</td><td class="NLM_def"><p class="first last">interleukin-1β</p></td></tr><tr><td class="NLM_term">MD</td><td class="NLM_def"><p class="first last">molecular dynamics</p></td></tr><tr><td class="NLM_term">MEF</td><td class="NLM_def"><p class="first last">mouse embryonic fibroblasts</p></td></tr><tr><td class="NLM_term">NAM</td><td class="NLM_def"><p class="first last">noraristeromycin</p></td></tr><tr><td class="NLM_term">NF-kB</td><td class="NLM_def"><p class="first last">nuclear factor kappa-light-chain-enhancer of activated B cells</p></td></tr><tr><td class="NLM_term">RLU</td><td class="NLM_def"><p class="first last">relative light units</p></td></tr><tr><td class="NLM_term">TNFα</td><td class="NLM_def"><p class="first last">tumor necrosis factor α</p></td></tr><tr><td class="NLM_term">U2OS</td><td class="NLM_def"><p class="first last">human bone osteosarcoma cells</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i93">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_52284" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_52284" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 47 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Karin, M.</span><span> </span><span class="NLM_article-title">Nuclear factor-kappa B in cancer development and progression</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">441</span><span class="NLM_x">, </span> <span class="NLM_fpage">431</span><span class="NLM_x">–</span> <span class="NLM_lpage">436</span><span class="refDoi"> DOI: 10.1038/nature04870</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;key=10.1038%2Fnature04870" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=441&publication_year=2006&pages=431-436&author=M.+Karin&title=Nuclear+factor-kappa+B+in+cancer+development+and+progression&doi=10.1038%2Fnature04870"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fnature04870&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature04870%26sid%3Dliteratum%253Aachs%26aulast%3DKarin%26aufirst%3DM.%26atitle%3DNuclear%2520factor-kappa%2520B%2520in%2520cancer%2520development%2520and%2520progression%26jtitle%3DNature%26date%3D2006%26volume%3D441%26spage%3D431%26epage%3D436%26doi%3D10.1038%2Fnature04870" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Xiao, C. C.; Ghosh, S.</span><span> </span><span class="NLM_article-title">NF-kappa B, an evolutionarily conserved mediator of immune and inflammatory responses</span>. In  <span class="citation_source-book">Mechanisms of Lymphocyte Activation and Immune Regulation X: Innate Immunity</span>, <span class="NLM_contrib-group">Gupta, S.; Paul, W. E.; Steinman, R.</span>, Eds.; <span class="NLM_publisher-name">Springer</span>: <span class="NLM_publisher-loc">Boston, MA</span>,<span class="NLM_x"> </span><span class="NLM_year">2005</span><span class="NLM_x">; </span>Vol.  <span class="NLM_volume">560</span>, pp  <span class="NLM_fpage">41</span><span class="NLM_x">–</span> <span class="NLM_lpage">45</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;key=10.1007%2F0-387-24180-9_5" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&pages=41-45&author=C.+C.+Xiao&author=S.+Ghoshauthor=S.+Gupta&author=W.+E.+Paul&author=R.+Steinman&title=Mechanisms+of+Lymphocyte+Activation+and+Immune+Regulation+X%3A+Innate+Immunity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1007%2F0-387-24180-9_5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F0-387-24180-9_5%26sid%3Dliteratum%253Aachs%26aulast%3DXiao%26aufirst%3DC.%2BC.%26atitle%3DNF-kappa%2520B%252C%2520an%2520evolutionarily%2520conserved%2520mediator%2520of%2520immune%2520and%2520inflammatory%2520responses%26btitle%3DMechanisms%2520of%2520Lymphocyte%2520Activation%2520and%2520Immune%2520Regulation%2520X%253A%2520Innate%2520Immunity%26aulast%3DGupta%26aufirst%3DS.%26pub%3DSpringer%26date%3D2005%26volume%3D560%26spage%3D41%26epage%3D45" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Häcker, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karin, M.</span><span> </span><span class="NLM_article-title">Regulation and function of IKK and IKK-related kinases</span> <span class="citation_source-journal">Science’s STKE</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">2006</span><span class="NLM_x">, </span> <span class="NLM_fpage">re13</span><span class="refDoi"> DOI: 10.1126/stke.3572006re13</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;key=10.1126%2Fstke.3572006re13" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;key=17047224" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;key=1%3ACAS%3A280%3ADC%252BD28nhsFalsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2006&publication_year=2006&pages=re13&author=H.+H%C3%A4ckerauthor=M.+Karin&title=Regulation+and+function+of+IKK+and+IKK-related+kinases&doi=10.1126%2Fstke.3572006re13"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation and function of IKK and IKK-related kinases</span></div><div class="casAuthors">Hacker Hans; Karin Michael</div><div class="citationInfo"><span class="NLM_cas:title">Science's STKE : signal transduction knowledge environment</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">2006</span>
        (<span class="NLM_cas:issue">357</span>),
    <span class="NLM_cas:pages">re13</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Members of the nuclear factor kappa B (NF-kappaB) family of dimeric transcription factors (TFs) regulate expression of a large number of genes involved in immune responses, inflammation, cell survival, and cancer.  NF-kappaB TFs are rapidly activated in response to various stimuli, including cytokines, infectious agents, and radiation-induced DNA double-strand breaks.  In nonstimulated cells, some NF-kappaB TFs are bound to inhibitory IkappaB proteins and are thereby sequestered in the cytoplasm.  Activation leads to phosphorylation of IkappaB proteins and their subsequent recognition by ubiquitinating enzymes.  The resulting proteasomal degradation of IkappaB proteins liberates IkappaB-bound NF-kappaB TFs, which translocate to the nucleus to drive expression of target genes.  Two protein kinases with a high degree of sequence similarity, IKKalpha and IKKbeta, mediate phosphorylation of IkappaB proteins and represent a convergence point for most signal transduction pathways leading to NF-kappaB activation.  Most of the IKKalpha and IKKbeta molecules in the cell are part of IKK complexes that also contain a regulatory subunit called IKKgamma or NEMO.  Despite extensive sequence similarity, IKKalpha and IKKbeta have largely distinct functions, due to their different substrate specificities and modes of regulation.  IKKbeta (and IKKgamma) are essential for rapid NF-kappaB activation by proinflammatory signaling cascades, such as those triggered by tumor necrosis factor alpha (TNFalpha) or lipopolysaccharide (LPS).  In contrast, IKKalpha functions in the activation of a specific form of NF-kappaB in response to a subset of TNF family members and may also serve to attenuate IKKbeta-driven NF-kappaB activation.  Moreover, IKKalpha is involved in keratinocyte differentiation, but this function is independent of its kinase activity.  Several years ago, two protein kinases, one called IKKepsilon or IKK-i and one variously named TBK1 (TANK-binding kinase), NAK (NF-kappaB-activated kinase), or T2K (TRAF2-associated kinase), were identified that exhibit structural similarity to IKKalpha and IKKbeta.  These protein kinases are important for the activation of interferon response factor 3 (IRF3) and IRF7, TFs that play key roles in the induction of type I interferon (IFN-I).  Together, the IKKs and IKK-related kinases are instrumental for activation of the host defense system.  This Review focuses on the functions of IKK and IKK-related kinases and the molecular mechanisms that regulate their activities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSMHh8QyF1EzrFU0A1HOshhfW6udTcc2ebxCjBdDI1icrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28nhsFalsg%253D%253D&md5=31e5e57982ec416f6eb6de1566437258</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1126%2Fstke.3572006re13&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fstke.3572006re13%26sid%3Dliteratum%253Aachs%26aulast%3DH%25C3%25A4cker%26aufirst%3DH.%26aulast%3DKarin%26aufirst%3DM.%26atitle%3DRegulation%2520and%2520function%2520of%2520IKK%2520and%2520IKK-related%2520kinases%26jtitle%3DScience%25E2%2580%2599s%2520STKE%26date%3D2006%26volume%3D2006%26spage%3Dre13%26doi%3D10.1126%2Fstke.3572006re13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Xiao, G. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rabson, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qing, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qu, Z. X.</span><span> </span><span class="NLM_article-title">Alternative pathways of NF-kappa B activation: A double-edged sword in health and disease</span> <span class="citation_source-journal">Cytokine Growth Factor Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">281</span><span class="NLM_x">–</span> <span class="NLM_lpage">293</span><span class="refDoi"> DOI: 10.1016/j.cytogfr.2006.04.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;key=10.1016%2Fj.cytogfr.2006.04.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;key=16793322" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;key=1%3ACAS%3A528%3ADC%252BD28XntFSgsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2006&pages=281-293&author=G.+T.+Xiaoauthor=A.+B.+Rabsonauthor=W.+Youngauthor=G.+L.+Qingauthor=Z.+X.+Qu&title=Alternative+pathways+of+NF-kappa+B+activation%3A+A+double-edged+sword+in+health+and+disease&doi=10.1016%2Fj.cytogfr.2006.04.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Alternative pathways of NF-κB activation: A double-edged sword in health and disease</span></div><div class="casAuthors">Xiao, Gutian; Rabson, Arnold B.; Young, Wise; Qing, Guoliang; Qu, Zhaoxia</div><div class="citationInfo"><span class="NLM_cas:title">Cytokine & Growth Factor Reviews</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">281-293</span>CODEN:
                <span class="NLM_cas:coden">CGFRFB</span>;
        ISSN:<span class="NLM_cas:issn">1359-6101</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  While the classical pathway of NF-κB activation plays crit. roles in a wide range of biol. processes, the more recently described "non-canonical" NF-κB pathway has important but more restricted roles in both normal and pathol. processes.  The non-canonical NF-κB pathway, based on processing of the nf-κb2 gene product p100 to generate p52, appears to be involved in B-cell maturation and lymphoid development.  Deregulated activation of this pathway has been obsd. in a variety of malignant and autoimmune diseases, thus inhibitors that specifically target p100 processing might be predicted to have potential roles as immunomodulators and in the therapy of malignant diseases.  We review current understandings of NF-κB activation, particularly the mechanisms of p100 processing under both physiol. and pathol. conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGquHFIxIuoo_LVg90H21EOLACvtfcHk0lhD1T4qBcyCQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XntFSgsbo%253D&md5=93a55ea72f4cf701f0020ca7eecc40e2</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.cytogfr.2006.04.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cytogfr.2006.04.005%26sid%3Dliteratum%253Aachs%26aulast%3DXiao%26aufirst%3DG.%2BT.%26aulast%3DRabson%26aufirst%3DA.%2BB.%26aulast%3DYoung%26aufirst%3DW.%26aulast%3DQing%26aufirst%3DG.%2BL.%26aulast%3DQu%26aufirst%3DZ.%2BX.%26atitle%3DAlternative%2520pathways%2520of%2520NF-kappa%2520B%2520activation%253A%2520A%2520double-edged%2520sword%2520in%2520health%2520and%2520disease%26jtitle%3DCytokine%2520Growth%2520Factor%2520Rev.%26date%3D2006%26volume%3D17%26spage%3D281%26epage%3D293%26doi%3D10.1016%2Fj.cytogfr.2006.04.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Hu, Y. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baud, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oga, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, K. I. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshida, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karin, M.</span><span> </span><span class="NLM_article-title">IKKalpha controls formation of the epidermis independently of NF-kappa B</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">410</span><span class="NLM_x">, </span> <span class="NLM_fpage">710</span><span class="NLM_x">–</span> <span class="NLM_lpage">714</span><span class="refDoi"> DOI: 10.1038/35070605</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;key=10.1038%2F35070605" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=410&publication_year=2001&pages=710-714&author=Y.+L.+Huauthor=V.+Baudauthor=T.+Ogaauthor=K.+I.+I.+Kimauthor=K.+Yoshidaauthor=M.+Karin&title=IKKalpha+controls+formation+of+the+epidermis+independently+of+NF-kappa+B&doi=10.1038%2F35070605"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2F35070605&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F35070605%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DY.%2BL.%26aulast%3DBaud%26aufirst%3DV.%26aulast%3DOga%26aufirst%3DT.%26aulast%3DKim%26aufirst%3DK.%2BI.%2BI.%26aulast%3DYoshida%26aufirst%3DK.%26aulast%3DKarin%26aufirst%3DM.%26atitle%3DIKKalpha%2520controls%2520formation%2520of%2520the%2520epidermis%2520independently%2520of%2520NF-kappa%2520B%26jtitle%3DNature%26date%3D2001%26volume%3D410%26spage%3D710%26epage%3D714%26doi%3D10.1038%2F35070605" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Karin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greten, F. R.</span><span> </span><span class="NLM_article-title">NF kappa B: Linking inflammation and immunity to cancer development and progression</span> <span class="citation_source-journal">Nat. Rev. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">749</span><span class="NLM_x">–</span> <span class="NLM_lpage">759</span><span class="refDoi"> DOI: 10.1038/nri1703</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;key=10.1038%2Fnri1703" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;key=16175180" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVGrurvL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=749-759&author=M.+Karinauthor=F.+R.+Greten&title=NF+kappa+B%3A+Linking+inflammation+and+immunity+to+cancer+development+and+progression&doi=10.1038%2Fnri1703"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">NF-κB: linking inflammation and immunity to cancer development and progression</span></div><div class="casAuthors">Karin, Michael; Greten, Florian R.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Immunology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">749-759</span>CODEN:
                <span class="NLM_cas:coden">NRIABX</span>;
        ISSN:<span class="NLM_cas:issn">1474-1733</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  A review.  There has been much effort recently to probe the long-recognized relationship between the pathol. processes of infection, inflammation and cancer.  For example, epidemiol. studies have shown that ∼15% of human deaths from cancer are assocd. with chronic viral or bacterial infections.  This Review focuses on the mol. mechanisms that connect infection, inflammation and cancer, and it puts forward the hypothesis that activation of nuclear factor-κB (NF-κB) by the classical, IKK-β (inhibitor-of-NF-κB kinase-β)-dependent pathway is a crucial mediator of inflammation-induced tumor growth and progression, as well as an important modulator of tumor surveillance and rejection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbLJjlXSNvCLVg90H21EOLACvtfcHk0lgfkxjOH_GL7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVGrurvL&md5=84c639c714d2c8d3a3d29e2025a2b789</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2Fnri1703&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnri1703%26sid%3Dliteratum%253Aachs%26aulast%3DKarin%26aufirst%3DM.%26aulast%3DGreten%26aufirst%3DF.%2BR.%26atitle%3DNF%2520kappa%2520B%253A%2520Linking%2520inflammation%2520and%2520immunity%2520to%2520cancer%2520development%2520and%2520progression%26jtitle%3DNat.%2520Rev.%2520Immunol.%26date%3D2005%26volume%3D5%26spage%3D749%26epage%3D759%26doi%3D10.1038%2Fnri1703" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Sizemore, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lerner, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dombrowski, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakurai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stark, G. R.</span><span> </span><span class="NLM_article-title">Distinct roles of the IkappaB kinase alpha and beta subunits in liberating nuclear factor kappa B (NF-kappa-B) from IkappaB and in phosphorylating the p65 subunit of NF-kappa B</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">277</span><span class="NLM_x">, </span> <span class="NLM_fpage">3863</span><span class="NLM_x">–</span> <span class="NLM_lpage">3869</span><span class="refDoi"> DOI: 10.1074/jbc.M110572200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;key=10.1074%2Fjbc.M110572200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=277&publication_year=2002&pages=3863-3869&author=N.+Sizemoreauthor=N.+Lernerauthor=N.+Dombrowskiauthor=H.+Sakuraiauthor=G.+R.+Stark&title=Distinct+roles+of+the+IkappaB+kinase+alpha+and+beta+subunits+in+liberating+nuclear+factor+kappa+B+%28NF-kappa-B%29+from+IkappaB+and+in+phosphorylating+the+p65+subunit+of+NF-kappa+B&doi=10.1074%2Fjbc.M110572200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M110572200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M110572200%26sid%3Dliteratum%253Aachs%26aulast%3DSizemore%26aufirst%3DN.%26aulast%3DLerner%26aufirst%3DN.%26aulast%3DDombrowski%26aufirst%3DN.%26aulast%3DSakurai%26aufirst%3DH.%26aulast%3DStark%26aufirst%3DG.%2BR.%26atitle%3DDistinct%2520roles%2520of%2520the%2520IkappaB%2520kinase%2520alpha%2520and%2520beta%2520subunits%2520in%2520liberating%2520nuclear%2520factor%2520kappa%2520B%2520%2528NF-kappa-B%2529%2520from%2520IkappaB%2520and%2520in%2520phosphorylating%2520the%2520p65%2520subunit%2520of%2520NF-kappa%2520B%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2002%26volume%3D277%26spage%3D3863%26epage%3D3869%26doi%3D10.1074%2Fjbc.M110572200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Park, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krishnan, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Malley, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaynor, R. B.</span><span> </span><span class="NLM_article-title">Formation of an IKK alpha-dependent transcription complex is required for estrogen receptor-mediated gene activation</span> <span class="citation_source-journal">Mol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">71</span><span class="NLM_x">–</span> <span class="NLM_lpage">82</span><span class="refDoi"> DOI: 10.1016/j.molcel.2005.03.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;key=10.1016%2Fj.molcel.2005.03.006" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2005&pages=71-82&author=K.+J.+Parkauthor=V.+Krishnanauthor=B.+W.+O%E2%80%99Malleyauthor=Y.+Yamamotoauthor=R.+B.+Gaynor&title=Formation+of+an+IKK+alpha-dependent+transcription+complex+is+required+for+estrogen+receptor-mediated+gene+activation&doi=10.1016%2Fj.molcel.2005.03.006"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2005.03.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2005.03.006%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DK.%2BJ.%26aulast%3DKrishnan%26aufirst%3DV.%26aulast%3DO%25E2%2580%2599Malley%26aufirst%3DB.%2BW.%26aulast%3DYamamoto%26aufirst%3DY.%26aulast%3DGaynor%26aufirst%3DR.%2BB.%26atitle%3DFormation%2520of%2520an%2520IKK%2520alpha-dependent%2520transcription%2520complex%2520is%2520required%2520for%2520estrogen%2520receptor-mediated%2520gene%2520activation%26jtitle%3DMol.%2520Cell%26date%3D2005%26volume%3D18%26spage%3D71%26epage%3D82%26doi%3D10.1016%2Fj.molcel.2005.03.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Wen, D. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nong, Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgan, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gangurde, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bielecki, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DaSilva, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keaveney, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fraser, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schopf, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hepperle, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harriman, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaffee, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ocain, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Y. J.</span><span> </span><span class="NLM_article-title">A selective small molecule IkappaB kinase beta inhibitor blocks nuclear factor kappa B-mediated inflammatory responses in human fibroblast-like synoviocytes, chondrocytes, and mast cells</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">317</span><span class="NLM_x">, </span> <span class="NLM_fpage">989</span><span class="NLM_x">–</span> <span class="NLM_lpage">1001</span><span class="refDoi"> DOI: 10.1124/jpet.105.097584</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;key=10.1124%2Fjpet.105.097584" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;key=16525037" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;key=1%3ACAS%3A528%3ADC%252BD28Xlt1eqtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=317&publication_year=2006&pages=989-1001&author=D.+Y.+Wenauthor=Y.+H.+Nongauthor=J.+G.+Morganauthor=P.+Gangurdeauthor=A.+Bieleckiauthor=J.+DaSilvaauthor=M.+Keaveneyauthor=H.+Chengauthor=C.+Fraserauthor=L.+Schopfauthor=M.+Hepperleauthor=G.+Harrimanauthor=B.+D.+Jaffeeauthor=T.+D.+Ocainauthor=Y.+J.+Xu&title=A+selective+small+molecule+IkappaB+kinase+beta+inhibitor+blocks+nuclear+factor+kappa+B-mediated+inflammatory+responses+in+human+fibroblast-like+synoviocytes%2C+chondrocytes%2C+and+mast+cells&doi=10.1124%2Fjpet.105.097584"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">A selective small molecule IκB kinase β inhibitor blocks nuclear factor κB-mediated inflammatory responses in human fibroblast-like synoviocytes, chondrocytes, and mast cells</span></div><div class="casAuthors">Wen, Danyi; Nong, Yuhua; Morgan, Jennifer G.; Gangurde, Pranoti; Bielecki, Andrew; DaSilva, Jennifer; Keaveney, Marie; Cheng, Hong; Fraser, Chris; Schopf, Lisa; Hepperle, Michael; Harriman, Geraldine; Jaffee, Bruce D.; Ocain, Timothy D.; Xu, Yajun</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">317</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">989-1001</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">IκB kinase (IKK) β is essential for inflammatory cytokine-induced activation of nuclear factor κB (NF-κB).  NF-κB plays a pivotal role in the function of major cell types that contribute to the pathophysiol. process of rheumatoid arthritis (RA).  Here, we report the mechanism and the effect of the IKKβ inhibitor N-(6-chloro-7-methoxy-9H-β-carbolin-8-yl)-2-methylnicotinamide (ML120B), a β-carboline deriv., on NF-κB signaling and gene activation in RA-relevant cell systems.  ML120B is a potent, selective, reversible, and ATP-competitive inhibitor of IKKβ with an IC50 of 60 nM when evaluated in an IκBα kinase complex assay.  ML120B does not inhibit other IKK isoforms or a panel of other kinases.  ML120B concn.-dependently inhibits tumor necrosis factor α (TNFα)-stimulated NF-κB signaling via inhibition of IκBα phosphorylation, degrdn., and NF-κB translocation into the nucleus.  For the first time, we have demonstrated that in human fibroblast-like synoviocytes, TNFα- or interleukin (IL)-1β-induced monocyte chemoattractant protein-1 regulated on activation, normal T cell expressed and secreted and prodn. is IKKβ-dependent.  In addn., for the first time, we have demonstrated that lipopolysaccharide- or peptidoglycan-induced cytokine prodn. in human cord blood-derived mast cells is IKKβ-dependent.  In addn., in human chondrocytes, ML120B inhibited IL-1β-induced matrix metalloproteinase prodn. with an IC50 of approx. 1 μM.  ML120B also blocked IL-1β-induced prostaglandin E2 prodn.  In summary, ML120B blocked numerous NF-κB-regulated cell responses that are involved in inflammation and destructive processes in the RA joint.  Our findings support the evaluation of IKKβ inhibitors as anti-inflammatory agents for the treatment of RA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoiioh_R_Vy_LVg90H21EOLACvtfcHk0lisoE4jVMytsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xlt1eqtrY%253D&md5=620a2ba27d791849b613d1160add85e8</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1124%2Fjpet.105.097584&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.105.097584%26sid%3Dliteratum%253Aachs%26aulast%3DWen%26aufirst%3DD.%2BY.%26aulast%3DNong%26aufirst%3DY.%2BH.%26aulast%3DMorgan%26aufirst%3DJ.%2BG.%26aulast%3DGangurde%26aufirst%3DP.%26aulast%3DBielecki%26aufirst%3DA.%26aulast%3DDaSilva%26aufirst%3DJ.%26aulast%3DKeaveney%26aufirst%3DM.%26aulast%3DCheng%26aufirst%3DH.%26aulast%3DFraser%26aufirst%3DC.%26aulast%3DSchopf%26aufirst%3DL.%26aulast%3DHepperle%26aufirst%3DM.%26aulast%3DHarriman%26aufirst%3DG.%26aulast%3DJaffee%26aufirst%3DB.%2BD.%26aulast%3DOcain%26aufirst%3DT.%2BD.%26aulast%3DXu%26aufirst%3DY.%2BJ.%26atitle%3DA%2520selective%2520small%2520molecule%2520IkappaB%2520kinase%2520beta%2520inhibitor%2520blocks%2520nuclear%2520factor%2520kappa%2520B-mediated%2520inflammatory%2520responses%2520in%2520human%2520fibroblast-like%2520synoviocytes%252C%2520chondrocytes%252C%2520and%2520mast%2520cells%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2006%26volume%3D317%26spage%3D989%26epage%3D1001%26doi%3D10.1124%2Fjpet.105.097584" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Burke, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pattoli, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gregor, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brassil, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacMaster, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McIntyre, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, X. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iotzova, V. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarke, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strnad, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiu, Y. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zusi, F. C.</span><span> </span><span class="NLM_article-title">BMS-345541 is a highly selective inhibitor of IkappaB kinase that binds at an allosteric site of the enzyme and blocks NF-kappa B-dependent transcription in mice</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">278</span><span class="NLM_x">, </span> <span class="NLM_fpage">1450</span><span class="NLM_x">–</span> <span class="NLM_lpage">1456</span><span class="refDoi"> DOI: 10.1074/jbc.M209677200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;key=10.1074%2Fjbc.M209677200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2003&pages=1450-1456&author=J.+R.+Burkeauthor=M.+A.+Pattoliauthor=K.+R.+Gregorauthor=P.+J.+Brassilauthor=J.+F.+MacMasterauthor=K.+W.+McIntyreauthor=X.+X.+Yangauthor=V.+S.+Iotzovaauthor=W.+Clarkeauthor=J.+Strnadauthor=Y.+P.+Qiuauthor=F.+C.+Zusi&title=BMS-345541+is+a+highly+selective+inhibitor+of+IkappaB+kinase+that+binds+at+an+allosteric+site+of+the+enzyme+and+blocks+NF-kappa+B-dependent+transcription+in+mice&doi=10.1074%2Fjbc.M209677200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M209677200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M209677200%26sid%3Dliteratum%253Aachs%26aulast%3DBurke%26aufirst%3DJ.%2BR.%26aulast%3DPattoli%26aufirst%3DM.%2BA.%26aulast%3DGregor%26aufirst%3DK.%2BR.%26aulast%3DBrassil%26aufirst%3DP.%2BJ.%26aulast%3DMacMaster%26aufirst%3DJ.%2BF.%26aulast%3DMcIntyre%26aufirst%3DK.%2BW.%26aulast%3DYang%26aufirst%3DX.%2BX.%26aulast%3DIotzova%26aufirst%3DV.%2BS.%26aulast%3DClarke%26aufirst%3DW.%26aulast%3DStrnad%26aufirst%3DJ.%26aulast%3DQiu%26aufirst%3DY.%2BP.%26aulast%3DZusi%26aufirst%3DF.%2BC.%26atitle%3DBMS-345541%2520is%2520a%2520highly%2520selective%2520inhibitor%2520of%2520IkappaB%2520kinase%2520that%2520binds%2520at%2520an%2520allosteric%2520site%2520of%2520the%2520enzyme%2520and%2520blocks%2520NF-kappa%2520B-dependent%2520transcription%2520in%2520mice%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2003%26volume%3D278%26spage%3D1450%26epage%3D1456%26doi%3D10.1074%2Fjbc.M209677200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Kim, B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seo, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryu, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahn, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hwang, B. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, Y.</span><span> </span><span class="NLM_article-title">Artemisolide is a typical inhibitor of IkappaB kinase beta targeting cysteine-179 residue and down-regulates NF-kappa B-dependent TNF-alpha expression in LPS-activated macrophages</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">361</span><span class="NLM_x">, </span> <span class="NLM_fpage">593</span><span class="NLM_x">–</span> <span class="NLM_lpage">598</span><span class="refDoi"> DOI: 10.1016/j.bbrc.2007.07.069</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;key=10.1016%2Fj.bbrc.2007.07.069" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=361&publication_year=2007&pages=593-598&author=B.+H.+Kimauthor=J.+Y.+Leeauthor=J.+H.+Seoauthor=H.+Y.+Leeauthor=S.+Y.+Ryuauthor=B.+W.+Ahnauthor=C.+K.+Leeauthor=B.+Y.+Hwangauthor=S.+B.+Hanauthor=Y.+Kim&title=Artemisolide+is+a+typical+inhibitor+of+IkappaB+kinase+beta+targeting+cysteine-179+residue+and+down-regulates+NF-kappa+B-dependent+TNF-alpha+expression+in+LPS-activated+macrophages&doi=10.1016%2Fj.bbrc.2007.07.069"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2007.07.069&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2007.07.069%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DB.%2BH.%26aulast%3DLee%26aufirst%3DJ.%2BY.%26aulast%3DSeo%26aufirst%3DJ.%2BH.%26aulast%3DLee%26aufirst%3DH.%2BY.%26aulast%3DRyu%26aufirst%3DS.%2BY.%26aulast%3DAhn%26aufirst%3DB.%2BW.%26aulast%3DLee%26aufirst%3DC.%2BK.%26aulast%3DHwang%26aufirst%3DB.%2BY.%26aulast%3DHan%26aufirst%3DS.%2BB.%26aulast%3DKim%26aufirst%3DY.%26atitle%3DArtemisolide%2520is%2520a%2520typical%2520inhibitor%2520of%2520IkappaB%2520kinase%2520beta%2520targeting%2520cysteine-179%2520residue%2520and%2520down-regulates%2520NF-kappa%2520B-dependent%2520TNF-alpha%2520expression%2520in%2520LPS-activated%2520macrophages%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2007%26volume%3D361%26spage%3D593%26epage%3D598%26doi%3D10.1016%2Fj.bbrc.2007.07.069" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Podolin, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Callahan, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolognese, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carlson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, T. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mellor, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roshak, A. K.</span><span> </span><span class="NLM_article-title">Attenuation of murine collagen-induced arthritis by a novel, potent, selective small molecule inhibitor of IkappaB kinase 2, TPCA-1 (2-(aminocarbonyl)amino-5-(4-fluorophenyl)-3-thiophenecarboxamide), occurs via reduction of proinflammatory cytokines and antigen-induced T cell proliferation</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">312</span><span class="NLM_x">, </span> <span class="NLM_fpage">373</span><span class="NLM_x">–</span> <span class="NLM_lpage">381</span><span class="refDoi"> DOI: 10.1124/jpet.104.074484</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;key=10.1124%2Fjpet.104.074484" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;key=15316093" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVWmurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=312&publication_year=2005&pages=373-381&author=P.+L.+Podolinauthor=J.+F.+Callahanauthor=B.+J.+Bologneseauthor=Y.+H.+Liauthor=K.+Carlsonauthor=T.+G.+Davisauthor=G.+W.+Mellorauthor=C.+Evansauthor=A.+K.+Roshak&title=Attenuation+of+murine+collagen-induced+arthritis+by+a+novel%2C+potent%2C+selective+small+molecule+inhibitor+of+IkappaB+kinase+2%2C+TPCA-1+%282-%28aminocarbonyl%29amino-5-%284-fluorophenyl%29-3-thiophenecarboxamide%29%2C+occurs+via+reduction+of+proinflammatory+cytokines+and+antigen-induced+T+cell+proliferation&doi=10.1124%2Fjpet.104.074484"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Attenuation of murine collagen-induced arthritis by a novel, potent, selective small molecule inhibitor of IκB kinase 2, TPCA-1 (2-[(aminocarbonyl)amino]-5-(4-fluorophenyl)-3-thiophenecarboxamide), occurs via reduction of proinflammatory cytokines and antigen-induced t cell proliferation</span></div><div class="casAuthors">Podolin, Patricia L.; Callahan, James F.; Bolognese, Brian J.; Li, Yue H.; Carlson, Karey; Davis, T. Gregg; Mellor, Geoff W.; Evans, Christopher; Roshak, Amy K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">312</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">373-381</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Demonstration that IκB kinase 2 (IKK-2) plays a pivotal role in the nuclear factor-κB-regulated prodn. of proinflammatory mols. by stimuli such as tumor necrosis factor (TNF)-α and interleukin (IL)-1 suggests that inhibition of IKK-2 may be beneficial in the treatment of rheumatoid arthritis.  In the present study, we demonstrate that a novel, potent (IC50 = 17.9 nM), and selective inhibitor of human IKK-2, 2-[(aminocarbonyl)amino]-5-(4-fluorophenyl)-3-thiophenecarboxamide (TPCA-1), inhibits lipopolysaccharide-induced human monocyte prodn. of TNF-α, IL-6, and IL-8 with an IC50 = 170 to 320 nM.  Prophylactic administration of TPCA-1 at 3, 10, or 20 mg/kg, i.p., b.i.d., resulted in a dose-dependent redn. in the severity of murine collagen-induced arthritis (CIA).  The significantly reduced disease severity and delay of disease onset resulting from administration of TPCA-1 at 10 mg/kg, i.p., b.i.d. were comparable to the effects of the antirheumatic drug, etanercept, when administered prophylactically at 4 mg/kg, i.p., every other day.  Nuclear localization of p65, as well as levels of IL-1β, IL-6, TNF-α, and interferon-γ, were significantly reduced in the paw tissue of TPCA-1- and etanercept-treated mice.  In addn., administration of TPCA-1 in vivo resulted in significantly decreased collagen-induced T cell proliferation ex vivo.  Therapeutic administration of TPCA-1 at 20 mg/kg, but not at 3 or 10 mg/kg, i.p., b.i.d., significantly reduced the severity of CIA, as did etanercept administration at 12.5 mg/kg, i.p., every other day.  These results suggest that redn. of proinflammatory mediators and inhibition of antigen-induced T cell proliferation are mechanisms underlying the attenuation of CIA by the IKK-2 inhibitor, TPCA-1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGrpRJjpOGVrVg90H21EOLACvtfcHk0lisoE4jVMytsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVWmurk%253D&md5=56712e228f6d6369b8b88e4288feb359</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1124%2Fjpet.104.074484&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.104.074484%26sid%3Dliteratum%253Aachs%26aulast%3DPodolin%26aufirst%3DP.%2BL.%26aulast%3DCallahan%26aufirst%3DJ.%2BF.%26aulast%3DBolognese%26aufirst%3DB.%2BJ.%26aulast%3DLi%26aufirst%3DY.%2BH.%26aulast%3DCarlson%26aufirst%3DK.%26aulast%3DDavis%26aufirst%3DT.%2BG.%26aulast%3DMellor%26aufirst%3DG.%2BW.%26aulast%3DEvans%26aufirst%3DC.%26aulast%3DRoshak%26aufirst%3DA.%2BK.%26atitle%3DAttenuation%2520of%2520murine%2520collagen-induced%2520arthritis%2520by%2520a%2520novel%252C%2520potent%252C%2520selective%2520small%2520molecule%2520inhibitor%2520of%2520IkappaB%2520kinase%25202%252C%2520TPCA-1%2520%25282-%2528aminocarbonyl%2529amino-5-%25284-fluorophenyl%2529-3-thiophenecarboxamide%2529%252C%2520occurs%2520via%2520reduction%2520of%2520proinflammatory%2520cytokines%2520and%2520antigen-induced%2520T%2520cell%2520proliferation%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2005%26volume%3D312%26spage%3D373%26epage%3D381%26doi%3D10.1124%2Fjpet.104.074484" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Strnad, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burke, J. R.</span><span> </span><span class="NLM_article-title">IkappaB kinase inhibitors for treating autoimmune and inflammatory disorders: potential and challenges</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">142</span><span class="NLM_x">–</span> <span class="NLM_lpage">148</span><span class="refDoi"> DOI: 10.1016/j.tips.2007.01.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;key=10.1016%2Fj.tips.2007.01.005" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2007&pages=142-148&author=J.+Strnadauthor=J.+R.+Burke&title=IkappaB+kinase+inhibitors+for+treating+autoimmune+and+inflammatory+disorders%3A+potential+and+challenges&doi=10.1016%2Fj.tips.2007.01.005"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2007.01.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2007.01.005%26sid%3Dliteratum%253Aachs%26aulast%3DStrnad%26aufirst%3DJ.%26aulast%3DBurke%26aufirst%3DJ.%2BR.%26atitle%3DIkappaB%2520kinase%2520inhibitors%2520for%2520treating%2520autoimmune%2520and%2520inflammatory%2520disorders%253A%2520potential%2520and%2520challenges%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2007%26volume%3D28%26spage%3D142%26epage%3D148%26doi%3D10.1016%2Fj.tips.2007.01.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Pasparakis, M.</span><span> </span><span class="NLM_article-title">Regulation of tissue homeostasis by NF-kappa B signalling: implications for inflammatory diseases</span> <span class="citation_source-journal">Nat. Rev. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">778</span><span class="NLM_x">–</span> <span class="NLM_lpage">788</span><span class="refDoi"> DOI: 10.1038/nri2655</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;key=10.1038%2Fnri2655" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;key=19855404" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlSqsbzI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=778-788&author=M.+Pasparakis&title=Regulation+of+tissue+homeostasis+by+NF-kappa+B+signalling%3A+implications+for+inflammatory+diseases&doi=10.1038%2Fnri2655"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of tissue homeostasis by NF-κB signaling: implications for inflammatory diseases</span></div><div class="casAuthors">Pasparakis, Manolis</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Immunology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">778-788</span>CODEN:
                <span class="NLM_cas:coden">NRIABX</span>;
        ISSN:<span class="NLM_cas:issn">1474-1733</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The nuclear factor-κB (NF-κB) signaling pathway regulates immune responses and is implicated in the pathogenesis of many inflammatory diseases.  Given the well established pro-inflammatory functions of NF-κB, inhibition of this pathway would be expected to have anti-inflammatory effects.  However, recent studies in mouse models have led to surprising and provocative results, as NF-κB inhibition in epithelial cells resulted in the spontaneous development of severe chronic inflammatory conditions.  These findings indicate that NF-κB signaling acts in non-immune cells to control the maintenance of tissue immune homeostasis.  This Review discusses the mechanisms by which NF-κB activity in non-immune cells regulates tissue immune homeostasis and prevents the pathogenesis of inflammatory diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8bGJpyA8ZFLVg90H21EOLACvtfcHk0ljB3kJvX1kxjg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlSqsbzI&md5=b4e1387aabd3f821a6fa3f33fe44292c</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1038%2Fnri2655&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnri2655%26sid%3Dliteratum%253Aachs%26aulast%3DPasparakis%26aufirst%3DM.%26atitle%3DRegulation%2520of%2520tissue%2520homeostasis%2520by%2520NF-kappa%2520B%2520signalling%253A%2520implications%2520for%2520inflammatory%2520diseases%26jtitle%3DNat.%2520Rev.%2520Immunol.%26date%3D2009%26volume%3D9%26spage%3D778%26epage%3D788%26doi%3D10.1038%2Fnri2655" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Li, Q. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Antwerp, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mercurio, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verma, I. M.</span><span> </span><span class="NLM_article-title">Severe liver degeneration in mice lacking the IkappaB kinase 2 gene</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">284</span><span class="NLM_x">, </span> <span class="NLM_fpage">321</span><span class="NLM_x">–</span> <span class="NLM_lpage">325</span><span class="refDoi"> DOI: 10.1126/science.284.5412.321</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;key=10.1126%2Fscience.284.5412.321" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=284&publication_year=1999&pages=321-325&author=Q.+T.+Liauthor=D.+Van+Antwerpauthor=F.+Mercurioauthor=K.+F.+Leeauthor=I.+M.+Verma&title=Severe+liver+degeneration+in+mice+lacking+the+IkappaB+kinase+2+gene&doi=10.1126%2Fscience.284.5412.321"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1126%2Fscience.284.5412.321&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.284.5412.321%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DQ.%2BT.%26aulast%3DVan%2BAntwerp%26aufirst%3DD.%26aulast%3DMercurio%26aufirst%3DF.%26aulast%3DLee%26aufirst%3DK.%2BF.%26aulast%3DVerma%26aufirst%3DI.%2BM.%26atitle%3DSevere%2520liver%2520degeneration%2520in%2520mice%2520lacking%2520the%2520IkappaB%2520kinase%25202%2520gene%26jtitle%3DScience%26date%3D1999%26volume%3D284%26spage%3D321%26epage%3D325%26doi%3D10.1126%2Fscience.284.5412.321" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Llona-Minguez, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baiget, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mackay, S. P.</span><span> </span><span class="NLM_article-title">Small-molecule inhibitors of IκB kinase (IKK) and IKK-related kinases</span> <span class="citation_source-journal">Pharm. Pat. Anal.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">481</span><span class="NLM_x">–</span> <span class="NLM_lpage">498</span><span class="refDoi"> DOI: 10.4155/ppa.13.31</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;key=10.4155%2Fppa.13.31" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;key=24237125" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFSitLnP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2013&pages=481-498&author=S.+Llona-Minguezauthor=J.+Baigetauthor=S.+P.+Mackay&title=Small-molecule+inhibitors+of+I%CE%BAB+kinase+%28IKK%29+and+IKK-related+kinases&doi=10.4155%2Fppa.13.31"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Small-molecule inhibitors of IκB kinase (IKK) and IKK-related kinases</span></div><div class="casAuthors">Llona-Minguez, Sabin; Baiget, Jessica; MacKay, Simon P.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmaceutical Patent Analyst</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">481-498</span>CODEN:
                <span class="NLM_cas:coden">PPAHCN</span>;
        ISSN:<span class="NLM_cas:issn">2046-8954</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">A review.  The transcription factors NF-κB and IFN control important signaling cascades and mediate the expression of a no. of important pro-inflammatory cytokines, adhesion mols., growth factors and anti-apoptotic survival proteins.  IκB kinase (IKK) and IKK-related kinases (IKKε and TBK1) are key regulators of these biol. pathways and, as such, modulators of these enzymes may be useful in the treatment of inflammatory diseases and cancer.  We have reviewed the most recent IKK patent literature (2008-2012), added publications of interest overlooked in previous patent reviews and identified all the players involved in small-mol. inhibitors of the IKKs.  This will provide the reader with a decisive summary of the IKK arena, a field that has reached maturity over a decade of research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJOXVRu3U4HLVg90H21EOLACvtfcHk0lihTT7TpzxIjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFSitLnP&md5=4de9b946fbc367f3279dd6a0dd6084eb</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.4155%2Fppa.13.31&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Fppa.13.31%26sid%3Dliteratum%253Aachs%26aulast%3DLlona-Minguez%26aufirst%3DS.%26aulast%3DBaiget%26aufirst%3DJ.%26aulast%3DMackay%26aufirst%3DS.%2BP.%26atitle%3DSmall-molecule%2520inhibitors%2520of%2520I%25CE%25BAB%2520kinase%2520%2528IKK%2529%2520and%2520IKK-related%2520kinases%26jtitle%3DPharm.%2520Pat.%2520Anal.%26date%3D2013%26volume%3D2%26spage%3D481%26epage%3D498%26doi%3D10.4155%2Fppa.13.31" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Asamitsu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamaguchi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakata, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hibi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Victoriano, A. F. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imai, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Onozaki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitade, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okamoto, T.</span><span> </span><span class="NLM_article-title">Inhibition of human immunodeficiency virus type 1 replication by blocking IkappaB Kinase with noraristeromycin</span> <span class="citation_source-journal">J. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">144</span><span class="NLM_x">, </span> <span class="NLM_fpage">581</span><span class="NLM_x">–</span> <span class="NLM_lpage">589</span><span class="refDoi"> DOI: 10.1093/jb/mvn104</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;key=10.1093%2Fjb%2Fmvn104" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;key=18713798" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhvFSquw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=144&publication_year=2008&pages=581-589&author=K.+Asamitsuauthor=T.+Yamaguchiauthor=K.+Nakataauthor=Y.+Hibiauthor=A.+F.+B.+Victorianoauthor=K.+Imaiauthor=K.+Onozakiauthor=Y.+Kitadeauthor=T.+Okamoto&title=Inhibition+of+human+immunodeficiency+virus+type+1+replication+by+blocking+IkappaB+Kinase+with+noraristeromycin&doi=10.1093%2Fjb%2Fmvn104"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of human immunodeficiency virus type 1 replication by blocking IκB kinase with noraristeromycin</span></div><div class="casAuthors">Asamitsu, Kaori; Yamaguchi, Tsuyoshi; Nakata, Kenji; Hibi, Yurina; Victoriano, Ann-Florence B.; Imai, Kenichi; Onozaki, Kikuo; Kitade, Yukio; Okamoto, Takashi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biochemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">144</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">581-589</span>CODEN:
                <span class="NLM_cas:coden">JOBIAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-924X</span>.
    
            (<span class="NLM_cas:orgname">Japanese Biochemical Society</span>)
        </div><div class="casAbstract">Nuclear factor κB (NF-κB) is one of the crit. transcription factors in inflammatory responses and replication of viruses such as human immunodeficiency virus (HIV).  In fact, it has been demonstrated that various NF-κB inhibitors could block HIV replication.  To explore more potent NF-κB inhibitors, we focused on carbocyclic adenine nucleosides that had been reported to have anti-inflammatory effects.  We synthesized 15 carbocyclic adenine nucleoside compds. and examd. their effects on the NF-κB-dependent gene expression using HEK293 cell line.  Among these compds., noraristeromycin (NAM) exhibited the most potent inhibitory effect on the NF-κB activity under the non-cytotoxic concns.  NAM-inhibited IκBα phosphorylation and degrdn. upon stimulation of cells with tumor necrosis factor-α (TNF-α).  In addn., NAM prevented p65 phosphorylation.  These findings suggested that both IκB kinase-α (IKK-α) and -β were targeted by NAM.  Interestingly, in vitro kinase assay revealed that NAM inhibited the kinase activity of IKK-α more potently than that of IKK-β.  When we treated the cell lines, OM10.1 and Molt4/IIIB, in which HIV-1 is latently and chronically infected, we found a strong suppressive effect of NAM on HIV-1 viral replication upon stimulation with TNF-α.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8cq4M_wM-mLVg90H21EOLACvtfcHk0lihTT7TpzxIjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhvFSquw%253D%253D&md5=847c61a45b6792b0a49d7f75b21774f9</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1093%2Fjb%2Fmvn104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjb%252Fmvn104%26sid%3Dliteratum%253Aachs%26aulast%3DAsamitsu%26aufirst%3DK.%26aulast%3DYamaguchi%26aufirst%3DT.%26aulast%3DNakata%26aufirst%3DK.%26aulast%3DHibi%26aufirst%3DY.%26aulast%3DVictoriano%26aufirst%3DA.%2BF.%2BB.%26aulast%3DImai%26aufirst%3DK.%26aulast%3DOnozaki%26aufirst%3DK.%26aulast%3DKitade%26aufirst%3DY.%26aulast%3DOkamoto%26aufirst%3DT.%26atitle%3DInhibition%2520of%2520human%2520immunodeficiency%2520virus%2520type%25201%2520replication%2520by%2520blocking%2520IkappaB%2520Kinase%2520with%2520noraristeromycin%26jtitle%3DJ.%2520Biochem.%26date%3D2008%26volume%3D144%26spage%3D581%26epage%3D589%26doi%3D10.1093%2Fjb%2Fmvn104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Palayoor, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Youmell, M. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calderwood, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coleman, C. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, B. D.</span><span> </span><span class="NLM_article-title">Constitutive activation of IkappaB kinase alpha and NF-kappa B in prostate cancer cells is inhibited by ibuprofen</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">7389</span><span class="NLM_x">–</span> <span class="NLM_lpage">7394</span><span class="refDoi"> DOI: 10.1038/sj.onc.1203160</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;key=10.1038%2Fsj.onc.1203160" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=1999&pages=7389-7394&author=S.+T.+Palayoorauthor=M.+Y.+Youmellauthor=S.+K.+Calderwoodauthor=C.+N.+Colemanauthor=B.+D.+Price&title=Constitutive+activation+of+IkappaB+kinase+alpha+and+NF-kappa+B+in+prostate+cancer+cells+is+inhibited+by+ibuprofen&doi=10.1038%2Fsj.onc.1203160"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1038%2Fsj.onc.1203160&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.onc.1203160%26sid%3Dliteratum%253Aachs%26aulast%3DPalayoor%26aufirst%3DS.%2BT.%26aulast%3DYoumell%26aufirst%3DM.%2BY.%26aulast%3DCalderwood%26aufirst%3DS.%2BK.%26aulast%3DColeman%26aufirst%3DC.%2BN.%26aulast%3DPrice%26aufirst%3DB.%2BD.%26atitle%3DConstitutive%2520activation%2520of%2520IkappaB%2520kinase%2520alpha%2520and%2520NF-kappa%2520B%2520in%2520prostate%2520cancer%2520cells%2520is%2520inhibited%2520by%2520ibuprofen%26jtitle%3DOncogene%26date%3D1999%26volume%3D18%26spage%3D7389%26epage%3D7394%26doi%3D10.1038%2Fsj.onc.1203160" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Ammirante, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grivennikov, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nedospasov, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karin, M.</span><span> </span><span class="NLM_article-title">B-cell-derived lymphotoxin promotes castration-resistant prostate cancer</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">464</span><span class="NLM_x">, </span> <span class="NLM_fpage">302</span><span class="NLM_x">–</span> <span class="NLM_lpage">U187</span><span class="refDoi"> DOI: 10.1038/nature08782</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;key=10.1038%2Fnature08782" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=464&publication_year=2010&pages=302-U187&author=M.+Ammiranteauthor=J.+L.+Luoauthor=S.+Grivennikovauthor=S.+Nedospasovauthor=M.+Karin&title=B-cell-derived+lymphotoxin+promotes+castration-resistant+prostate+cancer&doi=10.1038%2Fnature08782"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1038%2Fnature08782&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature08782%26sid%3Dliteratum%253Aachs%26aulast%3DAmmirante%26aufirst%3DM.%26aulast%3DLuo%26aufirst%3DJ.%2BL.%26aulast%3DGrivennikov%26aufirst%3DS.%26aulast%3DNedospasov%26aufirst%3DS.%26aulast%3DKarin%26aufirst%3DM.%26atitle%3DB-cell-derived%2520lymphotoxin%2520promotes%2520castration-resistant%2520prostate%2520cancer%26jtitle%3DNature%26date%3D2010%26volume%3D464%26spage%3D302%26epage%3DU187%26doi%3D10.1038%2Fnature08782" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Ben-Neriah, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karin, M.</span><span> </span><span class="NLM_article-title">Inflammation meets cancer, with NF-kappa B as the matchmaker</span> <span class="citation_source-journal">Nat. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">715</span><span class="NLM_x">–</span> <span class="NLM_lpage">723</span><span class="refDoi"> DOI: 10.1038/ni.2060</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;key=10.1038%2Fni.2060" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;key=21772280" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;key=1%3ACAS%3A528%3ADC%252BC3MXptV2isrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2011&pages=715-723&author=Y.+Ben-Neriahauthor=M.+Karin&title=Inflammation+meets+cancer%2C+with+NF-kappa+B+as+the+matchmaker&doi=10.1038%2Fni.2060"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Inflammation meets cancer, with NF-κB as the matchmaker</span></div><div class="casAuthors">Ben-Neriah, Yinon; Karin, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Nature Immunology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">715-723</span>CODEN:
                <span class="NLM_cas:coden">NIAMCZ</span>;
        ISSN:<span class="NLM_cas:issn">1529-2908</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Inflammation is a fundamental protective response that sometimes goes awry and becomes a major cofactor in the pathogenesis of many chronic human diseases, including cancer.  Here we review the evolutionary relationship and opposing functions of the transcription factor NF-κB in inflammation and cancer.  Although it seems to fulfill a distinctly tumor-promoting role in many types of cancer, NF-κB has a confounding role in certain tumors.  Understanding the activity and function of NF-κB in the context of tumorigenesis is crit. for its successful taming, an important challenge for modern cancer biol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZ72-CDkj-sbVg90H21EOLACvtfcHk0lhAsVqj9rckaA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXptV2isrk%253D&md5=c162e8a3bed9ded763be4719b40a75f2</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1038%2Fni.2060&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fni.2060%26sid%3Dliteratum%253Aachs%26aulast%3DBen-Neriah%26aufirst%3DY.%26aulast%3DKarin%26aufirst%3DM.%26atitle%3DInflammation%2520meets%2520cancer%252C%2520with%2520NF-kappa%2520B%2520as%2520the%2520matchmaker%26jtitle%3DNat.%2520Immunol.%26date%3D2011%26volume%3D12%26spage%3D715%26epage%3D723%26doi%3D10.1038%2Fni.2060" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Luo, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ricono, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korchynskyi, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonias, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheresh, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karin, M.</span><span> </span><span class="NLM_article-title">Nuclear cytokine-activated IKKalpha controls prostate cancer metastasis by repressing Maspin</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">446</span><span class="NLM_x">, </span> <span class="NLM_fpage">690</span><span class="NLM_x">–</span> <span class="NLM_lpage">694</span><span class="refDoi"> DOI: 10.1038/nature05656</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;key=10.1038%2Fnature05656" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=446&publication_year=2007&pages=690-694&author=J.+L.+Luoauthor=W.+Tanauthor=J.+M.+Riconoauthor=O.+Korchynskyiauthor=M.+Zhangauthor=S.+L.+Goniasauthor=D.+A.+Chereshauthor=M.+Karin&title=Nuclear+cytokine-activated+IKKalpha+controls+prostate+cancer+metastasis+by+repressing+Maspin&doi=10.1038%2Fnature05656"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1038%2Fnature05656&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature05656%26sid%3Dliteratum%253Aachs%26aulast%3DLuo%26aufirst%3DJ.%2BL.%26aulast%3DTan%26aufirst%3DW.%26aulast%3DRicono%26aufirst%3DJ.%2BM.%26aulast%3DKorchynskyi%26aufirst%3DO.%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DGonias%26aufirst%3DS.%2BL.%26aulast%3DCheresh%26aufirst%3DD.%2BA.%26aulast%3DKarin%26aufirst%3DM.%26atitle%3DNuclear%2520cytokine-activated%2520IKKalpha%2520controls%2520prostate%2520cancer%2520metastasis%2520by%2520repressing%2520Maspin%26jtitle%3DNature%26date%3D2007%26volume%3D446%26spage%3D690%26epage%3D694%26doi%3D10.1038%2Fnature05656" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Hao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rizzo, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osipo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pannuti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wyatt, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheung, L. W. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sonenshein, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osborne, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miele, L.</span><span> </span><span class="NLM_article-title">Notch-1 activates estrogen receptor-alpha-dependent transcription via IKKalpha in breast cancer cells</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">201</span><span class="NLM_x">–</span> <span class="NLM_lpage">213</span><span class="refDoi"> DOI: 10.1038/onc.2009.323</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;key=10.1038%2Fonc.2009.323" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2010&pages=201-213&author=L.+Haoauthor=P.+Rizzoauthor=C.+Osipoauthor=A.+Pannutiauthor=D.+Wyattauthor=L.+W.+K.+Cheungauthor=G.+Sonensheinauthor=B.+A.+Osborneauthor=L.+Miele&title=Notch-1+activates+estrogen+receptor-alpha-dependent+transcription+via+IKKalpha+in+breast+cancer+cells&doi=10.1038%2Fonc.2009.323"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1038%2Fonc.2009.323&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fonc.2009.323%26sid%3Dliteratum%253Aachs%26aulast%3DHao%26aufirst%3DL.%26aulast%3DRizzo%26aufirst%3DP.%26aulast%3DOsipo%26aufirst%3DC.%26aulast%3DPannuti%26aufirst%3DA.%26aulast%3DWyatt%26aufirst%3DD.%26aulast%3DCheung%26aufirst%3DL.%2BW.%2BK.%26aulast%3DSonenshein%26aufirst%3DG.%26aulast%3DOsborne%26aufirst%3DB.%2BA.%26aulast%3DMiele%26aufirst%3DL.%26atitle%3DNotch-1%2520activates%2520estrogen%2520receptor-alpha-dependent%2520transcription%2520via%2520IKKalpha%2520in%2520breast%2520cancer%2520cells%26jtitle%3DOncogene%26date%3D2010%26volume%3D29%26spage%3D201%26epage%3D213%26doi%3D10.1038%2Fonc.2009.323" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Cao, Y. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karin, M.</span><span> </span><span class="NLM_article-title">I kappa B kinase a kinase activity is required for self-renewal of ErbB2/Her2-transformed mammary tumor-initiating cells</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">104</span><span class="NLM_x">, </span> <span class="NLM_fpage">15852</span><span class="NLM_x">–</span> <span class="NLM_lpage">15857</span><span class="refDoi"> DOI: 10.1073/pnas.0706728104</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;key=10.1073%2Fpnas.0706728104" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2007&pages=15852-15857&author=Y.+X.+Caoauthor=J.+L.+Luoauthor=M.+Karin&title=I+kappa+B+kinase+a+kinase+activity+is+required+for+self-renewal+of+ErbB2%2FHer2-transformed+mammary+tumor-initiating+cells&doi=10.1073%2Fpnas.0706728104"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0706728104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0706728104%26sid%3Dliteratum%253Aachs%26aulast%3DCao%26aufirst%3DY.%2BX.%26aulast%3DLuo%26aufirst%3DJ.%2BL.%26aulast%3DKarin%26aufirst%3DM.%26atitle%3DI%2520kappa%2520B%2520kinase%2520a%2520kinase%2520activity%2520is%2520required%2520for%2520self-renewal%2520of%2520ErbB2%252FHer2-transformed%2520mammary%2520tumor-initiating%2520cells%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2007%26volume%3D104%26spage%3D15852%26epage%3D15857%26doi%3D10.1073%2Fpnas.0706728104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Cao, Y. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonizzi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seagroves, T. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greten, F. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, E. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karin, M.</span><span> </span><span class="NLM_article-title">IKKalpha provides an essential link between RANK signaling and cyclin D1 expression during mammary gland development</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">107</span><span class="NLM_x">, </span> <span class="NLM_fpage">763</span><span class="NLM_x">–</span> <span class="NLM_lpage">775</span><span class="refDoi"> DOI: 10.1016/S0092-8674(01)00599-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;key=10.1016%2FS0092-8674%2801%2900599-2" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2001&pages=763-775&author=Y.+X.+Caoauthor=G.+Bonizziauthor=T.+N.+Seagrovesauthor=F.+R.+Gretenauthor=R.+Johnsonauthor=E.+V.+Schmidtauthor=M.+Karin&title=IKKalpha+provides+an+essential+link+between+RANK+signaling+and+cyclin+D1+expression+during+mammary+gland+development&doi=10.1016%2FS0092-8674%2801%2900599-2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2801%2900599-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252801%252900599-2%26sid%3Dliteratum%253Aachs%26aulast%3DCao%26aufirst%3DY.%2BX.%26aulast%3DBonizzi%26aufirst%3DG.%26aulast%3DSeagroves%26aufirst%3DT.%2BN.%26aulast%3DGreten%26aufirst%3DF.%2BR.%26aulast%3DJohnson%26aufirst%3DR.%26aulast%3DSchmidt%26aufirst%3DE.%2BV.%26aulast%3DKarin%26aufirst%3DM.%26atitle%3DIKKalpha%2520provides%2520an%2520essential%2520link%2520between%2520RANK%2520signaling%2520and%2520cyclin%2520D1%2520expression%2520during%2520mammary%2520gland%2520development%26jtitle%3DCell%26date%3D2001%26volume%3D107%26spage%3D763%26epage%3D775%26doi%3D10.1016%2FS0092-8674%2801%2900599-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Liou, G. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doppler, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Necela, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krishna, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crawford, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raimondo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Storz, P.</span><span> </span><span class="NLM_article-title">Macrophage-secreted cytokines drive pancreatic acinar-to-ductal metaplasia through NF-kappa B and MMPs</span> <span class="citation_source-journal">J. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">202</span><span class="NLM_x">, </span> <span class="NLM_fpage">563</span><span class="NLM_x">–</span> <span class="NLM_lpage">577</span><span class="refDoi"> DOI: 10.1083/jcb.201301001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;key=10.1083%2Fjcb.201301001" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=202&publication_year=2013&pages=563-577&author=G.+Y.+Liouauthor=H.+Dopplerauthor=B.+Necelaauthor=M.+Krishnaauthor=H.+C.+Crawfordauthor=M.+Raimondoauthor=P.+Storz&title=Macrophage-secreted+cytokines+drive+pancreatic+acinar-to-ductal+metaplasia+through+NF-kappa+B+and+MMPs&doi=10.1083%2Fjcb.201301001"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1083%2Fjcb.201301001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1083%252Fjcb.201301001%26sid%3Dliteratum%253Aachs%26aulast%3DLiou%26aufirst%3DG.%2BY.%26aulast%3DDoppler%26aufirst%3DH.%26aulast%3DNecela%26aufirst%3DB.%26aulast%3DKrishna%26aufirst%3DM.%26aulast%3DCrawford%26aufirst%3DH.%2BC.%26aulast%3DRaimondo%26aufirst%3DM.%26aulast%3DStorz%26aufirst%3DP.%26atitle%3DMacrophage-secreted%2520cytokines%2520drive%2520pancreatic%2520acinar-to-ductal%2520metaplasia%2520through%2520NF-kappa%2520B%2520and%2520MMPs%26jtitle%3DJ.%2520Cell%2520Biol.%26date%3D2013%26volume%3D202%26spage%3D563%26epage%3D577%26doi%3D10.1083%2Fjcb.201301001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Storz, P.</span><span> </span><span class="NLM_article-title">Targeting the alternative NF-kappa B pathway in pancreatic cancer: a new direction for therapy?</span> <span class="citation_source-journal">Expert Rev. Anticancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">501</span><span class="NLM_x">–</span> <span class="NLM_lpage">504</span><span class="refDoi"> DOI: 10.1586/era.13.28</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;key=10.1586%2Fera.13.28" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;key=23617340" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmsFWlsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2013&pages=501-504&author=P.+Storz&title=Targeting+the+alternative+NF-kappa+B+pathway+in+pancreatic+cancer%3A+a+new+direction+for+therapy%3F&doi=10.1586%2Fera.13.28"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the alternative NF-κB pathway in pancreatic cancer: a new direction for therapy?</span></div><div class="casAuthors">Storz, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Expert Review of Anticancer Therapy</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">501-504</span>CODEN:
                <span class="NLM_cas:coden">ERATBJ</span>;
        ISSN:<span class="NLM_cas:issn">1473-7140</span>.
    
            (<span class="NLM_cas:orgname">Expert Reviews Ltd.</span>)
        </div><div class="casAbstract">A review.  Pancreatic cancer, due to its late diagnosis,is difficult to treat.  In addn., current therapy options are insufficient and new approaches for combination treatment are required.  Recent demonstration of the importance of constitutive signaling of NF-κB-inducing kinase (NIK,also named MAP3K14) in maintaining the high basal activity of the alternative NF-κB pathway in pancreatic cancer suggests novel possibilities for therapeutic intervention.  Strategies to target the alternative NF-κB pathway include not only the use of small mol. inhibitors for NIK and IκB kinase a (IKKa), but also broad spectrum approaches such as using proteasome inhibitors or combinatorial approaches targeting both alternative and canonical pathways.  These may also act synergistically with currently used drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkO5O_6UCQkrVg90H21EOLACvtfcHk0lh5blY-VE-tHQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmsFWlsL4%253D&md5=a4945c62cf71cb211141608f6790b853</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1586%2Fera.13.28&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1586%252Fera.13.28%26sid%3Dliteratum%253Aachs%26aulast%3DStorz%26aufirst%3DP.%26atitle%3DTargeting%2520the%2520alternative%2520NF-kappa%2520B%2520pathway%2520in%2520pancreatic%2520cancer%253A%2520a%2520new%2520direction%2520for%2520therapy%253F%26jtitle%3DExpert%2520Rev.%2520Anticancer%2520Ther.%26date%3D2013%26volume%3D13%26spage%3D501%26epage%3D504%26doi%3D10.1586%2Fera.13.28" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Doppler, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liou, G. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Storz, P.</span><span> </span><span class="NLM_article-title">Downregulation of TRAF2 mediates NIK-induced pancreatic cancer cell proliferation and tumorigenicity</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">e53676</span><span class="refDoi"> DOI: 10.1371/journal.pone.0053676</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;key=10.1371%2Fjournal.pone.0053676" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;key=23301098" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;key=1%3ACAS%3A528%3ADC%252BC3sXpsFKhug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=e53676&author=H.+Dopplerauthor=G.+Y.+Liouauthor=P.+Storz&title=Downregulation+of+TRAF2+mediates+NIK-induced+pancreatic+cancer+cell+proliferation+and+tumorigenicity&doi=10.1371%2Fjournal.pone.0053676"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Downregulation of TRAF2 mediates NIK-induced pancreatic cancer cell proliferation and tumorigenicity</span></div><div class="casAuthors">Doppler, Heike; Liou, Geou-Yarh; Storz, Peter</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">e53676</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Background: Increased levels of NF-κB are hallmarks of pancreatic ductal adenocarcinoma (PDAC) and both classical and alternative NF-κB activation pathways have been implicated.  Methodol./Principal Findings: Here we show that activation of the alternative pathway is a source for the high basal NFκB activity in PDAC cell lines.  Increased activity of the p52/RelB NF-κB complex is mediated through stabilization and activation of NF-κB-inducing kinase (NIK).  We identify proteasomal downregulation of TNF receptor-assocd. factor 2 (TRAF2) as a mechanism by which levels of active NIK are increased in PDAC cell lines.  Such upregulation of NIK expression and activity levels relays to increased proliferation and anchorage-independent growth, but not migration or survival of PDAC cells.  Conclusions/Significance: Rapid growth is one characteristic of pancreatic cancer.  Our data indicates that the TRAF2/NIK/NF-κB2 pathway regulates PDAC cell tumorigenicity and could be a valuable target for therapy of this cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrnrJZVjqbQzbVg90H21EOLACvtfcHk0lh5blY-VE-tHQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXpsFKhug%253D%253D&md5=e03970c3c2c199c764e479c528245692</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0053676&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0053676%26sid%3Dliteratum%253Aachs%26aulast%3DDoppler%26aufirst%3DH.%26aulast%3DLiou%26aufirst%3DG.%2BY.%26aulast%3DStorz%26aufirst%3DP.%26atitle%3DDownregulation%2520of%2520TRAF2%2520mediates%2520NIK-induced%2520pancreatic%2520cancer%2520cell%2520proliferation%2520and%2520tumorigenicity%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26spage%3De53676%26doi%3D10.1371%2Fjournal.pone.0053676" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Liu, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Misquitta, Y. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olland, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelleher, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kriz, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stahl, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mosyak, L.</span><span> </span><span class="NLM_article-title">Crystal Structure of a human IkappaB Kinase beta asymmetric dimer</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">288</span><span class="NLM_x">, </span> <span class="NLM_fpage">22758</span><span class="NLM_x">–</span> <span class="NLM_lpage">22767</span><span class="refDoi"> DOI: 10.1074/jbc.M113.482596</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;key=10.1074%2Fjbc.M113.482596" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;key=23792959" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1Wiu73L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=288&publication_year=2013&pages=22758-22767&author=S.+P.+Liuauthor=Y.+R.+Misquittaauthor=A.+Ollandauthor=M.+A.+Johnsonauthor=K.+S.+Kelleherauthor=R.+Krizauthor=L.+L.+Linauthor=M.+Stahlauthor=L.+Mosyak&title=Crystal+Structure+of+a+human+IkappaB+Kinase+beta+asymmetric+dimer&doi=10.1074%2Fjbc.M113.482596"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal Structure of a Human IκB Kinase β Asymmetric Dimer</span></div><div class="casAuthors">Liu, Shenping; Misquitta, Yohann R.; Olland, Andrea; Johnson, Mark A.; Kelleher, Kerry S.; Kriz, Ron; Lin, Laura L.; Stahl, Mark; Mosyak, Lidia</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">288</span>
        (<span class="NLM_cas:issue">31</span>),
    <span class="NLM_cas:pages">22758-22767</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Phosphorylation of inhibitor of nuclear transcription factor κB (IκB) by IκB kinase (IKK) triggers the degrdn. of IκB and migration of cytoplasmic κB to the nucleus where it promotes the transcription of its target genes.  Activation of IKK is achieved by phosphorylation of its main subunit, IKKβ, at the activation loop sites.  Here, we report the 2.8 Å resoln. crystal structure of human IKKβ (hIKKβ), which is partially phosphorylated and bound to the staurosporine analog K252a.  The hIKKβ protomer adopts a trimodular structure that closely resembles that from Xenopus laevis (xIKKβ): an N-terminal kinase domain (KD), a central ubiquitin-like domain (ULD), and a C-terminal scaffold/dimerization domain (SDD).  Although hIKKβ and xIKKβ utilize a similar dimerization mode, their overall geometries are distinct.  In contrast to the structure resembling closed shears reported previously for xIKKβ, hIKKβ exists as an open asym. dimer in which the two KDs are further apart, with one in an active and the other in an inactive conformation.  Dimer interactions are limited to the C-terminal six-helix bundle that acts as a hinge between the two subunits.  The obsd. domain movements in the structures of IKKβ may represent trans-phosphorylation steps that accompany IKKβ activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGrQPn1lh907Vg90H21EOLACvtfcHk0lh5blY-VE-tHQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1Wiu73L&md5=7b7c11c3d9c2c3b37ccf40d3093116e1</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M113.482596&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M113.482596%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DS.%2BP.%26aulast%3DMisquitta%26aufirst%3DY.%2BR.%26aulast%3DOlland%26aufirst%3DA.%26aulast%3DJohnson%26aufirst%3DM.%2BA.%26aulast%3DKelleher%26aufirst%3DK.%2BS.%26aulast%3DKriz%26aufirst%3DR.%26aulast%3DLin%26aufirst%3DL.%2BL.%26aulast%3DStahl%26aufirst%3DM.%26aulast%3DMosyak%26aufirst%3DL.%26atitle%3DCrystal%2520Structure%2520of%2520a%2520human%2520IkappaB%2520Kinase%2520beta%2520asymmetric%2520dimer%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2013%26volume%3D288%26spage%3D22758%26epage%3D22767%26doi%3D10.1074%2Fjbc.M113.482596" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Shrestha, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhattarai, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, H.</span><span> </span><span class="NLM_article-title">PTP1B inhibitor ertiprotafib is also a potent inhibitor of IkappaB kinase beta (IKK-beta)</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">2728</span><span class="NLM_x">–</span> <span class="NLM_lpage">2730</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2007.03.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;key=10.1016%2Fj.bmcl.2007.03.001" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=2728-2730&author=S.+Shresthaauthor=B.+R.+Bhattaraiauthor=H.+Choauthor=J.+K.+Choiauthor=H.+Cho&title=PTP1B+inhibitor+ertiprotafib+is+also+a+potent+inhibitor+of+IkappaB+kinase+beta+%28IKK-beta%29&doi=10.1016%2Fj.bmcl.2007.03.001"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2007.03.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2007.03.001%26sid%3Dliteratum%253Aachs%26aulast%3DShrestha%26aufirst%3DS.%26aulast%3DBhattarai%26aufirst%3DB.%2BR.%26aulast%3DCho%26aufirst%3DH.%26aulast%3DChoi%26aufirst%3DJ.%2BK.%26aulast%3DCho%26aufirst%3DH.%26atitle%3DPTP1B%2520inhibitor%2520ertiprotafib%2520is%2520also%2520a%2520potent%2520inhibitor%2520of%2520IkappaB%2520kinase%2520beta%2520%2528IKK-beta%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D2728%26epage%3D2730%26doi%3D10.1016%2Fj.bmcl.2007.03.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Klepper, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polborn, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carell, T.</span><span> </span><span class="NLM_article-title">Robust synthesis and crystal-structure analysis of 7-cyano-7-deazaguanine (PreQ(0) base) and 7-(aminomethyl)-7-deazaguanine (PreQ(1) base)</span> <span class="citation_source-journal">Helv. Chim. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">88</span><span class="NLM_x">, </span> <span class="NLM_fpage">2610</span><span class="NLM_x">–</span> <span class="NLM_lpage">2616</span><span class="refDoi"> DOI: 10.1002/hlca.200590201</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;key=10.1002%2Fhlca.200590201" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=2005&pages=2610-2616&author=F.+Klepperauthor=K.+Polbornauthor=T.+Carell&title=Robust+synthesis+and+crystal-structure+analysis+of+7-cyano-7-deazaguanine+%28PreQ%280%29+base%29+and+7-%28aminomethyl%29-7-deazaguanine+%28PreQ%281%29+base%29&doi=10.1002%2Fhlca.200590201"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1002%2Fhlca.200590201&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fhlca.200590201%26sid%3Dliteratum%253Aachs%26aulast%3DKlepper%26aufirst%3DF.%26aulast%3DPolborn%26aufirst%3DK.%26aulast%3DCarell%26aufirst%3DT.%26atitle%3DRobust%2520synthesis%2520and%2520crystal-structure%2520analysis%2520of%25207-cyano-7-deazaguanine%2520%2528PreQ%25280%2529%2520base%2529%2520and%25207-%2528aminomethyl%2529-7-deazaguanine%2520%2528PreQ%25281%2529%2520base%2529%26jtitle%3DHelv.%2520Chim.%2520Acta%26date%3D2005%26volume%3D88%26spage%3D2610%26epage%3D2616%26doi%3D10.1002%2Fhlca.200590201" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Llona-Minguez, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mackay, S. P.</span><span> </span><span class="NLM_article-title">Stereoselective synthesis of carbocyclic analogues of the nucleoside Q precursor (PreQ(0))</span> <span class="citation_source-journal">Beilstein J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1333</span><span class="NLM_x">–</span> <span class="NLM_lpage">1338</span><span class="refDoi"> DOI: 10.3762/bjoc.10.135</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;key=10.3762%2Fbjoc.10.135" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;key=24991286" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFSrtLbF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2014&pages=1333-1338&author=S.+Llona-Minguezauthor=S.+P.+Mackay&title=Stereoselective+synthesis+of+carbocyclic+analogues+of+the+nucleoside+Q+precursor+%28PreQ%280%29%29&doi=10.3762%2Fbjoc.10.135"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Stereoselective synthesis of carbocyclic analogs of the nucleoside Q precursor (PreQ0)</span></div><div class="casAuthors">Llona-Minguez, Sabin; MacKay, Simon P.</div><div class="citationInfo"><span class="NLM_cas:title">Beilstein Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1333-1338, 6 pp.</span>CODEN:
                <span class="NLM_cas:coden">BJOCBH</span>;
        ISSN:<span class="NLM_cas:issn">1860-5397</span>.
    
            (<span class="NLM_cas:orgname">Beilstein-Institut zur Foerderung der Chemischen Wissenschaften</span>)
        </div><div class="casAbstract">A convergent and stereoselective synthesis of chiral cyclopentyl- and cyclohexyl-amine derivs. of nucleoside Q precursor (PreQ0) has been accomplished.  This synthetic route allows for an efficient prepn. of 4-substituted analogs with interesting three-dimensional character, including chiral cyclopentane-1,2-diol and -1,2,3-triol derivs.  This unusual substitution pattern provides a useful starting point for the discovery of novel bioactive mols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqukdcY9A8n_rVg90H21EOLACvtfcHk0liXlM3btp8GOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFSrtLbF&md5=0c4d4ec27df542f2f424ded6768dfcb4</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.3762%2Fbjoc.10.135&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3762%252Fbjoc.10.135%26sid%3Dliteratum%253Aachs%26aulast%3DLlona-Minguez%26aufirst%3DS.%26aulast%3DMackay%26aufirst%3DS.%2BP.%26atitle%3DStereoselective%2520synthesis%2520of%2520carbocyclic%2520analogues%2520of%2520the%2520nucleoside%2520Q%2520precursor%2520%2528PreQ%25280%2529%2529%26jtitle%3DBeilstein%2520J.%2520Org.%2520Chem.%26date%3D2014%26volume%3D10%26spage%3D1333%26epage%3D1338%26doi%3D10.3762%2Fbjoc.10.135" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Ziegler, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schenck, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krockow, E. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siebert, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wenz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, H.</span><span> </span><span class="NLM_article-title">The synthesis of cantharidin</span> <span class="citation_source-journal">Justus Liebigs Ann. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1942</span><span class="NLM_x">, </span> <span class="NLM_volume">551</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">79</span><span class="refDoi"> DOI: 10.1002/jlac.19425510102</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;key=10.1002%2Fjlac.19425510102" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=551&publication_year=1942&pages=1-79&author=K.+Zieglerauthor=G.+Schenckauthor=E.+W.+Krockowauthor=A.+Siebertauthor=A.+Wenzauthor=H.+Weber&title=The+synthesis+of+cantharidin&doi=10.1002%2Fjlac.19425510102"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1002%2Fjlac.19425510102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjlac.19425510102%26sid%3Dliteratum%253Aachs%26aulast%3DZiegler%26aufirst%3DK.%26aulast%3DSchenck%26aufirst%3DG.%26aulast%3DKrockow%26aufirst%3DE.%2BW.%26aulast%3DSiebert%26aufirst%3DA.%26aulast%3DWenz%26aufirst%3DA.%26aulast%3DWeber%26aufirst%3DH.%26atitle%3DThe%2520synthesis%2520of%2520cantharidin%26jtitle%3DJustus%2520Liebigs%2520Ann.%2520Chem.%26date%3D1942%26volume%3D551%26spage%3D1%26epage%3D79%26doi%3D10.1002%2Fjlac.19425510102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Blades, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donohoe, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winter, J. J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stemp, G.</span><span> </span><span class="NLM_article-title">A <i>syn</i> selective dihydroxylation of cyclic allylic trichloroacetamides using catalytic osmium tetroxide</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">4701</span><span class="NLM_x">–</span> <span class="NLM_lpage">4704</span><span class="refDoi"> DOI: 10.1016/S0040-4039(00)00714-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;key=10.1016%2FS0040-4039%2800%2900714-0" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2000&pages=4701-4704&author=K.+Bladesauthor=T.+J.+Donohoeauthor=J.+J.+G.+Winterauthor=G.+Stemp&title=A+syn+selective+dihydroxylation+of+cyclic+allylic+trichloroacetamides+using+catalytic+osmium+tetroxide&doi=10.1016%2FS0040-4039%2800%2900714-0"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2FS0040-4039%2800%2900714-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4039%252800%252900714-0%26sid%3Dliteratum%253Aachs%26aulast%3DBlades%26aufirst%3DK.%26aulast%3DDonohoe%26aufirst%3DT.%2BJ.%26aulast%3DWinter%26aufirst%3DJ.%2BJ.%2BG.%26aulast%3DStemp%26aufirst%3DG.%26atitle%3DA%2520syn%2520selective%2520dihydroxylation%2520of%2520cyclic%2520allylic%2520trichloroacetamides%2520using%2520catalytic%2520osmium%2520tetroxide%26jtitle%3DTetrahedron%2520Lett.%26date%3D2000%26volume%3D41%26spage%3D4701%26epage%3D4704%26doi%3D10.1016%2FS0040-4039%2800%2900714-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Lam, P. Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinto, D. J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orwat, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galemmo, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fevig, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teleha, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alexander, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smallwood, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rossi, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bai, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luettgen, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knabb, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wexler, R. R.</span><span> </span><span class="NLM_article-title">Structure-based design of novel guanidine/benzamidine mimics: Potent and orally bioavailable factor Xa inhibitors as novel anticoagulants</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">4405</span><span class="NLM_x">–</span> <span class="NLM_lpage">4418</span><span class="refDoi"> DOI: 10.1021/jm020578e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm020578e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;key=1%3ACAS%3A528%3ADC%252BD3sXnvVCjtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=4405-4418&author=P.+Y.+S.+Lamauthor=C.+G.+Clarkauthor=R.+H.+Liauthor=D.+J.+P.+Pintoauthor=M.+J.+Orwatauthor=R.+A.+Galemmoauthor=J.+M.+Fevigauthor=C.+A.+Telehaauthor=R.+S.+Alexanderauthor=A.+M.+Smallwoodauthor=K.+A.+Rossiauthor=M.+R.+Wrightauthor=S.+A.+Baiauthor=K.+Heauthor=J.+M.+Luettgenauthor=P.+C.+Wongauthor=R.+M.+Knabbauthor=R.+R.+Wexler&title=Structure-based+design+of+novel+guanidine%2Fbenzamidine+mimics%3A+Potent+and+orally+bioavailable+factor+Xa+inhibitors+as+novel+anticoagulants&doi=10.1021%2Fjm020578e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-based design of novel guanidine/benzamidine mimics: potent and orally bioavailable factor Xa inhibitors as novel anticoagulants</span></div><div class="casAuthors">Lam, Patrick Y. S.; Clark, Charles G.; Li, Renhua; Pinto, Donald J. P.; Orwat, Michael J.; Galemmo, Robert A.; Fevig, John M.; Teleha, Christopher A.; Alexander, Richard S.; Smallwood, Angela M.; Rossi, Karen A.; Wright, Matthew R.; Bai, Stephen A.; He, Kan; Luettgen, Joseph M.; Wong, Pancras C.; Knabb, Robert M.; Wexler, Ruth R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">4405-4418</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">As part of an ongoing effort to prep. orally active factor Xa inhibitors using structure-based drug design techniques and mol. recognition principles, a systematic study has been performed on the pharmacokinetic profile resulting from replacing the benzamidine in the P1 position with less basic benzamidine mimics or neutral residues.  It is demonstrated that lowering the pKa of the P1 ligand resulted in compds. (3-benzylamine, 15a; 1-aminoisoquinoline, 24a; 3-aminobenzisoxazole, 23a; 3-phenylcarboxamide, 22b; and 4-methoxyphenyl, 22a) with improved pharmacokinetic features mainly as a result of decreased clearance, increased vol. of distribution, and enhanced oral absorption.  This work resulted in a series of potent and orally bioavailable factor Xa inhibitors that ultimately led to the discovery of SQ311, 24a.  SQ311, which utilizes a 1-aminoisoquinoline as the P1 ligand, inhibits factor Xa with a Ki of 0.33 nM and demonstrates both good in vivo antithrombotic efficacy and oral bioavailability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqE6d2DUIccKrVg90H21EOLACvtfcHk0li7jeFd7vd8lg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXnvVCjtLs%253D&md5=f2c7ea82ae9df29352c9fa74e1563529</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fjm020578e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm020578e%26sid%3Dliteratum%253Aachs%26aulast%3DLam%26aufirst%3DP.%2BY.%2BS.%26aulast%3DClark%26aufirst%3DC.%2BG.%26aulast%3DLi%26aufirst%3DR.%2BH.%26aulast%3DPinto%26aufirst%3DD.%2BJ.%2BP.%26aulast%3DOrwat%26aufirst%3DM.%2BJ.%26aulast%3DGalemmo%26aufirst%3DR.%2BA.%26aulast%3DFevig%26aufirst%3DJ.%2BM.%26aulast%3DTeleha%26aufirst%3DC.%2BA.%26aulast%3DAlexander%26aufirst%3DR.%2BS.%26aulast%3DSmallwood%26aufirst%3DA.%2BM.%26aulast%3DRossi%26aufirst%3DK.%2BA.%26aulast%3DWright%26aufirst%3DM.%2BR.%26aulast%3DBai%26aufirst%3DS.%2BA.%26aulast%3DHe%26aufirst%3DK.%26aulast%3DLuettgen%26aufirst%3DJ.%2BM.%26aulast%3DWong%26aufirst%3DP.%2BC.%26aulast%3DKnabb%26aufirst%3DR.%2BM.%26aulast%3DWexler%26aufirst%3DR.%2BR.%26atitle%3DStructure-based%2520design%2520of%2520novel%2520guanidine%252Fbenzamidine%2520mimics%253A%2520Potent%2520and%2520orally%2520bioavailable%2520factor%2520Xa%2520inhibitors%2520as%2520novel%2520anticoagulants%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D4405%26epage%3D4418%26doi%3D10.1021%2Fjm020578e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Orsini, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menichincheri, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanotti, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panzeri, A.</span><span> </span><span class="NLM_article-title">Highly efficient synthesis of 5-benzyl-3-aminoindazoles</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">3098</span><span class="NLM_x">–</span> <span class="NLM_lpage">3100</span><span class="refDoi"> DOI: 10.1016/j.tetlet.2009.04.024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;key=10.1016%2Fj.tetlet.2009.04.024" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2009&pages=3098-3100&author=P.+Orsiniauthor=M.+Menichincheriauthor=E.+Vanottiauthor=A.+Panzeri&title=Highly+efficient+synthesis+of+5-benzyl-3-aminoindazoles&doi=10.1016%2Fj.tetlet.2009.04.024"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2Fj.tetlet.2009.04.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tetlet.2009.04.024%26sid%3Dliteratum%253Aachs%26aulast%3DOrsini%26aufirst%3DP.%26aulast%3DMenichincheri%26aufirst%3DM.%26aulast%3DVanotti%26aufirst%3DE.%26aulast%3DPanzeri%26aufirst%3DA.%26atitle%3DHighly%2520efficient%2520synthesis%2520of%25205-benzyl-3-aminoindazoles%26jtitle%3DTetrahedron%2520Lett.%26date%3D2009%26volume%3D50%26spage%3D3098%26epage%3D3100%26doi%3D10.1016%2Fj.tetlet.2009.04.024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Jones, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willett, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glen, R. C.</span><span> </span><span class="NLM_article-title">Molecular recognition of receptor-sites using a genetic algorithm with a description of desolvation</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">245</span><span class="NLM_x">, </span> <span class="NLM_fpage">43</span><span class="NLM_x">–</span> <span class="NLM_lpage">53</span><span class="refDoi"> DOI: 10.1016/S0022-2836(95)80037-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;key=10.1016%2FS0022-2836%2895%2980037-9" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=245&publication_year=1995&pages=43-53&author=G.+Jonesauthor=P.+Willettauthor=R.+C.+Glen&title=Molecular+recognition+of+receptor-sites+using+a+genetic+algorithm+with+a+description+of+desolvation&doi=10.1016%2FS0022-2836%2895%2980037-9"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2FS0022-2836%2895%2980037-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0022-2836%252895%252980037-9%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DG.%26aulast%3DWillett%26aufirst%3DP.%26aulast%3DGlen%26aufirst%3DR.%2BC.%26atitle%3DMolecular%2520recognition%2520of%2520receptor-sites%2520using%2520a%2520genetic%2520algorithm%2520with%2520a%2520description%2520of%2520desolvation%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D1995%26volume%3D245%26spage%3D43%26epage%3D53%26doi%3D10.1016%2FS0022-2836%2895%2980037-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Ghose, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herbertz, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pippin, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salvino, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mallamo, J. P.</span><span> </span><span class="NLM_article-title">Knowledge based prediction of ligand binding modes and rational inhibitor design for kinase drug discovery</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">5149</span><span class="NLM_x">–</span> <span class="NLM_lpage">5171</span><span class="refDoi"> DOI: 10.1021/jm800475y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm800475y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVWmurnM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=5149-5171&author=A.+K.+Ghoseauthor=T.+Herbertzauthor=D.+A.+Pippinauthor=J.+M.+Salvinoauthor=J.+P.+Mallamo&title=Knowledge+based+prediction+of+ligand+binding+modes+and+rational+inhibitor+design+for+kinase+drug+discovery&doi=10.1021%2Fjm800475y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Knowledge Based Prediction of Ligand Binding Modes and Rational Inhibitor Design for Kinase Drug Discovery</span></div><div class="casAuthors">Ghose, Arup K.; Herbertz, Torsten; Pippin, Douglas A.; Salvino, Joseph M.; Mallamo, John P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">5149-5171</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review describing the use of Protein Data Bank (PDB) entries specifically for kinase inhibitor drug discovery.  Topics discussed include: the current state of structure-aided ligand design, kinase structure queries and extn. from the PDB, alignment of protein structures, structural classification of ligands, anal. of ligands and binding modes, and ligand design strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDINDYVE15cbVg90H21EOLACvtfcHk0lh-yiiqM4BMOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVWmurnM&md5=a1afc4d6c7f6fa4dd6aa9da8d78f1ee3</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fjm800475y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800475y%26sid%3Dliteratum%253Aachs%26aulast%3DGhose%26aufirst%3DA.%2BK.%26aulast%3DHerbertz%26aufirst%3DT.%26aulast%3DPippin%26aufirst%3DD.%2BA.%26aulast%3DSalvino%26aufirst%3DJ.%2BM.%26aulast%3DMallamo%26aufirst%3DJ.%2BP.%26atitle%3DKnowledge%2520based%2520prediction%2520of%2520ligand%2520binding%2520modes%2520and%2520rational%2520inhibitor%2520design%2520for%2520kinase%2520drug%2520discovery%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D5149%26epage%3D5171%26doi%3D10.1021%2Fjm800475y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Carbain, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paterson, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anscombe, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cano, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Echalier, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Endicott, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golding, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haggerty, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hardcastle, I. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jewsbury, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newell, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noble, M. E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roche, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffin, R. J.</span><span> </span><span class="NLM_article-title">8-Substituted <i>O</i>-6-Cyclohexylmethylguanine CDK2 inhibitors: Using structure-based inhibitor design to optimize an alternative binding mode</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">56</span><span class="NLM_x">–</span> <span class="NLM_lpage">70</span><span class="refDoi"> DOI: 10.1021/jm401555v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401555v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=56-70&author=B.+Carbainauthor=D.+J.+Patersonauthor=E.+Anscombeauthor=A.+J.+Campbellauthor=C.+Canoauthor=A.+Echalierauthor=J.+A.+Endicottauthor=B.+T.+Goldingauthor=K.+Haggertyauthor=I.+R.+Hardcastleauthor=P.+J.+Jewsburyauthor=D.+R.+Newellauthor=M.+E.+M.+Nobleauthor=C.+Rocheauthor=L.+Z.+Wangauthor=R.+J.+Griffin&title=8-Substituted+O-6-Cyclohexylmethylguanine+CDK2+inhibitors%3A+Using+structure-based+inhibitor+design+to+optimize+an+alternative+binding+mode&doi=10.1021%2Fjm401555v"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Fjm401555v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401555v%26sid%3Dliteratum%253Aachs%26aulast%3DCarbain%26aufirst%3DB.%26aulast%3DPaterson%26aufirst%3DD.%2BJ.%26aulast%3DAnscombe%26aufirst%3DE.%26aulast%3DCampbell%26aufirst%3DA.%2BJ.%26aulast%3DCano%26aufirst%3DC.%26aulast%3DEchalier%26aufirst%3DA.%26aulast%3DEndicott%26aufirst%3DJ.%2BA.%26aulast%3DGolding%26aufirst%3DB.%2BT.%26aulast%3DHaggerty%26aufirst%3DK.%26aulast%3DHardcastle%26aufirst%3DI.%2BR.%26aulast%3DJewsbury%26aufirst%3DP.%2BJ.%26aulast%3DNewell%26aufirst%3DD.%2BR.%26aulast%3DNoble%26aufirst%3DM.%2BE.%2BM.%26aulast%3DRoche%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DL.%2BZ.%26aulast%3DGriffin%26aufirst%3DR.%2BJ.%26atitle%3D8-Substituted%2520O-6-Cyclohexylmethylguanine%2520CDK2%2520inhibitors%253A%2520Using%2520structure-based%2520inhibitor%2520design%2520to%2520optimize%2520an%2520alternative%2520binding%2520mode%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D56%26epage%3D70%26doi%3D10.1021%2Fjm401555v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Huang, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hung, M. C.</span><span> </span><span class="NLM_article-title">Beyond NF-kappa B activation: nuclear functions of IkappaB kinase alpha</span> <span class="citation_source-journal">J. Biomed. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">3</span><span class="refDoi"> DOI: 10.1186/1423-0127-20-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;key=10.1186%2F1423-0127-20-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;key=23343355" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;key=1%3ACAS%3A528%3ADC%252BC3sXivFGksb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2013&pages=3&author=W.+C.+Huangauthor=M.+C.+Hung&title=Beyond+NF-kappa+B+activation%3A+nuclear+functions+of+IkappaB+kinase+alpha&doi=10.1186%2F1423-0127-20-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Beyond NF-κB activation: nuclear functions of IκB kinase α</span></div><div class="casAuthors">Huang, Wei-Chien; Hung, Mien-Chie</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biomedical Science (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">3</span>CODEN:
                <span class="NLM_cas:coden">JBCIEA</span>;
        ISSN:<span class="NLM_cas:issn">1423-0127</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">A review.  IκB kinase (IKK) complex, the master kinase for NF-κB activation, contains two kinase subunits, IKKα and IKKβ.  In addn. to mediating NF-κB signaling by phosphorylating IκB proteins during inflammatory and immune responses, the activation of the IKK complex also responds to various stimuli to regulate diverse functions independently of NF-κB.  Although these two kinases share structural and biochem. similarities, different sub-cellular localization and phosphorylation targets between IKKα and IKKβ account for their distinct physiol. and pathol. roles.  While IKKβ is predominantly cytoplasmic, IKKα has been found to shuttle between the cytoplasm and the nucleus.  The nuclear-specific roles of IKKα have brought increasing complexity to its biol. function.  This review highlights major advances in the studies of the nuclear functions of IKKα and the mechanisms of IKKα nuclear translocation.  Understanding the nuclear activity is essential for targeting IKKα for therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNH6U3apkRf7Vg90H21EOLACvtfcHk0lh-yiiqM4BMOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXivFGksb8%253D&md5=a9015613c1588f7fe87a37bcddc0fc55</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1186%2F1423-0127-20-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1423-0127-20-3%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DW.%2BC.%26aulast%3DHung%26aufirst%3DM.%2BC.%26atitle%3DBeyond%2520NF-kappa%2520B%2520activation%253A%2520nuclear%2520functions%2520of%2520IkappaB%2520kinase%2520alpha%26jtitle%3DJ.%2520Biomed.%2520Sci.%26date%3D2013%26volume%3D20%26spage%3D3%26doi%3D10.1186%2F1423-0127-20-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Leopizzi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cocchiola, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milanetti, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raimondo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Politi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giordano, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scandurra, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scotto d’Abusco, A.</span><span> </span><span class="NLM_article-title">IKKα inibition by a glucosamine derivative enhances Maspin expression in osteosarcoma cell line</span> <span class="citation_source-journal">Chem.-Biol. Interact.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">262</span><span class="NLM_x">, </span> <span class="NLM_fpage">19</span><span class="NLM_x">–</span> <span class="NLM_lpage">28</span><span class="refDoi"> DOI: 10.1016/j.cbi.2016.12.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;key=10.1016%2Fj.cbi.2016.12.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;key=27931795" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;key=1%3ACAS%3A528%3ADC%252BC28XitVOjsrjK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=262&publication_year=2017&pages=19-28&author=M.+Leopizziauthor=R.+Cocchiolaauthor=E.+Milanettiauthor=D.+Raimondoauthor=L.+Politiauthor=C.+Giordanoauthor=R.+Scandurraauthor=A.+Scotto+d%E2%80%99Abusco&title=IKK%CE%B1+inibition+by+a+glucosamine+derivative+enhances+Maspin+expression+in+osteosarcoma+cell+line&doi=10.1016%2Fj.cbi.2016.12.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">IKKα inibition by a glucosamine derivative enhances Maspin expression in osteosarcoma cell line</span></div><div class="casAuthors">Leopizzi, Martina; Cocchiola, Rossana; Milanetti, Edoardo; Raimondo, Domenico; Politi, Laura; Giordano, Cesare; Scandurra, Roberto; Scotto d'Abusco, Anna</div><div class="citationInfo"><span class="NLM_cas:title">Chemico-Biological Interactions</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">262</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">19-28</span>CODEN:
                <span class="NLM_cas:coden">CBINA8</span>;
        ISSN:<span class="NLM_cas:issn">0009-2797</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">Chronic inflammation has been assocd. to cancer development by the alteration of several inflammatory pathways, such as Nuclear Factor-κB pathway.  In particular, IκB kinase α (IKKα), one of two catalytic subunit of IKK complex, has been described to be assocd. to cancer progression and metastasis in a no. of cancers.  The mol. mechanism by which IKKα affects cancer progression is not yet completely clarified, anyway an assocn. between IKKα and the expression of Maspin (Mammary Serine Protease Inhibitor or SerpinB5), a tumor suppressor protein, has been described.  IKKα shuttles between cytoplasm and nucleus, and when is localized into the nuclei, IKKα regulates the expression of several genes, among them Maspin gene, whose expression is repressed by high amt. of nuclear IKKα.  Considering that high levels of Maspin have been assocd. with reduced metastatic progression, it could be hypothesized that the repression of IKKα nuclear translocation could be assocd. with the repression of metastatic phenotype.  The present study is aimed to explore the ability of a glucosamine deriv., 2-(N-Carbobenzyloxy)L-phenylalanylamido-2-deoxy-β-D-glucose (NCPA), synthesized in our lab., to stimulate the prodn. of Maspin in an osteosarcoma cell line, 143B.  Immunofluorescence and Western blotting expts. showed that NCPA is able to inhibit IKKα nuclear translocation, and to stimulate Maspin prodn.  Moreover, in assocn. with stimulation of Maspin prodn. we found the decrease of β1 Integrin expression, the down-regulation of metalloproteases MMP-9 and MMP-13 prodn. and cell migration inhibition.  Taking in account that β1 Integrin and MMP-9 and -13 have been correlated with the invasiveness of osteosarcoma, considering that NCPA affects the invasiveness of 143B cell line, we suggest that this mol. could affect the osteosarcoma metastatic ability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoy_JzFyYCtHrVg90H21EOLACvtfcHk0li8IiwPdJwT0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitVOjsrjK&md5=679de7ab7445df8b2e8fee818ba526b0</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2Fj.cbi.2016.12.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cbi.2016.12.005%26sid%3Dliteratum%253Aachs%26aulast%3DLeopizzi%26aufirst%3DM.%26aulast%3DCocchiola%26aufirst%3DR.%26aulast%3DMilanetti%26aufirst%3DE.%26aulast%3DRaimondo%26aufirst%3DD.%26aulast%3DPoliti%26aufirst%3DL.%26aulast%3DGiordano%26aufirst%3DC.%26aulast%3DScandurra%26aufirst%3DR.%26aulast%3DScotto%2Bd%25E2%2580%2599Abusco%26aufirst%3DA.%26atitle%3DIKK%25CE%25B1%2520inibition%2520by%2520a%2520glucosamine%2520derivative%2520enhances%2520Maspin%2520expression%2520in%2520osteosarcoma%2520cell%2520line%26jtitle%3DChem.-Biol.%2520Interact.%26date%3D2017%26volume%3D262%26spage%3D19%26epage%3D28%26doi%3D10.1016%2Fj.cbi.2016.12.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Solt, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madge, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orange, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">May, M. J.</span><span> </span><span class="NLM_article-title">Interleukin-1-induced NF-kappa B activation is NEMO-dependent but does not require IKK beta</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">282</span><span class="NLM_x">, </span> <span class="NLM_fpage">8724</span><span class="NLM_x">–</span> <span class="NLM_lpage">8733</span><span class="refDoi"> DOI: 10.1074/jbc.M609613200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;key=10.1074%2Fjbc.M609613200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282&publication_year=2007&pages=8724-8733&author=L.+A.+Soltauthor=L.+A.+Madgeauthor=J.+S.+Orangeauthor=M.+J.+May&title=Interleukin-1-induced+NF-kappa+B+activation+is+NEMO-dependent+but+does+not+require+IKK+beta&doi=10.1074%2Fjbc.M609613200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M609613200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M609613200%26sid%3Dliteratum%253Aachs%26aulast%3DSolt%26aufirst%3DL.%2BA.%26aulast%3DMadge%26aufirst%3DL.%2BA.%26aulast%3DOrange%26aufirst%3DJ.%2BS.%26aulast%3DMay%26aufirst%3DM.%2BJ.%26atitle%3DInterleukin-1-induced%2520NF-kappa%2520B%2520activation%2520is%2520NEMO-dependent%2520but%2520does%2520not%2520require%2520IKK%2520beta%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2007%26volume%3D282%26spage%3D8724%26epage%3D8733%26doi%3D10.1074%2Fjbc.M609613200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Denk, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goebeler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmid, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berberich, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ritz, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindemann, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ludwig, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wirth, T.</span><span> </span><span class="NLM_article-title">Activation of NF-kappa B via the I kappa B kinase complex is both essential and sufficient for proinflammatory gene expression in primary endothelial cells</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">276</span><span class="NLM_x">, </span> <span class="NLM_fpage">28451</span><span class="NLM_x">–</span> <span class="NLM_lpage">28458</span><span class="refDoi"> DOI: 10.1074/jbc.M102698200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;key=10.1074%2Fjbc.M102698200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2001&pages=28451-28458&author=A.+Denkauthor=M.+Goebelerauthor=S.+Schmidauthor=I.+Berberichauthor=O.+Ritzauthor=D.+Lindemannauthor=S.+Ludwigauthor=T.+Wirth&title=Activation+of+NF-kappa+B+via+the+I+kappa+B+kinase+complex+is+both+essential+and+sufficient+for+proinflammatory+gene+expression+in+primary+endothelial+cells&doi=10.1074%2Fjbc.M102698200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M102698200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M102698200%26sid%3Dliteratum%253Aachs%26aulast%3DDenk%26aufirst%3DA.%26aulast%3DGoebeler%26aufirst%3DM.%26aulast%3DSchmid%26aufirst%3DS.%26aulast%3DBerberich%26aufirst%3DI.%26aulast%3DRitz%26aufirst%3DO.%26aulast%3DLindemann%26aufirst%3DD.%26aulast%3DLudwig%26aufirst%3DS.%26aulast%3DWirth%26aufirst%3DT.%26atitle%3DActivation%2520of%2520NF-kappa%2520B%2520via%2520the%2520I%2520kappa%2520B%2520kinase%2520complex%2520is%2520both%2520essential%2520and%2520sufficient%2520for%2520proinflammatory%2520gene%2520expression%2520in%2520primary%2520endothelial%2520cells%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2001%26volume%3D276%26spage%3D28451%26epage%3D28458%26doi%3D10.1074%2Fjbc.M102698200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Craft, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Legge, G. B.</span><span> </span><span class="NLM_article-title">An AMBER/DYANA/MOLMOL phosphorylated amino acid library set and incorporation into NMR structure calculations</span> <span class="citation_source-journal">J. Biomol. NMR</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">15</span><span class="NLM_x">–</span> <span class="NLM_lpage">24</span><span class="refDoi"> DOI: 10.1007/s10858-005-1199-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;key=10.1007%2Fs10858-005-1199-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;key=16222554" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFShsL7O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2005&pages=15-24&author=J.+W.+Craftauthor=G.+B.+Legge&title=An+AMBER%2FDYANA%2FMOLMOL+phosphorylated+amino+acid+library+set+and+incorporation+into+NMR+structure+calculations&doi=10.1007%2Fs10858-005-1199-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">An AMBER/DYANA/MOLMOL Phosphorylated Amino Acid Library Set and Incorporation into NMR Structure Calculations</span></div><div class="casAuthors">Craft, John W., Jr.; Legge, Glen B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biomolecular NMR</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">15-24</span>CODEN:
                <span class="NLM_cas:coden">JBNME9</span>;
        ISSN:<span class="NLM_cas:issn">0925-2738</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Protein structure detn. using NMR requires the use of mol. dynamics programs that incorporate both NMR exptl. and implicit at. data.  At. parameters for each amino acid type are encoded in libraries used by structure calcn. programs such as DYANA and AMBER.  However, only a few non-std. amino acid library sets are included in these programs or the mol. visualization program MOLMOL.  Our lab. is calcg. the phosphorylated and non-phosphorylated states of peptides and proteins using NMR methods.  To calc. chem. correct structures, we have extended the available mol. libraries for these programs to include the modified amino acids phosphoserine, phosphothreonine, and phosphotyrosine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1yJFz3WV4VbVg90H21EOLACvtfcHk0li8IiwPdJwT0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFShsL7O&md5=1010e86682ceac20c6a114b8d9352ca7</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1007%2Fs10858-005-1199-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10858-005-1199-0%26sid%3Dliteratum%253Aachs%26aulast%3DCraft%26aufirst%3DJ.%2BW.%26aulast%3DLegge%26aufirst%3DG.%2BB.%26atitle%3DAn%2520AMBER%252FDYANA%252FMOLMOL%2520phosphorylated%2520amino%2520acid%2520library%2520set%2520and%2520incorporation%2520into%2520NMR%2520structure%2520calculations%26jtitle%3DJ.%2520Biomol.%2520NMR%26date%3D2005%26volume%3D33%26spage%3D15%26epage%3D24%26doi%3D10.1007%2Fs10858-005-1199-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Talapatra, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anthony, N. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mackay, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kozielski, F.</span><span> </span><span class="NLM_article-title">Mitotic kinesin Eg5 overcomes inhibition to the phase I/II clinical candidate SB743921 by an allosteric resistance mechanism</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">6317</span><span class="NLM_x">–</span> <span class="NLM_lpage">6329</span><span class="refDoi"> DOI: 10.1021/jm4006274</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm4006274" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFeqsbrN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=6317-6329&author=S.+K.+Talapatraauthor=N.+G.+Anthonyauthor=S.+P.+Mackayauthor=F.+Kozielski&title=Mitotic+kinesin+Eg5+overcomes+inhibition+to+the+phase+I%2FII+clinical+candidate+SB743921+by+an+allosteric+resistance+mechanism&doi=10.1021%2Fjm4006274"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Mitotic Kinesin Eg5 Overcomes Inhibition to the Phase I/II Clinical Candidate SB743921 by an Allosteric Resistance Mechanism</span></div><div class="casAuthors">Talapatra, Sandeep K.; Anthony, Nahoum G.; Mackay, Simon P.; Kozielski, Frank</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">6317-6329</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Development of drug resistance during cancer chemotherapy is one of the major causes of chemotherapeutic failure for the majority of clin. agents.  The aim of this study was to investigate the underlying mol. mechanism of resistance developed by the mitotic kinesin Eg5 against the potent second-generation ispinesib analog SB743921 (1), a phase I/II clin. candidate.  Biochem. and biophys. data demonstrate that point mutations in the inhibitor-binding pocket decrease the efficacy of 1 by several 1000-fold.  Surprisingly, the structures of wild-type and mutant Eg5 in complex with 1 display no apparent structural changes in the binding configuration of the drug candidate.  Furthermore, ITC and modeling approaches reveal that resistance to 1 is not through conventional steric effects at the binding site but through reduced flexibility and changes in energy fluctuation pathways through the protein that influence its function.  This is a phenomenon we have called "resistance by allostery".</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqaoYhxRvlbd7Vg90H21EOLACvtfcHk0li8IiwPdJwT0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFeqsbrN&md5=cff47090a835eb61eada53dd7d8d0343</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1021%2Fjm4006274&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm4006274%26sid%3Dliteratum%253Aachs%26aulast%3DTalapatra%26aufirst%3DS.%2BK.%26aulast%3DAnthony%26aufirst%3DN.%2BG.%26aulast%3DMackay%26aufirst%3DS.%2BP.%26aulast%3DKozielski%26aufirst%3DF.%26atitle%3DMitotic%2520kinesin%2520Eg5%2520overcomes%2520inhibition%2520to%2520the%2520phase%2520I%252FII%2520clinical%2520candidate%2520SB743921%2520by%2520an%2520allosteric%2520resistance%2520mechanism%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D6317%26epage%3D6329%26doi%3D10.1021%2Fjm4006274" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Ryckaert, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciccotti, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berendsen, H. J. C.</span><span> </span><span class="NLM_article-title">Numerical-integration of cartesian equations of motion of a system with constraints - molecular dynamics of <i>N</i>-alkanes</span> <span class="citation_source-journal">J. Comput. Phys.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1977</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">327</span><span class="NLM_x">–</span> <span class="NLM_lpage">341</span><span class="refDoi"> DOI: 10.1016/0021-9991(77)90098-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;key=10.1016%2F0021-9991%2877%2990098-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;key=1%3ACAS%3A528%3ADyaE2sXktVGhsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1977&pages=327-341&author=J.+P.+Ryckaertauthor=G.+Ciccottiauthor=H.+J.+C.+Berendsen&title=Numerical-integration+of+cartesian+equations+of+motion+of+a+system+with+constraints+-+molecular+dynamics+of+N-alkanes&doi=10.1016%2F0021-9991%2877%2990098-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Numerical integration of the Cartesian equations of motion of a system with constraints:  molecular dynamics of n-alkanes</span></div><div class="casAuthors">Ryckaert, Jean Paul; Ciccotti, Giovanni; Berendsen, Herman J. C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computational Physics</span>
        (<span class="NLM_cas:date">1977</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">327-41</span>CODEN:
                <span class="NLM_cas:coden">JCTPAH</span>;
        ISSN:<span class="NLM_cas:issn">0021-9991</span>.
    </div><div class="casAbstract">A numerical algorithm integrating the 3N Cartesian equation of motion of a system of N points subject to holonomic constraints is applied to mol. dynamics simulation of a liq. of 64 butane mols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYPlhG1U3Uw7Vg90H21EOLACvtfcHk0lhGzYM-GGFKXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE2sXktVGhsL4%253D&md5=b4aecddfde149117813a5ea4f5353ce2</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1016%2F0021-9991%2877%2990098-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0021-9991%252877%252990098-5%26sid%3Dliteratum%253Aachs%26aulast%3DRyckaert%26aufirst%3DJ.%2BP.%26aulast%3DCiccotti%26aufirst%3DG.%26aulast%3DBerendsen%26aufirst%3DH.%2BJ.%2BC.%26atitle%3DNumerical-integration%2520of%2520cartesian%2520equations%2520of%2520motion%2520of%2520a%2520system%2520with%2520constraints%2520-%2520molecular%2520dynamics%2520of%2520N-alkanes%26jtitle%3DJ.%2520Comput.%2520Phys.%26date%3D1977%26volume%3D23%26spage%3D327%26epage%3D341%26doi%3D10.1016%2F0021-9991%2877%2990098-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">MacKenzie, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ritchie, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paul, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plevin, R.</span><span> </span><span class="NLM_article-title">IKK alpha and IKK beta function in TNF alpha-stimulated adhesion molecule expression in human aortic smooth muscle cells</span> <span class="citation_source-journal">Cell. Signalling</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">75</span><span class="NLM_x">–</span> <span class="NLM_lpage">80</span><span class="refDoi"> DOI: 10.1016/j.cellsig.2006.06.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;key=10.1016%2Fj.cellsig.2006.06.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;key=16872805" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;key=1%3ACAS%3A528%3ADC%252BD28Xhtlalt7nI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2007&pages=75-80&author=C.+J.+MacKenzieauthor=E.+Ritchieauthor=A.+Paulauthor=R.+Plevin&title=IKK+alpha+and+IKK+beta+function+in+TNF+alpha-stimulated+adhesion+molecule+expression+in+human+aortic+smooth+muscle+cells&doi=10.1016%2Fj.cellsig.2006.06.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">IKKα and IKKβ function in TNFα-stimulated adhesion molecule expression in human aortic smooth muscle cells</span></div><div class="casAuthors">MacKenzie, Christopher J.; Ritchie, Elwyn; Paul, Andrew; Plevin, Robin</div><div class="citationInfo"><span class="NLM_cas:title">Cellular Signalling</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">75-80</span>CODEN:
                <span class="NLM_cas:coden">CESIEY</span>;
        ISSN:<span class="NLM_cas:issn">0898-6568</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The role of NFκB and it's upstream kinases in regulating adhesion mol. expression in the smooth muscle of the vasculature remains controversial.  We therefore examd. the effect of blocking the NFκB pathway on TNFα-stimulated ICAM-1 and VCAM-1 expression in primary cultures of human aortic smooth muscle cells using an adenoviral wild-type IκBα construct (Ad.IκBα) and dominant-neg. IKKα (Ad.IKKα+/-) and IKKβ (Ad.IKKβ+/-) constructs.  Ad.IκBα treatment was found to block NFκB DNA-binding, and thereby completely prevent TNFα-stimulated ICAM-1 and VCAM-1 expression without influencing IKK activity.  Ad.IKKβ+/- treatment completely inhibited TNFα-stimulated IKK kinase activity, IκBα degrdn. and NFκB DNA-binding in addn. to completely blocking TNFα-stimulated ICAM-1 and VCAM-1 expression.  Ad.IKKα+/- treatment however had no detectable effect on NFκB DNA-binding or ICAM-1 and VCAM-1 expression.  Our results demonstrate that TNFα-stimulated ICAM-1 and VCAM-1 expression in human aortic smooth muscle cells is NFκB-dependent, that IKKβ is a suitable target for drug therapy and Ad.IKKβ+/- an effective inhibitor of TNFα-stimulated ICAM-1 and VCAM-1 expression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZrRgMZkEKsbVg90H21EOLACvtfcHk0lhGzYM-GGFKXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xhtlalt7nI&md5=6a76d5e67e904b66b66fe2b3c2a9f542</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1016%2Fj.cellsig.2006.06.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cellsig.2006.06.001%26sid%3Dliteratum%253Aachs%26aulast%3DMacKenzie%26aufirst%3DC.%2BJ.%26aulast%3DRitchie%26aufirst%3DE.%26aulast%3DPaul%26aufirst%3DA.%26aulast%3DPlevin%26aufirst%3DR.%26atitle%3DIKK%2520alpha%2520and%2520IKK%2520beta%2520function%2520in%2520TNF%2520alpha-stimulated%2520adhesion%2520molecule%2520expression%2520in%2520human%2520aortic%2520smooth%2520muscle%2520cells%26jtitle%3DCell.%2520Signalling%26date%3D2007%26volume%3D19%26spage%3D75%26epage%3D80%26doi%3D10.1016%2Fj.cellsig.2006.06.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Nicklin, S. A.; Baker, A. H.</span><span> </span><span class="NLM_article-title">Simple methods for preparing recombinant adenoviruses for high-efficiency transduction of vascular cells</span>. In  <span class="citation_source-book">Vascular Disease: Molecular Biology and Gene Therapy Protocols</span>; <span class="NLM_contrib-group">Baker, A. H.</span>, Ed.; <span class="NLM_publisher-name">Humana Press</span>: <span class="NLM_publisher-loc">Totowa, NJ</span>,<span class="NLM_x"> </span><span class="NLM_year">1999</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">271</span><span class="NLM_x">–</span> <span class="NLM_lpage">283</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;key=10.1385%2F1-59259-247-3%3A271" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1999&pages=271-283&author=S.+A.+Nicklin&author=A.+H.+Bakerauthor=A.+H.+Baker&title=Vascular+Disease%3A+Molecular+Biology+and+Gene+Therapy+Protocols"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1385%2F1-59259-247-3%3A271&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1385%252F1-59259-247-3%253A271%26sid%3Dliteratum%253Aachs%26aulast%3DNicklin%26aufirst%3DS.%2BA.%26atitle%3DSimple%2520methods%2520for%2520preparing%2520recombinant%2520adenoviruses%2520for%2520high-efficiency%2520transduction%2520of%2520vascular%2520cells%26btitle%3DVascular%2520Disease%253A%2520Molecular%2520Biology%2520and%2520Gene%2520Therapy%2520Protocols%26aulast%3DBaker%26aufirst%3DA.%2BH.%26pub%3DHumana%2520Press%26date%3D1999%26spage%3D271%26epage%3D283" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 13 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jack A.  Prescott</span>, <span class="hlFld-ContribAuthor ">Jennifer P.  Mitchell</span>, <span class="hlFld-ContribAuthor ">Simon J.  Cook</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibitory feedback control of NF-κB signalling in health and disease. </span><span class="cited-content_cbyCitation_journal-name">Biochemical Journal</span><span> <strong>2021,</strong> <em>478 </em>
                                    (13)
                                     , 2619-2664. <a href="https://doi.org/10.1042/BCJ20210139" title="DOI URL">https://doi.org/10.1042/BCJ20210139</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1042/BCJ20210139&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1042%2FBCJ20210139%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemical%2520Journal%26atitle%3DInhibitory%252Bfeedback%252Bcontrol%252Bof%252BNF-%2525CE%2525BAB%252Bsignalling%252Bin%252Bhealth%252Band%252Bdisease%26aulast%3DPrescott%26aufirst%3DJack%2BA.%26date%3D2021%26date%3D2021%26volume%3D478%26issue%3D13%26spage%3D2619%26epage%3D2664" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marco  Haselager</span>, <span class="hlFld-ContribAuthor ">Rachel  Thijssen</span>, <span class="hlFld-ContribAuthor ">Christopher  West</span>, <span class="hlFld-ContribAuthor ">Louise  Young</span>, <span class="hlFld-ContribAuthor ">Roel  Van Kampen</span>, <span class="hlFld-ContribAuthor ">Elaine  Willmore</span>, <span class="hlFld-ContribAuthor ">Simon  Mackay</span>, <span class="hlFld-ContribAuthor ">Arnon  Kater</span>, <span class="hlFld-ContribAuthor ">Eric  Eldering</span>. </span><span class="cited-content_cbyCitation_article-title">Regulation of Bcl-XL by non-canonical NF-κB in the context of CD40-induced drug resistance in CLL. </span><span class="cited-content_cbyCitation_journal-name">Cell Death & Differentiation</span><span> <strong>2021,</strong> <em>28 </em>
                                    (5)
                                     , 1658-1668. <a href="https://doi.org/10.1038/s41418-020-00692-w" title="DOI URL">https://doi.org/10.1038/s41418-020-00692-w</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41418-020-00692-w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41418-020-00692-w%26sid%3Dliteratum%253Aachs%26jtitle%3DCell%2520Death%2520%2526%2520Differentiation%26atitle%3DRegulation%252Bof%252BBcl-XL%252Bby%252Bnon-canonical%252BNF-%2525CE%2525BAB%252Bin%252Bthe%252Bcontext%252Bof%252BCD40-induced%252Bdrug%252Bresistance%252Bin%252BCLL%26aulast%3DHaselager%26aufirst%3DMarco%26date%3D2021%26date%3D2021%26volume%3D28%26issue%3D5%26spage%3D1658%26epage%3D1668" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Aishat  Motolani</span>, <span class="hlFld-ContribAuthor ">Matthew  Martin</span>, <span class="hlFld-ContribAuthor ">Mengyao  Sun</span>, <span class="hlFld-ContribAuthor ">Tao  Lu</span>. </span><span class="cited-content_cbyCitation_article-title">Phosphorylation of the Regulators, a Complex Facet of NF-κB Signaling in Cancer. </span><span class="cited-content_cbyCitation_journal-name">Biomolecules</span><span> <strong>2021,</strong> <em>11 </em>
                                    (1)
                                     , 15. <a href="https://doi.org/10.3390/biom11010015" title="DOI URL">https://doi.org/10.3390/biom11010015</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/biom11010015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fbiom11010015%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomolecules%26atitle%3DPhosphorylation%252Bof%252Bthe%252BRegulators%25252C%252Ba%252BComplex%252BFacet%252Bof%252BNF-%2525CE%2525BAB%252BSignaling%252Bin%252BCancer%26aulast%3DMotolani%26aufirst%3DAishat%26date%3D2021%26date%3D2020%26volume%3D11%26issue%3D1%26spage%3D15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alessandra C.  Pinheiro</span>, <span class="hlFld-ContribAuthor ">Thaís C. M.  Nogueira</span>, <span class="hlFld-ContribAuthor ">Cristiane França  da Costa</span>, <span class="hlFld-ContribAuthor ">Cristina  Lourenço</span>, <span class="hlFld-ContribAuthor ">John N.  Low</span>, <span class="hlFld-ContribAuthor ">James L.  Wardell</span>, <span class="hlFld-ContribAuthor ">Solange M. S. V.  Wardell</span>, <span class="hlFld-ContribAuthor ">Marcus V. N.  de Souza</span>. </span><span class="cited-content_cbyCitation_article-title">A study of antituberculosis activities and crystal structures of (
              E
              )-2-[2-(arylidene)hydrazinyl]pyrimidine and (
              E
              )-
              N
              1
              -(arylidene)pyrimidine-2-carbohydrazide derivatives. </span><span class="cited-content_cbyCitation_journal-name">Zeitschrift für Naturforschung B</span><span> <strong>2020,</strong> <em>75 </em>
                                    (12)
                                     , 1011-1028. <a href="https://doi.org/10.1515/znb-2020-0108" title="DOI URL">https://doi.org/10.1515/znb-2020-0108</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1515/znb-2020-0108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1515%2Fznb-2020-0108%26sid%3Dliteratum%253Aachs%26jtitle%3DZeitschrift%2520f%25C3%25BCr%2520Naturforschung%2520B%26atitle%3DA%252Bstudy%252Bof%252Bantituberculosis%252Bactivities%252Band%252Bcrystal%252Bstructures%252Bof%252B%252528%252BE%252B%252529-2-%25255B2-%252528arylidene%252529hydrazinyl%25255Dpyrimidine%252Band%252B%252528%252BE%252B%252529-%252BN%252B1%252B-%252528arylidene%252529pyrimidine-2-carbohydrazide%252Bderivatives%26aulast%3DPinheiro%26aufirst%3DAlessandra%2BC.%26date%3D2020%26date%3D2020%26volume%3D75%26issue%3D12%26spage%3D1011%26epage%3D1028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dhakshayini  Morgan</span>, <span class="hlFld-ContribAuthor ">Manoj  Garg</span>, <span class="hlFld-ContribAuthor ">Vinay  Tergaonkar</span>, <span class="hlFld-ContribAuthor ">Soo Yong  Tan</span>, <span class="hlFld-ContribAuthor ">Gautam  Sethi</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacological significance of the non-canonical NF-κB pathway in tumorigenesis. </span><span class="cited-content_cbyCitation_journal-name">Biochimica et Biophysica Acta (BBA) - Reviews on Cancer</span><span> <strong>2020,</strong> <em>1874 </em>
                                    (2)
                                     , 188449. <a href="https://doi.org/10.1016/j.bbcan.2020.188449" title="DOI URL">https://doi.org/10.1016/j.bbcan.2020.188449</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bbcan.2020.188449&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bbcan.2020.188449%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochimica%2520et%2520Biophysica%2520Acta%2520%2528BBA%2529%2520-%2520Reviews%2520on%2520Cancer%26atitle%3DPharmacological%252Bsignificance%252Bof%252Bthe%252Bnon-canonical%252BNF-%2525CE%2525BAB%252Bpathway%252Bin%252Btumorigenesis%26aulast%3DMorgan%26aufirst%3DDhakshayini%26date%3D2020%26volume%3D1874%26issue%3D2%26spage%3D188449" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Eckhard U.  Alt</span>, <span class="hlFld-ContribAuthor ">Philipp M.  Wörner</span>, <span class="hlFld-ContribAuthor ">Andreas  Pfnür</span>, <span class="hlFld-ContribAuthor ">Joana E.  Ochoa</span>, <span class="hlFld-ContribAuthor ">Deborah J.  Schächtele</span>, <span class="hlFld-ContribAuthor ">Zahra  Barabadi</span>, <span class="hlFld-ContribAuthor ">Lea M.  Lang</span>, <span class="hlFld-ContribAuthor ">Sudesh  Srivastav</span>, <span class="hlFld-ContribAuthor ">Matthew E.  Burow</span>, <span class="hlFld-ContribAuthor ">Bysani  Chandrasekar</span>, <span class="hlFld-ContribAuthor ">Reza  Izadpanah</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting TRAF3IP2, Compared to Rab27, is More Effective in Suppressing the Development and Metastasis of Breast Cancer. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2020,</strong> <em>10 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41598-020-64781-z" title="DOI URL">https://doi.org/10.1038/s41598-020-64781-z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41598-020-64781-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41598-020-64781-z%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DTargeting%252BTRAF3IP2%25252C%252BCompared%252Bto%252BRab27%25252C%252Bis%252BMore%252BEffective%252Bin%252BSuppressing%252Bthe%252BDevelopment%252Band%252BMetastasis%252Bof%252BBreast%252BCancer%26aulast%3DAlt%26aufirst%3DEckhard%2BU.%26date%3D2020%26date%3D2020%26volume%3D10%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Melania  Montes</span>, <span class="hlFld-ContribAuthor ">Lewis  MacKenzie</span>, <span class="hlFld-ContribAuthor ">Milly J.  McAllister</span>, <span class="hlFld-ContribAuthor ">Antonia  Roseweir</span>, <span class="hlFld-ContribAuthor ">Pamela  McCall</span>, <span class="hlFld-ContribAuthor ">Sophia  Hatziieremia</span>, <span class="hlFld-ContribAuthor ">Mark A.  Underwood</span>, <span class="hlFld-ContribAuthor ">Marie  Boyd</span>, <span class="hlFld-ContribAuthor ">Andrew  Paul</span>, <span class="hlFld-ContribAuthor ">Robin  Plevin</span>, <span class="hlFld-ContribAuthor ">Simon P.  MacKay</span>, <span class="hlFld-ContribAuthor ">Joanne  Edwards</span>. </span><span class="cited-content_cbyCitation_article-title">Determining the prognostic significance of IKKα in prostate cancer. </span><span class="cited-content_cbyCitation_journal-name">The Prostate</span><span> <strong>2020,</strong> <em>80 </em>
                                    (14)
                                     , 1188-1202. <a href="https://doi.org/10.1002/pros.24045" title="DOI URL">https://doi.org/10.1002/pros.24045</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/pros.24045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fpros.24045%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Prostate%26atitle%3DDetermining%252Bthe%252Bprognostic%252Bsignificance%252Bof%252BIKK%2525CE%2525B1%252Bin%252Bprostate%252Bcancer%26aulast%3DMontes%26aufirst%3DMelania%26date%3D2020%26date%3D2020%26volume%3D80%26issue%3D14%26spage%3D1188%26epage%3D1202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Emine  Salamci</span>. </span><span class="cited-content_cbyCitation_article-title">Recent developments concerned with the synthesis of aminocyclitols. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2020,</strong> <em>61 </em>
                                    (15)
                                     , 151728. <a href="https://doi.org/10.1016/j.tetlet.2020.151728" title="DOI URL">https://doi.org/10.1016/j.tetlet.2020.151728</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2020.151728&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2020.151728%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DRecent%252Bdevelopments%252Bconcerned%252Bwith%252Bthe%252Bsynthesis%252Bof%252Baminocyclitols%26aulast%3DSalamci%26aufirst%3DEmine%26date%3D2020%26volume%3D61%26issue%3D15%26spage%3D151728" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kathryn A.F.  Pennel</span>, <span class="hlFld-ContribAuthor ">James H.  Park</span>, <span class="hlFld-ContribAuthor ">Donald C.  McMillan</span>, <span class="hlFld-ContribAuthor ">Antonia K.  Roseweir</span>, <span class="hlFld-ContribAuthor ">Joanne  Edwards</span>. </span><span class="cited-content_cbyCitation_article-title">Signal interaction between the tumour and inflammatory cells in patients with gastrointestinal cancer: Implications for treatment. </span><span class="cited-content_cbyCitation_journal-name">Cellular Signalling</span><span> <strong>2019,</strong> <em>54 </em>, 81-90. <a href="https://doi.org/10.1016/j.cellsig.2018.11.013" title="DOI URL">https://doi.org/10.1016/j.cellsig.2018.11.013</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cellsig.2018.11.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cellsig.2018.11.013%26sid%3Dliteratum%253Aachs%26jtitle%3DCellular%2520Signalling%26atitle%3DSignal%252Binteraction%252Bbetween%252Bthe%252Btumour%252Band%252Binflammatory%252Bcells%252Bin%252Bpatients%252Bwith%252Bgastrointestinal%252Bcancer%25253A%252BImplications%252Bfor%252Btreatment%26aulast%3DPennel%26aufirst%3DKathryn%2BA.F.%26date%3D2019%26volume%3D54%26spage%3D81%26epage%3D90" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaojun  Zhou</span>, <span class="hlFld-ContribAuthor ">Zhili  Shan</span>, <span class="hlFld-ContribAuthor ">Hengying  Yang</span>, <span class="hlFld-ContribAuthor ">Jingjing  Xu</span>, <span class="hlFld-ContribAuthor ">Wenjing  Li</span>, <span class="hlFld-ContribAuthor ">Feng  Guo</span>. </span><span class="cited-content_cbyCitation_article-title">RelB plays an oncogenic role and conveys chemo-resistance to DLD-1 colon cancer cells. </span><span class="cited-content_cbyCitation_journal-name">Cancer Cell International</span><span> <strong>2018,</strong> <em>18 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s12935-018-0677-x" title="DOI URL">https://doi.org/10.1186/s12935-018-0677-x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s12935-018-0677-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs12935-018-0677-x%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520Cell%2520International%26atitle%3DRelB%252Bplays%252Ban%252Boncogenic%252Brole%252Band%252Bconveys%252Bchemo-resistance%252Bto%252BDLD-1%252Bcolon%252Bcancer%252Bcells%26aulast%3DZhou%26aufirst%3DXiaojun%26date%3D2018%26date%3D2018%26volume%3D18%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrew  Paul</span>, <span class="hlFld-ContribAuthor ">Joanne  Edwards</span>, <span class="hlFld-ContribAuthor ">Christopher  Pepper</span>, <span class="hlFld-ContribAuthor ">Simon  Mackay</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibitory-κB Kinase (IKK) α and Nuclear Factor-κB (NFκB)-Inducing Kinase (NIK) as Anti-Cancer Drug Targets. </span><span class="cited-content_cbyCitation_journal-name">Cells</span><span> <strong>2018,</strong> <em>7 </em>
                                    (10)
                                     , 176. <a href="https://doi.org/10.3390/cells7100176" title="DOI URL">https://doi.org/10.3390/cells7100176</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cells7100176&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcells7100176%26sid%3Dliteratum%253Aachs%26jtitle%3DCells%26atitle%3DInhibitory-%2525CE%2525BAB%252BKinase%252B%252528IKK%252529%252B%2525CE%2525B1%252Band%252BNuclear%252BFactor-%2525CE%2525BAB%252B%252528NF%2525CE%2525BAB%252529-Inducing%252BKinase%252B%252528NIK%252529%252Bas%252BAnti-Cancer%252BDrug%252BTargets%26aulast%3DPaul%26aufirst%3DAndrew%26date%3D2018%26date%3D2018%26volume%3D7%26issue%3D10%26spage%3D176" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jack  Prescott</span>, <span class="hlFld-ContribAuthor ">Simon  Cook</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting IKKβ in Cancer: Challenges and Opportunities for the Therapeutic Utilisation of IKKβ Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Cells</span><span> <strong>2018,</strong> <em>7 </em>
                                    (9)
                                     , 115. <a href="https://doi.org/10.3390/cells7090115" title="DOI URL">https://doi.org/10.3390/cells7090115</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cells7090115&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcells7090115%26sid%3Dliteratum%253Aachs%26jtitle%3DCells%26atitle%3DTargeting%252BIKK%2525CE%2525B2%252Bin%252BCancer%25253A%252BChallenges%252Band%252BOpportunities%252Bfor%252Bthe%252BTherapeutic%252BUtilisation%252Bof%252BIKK%2525CE%2525B2%252BInhibitors%26aulast%3DPrescott%26aufirst%3DJack%26date%3D2018%26date%3D2018%26volume%3D7%26issue%3D9%26spage%3D115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Meera  Patel</span>, <span class="hlFld-ContribAuthor ">Paul G.  Horgan</span>, <span class="hlFld-ContribAuthor ">Donald C.  McMillan</span>, <span class="hlFld-ContribAuthor ">Joanne  Edwards</span>. </span><span class="cited-content_cbyCitation_article-title">NF-κB pathways in the development and progression of colorectal cancer. </span><span class="cited-content_cbyCitation_journal-name">Translational Research</span><span> <strong>2018,</strong> <em>197 </em>, 43-56. <a href="https://doi.org/10.1016/j.trsl.2018.02.002" title="DOI URL">https://doi.org/10.1016/j.trsl.2018.02.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.trsl.2018.02.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.trsl.2018.02.002%26sid%3Dliteratum%253Aachs%26jtitle%3DTranslational%2520Research%26atitle%3DNF-%2525CE%2525BAB%252Bpathways%252Bin%252Bthe%252Bdevelopment%252Band%252Bprogression%252Bof%252Bcolorectal%252Bcancer%26aulast%3DPatel%26aufirst%3DMeera%26date%3D2018%26volume%3D197%26spage%3D43%26epage%3D56" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-16/acs.jmedchem.7b00484/20170818/images/medium/jm-2017-004846_0021.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-16/acs.jmedchem.7b00484/20170818/images/large/jm-2017-004846_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00484&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-16/acs.jmedchem.7b00484/20170818/images/medium/jm-2017-004846_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-16/acs.jmedchem.7b00484/20170818/images/large/jm-2017-004846_0001.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Sequence alignment for the kinase domains of IKKα and IKKβ (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4KIK">4KIK</a>_chainB) showing 61% of identical residues (colored in turquoise), a further 14% similar residues (polar for polar, hydrophobic for hydrophobic; in light blue), and 25% nonsimilar residues (white).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-16/acs.jmedchem.7b00484/20170818/images/large/jm-2017-004846_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00484&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-16/acs.jmedchem.7b00484/20170818/images/medium/jm-2017-004846_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-16/acs.jmedchem.7b00484/20170818/images/large/jm-2017-004846_0002.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (left) Minimized average structure of IKKβ highlighting residues that are identical to (turquoise), similar to (light blue), or different from (white) IKKα. The ATP analogue marks the ATP binding site and is surrounded by turquoise residues. (right) Residual fluctuations of IKKα (black line) and IKKβ (blue line) arising during the MD simulations. Several areas were found to be more flexible in IKKα (red underline).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-16/acs.jmedchem.7b00484/20170818/images/large/jm-2017-004846_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00484&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-16/acs.jmedchem.7b00484/20170818/images/medium/jm-2017-004846_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-16/acs.jmedchem.7b00484/20170818/images/large/jm-2017-004846_0003.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Superimposition of IKKα (white) and IKKβ (blue) highlighting the differences near/in the ATP binding site (marked by the staurosporine analogue as a stick model) between the two isoforms. The expanded area shows equivalent residues in IKKα (Asn28, Leu48, and Thr52) and IKKβ (Asn28, Gln48, and Pro52) engaged in different interactions/structural effects, resulting in Asn28 being available to interact with putative ligands in the binding pocket of IKKα but not IKKβ.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-16/acs.jmedchem.7b00484/20170818/images/large/jm-2017-004846_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00484&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-16/acs.jmedchem.7b00484/20170818/images/medium/jm-2017-004846_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-16/acs.jmedchem.7b00484/20170818/images/large/jm-2017-004846_0004.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. (left) Loop conformation located below the active site in IKKα (white) and IKKβ (blue) and its relationship with α-helix 3 residue Asp127 (IKKα)/Asp128 (IKKβ). In IKKβ, Arg159 makes a reciprocal hydrogen bond dimer interaction with Asp128, whereas in IKKα Lys158 has no close interactions with Asp127. (right) Side chain amine nitrogen (Lys158 (IKKα)/Arg159 (IKKβ)) to side chain acid oxygen (Asp127 (IKKα)/Asp128 (IKKβ)) distance throughout the equilibrated phase of the simulation.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-16/acs.jmedchem.7b00484/20170818/images/large/jm-2017-004846_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00484&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-16/acs.jmedchem.7b00484/20170818/images/medium/jm-2017-004846_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-16/acs.jmedchem.7b00484/20170818/images/large/jm-2017-004846_0011.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-16/acs.jmedchem.7b00484/20170818/images/large/jm-2017-004846_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00484&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Ac<sub>2</sub>O, DMF, 150 °C, 4 h; (b) PivCl, pyridine, 85 °C; (c) POCl<sub>3</sub>, DMA; (d) amine, Et<sub>3</sub>N, 1,4-dioxane 200 °C (μW) 20 min; (e) amine, Et<sub>3</sub>N, <i>n</i>-BuOH, reflux, 16 h then KOH, EtOH, 80 °C, 20 h; (f) boronic acid/ester, Pd(dppf)Cl<sub>2</sub>, KOAc, H<sub>2</sub>O/dioxane, 110 °C 16 h.</p></p></figure><figure data-id="sch2" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-16/acs.jmedchem.7b00484/20170818/images/medium/jm-2017-004846_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-16/acs.jmedchem.7b00484/20170818/images/large/jm-2017-004846_0012.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-16/acs.jmedchem.7b00484/20170818/images/large/jm-2017-004846_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00484&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) NBS, (PhCO<sub>2</sub>)<sub>2</sub>, CCl<sub>4</sub>, 90 °C, 1 h; (b) NH(Bn)<sub>2</sub>, CCl<sub>4</sub>, rt, 12 h, 70%; (c) OsO<sub>4</sub>, NMO, acetone/H<sub>2</sub>O, rt, 4 h, 71%, 96:4 dr; (d) BzCl, pyridine, 0 °C to rt, 24 h, 84%; (e) H<sub>2</sub> (1 atm), Pd(OH)<sub>2</sub>, rt, 16 h, 98% (f) <b>5</b>, Et<sub>3</sub>N, <i>n</i>-BuOH, reflux, 16 h then KOH, EtOH 80 °C, 20 h, 42%.</p></p></figure><figure data-id="sch3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-16/acs.jmedchem.7b00484/20170818/images/medium/jm-2017-004846_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-16/acs.jmedchem.7b00484/20170818/images/large/jm-2017-004846_0013.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-16/acs.jmedchem.7b00484/20170818/images/large/jm-2017-004846_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00484&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Pd(PPh<sub>3</sub>)<sub>4</sub>, PPh<sub>3</sub>, NaH, NH(BOC)<sub>2</sub>, THF/DMF, 50 °C 24 h, 42%; (b) OsO<sub>4</sub>, NMO, acetone/H<sub>2</sub>O, rt, 24 h, 89%; (c) BzCl, pyridine, 0 °C to rt, 17 h, 74%; (d) 4 N HCl in 1,4-dioxane, 0 °C to rt, 16 h, 76%; (e) <b>7</b>, Et<sub>3</sub>N, nBuOH, reflux, 16 h then KOH, EtOH 80 °C, 20 h, 33%.</p></p></figure><figure data-id="sch4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-16/acs.jmedchem.7b00484/20170818/images/medium/jm-2017-004846_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-16/acs.jmedchem.7b00484/20170818/images/large/jm-2017-004846_0014.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 4. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-16/acs.jmedchem.7b00484/20170818/images/large/jm-2017-004846_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00484&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) alkylamine, Et<sub>3</sub>N, 1,4-dioxane 200 °C (μW) 20 min; (b) boronic acid/ester, Pd(dppf)Cl<sub>2</sub>, KOAc, H<sub>2</sub>O/dioxane, 110 °C, 16 h.</p></p></figure><figure data-id="fig5" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-16/acs.jmedchem.7b00484/20170818/images/medium/jm-2017-004846_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-16/acs.jmedchem.7b00484/20170818/images/large/jm-2017-004846_0005.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Percent residual activity of 40 kinases challenged with compound <b>48</b> at 10 μM.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-16/acs.jmedchem.7b00484/20170818/images/large/jm-2017-004846_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00484&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-16/acs.jmedchem.7b00484/20170818/images/medium/jm-2017-004846_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-16/acs.jmedchem.7b00484/20170818/images/large/jm-2017-004846_0006.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Docked poses of <b>4</b>, <b>9</b>, <b>43</b>, and <b>47</b> (A–D, respectively) binding to the back of the ATP pocket in IKKα, where the 2-aminopyrrolo[2,3-<i>d</i>]pyrimidine motif forms H-bonds (shown in green) with the side chain carboxylate of Glu61, the side chain ammonium group of Lys44, and the side chain carbonyl group of Asn28. No equivalent poses were identified when these compounds were docked with IKKβ. (D) An MD simulation of <b>47</b> revealed an additional interaction with a molecule of water that formed an H-bond bridging interaction between the 5-cyano group, the side chain of Asp102, and the backbone NH of the same residue.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-16/acs.jmedchem.7b00484/20170818/images/large/jm-2017-004846_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00484&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-16/acs.jmedchem.7b00484/20170818/images/medium/jm-2017-004846_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-16/acs.jmedchem.7b00484/20170818/images/large/jm-2017-004846_0007.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. (left) Docked pose of <b>48</b>. As before, the 2-aminopyrrolo[2,3-<i>d</i>]pyrimidine moiety engages with the back of the ATP pocket in IKKα and the sulfonamide group generates additional H-bonds with the main chain carbonyl and NH of GK+3 that produce nanomolar activity. (right) Schematic representation of the proposed binding mode in the IKKα-ATP binding site showing key interactions for compound <b>48</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-16/acs.jmedchem.7b00484/20170818/images/large/jm-2017-004846_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00484&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-16/acs.jmedchem.7b00484/20170818/images/medium/jm-2017-004846_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-16/acs.jmedchem.7b00484/20170818/images/large/jm-2017-004846_0008.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. (left) Docked pose of <b>50</b> in IKKβ. Unlike IKKα, the aminopyrrolo[2,3-<i>d</i>]pyrimidine moiety has flipped and H-bonds to GK+1 and GK+3. The rotation of Asn28 out of the pocket to H-bond with Glu48 allows the sulfonyl group to H-bond to Lys44 and accommodates the lipophilic methyl group in the cleft opened up by this rotation. (right) Schematic representation of the proposed binding mode in the IKKβ-ATP binding site showing key interactions for compound <b>50</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-16/acs.jmedchem.7b00484/20170818/images/large/jm-2017-004846_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00484&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-16/acs.jmedchem.7b00484/20170818/images/medium/jm-2017-004846_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-16/acs.jmedchem.7b00484/20170818/images/large/jm-2017-004846_0009.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Effect of compound <b>48</b> on (a) FCS-stimulated noncanonical and (b) TNF-α-induced canonical NF-kB activation in U2OS cells. Cells were pretreated with <b>48</b> 1 h prior to stimulation with FCS (10%) for 4 h or TNF-α (10 ng/mL) for 30 min. Whole cell lysate were prepared, separated by SDS-PAGE, and assessed for (a) inhibition of p100 phosphorylation (Ser866/870) and (b) IkB-α and p-p65 (Ser536) status. (c) Blots were quantified, and the IC<sub>50</sub> value for inhibition of p100 phosphorylation was determined (<b>48</b> IC<sub>50</sub> = 5.8 μM). The results are representative of three independent experiments.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-16/acs.jmedchem.7b00484/20170818/images/large/jm-2017-004846_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00484&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig10" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-16/acs.jmedchem.7b00484/20170818/images/medium/jm-2017-004846_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-16/acs.jmedchem.7b00484/20170818/images/large/jm-2017-004846_0010.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Effect of compound <b>47</b> on (a) FCS-stimulated noncanonical and (b) TNF-α-induced canonical NF-kB activation in U2OS cells. Cells were pretreated with <b>47</b> 1 h prior to stimulation with FCS (10%) for 4 h or TNF-α (10 ng/mL) for 30 min. Whole cell lysate were prepared, separated by SDS-PAGE, and assessed for (a) inhibition of p100 phosphorylation (Ser866/870) and (b) IkB-α and p-p65 (Ser536) status. (c) Blots were quantified, and the IC<sub>50</sub> value for inhibition of p-p100 was determined (<b>47</b> IC<sub>50</sub> = 19.1 μM). The results are representative of three independent experiments.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-16/acs.jmedchem.7b00484/20170818/images/large/jm-2017-004846_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00484&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i93">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_54305" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_54305" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 47 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Karin, M.</span><span> </span><span class="NLM_article-title">Nuclear factor-kappa B in cancer development and progression</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">441</span><span class="NLM_x">, </span> <span class="NLM_fpage">431</span><span class="NLM_x">–</span> <span class="NLM_lpage">436</span><span class="refDoi"> DOI: 10.1038/nature04870</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;key=10.1038%2Fnature04870" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=441&publication_year=2006&pages=431-436&author=M.+Karin&title=Nuclear+factor-kappa+B+in+cancer+development+and+progression&doi=10.1038%2Fnature04870"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fnature04870&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature04870%26sid%3Dliteratum%253Aachs%26aulast%3DKarin%26aufirst%3DM.%26atitle%3DNuclear%2520factor-kappa%2520B%2520in%2520cancer%2520development%2520and%2520progression%26jtitle%3DNature%26date%3D2006%26volume%3D441%26spage%3D431%26epage%3D436%26doi%3D10.1038%2Fnature04870" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Xiao, C. C.; Ghosh, S.</span><span> </span><span class="NLM_article-title">NF-kappa B, an evolutionarily conserved mediator of immune and inflammatory responses</span>. In  <span class="citation_source-book">Mechanisms of Lymphocyte Activation and Immune Regulation X: Innate Immunity</span>, <span class="NLM_contrib-group">Gupta, S.; Paul, W. E.; Steinman, R.</span>, Eds.; <span class="NLM_publisher-name">Springer</span>: <span class="NLM_publisher-loc">Boston, MA</span>,<span class="NLM_x"> </span><span class="NLM_year">2005</span><span class="NLM_x">; </span>Vol.  <span class="NLM_volume">560</span>, pp  <span class="NLM_fpage">41</span><span class="NLM_x">–</span> <span class="NLM_lpage">45</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;key=10.1007%2F0-387-24180-9_5" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&pages=41-45&author=C.+C.+Xiao&author=S.+Ghoshauthor=S.+Gupta&author=W.+E.+Paul&author=R.+Steinman&title=Mechanisms+of+Lymphocyte+Activation+and+Immune+Regulation+X%3A+Innate+Immunity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1007%2F0-387-24180-9_5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F0-387-24180-9_5%26sid%3Dliteratum%253Aachs%26aulast%3DXiao%26aufirst%3DC.%2BC.%26atitle%3DNF-kappa%2520B%252C%2520an%2520evolutionarily%2520conserved%2520mediator%2520of%2520immune%2520and%2520inflammatory%2520responses%26btitle%3DMechanisms%2520of%2520Lymphocyte%2520Activation%2520and%2520Immune%2520Regulation%2520X%253A%2520Innate%2520Immunity%26aulast%3DGupta%26aufirst%3DS.%26pub%3DSpringer%26date%3D2005%26volume%3D560%26spage%3D41%26epage%3D45" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Häcker, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karin, M.</span><span> </span><span class="NLM_article-title">Regulation and function of IKK and IKK-related kinases</span> <span class="citation_source-journal">Science’s STKE</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">2006</span><span class="NLM_x">, </span> <span class="NLM_fpage">re13</span><span class="refDoi"> DOI: 10.1126/stke.3572006re13</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;key=10.1126%2Fstke.3572006re13" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;key=17047224" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;key=1%3ACAS%3A280%3ADC%252BD28nhsFalsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2006&publication_year=2006&pages=re13&author=H.+H%C3%A4ckerauthor=M.+Karin&title=Regulation+and+function+of+IKK+and+IKK-related+kinases&doi=10.1126%2Fstke.3572006re13"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation and function of IKK and IKK-related kinases</span></div><div class="casAuthors">Hacker Hans; Karin Michael</div><div class="citationInfo"><span class="NLM_cas:title">Science's STKE : signal transduction knowledge environment</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">2006</span>
        (<span class="NLM_cas:issue">357</span>),
    <span class="NLM_cas:pages">re13</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Members of the nuclear factor kappa B (NF-kappaB) family of dimeric transcription factors (TFs) regulate expression of a large number of genes involved in immune responses, inflammation, cell survival, and cancer.  NF-kappaB TFs are rapidly activated in response to various stimuli, including cytokines, infectious agents, and radiation-induced DNA double-strand breaks.  In nonstimulated cells, some NF-kappaB TFs are bound to inhibitory IkappaB proteins and are thereby sequestered in the cytoplasm.  Activation leads to phosphorylation of IkappaB proteins and their subsequent recognition by ubiquitinating enzymes.  The resulting proteasomal degradation of IkappaB proteins liberates IkappaB-bound NF-kappaB TFs, which translocate to the nucleus to drive expression of target genes.  Two protein kinases with a high degree of sequence similarity, IKKalpha and IKKbeta, mediate phosphorylation of IkappaB proteins and represent a convergence point for most signal transduction pathways leading to NF-kappaB activation.  Most of the IKKalpha and IKKbeta molecules in the cell are part of IKK complexes that also contain a regulatory subunit called IKKgamma or NEMO.  Despite extensive sequence similarity, IKKalpha and IKKbeta have largely distinct functions, due to their different substrate specificities and modes of regulation.  IKKbeta (and IKKgamma) are essential for rapid NF-kappaB activation by proinflammatory signaling cascades, such as those triggered by tumor necrosis factor alpha (TNFalpha) or lipopolysaccharide (LPS).  In contrast, IKKalpha functions in the activation of a specific form of NF-kappaB in response to a subset of TNF family members and may also serve to attenuate IKKbeta-driven NF-kappaB activation.  Moreover, IKKalpha is involved in keratinocyte differentiation, but this function is independent of its kinase activity.  Several years ago, two protein kinases, one called IKKepsilon or IKK-i and one variously named TBK1 (TANK-binding kinase), NAK (NF-kappaB-activated kinase), or T2K (TRAF2-associated kinase), were identified that exhibit structural similarity to IKKalpha and IKKbeta.  These protein kinases are important for the activation of interferon response factor 3 (IRF3) and IRF7, TFs that play key roles in the induction of type I interferon (IFN-I).  Together, the IKKs and IKK-related kinases are instrumental for activation of the host defense system.  This Review focuses on the functions of IKK and IKK-related kinases and the molecular mechanisms that regulate their activities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSMHh8QyF1EzrFU0A1HOshhfW6udTcc2eZYKXU-Z6_p_7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28nhsFalsg%253D%253D&md5=31e5e57982ec416f6eb6de1566437258</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1126%2Fstke.3572006re13&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fstke.3572006re13%26sid%3Dliteratum%253Aachs%26aulast%3DH%25C3%25A4cker%26aufirst%3DH.%26aulast%3DKarin%26aufirst%3DM.%26atitle%3DRegulation%2520and%2520function%2520of%2520IKK%2520and%2520IKK-related%2520kinases%26jtitle%3DScience%25E2%2580%2599s%2520STKE%26date%3D2006%26volume%3D2006%26spage%3Dre13%26doi%3D10.1126%2Fstke.3572006re13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Xiao, G. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rabson, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qing, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qu, Z. X.</span><span> </span><span class="NLM_article-title">Alternative pathways of NF-kappa B activation: A double-edged sword in health and disease</span> <span class="citation_source-journal">Cytokine Growth Factor Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">281</span><span class="NLM_x">–</span> <span class="NLM_lpage">293</span><span class="refDoi"> DOI: 10.1016/j.cytogfr.2006.04.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;key=10.1016%2Fj.cytogfr.2006.04.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;key=16793322" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;key=1%3ACAS%3A528%3ADC%252BD28XntFSgsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2006&pages=281-293&author=G.+T.+Xiaoauthor=A.+B.+Rabsonauthor=W.+Youngauthor=G.+L.+Qingauthor=Z.+X.+Qu&title=Alternative+pathways+of+NF-kappa+B+activation%3A+A+double-edged+sword+in+health+and+disease&doi=10.1016%2Fj.cytogfr.2006.04.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Alternative pathways of NF-κB activation: A double-edged sword in health and disease</span></div><div class="casAuthors">Xiao, Gutian; Rabson, Arnold B.; Young, Wise; Qing, Guoliang; Qu, Zhaoxia</div><div class="citationInfo"><span class="NLM_cas:title">Cytokine & Growth Factor Reviews</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">281-293</span>CODEN:
                <span class="NLM_cas:coden">CGFRFB</span>;
        ISSN:<span class="NLM_cas:issn">1359-6101</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  While the classical pathway of NF-κB activation plays crit. roles in a wide range of biol. processes, the more recently described "non-canonical" NF-κB pathway has important but more restricted roles in both normal and pathol. processes.  The non-canonical NF-κB pathway, based on processing of the nf-κb2 gene product p100 to generate p52, appears to be involved in B-cell maturation and lymphoid development.  Deregulated activation of this pathway has been obsd. in a variety of malignant and autoimmune diseases, thus inhibitors that specifically target p100 processing might be predicted to have potential roles as immunomodulators and in the therapy of malignant diseases.  We review current understandings of NF-κB activation, particularly the mechanisms of p100 processing under both physiol. and pathol. conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGquHFIxIuoo_LVg90H21EOLACvtfcHk0ljzuANdYdc0kA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XntFSgsbo%253D&md5=93a55ea72f4cf701f0020ca7eecc40e2</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.cytogfr.2006.04.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cytogfr.2006.04.005%26sid%3Dliteratum%253Aachs%26aulast%3DXiao%26aufirst%3DG.%2BT.%26aulast%3DRabson%26aufirst%3DA.%2BB.%26aulast%3DYoung%26aufirst%3DW.%26aulast%3DQing%26aufirst%3DG.%2BL.%26aulast%3DQu%26aufirst%3DZ.%2BX.%26atitle%3DAlternative%2520pathways%2520of%2520NF-kappa%2520B%2520activation%253A%2520A%2520double-edged%2520sword%2520in%2520health%2520and%2520disease%26jtitle%3DCytokine%2520Growth%2520Factor%2520Rev.%26date%3D2006%26volume%3D17%26spage%3D281%26epage%3D293%26doi%3D10.1016%2Fj.cytogfr.2006.04.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Hu, Y. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baud, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oga, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, K. I. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshida, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karin, M.</span><span> </span><span class="NLM_article-title">IKKalpha controls formation of the epidermis independently of NF-kappa B</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">410</span><span class="NLM_x">, </span> <span class="NLM_fpage">710</span><span class="NLM_x">–</span> <span class="NLM_lpage">714</span><span class="refDoi"> DOI: 10.1038/35070605</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;key=10.1038%2F35070605" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=410&publication_year=2001&pages=710-714&author=Y.+L.+Huauthor=V.+Baudauthor=T.+Ogaauthor=K.+I.+I.+Kimauthor=K.+Yoshidaauthor=M.+Karin&title=IKKalpha+controls+formation+of+the+epidermis+independently+of+NF-kappa+B&doi=10.1038%2F35070605"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2F35070605&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F35070605%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DY.%2BL.%26aulast%3DBaud%26aufirst%3DV.%26aulast%3DOga%26aufirst%3DT.%26aulast%3DKim%26aufirst%3DK.%2BI.%2BI.%26aulast%3DYoshida%26aufirst%3DK.%26aulast%3DKarin%26aufirst%3DM.%26atitle%3DIKKalpha%2520controls%2520formation%2520of%2520the%2520epidermis%2520independently%2520of%2520NF-kappa%2520B%26jtitle%3DNature%26date%3D2001%26volume%3D410%26spage%3D710%26epage%3D714%26doi%3D10.1038%2F35070605" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Karin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greten, F. R.</span><span> </span><span class="NLM_article-title">NF kappa B: Linking inflammation and immunity to cancer development and progression</span> <span class="citation_source-journal">Nat. Rev. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">749</span><span class="NLM_x">–</span> <span class="NLM_lpage">759</span><span class="refDoi"> DOI: 10.1038/nri1703</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;key=10.1038%2Fnri1703" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;key=16175180" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVGrurvL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=749-759&author=M.+Karinauthor=F.+R.+Greten&title=NF+kappa+B%3A+Linking+inflammation+and+immunity+to+cancer+development+and+progression&doi=10.1038%2Fnri1703"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">NF-κB: linking inflammation and immunity to cancer development and progression</span></div><div class="casAuthors">Karin, Michael; Greten, Florian R.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Immunology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">749-759</span>CODEN:
                <span class="NLM_cas:coden">NRIABX</span>;
        ISSN:<span class="NLM_cas:issn">1474-1733</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  A review.  There has been much effort recently to probe the long-recognized relationship between the pathol. processes of infection, inflammation and cancer.  For example, epidemiol. studies have shown that ∼15% of human deaths from cancer are assocd. with chronic viral or bacterial infections.  This Review focuses on the mol. mechanisms that connect infection, inflammation and cancer, and it puts forward the hypothesis that activation of nuclear factor-κB (NF-κB) by the classical, IKK-β (inhibitor-of-NF-κB kinase-β)-dependent pathway is a crucial mediator of inflammation-induced tumor growth and progression, as well as an important modulator of tumor surveillance and rejection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbLJjlXSNvCLVg90H21EOLACvtfcHk0ljzuANdYdc0kA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVGrurvL&md5=84c639c714d2c8d3a3d29e2025a2b789</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2Fnri1703&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnri1703%26sid%3Dliteratum%253Aachs%26aulast%3DKarin%26aufirst%3DM.%26aulast%3DGreten%26aufirst%3DF.%2BR.%26atitle%3DNF%2520kappa%2520B%253A%2520Linking%2520inflammation%2520and%2520immunity%2520to%2520cancer%2520development%2520and%2520progression%26jtitle%3DNat.%2520Rev.%2520Immunol.%26date%3D2005%26volume%3D5%26spage%3D749%26epage%3D759%26doi%3D10.1038%2Fnri1703" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Sizemore, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lerner, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dombrowski, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakurai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stark, G. R.</span><span> </span><span class="NLM_article-title">Distinct roles of the IkappaB kinase alpha and beta subunits in liberating nuclear factor kappa B (NF-kappa-B) from IkappaB and in phosphorylating the p65 subunit of NF-kappa B</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">277</span><span class="NLM_x">, </span> <span class="NLM_fpage">3863</span><span class="NLM_x">–</span> <span class="NLM_lpage">3869</span><span class="refDoi"> DOI: 10.1074/jbc.M110572200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;key=10.1074%2Fjbc.M110572200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=277&publication_year=2002&pages=3863-3869&author=N.+Sizemoreauthor=N.+Lernerauthor=N.+Dombrowskiauthor=H.+Sakuraiauthor=G.+R.+Stark&title=Distinct+roles+of+the+IkappaB+kinase+alpha+and+beta+subunits+in+liberating+nuclear+factor+kappa+B+%28NF-kappa-B%29+from+IkappaB+and+in+phosphorylating+the+p65+subunit+of+NF-kappa+B&doi=10.1074%2Fjbc.M110572200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M110572200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M110572200%26sid%3Dliteratum%253Aachs%26aulast%3DSizemore%26aufirst%3DN.%26aulast%3DLerner%26aufirst%3DN.%26aulast%3DDombrowski%26aufirst%3DN.%26aulast%3DSakurai%26aufirst%3DH.%26aulast%3DStark%26aufirst%3DG.%2BR.%26atitle%3DDistinct%2520roles%2520of%2520the%2520IkappaB%2520kinase%2520alpha%2520and%2520beta%2520subunits%2520in%2520liberating%2520nuclear%2520factor%2520kappa%2520B%2520%2528NF-kappa-B%2529%2520from%2520IkappaB%2520and%2520in%2520phosphorylating%2520the%2520p65%2520subunit%2520of%2520NF-kappa%2520B%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2002%26volume%3D277%26spage%3D3863%26epage%3D3869%26doi%3D10.1074%2Fjbc.M110572200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Park, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krishnan, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Malley, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaynor, R. B.</span><span> </span><span class="NLM_article-title">Formation of an IKK alpha-dependent transcription complex is required for estrogen receptor-mediated gene activation</span> <span class="citation_source-journal">Mol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">71</span><span class="NLM_x">–</span> <span class="NLM_lpage">82</span><span class="refDoi"> DOI: 10.1016/j.molcel.2005.03.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;key=10.1016%2Fj.molcel.2005.03.006" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2005&pages=71-82&author=K.+J.+Parkauthor=V.+Krishnanauthor=B.+W.+O%E2%80%99Malleyauthor=Y.+Yamamotoauthor=R.+B.+Gaynor&title=Formation+of+an+IKK+alpha-dependent+transcription+complex+is+required+for+estrogen+receptor-mediated+gene+activation&doi=10.1016%2Fj.molcel.2005.03.006"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2005.03.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2005.03.006%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DK.%2BJ.%26aulast%3DKrishnan%26aufirst%3DV.%26aulast%3DO%25E2%2580%2599Malley%26aufirst%3DB.%2BW.%26aulast%3DYamamoto%26aufirst%3DY.%26aulast%3DGaynor%26aufirst%3DR.%2BB.%26atitle%3DFormation%2520of%2520an%2520IKK%2520alpha-dependent%2520transcription%2520complex%2520is%2520required%2520for%2520estrogen%2520receptor-mediated%2520gene%2520activation%26jtitle%3DMol.%2520Cell%26date%3D2005%26volume%3D18%26spage%3D71%26epage%3D82%26doi%3D10.1016%2Fj.molcel.2005.03.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Wen, D. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nong, Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgan, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gangurde, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bielecki, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DaSilva, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keaveney, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fraser, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schopf, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hepperle, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harriman, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaffee, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ocain, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Y. J.</span><span> </span><span class="NLM_article-title">A selective small molecule IkappaB kinase beta inhibitor blocks nuclear factor kappa B-mediated inflammatory responses in human fibroblast-like synoviocytes, chondrocytes, and mast cells</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">317</span><span class="NLM_x">, </span> <span class="NLM_fpage">989</span><span class="NLM_x">–</span> <span class="NLM_lpage">1001</span><span class="refDoi"> DOI: 10.1124/jpet.105.097584</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;key=10.1124%2Fjpet.105.097584" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;key=16525037" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;key=1%3ACAS%3A528%3ADC%252BD28Xlt1eqtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=317&publication_year=2006&pages=989-1001&author=D.+Y.+Wenauthor=Y.+H.+Nongauthor=J.+G.+Morganauthor=P.+Gangurdeauthor=A.+Bieleckiauthor=J.+DaSilvaauthor=M.+Keaveneyauthor=H.+Chengauthor=C.+Fraserauthor=L.+Schopfauthor=M.+Hepperleauthor=G.+Harrimanauthor=B.+D.+Jaffeeauthor=T.+D.+Ocainauthor=Y.+J.+Xu&title=A+selective+small+molecule+IkappaB+kinase+beta+inhibitor+blocks+nuclear+factor+kappa+B-mediated+inflammatory+responses+in+human+fibroblast-like+synoviocytes%2C+chondrocytes%2C+and+mast+cells&doi=10.1124%2Fjpet.105.097584"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">A selective small molecule IκB kinase β inhibitor blocks nuclear factor κB-mediated inflammatory responses in human fibroblast-like synoviocytes, chondrocytes, and mast cells</span></div><div class="casAuthors">Wen, Danyi; Nong, Yuhua; Morgan, Jennifer G.; Gangurde, Pranoti; Bielecki, Andrew; DaSilva, Jennifer; Keaveney, Marie; Cheng, Hong; Fraser, Chris; Schopf, Lisa; Hepperle, Michael; Harriman, Geraldine; Jaffee, Bruce D.; Ocain, Timothy D.; Xu, Yajun</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">317</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">989-1001</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">IκB kinase (IKK) β is essential for inflammatory cytokine-induced activation of nuclear factor κB (NF-κB).  NF-κB plays a pivotal role in the function of major cell types that contribute to the pathophysiol. process of rheumatoid arthritis (RA).  Here, we report the mechanism and the effect of the IKKβ inhibitor N-(6-chloro-7-methoxy-9H-β-carbolin-8-yl)-2-methylnicotinamide (ML120B), a β-carboline deriv., on NF-κB signaling and gene activation in RA-relevant cell systems.  ML120B is a potent, selective, reversible, and ATP-competitive inhibitor of IKKβ with an IC50 of 60 nM when evaluated in an IκBα kinase complex assay.  ML120B does not inhibit other IKK isoforms or a panel of other kinases.  ML120B concn.-dependently inhibits tumor necrosis factor α (TNFα)-stimulated NF-κB signaling via inhibition of IκBα phosphorylation, degrdn., and NF-κB translocation into the nucleus.  For the first time, we have demonstrated that in human fibroblast-like synoviocytes, TNFα- or interleukin (IL)-1β-induced monocyte chemoattractant protein-1 regulated on activation, normal T cell expressed and secreted and prodn. is IKKβ-dependent.  In addn., for the first time, we have demonstrated that lipopolysaccharide- or peptidoglycan-induced cytokine prodn. in human cord blood-derived mast cells is IKKβ-dependent.  In addn., in human chondrocytes, ML120B inhibited IL-1β-induced matrix metalloproteinase prodn. with an IC50 of approx. 1 μM.  ML120B also blocked IL-1β-induced prostaglandin E2 prodn.  In summary, ML120B blocked numerous NF-κB-regulated cell responses that are involved in inflammation and destructive processes in the RA joint.  Our findings support the evaluation of IKKβ inhibitors as anti-inflammatory agents for the treatment of RA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoiioh_R_Vy_LVg90H21EOLACvtfcHk0lg46hspljD4rw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xlt1eqtrY%253D&md5=620a2ba27d791849b613d1160add85e8</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1124%2Fjpet.105.097584&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.105.097584%26sid%3Dliteratum%253Aachs%26aulast%3DWen%26aufirst%3DD.%2BY.%26aulast%3DNong%26aufirst%3DY.%2BH.%26aulast%3DMorgan%26aufirst%3DJ.%2BG.%26aulast%3DGangurde%26aufirst%3DP.%26aulast%3DBielecki%26aufirst%3DA.%26aulast%3DDaSilva%26aufirst%3DJ.%26aulast%3DKeaveney%26aufirst%3DM.%26aulast%3DCheng%26aufirst%3DH.%26aulast%3DFraser%26aufirst%3DC.%26aulast%3DSchopf%26aufirst%3DL.%26aulast%3DHepperle%26aufirst%3DM.%26aulast%3DHarriman%26aufirst%3DG.%26aulast%3DJaffee%26aufirst%3DB.%2BD.%26aulast%3DOcain%26aufirst%3DT.%2BD.%26aulast%3DXu%26aufirst%3DY.%2BJ.%26atitle%3DA%2520selective%2520small%2520molecule%2520IkappaB%2520kinase%2520beta%2520inhibitor%2520blocks%2520nuclear%2520factor%2520kappa%2520B-mediated%2520inflammatory%2520responses%2520in%2520human%2520fibroblast-like%2520synoviocytes%252C%2520chondrocytes%252C%2520and%2520mast%2520cells%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2006%26volume%3D317%26spage%3D989%26epage%3D1001%26doi%3D10.1124%2Fjpet.105.097584" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Burke, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pattoli, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gregor, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brassil, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacMaster, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McIntyre, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, X. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iotzova, V. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarke, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strnad, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiu, Y. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zusi, F. C.</span><span> </span><span class="NLM_article-title">BMS-345541 is a highly selective inhibitor of IkappaB kinase that binds at an allosteric site of the enzyme and blocks NF-kappa B-dependent transcription in mice</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">278</span><span class="NLM_x">, </span> <span class="NLM_fpage">1450</span><span class="NLM_x">–</span> <span class="NLM_lpage">1456</span><span class="refDoi"> DOI: 10.1074/jbc.M209677200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;key=10.1074%2Fjbc.M209677200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2003&pages=1450-1456&author=J.+R.+Burkeauthor=M.+A.+Pattoliauthor=K.+R.+Gregorauthor=P.+J.+Brassilauthor=J.+F.+MacMasterauthor=K.+W.+McIntyreauthor=X.+X.+Yangauthor=V.+S.+Iotzovaauthor=W.+Clarkeauthor=J.+Strnadauthor=Y.+P.+Qiuauthor=F.+C.+Zusi&title=BMS-345541+is+a+highly+selective+inhibitor+of+IkappaB+kinase+that+binds+at+an+allosteric+site+of+the+enzyme+and+blocks+NF-kappa+B-dependent+transcription+in+mice&doi=10.1074%2Fjbc.M209677200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M209677200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M209677200%26sid%3Dliteratum%253Aachs%26aulast%3DBurke%26aufirst%3DJ.%2BR.%26aulast%3DPattoli%26aufirst%3DM.%2BA.%26aulast%3DGregor%26aufirst%3DK.%2BR.%26aulast%3DBrassil%26aufirst%3DP.%2BJ.%26aulast%3DMacMaster%26aufirst%3DJ.%2BF.%26aulast%3DMcIntyre%26aufirst%3DK.%2BW.%26aulast%3DYang%26aufirst%3DX.%2BX.%26aulast%3DIotzova%26aufirst%3DV.%2BS.%26aulast%3DClarke%26aufirst%3DW.%26aulast%3DStrnad%26aufirst%3DJ.%26aulast%3DQiu%26aufirst%3DY.%2BP.%26aulast%3DZusi%26aufirst%3DF.%2BC.%26atitle%3DBMS-345541%2520is%2520a%2520highly%2520selective%2520inhibitor%2520of%2520IkappaB%2520kinase%2520that%2520binds%2520at%2520an%2520allosteric%2520site%2520of%2520the%2520enzyme%2520and%2520blocks%2520NF-kappa%2520B-dependent%2520transcription%2520in%2520mice%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2003%26volume%3D278%26spage%3D1450%26epage%3D1456%26doi%3D10.1074%2Fjbc.M209677200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Kim, B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seo, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryu, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahn, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hwang, B. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, Y.</span><span> </span><span class="NLM_article-title">Artemisolide is a typical inhibitor of IkappaB kinase beta targeting cysteine-179 residue and down-regulates NF-kappa B-dependent TNF-alpha expression in LPS-activated macrophages</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">361</span><span class="NLM_x">, </span> <span class="NLM_fpage">593</span><span class="NLM_x">–</span> <span class="NLM_lpage">598</span><span class="refDoi"> DOI: 10.1016/j.bbrc.2007.07.069</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;key=10.1016%2Fj.bbrc.2007.07.069" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=361&publication_year=2007&pages=593-598&author=B.+H.+Kimauthor=J.+Y.+Leeauthor=J.+H.+Seoauthor=H.+Y.+Leeauthor=S.+Y.+Ryuauthor=B.+W.+Ahnauthor=C.+K.+Leeauthor=B.+Y.+Hwangauthor=S.+B.+Hanauthor=Y.+Kim&title=Artemisolide+is+a+typical+inhibitor+of+IkappaB+kinase+beta+targeting+cysteine-179+residue+and+down-regulates+NF-kappa+B-dependent+TNF-alpha+expression+in+LPS-activated+macrophages&doi=10.1016%2Fj.bbrc.2007.07.069"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2007.07.069&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2007.07.069%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DB.%2BH.%26aulast%3DLee%26aufirst%3DJ.%2BY.%26aulast%3DSeo%26aufirst%3DJ.%2BH.%26aulast%3DLee%26aufirst%3DH.%2BY.%26aulast%3DRyu%26aufirst%3DS.%2BY.%26aulast%3DAhn%26aufirst%3DB.%2BW.%26aulast%3DLee%26aufirst%3DC.%2BK.%26aulast%3DHwang%26aufirst%3DB.%2BY.%26aulast%3DHan%26aufirst%3DS.%2BB.%26aulast%3DKim%26aufirst%3DY.%26atitle%3DArtemisolide%2520is%2520a%2520typical%2520inhibitor%2520of%2520IkappaB%2520kinase%2520beta%2520targeting%2520cysteine-179%2520residue%2520and%2520down-regulates%2520NF-kappa%2520B-dependent%2520TNF-alpha%2520expression%2520in%2520LPS-activated%2520macrophages%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2007%26volume%3D361%26spage%3D593%26epage%3D598%26doi%3D10.1016%2Fj.bbrc.2007.07.069" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Podolin, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Callahan, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolognese, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carlson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, T. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mellor, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roshak, A. K.</span><span> </span><span class="NLM_article-title">Attenuation of murine collagen-induced arthritis by a novel, potent, selective small molecule inhibitor of IkappaB kinase 2, TPCA-1 (2-(aminocarbonyl)amino-5-(4-fluorophenyl)-3-thiophenecarboxamide), occurs via reduction of proinflammatory cytokines and antigen-induced T cell proliferation</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">312</span><span class="NLM_x">, </span> <span class="NLM_fpage">373</span><span class="NLM_x">–</span> <span class="NLM_lpage">381</span><span class="refDoi"> DOI: 10.1124/jpet.104.074484</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;key=10.1124%2Fjpet.104.074484" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;key=15316093" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVWmurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=312&publication_year=2005&pages=373-381&author=P.+L.+Podolinauthor=J.+F.+Callahanauthor=B.+J.+Bologneseauthor=Y.+H.+Liauthor=K.+Carlsonauthor=T.+G.+Davisauthor=G.+W.+Mellorauthor=C.+Evansauthor=A.+K.+Roshak&title=Attenuation+of+murine+collagen-induced+arthritis+by+a+novel%2C+potent%2C+selective+small+molecule+inhibitor+of+IkappaB+kinase+2%2C+TPCA-1+%282-%28aminocarbonyl%29amino-5-%284-fluorophenyl%29-3-thiophenecarboxamide%29%2C+occurs+via+reduction+of+proinflammatory+cytokines+and+antigen-induced+T+cell+proliferation&doi=10.1124%2Fjpet.104.074484"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Attenuation of murine collagen-induced arthritis by a novel, potent, selective small molecule inhibitor of IκB kinase 2, TPCA-1 (2-[(aminocarbonyl)amino]-5-(4-fluorophenyl)-3-thiophenecarboxamide), occurs via reduction of proinflammatory cytokines and antigen-induced t cell proliferation</span></div><div class="casAuthors">Podolin, Patricia L.; Callahan, James F.; Bolognese, Brian J.; Li, Yue H.; Carlson, Karey; Davis, T. Gregg; Mellor, Geoff W.; Evans, Christopher; Roshak, Amy K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">312</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">373-381</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Demonstration that IκB kinase 2 (IKK-2) plays a pivotal role in the nuclear factor-κB-regulated prodn. of proinflammatory mols. by stimuli such as tumor necrosis factor (TNF)-α and interleukin (IL)-1 suggests that inhibition of IKK-2 may be beneficial in the treatment of rheumatoid arthritis.  In the present study, we demonstrate that a novel, potent (IC50 = 17.9 nM), and selective inhibitor of human IKK-2, 2-[(aminocarbonyl)amino]-5-(4-fluorophenyl)-3-thiophenecarboxamide (TPCA-1), inhibits lipopolysaccharide-induced human monocyte prodn. of TNF-α, IL-6, and IL-8 with an IC50 = 170 to 320 nM.  Prophylactic administration of TPCA-1 at 3, 10, or 20 mg/kg, i.p., b.i.d., resulted in a dose-dependent redn. in the severity of murine collagen-induced arthritis (CIA).  The significantly reduced disease severity and delay of disease onset resulting from administration of TPCA-1 at 10 mg/kg, i.p., b.i.d. were comparable to the effects of the antirheumatic drug, etanercept, when administered prophylactically at 4 mg/kg, i.p., every other day.  Nuclear localization of p65, as well as levels of IL-1β, IL-6, TNF-α, and interferon-γ, were significantly reduced in the paw tissue of TPCA-1- and etanercept-treated mice.  In addn., administration of TPCA-1 in vivo resulted in significantly decreased collagen-induced T cell proliferation ex vivo.  Therapeutic administration of TPCA-1 at 20 mg/kg, but not at 3 or 10 mg/kg, i.p., b.i.d., significantly reduced the severity of CIA, as did etanercept administration at 12.5 mg/kg, i.p., every other day.  These results suggest that redn. of proinflammatory mediators and inhibition of antigen-induced T cell proliferation are mechanisms underlying the attenuation of CIA by the IKK-2 inhibitor, TPCA-1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGrpRJjpOGVrVg90H21EOLACvtfcHk0lgHFMUB9WuDtg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVWmurk%253D&md5=56712e228f6d6369b8b88e4288feb359</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1124%2Fjpet.104.074484&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.104.074484%26sid%3Dliteratum%253Aachs%26aulast%3DPodolin%26aufirst%3DP.%2BL.%26aulast%3DCallahan%26aufirst%3DJ.%2BF.%26aulast%3DBolognese%26aufirst%3DB.%2BJ.%26aulast%3DLi%26aufirst%3DY.%2BH.%26aulast%3DCarlson%26aufirst%3DK.%26aulast%3DDavis%26aufirst%3DT.%2BG.%26aulast%3DMellor%26aufirst%3DG.%2BW.%26aulast%3DEvans%26aufirst%3DC.%26aulast%3DRoshak%26aufirst%3DA.%2BK.%26atitle%3DAttenuation%2520of%2520murine%2520collagen-induced%2520arthritis%2520by%2520a%2520novel%252C%2520potent%252C%2520selective%2520small%2520molecule%2520inhibitor%2520of%2520IkappaB%2520kinase%25202%252C%2520TPCA-1%2520%25282-%2528aminocarbonyl%2529amino-5-%25284-fluorophenyl%2529-3-thiophenecarboxamide%2529%252C%2520occurs%2520via%2520reduction%2520of%2520proinflammatory%2520cytokines%2520and%2520antigen-induced%2520T%2520cell%2520proliferation%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2005%26volume%3D312%26spage%3D373%26epage%3D381%26doi%3D10.1124%2Fjpet.104.074484" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Strnad, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burke, J. R.</span><span> </span><span class="NLM_article-title">IkappaB kinase inhibitors for treating autoimmune and inflammatory disorders: potential and challenges</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">142</span><span class="NLM_x">–</span> <span class="NLM_lpage">148</span><span class="refDoi"> DOI: 10.1016/j.tips.2007.01.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;key=10.1016%2Fj.tips.2007.01.005" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2007&pages=142-148&author=J.+Strnadauthor=J.+R.+Burke&title=IkappaB+kinase+inhibitors+for+treating+autoimmune+and+inflammatory+disorders%3A+potential+and+challenges&doi=10.1016%2Fj.tips.2007.01.005"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2007.01.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2007.01.005%26sid%3Dliteratum%253Aachs%26aulast%3DStrnad%26aufirst%3DJ.%26aulast%3DBurke%26aufirst%3DJ.%2BR.%26atitle%3DIkappaB%2520kinase%2520inhibitors%2520for%2520treating%2520autoimmune%2520and%2520inflammatory%2520disorders%253A%2520potential%2520and%2520challenges%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2007%26volume%3D28%26spage%3D142%26epage%3D148%26doi%3D10.1016%2Fj.tips.2007.01.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Pasparakis, M.</span><span> </span><span class="NLM_article-title">Regulation of tissue homeostasis by NF-kappa B signalling: implications for inflammatory diseases</span> <span class="citation_source-journal">Nat. Rev. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">778</span><span class="NLM_x">–</span> <span class="NLM_lpage">788</span><span class="refDoi"> DOI: 10.1038/nri2655</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;key=10.1038%2Fnri2655" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;key=19855404" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlSqsbzI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=778-788&author=M.+Pasparakis&title=Regulation+of+tissue+homeostasis+by+NF-kappa+B+signalling%3A+implications+for+inflammatory+diseases&doi=10.1038%2Fnri2655"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of tissue homeostasis by NF-κB signaling: implications for inflammatory diseases</span></div><div class="casAuthors">Pasparakis, Manolis</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Immunology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">778-788</span>CODEN:
                <span class="NLM_cas:coden">NRIABX</span>;
        ISSN:<span class="NLM_cas:issn">1474-1733</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The nuclear factor-κB (NF-κB) signaling pathway regulates immune responses and is implicated in the pathogenesis of many inflammatory diseases.  Given the well established pro-inflammatory functions of NF-κB, inhibition of this pathway would be expected to have anti-inflammatory effects.  However, recent studies in mouse models have led to surprising and provocative results, as NF-κB inhibition in epithelial cells resulted in the spontaneous development of severe chronic inflammatory conditions.  These findings indicate that NF-κB signaling acts in non-immune cells to control the maintenance of tissue immune homeostasis.  This Review discusses the mechanisms by which NF-κB activity in non-immune cells regulates tissue immune homeostasis and prevents the pathogenesis of inflammatory diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8bGJpyA8ZFLVg90H21EOLACvtfcHk0lgHFMUB9WuDtg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlSqsbzI&md5=b4e1387aabd3f821a6fa3f33fe44292c</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1038%2Fnri2655&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnri2655%26sid%3Dliteratum%253Aachs%26aulast%3DPasparakis%26aufirst%3DM.%26atitle%3DRegulation%2520of%2520tissue%2520homeostasis%2520by%2520NF-kappa%2520B%2520signalling%253A%2520implications%2520for%2520inflammatory%2520diseases%26jtitle%3DNat.%2520Rev.%2520Immunol.%26date%3D2009%26volume%3D9%26spage%3D778%26epage%3D788%26doi%3D10.1038%2Fnri2655" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Li, Q. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Antwerp, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mercurio, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verma, I. M.</span><span> </span><span class="NLM_article-title">Severe liver degeneration in mice lacking the IkappaB kinase 2 gene</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">284</span><span class="NLM_x">, </span> <span class="NLM_fpage">321</span><span class="NLM_x">–</span> <span class="NLM_lpage">325</span><span class="refDoi"> DOI: 10.1126/science.284.5412.321</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;key=10.1126%2Fscience.284.5412.321" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=284&publication_year=1999&pages=321-325&author=Q.+T.+Liauthor=D.+Van+Antwerpauthor=F.+Mercurioauthor=K.+F.+Leeauthor=I.+M.+Verma&title=Severe+liver+degeneration+in+mice+lacking+the+IkappaB+kinase+2+gene&doi=10.1126%2Fscience.284.5412.321"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1126%2Fscience.284.5412.321&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.284.5412.321%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DQ.%2BT.%26aulast%3DVan%2BAntwerp%26aufirst%3DD.%26aulast%3DMercurio%26aufirst%3DF.%26aulast%3DLee%26aufirst%3DK.%2BF.%26aulast%3DVerma%26aufirst%3DI.%2BM.%26atitle%3DSevere%2520liver%2520degeneration%2520in%2520mice%2520lacking%2520the%2520IkappaB%2520kinase%25202%2520gene%26jtitle%3DScience%26date%3D1999%26volume%3D284%26spage%3D321%26epage%3D325%26doi%3D10.1126%2Fscience.284.5412.321" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Llona-Minguez, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baiget, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mackay, S. P.</span><span> </span><span class="NLM_article-title">Small-molecule inhibitors of IκB kinase (IKK) and IKK-related kinases</span> <span class="citation_source-journal">Pharm. Pat. Anal.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">481</span><span class="NLM_x">–</span> <span class="NLM_lpage">498</span><span class="refDoi"> DOI: 10.4155/ppa.13.31</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;key=10.4155%2Fppa.13.31" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;key=24237125" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFSitLnP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2013&pages=481-498&author=S.+Llona-Minguezauthor=J.+Baigetauthor=S.+P.+Mackay&title=Small-molecule+inhibitors+of+I%CE%BAB+kinase+%28IKK%29+and+IKK-related+kinases&doi=10.4155%2Fppa.13.31"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Small-molecule inhibitors of IκB kinase (IKK) and IKK-related kinases</span></div><div class="casAuthors">Llona-Minguez, Sabin; Baiget, Jessica; MacKay, Simon P.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmaceutical Patent Analyst</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">481-498</span>CODEN:
                <span class="NLM_cas:coden">PPAHCN</span>;
        ISSN:<span class="NLM_cas:issn">2046-8954</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">A review.  The transcription factors NF-κB and IFN control important signaling cascades and mediate the expression of a no. of important pro-inflammatory cytokines, adhesion mols., growth factors and anti-apoptotic survival proteins.  IκB kinase (IKK) and IKK-related kinases (IKKε and TBK1) are key regulators of these biol. pathways and, as such, modulators of these enzymes may be useful in the treatment of inflammatory diseases and cancer.  We have reviewed the most recent IKK patent literature (2008-2012), added publications of interest overlooked in previous patent reviews and identified all the players involved in small-mol. inhibitors of the IKKs.  This will provide the reader with a decisive summary of the IKK arena, a field that has reached maturity over a decade of research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJOXVRu3U4HLVg90H21EOLACvtfcHk0lgHFMUB9WuDtg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFSitLnP&md5=4de9b946fbc367f3279dd6a0dd6084eb</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.4155%2Fppa.13.31&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Fppa.13.31%26sid%3Dliteratum%253Aachs%26aulast%3DLlona-Minguez%26aufirst%3DS.%26aulast%3DBaiget%26aufirst%3DJ.%26aulast%3DMackay%26aufirst%3DS.%2BP.%26atitle%3DSmall-molecule%2520inhibitors%2520of%2520I%25CE%25BAB%2520kinase%2520%2528IKK%2529%2520and%2520IKK-related%2520kinases%26jtitle%3DPharm.%2520Pat.%2520Anal.%26date%3D2013%26volume%3D2%26spage%3D481%26epage%3D498%26doi%3D10.4155%2Fppa.13.31" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Asamitsu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamaguchi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakata, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hibi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Victoriano, A. F. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imai, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Onozaki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitade, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okamoto, T.</span><span> </span><span class="NLM_article-title">Inhibition of human immunodeficiency virus type 1 replication by blocking IkappaB Kinase with noraristeromycin</span> <span class="citation_source-journal">J. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">144</span><span class="NLM_x">, </span> <span class="NLM_fpage">581</span><span class="NLM_x">–</span> <span class="NLM_lpage">589</span><span class="refDoi"> DOI: 10.1093/jb/mvn104</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;key=10.1093%2Fjb%2Fmvn104" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;key=18713798" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhvFSquw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=144&publication_year=2008&pages=581-589&author=K.+Asamitsuauthor=T.+Yamaguchiauthor=K.+Nakataauthor=Y.+Hibiauthor=A.+F.+B.+Victorianoauthor=K.+Imaiauthor=K.+Onozakiauthor=Y.+Kitadeauthor=T.+Okamoto&title=Inhibition+of+human+immunodeficiency+virus+type+1+replication+by+blocking+IkappaB+Kinase+with+noraristeromycin&doi=10.1093%2Fjb%2Fmvn104"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of human immunodeficiency virus type 1 replication by blocking IκB kinase with noraristeromycin</span></div><div class="casAuthors">Asamitsu, Kaori; Yamaguchi, Tsuyoshi; Nakata, Kenji; Hibi, Yurina; Victoriano, Ann-Florence B.; Imai, Kenichi; Onozaki, Kikuo; Kitade, Yukio; Okamoto, Takashi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biochemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">144</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">581-589</span>CODEN:
                <span class="NLM_cas:coden">JOBIAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-924X</span>.
    
            (<span class="NLM_cas:orgname">Japanese Biochemical Society</span>)
        </div><div class="casAbstract">Nuclear factor κB (NF-κB) is one of the crit. transcription factors in inflammatory responses and replication of viruses such as human immunodeficiency virus (HIV).  In fact, it has been demonstrated that various NF-κB inhibitors could block HIV replication.  To explore more potent NF-κB inhibitors, we focused on carbocyclic adenine nucleosides that had been reported to have anti-inflammatory effects.  We synthesized 15 carbocyclic adenine nucleoside compds. and examd. their effects on the NF-κB-dependent gene expression using HEK293 cell line.  Among these compds., noraristeromycin (NAM) exhibited the most potent inhibitory effect on the NF-κB activity under the non-cytotoxic concns.  NAM-inhibited IκBα phosphorylation and degrdn. upon stimulation of cells with tumor necrosis factor-α (TNF-α).  In addn., NAM prevented p65 phosphorylation.  These findings suggested that both IκB kinase-α (IKK-α) and -β were targeted by NAM.  Interestingly, in vitro kinase assay revealed that NAM inhibited the kinase activity of IKK-α more potently than that of IKK-β.  When we treated the cell lines, OM10.1 and Molt4/IIIB, in which HIV-1 is latently and chronically infected, we found a strong suppressive effect of NAM on HIV-1 viral replication upon stimulation with TNF-α.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8cq4M_wM-mLVg90H21EOLACvtfcHk0ljHbhrv5lMDcg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhvFSquw%253D%253D&md5=847c61a45b6792b0a49d7f75b21774f9</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1093%2Fjb%2Fmvn104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjb%252Fmvn104%26sid%3Dliteratum%253Aachs%26aulast%3DAsamitsu%26aufirst%3DK.%26aulast%3DYamaguchi%26aufirst%3DT.%26aulast%3DNakata%26aufirst%3DK.%26aulast%3DHibi%26aufirst%3DY.%26aulast%3DVictoriano%26aufirst%3DA.%2BF.%2BB.%26aulast%3DImai%26aufirst%3DK.%26aulast%3DOnozaki%26aufirst%3DK.%26aulast%3DKitade%26aufirst%3DY.%26aulast%3DOkamoto%26aufirst%3DT.%26atitle%3DInhibition%2520of%2520human%2520immunodeficiency%2520virus%2520type%25201%2520replication%2520by%2520blocking%2520IkappaB%2520Kinase%2520with%2520noraristeromycin%26jtitle%3DJ.%2520Biochem.%26date%3D2008%26volume%3D144%26spage%3D581%26epage%3D589%26doi%3D10.1093%2Fjb%2Fmvn104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Palayoor, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Youmell, M. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calderwood, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coleman, C. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, B. D.</span><span> </span><span class="NLM_article-title">Constitutive activation of IkappaB kinase alpha and NF-kappa B in prostate cancer cells is inhibited by ibuprofen</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">7389</span><span class="NLM_x">–</span> <span class="NLM_lpage">7394</span><span class="refDoi"> DOI: 10.1038/sj.onc.1203160</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;key=10.1038%2Fsj.onc.1203160" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=1999&pages=7389-7394&author=S.+T.+Palayoorauthor=M.+Y.+Youmellauthor=S.+K.+Calderwoodauthor=C.+N.+Colemanauthor=B.+D.+Price&title=Constitutive+activation+of+IkappaB+kinase+alpha+and+NF-kappa+B+in+prostate+cancer+cells+is+inhibited+by+ibuprofen&doi=10.1038%2Fsj.onc.1203160"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1038%2Fsj.onc.1203160&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.onc.1203160%26sid%3Dliteratum%253Aachs%26aulast%3DPalayoor%26aufirst%3DS.%2BT.%26aulast%3DYoumell%26aufirst%3DM.%2BY.%26aulast%3DCalderwood%26aufirst%3DS.%2BK.%26aulast%3DColeman%26aufirst%3DC.%2BN.%26aulast%3DPrice%26aufirst%3DB.%2BD.%26atitle%3DConstitutive%2520activation%2520of%2520IkappaB%2520kinase%2520alpha%2520and%2520NF-kappa%2520B%2520in%2520prostate%2520cancer%2520cells%2520is%2520inhibited%2520by%2520ibuprofen%26jtitle%3DOncogene%26date%3D1999%26volume%3D18%26spage%3D7389%26epage%3D7394%26doi%3D10.1038%2Fsj.onc.1203160" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Ammirante, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grivennikov, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nedospasov, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karin, M.</span><span> </span><span class="NLM_article-title">B-cell-derived lymphotoxin promotes castration-resistant prostate cancer</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">464</span><span class="NLM_x">, </span> <span class="NLM_fpage">302</span><span class="NLM_x">–</span> <span class="NLM_lpage">U187</span><span class="refDoi"> DOI: 10.1038/nature08782</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;key=10.1038%2Fnature08782" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=464&publication_year=2010&pages=302-U187&author=M.+Ammiranteauthor=J.+L.+Luoauthor=S.+Grivennikovauthor=S.+Nedospasovauthor=M.+Karin&title=B-cell-derived+lymphotoxin+promotes+castration-resistant+prostate+cancer&doi=10.1038%2Fnature08782"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1038%2Fnature08782&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature08782%26sid%3Dliteratum%253Aachs%26aulast%3DAmmirante%26aufirst%3DM.%26aulast%3DLuo%26aufirst%3DJ.%2BL.%26aulast%3DGrivennikov%26aufirst%3DS.%26aulast%3DNedospasov%26aufirst%3DS.%26aulast%3DKarin%26aufirst%3DM.%26atitle%3DB-cell-derived%2520lymphotoxin%2520promotes%2520castration-resistant%2520prostate%2520cancer%26jtitle%3DNature%26date%3D2010%26volume%3D464%26spage%3D302%26epage%3DU187%26doi%3D10.1038%2Fnature08782" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Ben-Neriah, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karin, M.</span><span> </span><span class="NLM_article-title">Inflammation meets cancer, with NF-kappa B as the matchmaker</span> <span class="citation_source-journal">Nat. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">715</span><span class="NLM_x">–</span> <span class="NLM_lpage">723</span><span class="refDoi"> DOI: 10.1038/ni.2060</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;key=10.1038%2Fni.2060" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;key=21772280" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;key=1%3ACAS%3A528%3ADC%252BC3MXptV2isrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2011&pages=715-723&author=Y.+Ben-Neriahauthor=M.+Karin&title=Inflammation+meets+cancer%2C+with+NF-kappa+B+as+the+matchmaker&doi=10.1038%2Fni.2060"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Inflammation meets cancer, with NF-κB as the matchmaker</span></div><div class="casAuthors">Ben-Neriah, Yinon; Karin, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Nature Immunology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">715-723</span>CODEN:
                <span class="NLM_cas:coden">NIAMCZ</span>;
        ISSN:<span class="NLM_cas:issn">1529-2908</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Inflammation is a fundamental protective response that sometimes goes awry and becomes a major cofactor in the pathogenesis of many chronic human diseases, including cancer.  Here we review the evolutionary relationship and opposing functions of the transcription factor NF-κB in inflammation and cancer.  Although it seems to fulfill a distinctly tumor-promoting role in many types of cancer, NF-κB has a confounding role in certain tumors.  Understanding the activity and function of NF-κB in the context of tumorigenesis is crit. for its successful taming, an important challenge for modern cancer biol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZ72-CDkj-sbVg90H21EOLACvtfcHk0ljHbhrv5lMDcg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXptV2isrk%253D&md5=c162e8a3bed9ded763be4719b40a75f2</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1038%2Fni.2060&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fni.2060%26sid%3Dliteratum%253Aachs%26aulast%3DBen-Neriah%26aufirst%3DY.%26aulast%3DKarin%26aufirst%3DM.%26atitle%3DInflammation%2520meets%2520cancer%252C%2520with%2520NF-kappa%2520B%2520as%2520the%2520matchmaker%26jtitle%3DNat.%2520Immunol.%26date%3D2011%26volume%3D12%26spage%3D715%26epage%3D723%26doi%3D10.1038%2Fni.2060" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Luo, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ricono, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korchynskyi, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonias, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheresh, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karin, M.</span><span> </span><span class="NLM_article-title">Nuclear cytokine-activated IKKalpha controls prostate cancer metastasis by repressing Maspin</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">446</span><span class="NLM_x">, </span> <span class="NLM_fpage">690</span><span class="NLM_x">–</span> <span class="NLM_lpage">694</span><span class="refDoi"> DOI: 10.1038/nature05656</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;key=10.1038%2Fnature05656" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=446&publication_year=2007&pages=690-694&author=J.+L.+Luoauthor=W.+Tanauthor=J.+M.+Riconoauthor=O.+Korchynskyiauthor=M.+Zhangauthor=S.+L.+Goniasauthor=D.+A.+Chereshauthor=M.+Karin&title=Nuclear+cytokine-activated+IKKalpha+controls+prostate+cancer+metastasis+by+repressing+Maspin&doi=10.1038%2Fnature05656"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1038%2Fnature05656&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature05656%26sid%3Dliteratum%253Aachs%26aulast%3DLuo%26aufirst%3DJ.%2BL.%26aulast%3DTan%26aufirst%3DW.%26aulast%3DRicono%26aufirst%3DJ.%2BM.%26aulast%3DKorchynskyi%26aufirst%3DO.%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DGonias%26aufirst%3DS.%2BL.%26aulast%3DCheresh%26aufirst%3DD.%2BA.%26aulast%3DKarin%26aufirst%3DM.%26atitle%3DNuclear%2520cytokine-activated%2520IKKalpha%2520controls%2520prostate%2520cancer%2520metastasis%2520by%2520repressing%2520Maspin%26jtitle%3DNature%26date%3D2007%26volume%3D446%26spage%3D690%26epage%3D694%26doi%3D10.1038%2Fnature05656" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Hao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rizzo, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osipo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pannuti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wyatt, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheung, L. W. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sonenshein, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osborne, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miele, L.</span><span> </span><span class="NLM_article-title">Notch-1 activates estrogen receptor-alpha-dependent transcription via IKKalpha in breast cancer cells</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">201</span><span class="NLM_x">–</span> <span class="NLM_lpage">213</span><span class="refDoi"> DOI: 10.1038/onc.2009.323</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;key=10.1038%2Fonc.2009.323" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2010&pages=201-213&author=L.+Haoauthor=P.+Rizzoauthor=C.+Osipoauthor=A.+Pannutiauthor=D.+Wyattauthor=L.+W.+K.+Cheungauthor=G.+Sonensheinauthor=B.+A.+Osborneauthor=L.+Miele&title=Notch-1+activates+estrogen+receptor-alpha-dependent+transcription+via+IKKalpha+in+breast+cancer+cells&doi=10.1038%2Fonc.2009.323"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1038%2Fonc.2009.323&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fonc.2009.323%26sid%3Dliteratum%253Aachs%26aulast%3DHao%26aufirst%3DL.%26aulast%3DRizzo%26aufirst%3DP.%26aulast%3DOsipo%26aufirst%3DC.%26aulast%3DPannuti%26aufirst%3DA.%26aulast%3DWyatt%26aufirst%3DD.%26aulast%3DCheung%26aufirst%3DL.%2BW.%2BK.%26aulast%3DSonenshein%26aufirst%3DG.%26aulast%3DOsborne%26aufirst%3DB.%2BA.%26aulast%3DMiele%26aufirst%3DL.%26atitle%3DNotch-1%2520activates%2520estrogen%2520receptor-alpha-dependent%2520transcription%2520via%2520IKKalpha%2520in%2520breast%2520cancer%2520cells%26jtitle%3DOncogene%26date%3D2010%26volume%3D29%26spage%3D201%26epage%3D213%26doi%3D10.1038%2Fonc.2009.323" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Cao, Y. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karin, M.</span><span> </span><span class="NLM_article-title">I kappa B kinase a kinase activity is required for self-renewal of ErbB2/Her2-transformed mammary tumor-initiating cells</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">104</span><span class="NLM_x">, </span> <span class="NLM_fpage">15852</span><span class="NLM_x">–</span> <span class="NLM_lpage">15857</span><span class="refDoi"> DOI: 10.1073/pnas.0706728104</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;key=10.1073%2Fpnas.0706728104" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2007&pages=15852-15857&author=Y.+X.+Caoauthor=J.+L.+Luoauthor=M.+Karin&title=I+kappa+B+kinase+a+kinase+activity+is+required+for+self-renewal+of+ErbB2%2FHer2-transformed+mammary+tumor-initiating+cells&doi=10.1073%2Fpnas.0706728104"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0706728104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0706728104%26sid%3Dliteratum%253Aachs%26aulast%3DCao%26aufirst%3DY.%2BX.%26aulast%3DLuo%26aufirst%3DJ.%2BL.%26aulast%3DKarin%26aufirst%3DM.%26atitle%3DI%2520kappa%2520B%2520kinase%2520a%2520kinase%2520activity%2520is%2520required%2520for%2520self-renewal%2520of%2520ErbB2%252FHer2-transformed%2520mammary%2520tumor-initiating%2520cells%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2007%26volume%3D104%26spage%3D15852%26epage%3D15857%26doi%3D10.1073%2Fpnas.0706728104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Cao, Y. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonizzi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seagroves, T. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greten, F. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, E. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karin, M.</span><span> </span><span class="NLM_article-title">IKKalpha provides an essential link between RANK signaling and cyclin D1 expression during mammary gland development</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">107</span><span class="NLM_x">, </span> <span class="NLM_fpage">763</span><span class="NLM_x">–</span> <span class="NLM_lpage">775</span><span class="refDoi"> DOI: 10.1016/S0092-8674(01)00599-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;key=10.1016%2FS0092-8674%2801%2900599-2" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2001&pages=763-775&author=Y.+X.+Caoauthor=G.+Bonizziauthor=T.+N.+Seagrovesauthor=F.+R.+Gretenauthor=R.+Johnsonauthor=E.+V.+Schmidtauthor=M.+Karin&title=IKKalpha+provides+an+essential+link+between+RANK+signaling+and+cyclin+D1+expression+during+mammary+gland+development&doi=10.1016%2FS0092-8674%2801%2900599-2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2801%2900599-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252801%252900599-2%26sid%3Dliteratum%253Aachs%26aulast%3DCao%26aufirst%3DY.%2BX.%26aulast%3DBonizzi%26aufirst%3DG.%26aulast%3DSeagroves%26aufirst%3DT.%2BN.%26aulast%3DGreten%26aufirst%3DF.%2BR.%26aulast%3DJohnson%26aufirst%3DR.%26aulast%3DSchmidt%26aufirst%3DE.%2BV.%26aulast%3DKarin%26aufirst%3DM.%26atitle%3DIKKalpha%2520provides%2520an%2520essential%2520link%2520between%2520RANK%2520signaling%2520and%2520cyclin%2520D1%2520expression%2520during%2520mammary%2520gland%2520development%26jtitle%3DCell%26date%3D2001%26volume%3D107%26spage%3D763%26epage%3D775%26doi%3D10.1016%2FS0092-8674%2801%2900599-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Liou, G. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doppler, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Necela, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krishna, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crawford, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raimondo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Storz, P.</span><span> </span><span class="NLM_article-title">Macrophage-secreted cytokines drive pancreatic acinar-to-ductal metaplasia through NF-kappa B and MMPs</span> <span class="citation_source-journal">J. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">202</span><span class="NLM_x">, </span> <span class="NLM_fpage">563</span><span class="NLM_x">–</span> <span class="NLM_lpage">577</span><span class="refDoi"> DOI: 10.1083/jcb.201301001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;key=10.1083%2Fjcb.201301001" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=202&publication_year=2013&pages=563-577&author=G.+Y.+Liouauthor=H.+Dopplerauthor=B.+Necelaauthor=M.+Krishnaauthor=H.+C.+Crawfordauthor=M.+Raimondoauthor=P.+Storz&title=Macrophage-secreted+cytokines+drive+pancreatic+acinar-to-ductal+metaplasia+through+NF-kappa+B+and+MMPs&doi=10.1083%2Fjcb.201301001"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1083%2Fjcb.201301001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1083%252Fjcb.201301001%26sid%3Dliteratum%253Aachs%26aulast%3DLiou%26aufirst%3DG.%2BY.%26aulast%3DDoppler%26aufirst%3DH.%26aulast%3DNecela%26aufirst%3DB.%26aulast%3DKrishna%26aufirst%3DM.%26aulast%3DCrawford%26aufirst%3DH.%2BC.%26aulast%3DRaimondo%26aufirst%3DM.%26aulast%3DStorz%26aufirst%3DP.%26atitle%3DMacrophage-secreted%2520cytokines%2520drive%2520pancreatic%2520acinar-to-ductal%2520metaplasia%2520through%2520NF-kappa%2520B%2520and%2520MMPs%26jtitle%3DJ.%2520Cell%2520Biol.%26date%3D2013%26volume%3D202%26spage%3D563%26epage%3D577%26doi%3D10.1083%2Fjcb.201301001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Storz, P.</span><span> </span><span class="NLM_article-title">Targeting the alternative NF-kappa B pathway in pancreatic cancer: a new direction for therapy?</span> <span class="citation_source-journal">Expert Rev. Anticancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">501</span><span class="NLM_x">–</span> <span class="NLM_lpage">504</span><span class="refDoi"> DOI: 10.1586/era.13.28</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;key=10.1586%2Fera.13.28" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;key=23617340" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmsFWlsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2013&pages=501-504&author=P.+Storz&title=Targeting+the+alternative+NF-kappa+B+pathway+in+pancreatic+cancer%3A+a+new+direction+for+therapy%3F&doi=10.1586%2Fera.13.28"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the alternative NF-κB pathway in pancreatic cancer: a new direction for therapy?</span></div><div class="casAuthors">Storz, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Expert Review of Anticancer Therapy</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">501-504</span>CODEN:
                <span class="NLM_cas:coden">ERATBJ</span>;
        ISSN:<span class="NLM_cas:issn">1473-7140</span>.
    
            (<span class="NLM_cas:orgname">Expert Reviews Ltd.</span>)
        </div><div class="casAbstract">A review.  Pancreatic cancer, due to its late diagnosis,is difficult to treat.  In addn., current therapy options are insufficient and new approaches for combination treatment are required.  Recent demonstration of the importance of constitutive signaling of NF-κB-inducing kinase (NIK,also named MAP3K14) in maintaining the high basal activity of the alternative NF-κB pathway in pancreatic cancer suggests novel possibilities for therapeutic intervention.  Strategies to target the alternative NF-κB pathway include not only the use of small mol. inhibitors for NIK and IκB kinase a (IKKa), but also broad spectrum approaches such as using proteasome inhibitors or combinatorial approaches targeting both alternative and canonical pathways.  These may also act synergistically with currently used drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkO5O_6UCQkrVg90H21EOLACvtfcHk0ljVpEa21XccXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmsFWlsL4%253D&md5=a4945c62cf71cb211141608f6790b853</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1586%2Fera.13.28&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1586%252Fera.13.28%26sid%3Dliteratum%253Aachs%26aulast%3DStorz%26aufirst%3DP.%26atitle%3DTargeting%2520the%2520alternative%2520NF-kappa%2520B%2520pathway%2520in%2520pancreatic%2520cancer%253A%2520a%2520new%2520direction%2520for%2520therapy%253F%26jtitle%3DExpert%2520Rev.%2520Anticancer%2520Ther.%26date%3D2013%26volume%3D13%26spage%3D501%26epage%3D504%26doi%3D10.1586%2Fera.13.28" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Doppler, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liou, G. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Storz, P.</span><span> </span><span class="NLM_article-title">Downregulation of TRAF2 mediates NIK-induced pancreatic cancer cell proliferation and tumorigenicity</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">e53676</span><span class="refDoi"> DOI: 10.1371/journal.pone.0053676</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;key=10.1371%2Fjournal.pone.0053676" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;key=23301098" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;key=1%3ACAS%3A528%3ADC%252BC3sXpsFKhug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=e53676&author=H.+Dopplerauthor=G.+Y.+Liouauthor=P.+Storz&title=Downregulation+of+TRAF2+mediates+NIK-induced+pancreatic+cancer+cell+proliferation+and+tumorigenicity&doi=10.1371%2Fjournal.pone.0053676"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Downregulation of TRAF2 mediates NIK-induced pancreatic cancer cell proliferation and tumorigenicity</span></div><div class="casAuthors">Doppler, Heike; Liou, Geou-Yarh; Storz, Peter</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">e53676</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Background: Increased levels of NF-κB are hallmarks of pancreatic ductal adenocarcinoma (PDAC) and both classical and alternative NF-κB activation pathways have been implicated.  Methodol./Principal Findings: Here we show that activation of the alternative pathway is a source for the high basal NFκB activity in PDAC cell lines.  Increased activity of the p52/RelB NF-κB complex is mediated through stabilization and activation of NF-κB-inducing kinase (NIK).  We identify proteasomal downregulation of TNF receptor-assocd. factor 2 (TRAF2) as a mechanism by which levels of active NIK are increased in PDAC cell lines.  Such upregulation of NIK expression and activity levels relays to increased proliferation and anchorage-independent growth, but not migration or survival of PDAC cells.  Conclusions/Significance: Rapid growth is one characteristic of pancreatic cancer.  Our data indicates that the TRAF2/NIK/NF-κB2 pathway regulates PDAC cell tumorigenicity and could be a valuable target for therapy of this cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrnrJZVjqbQzbVg90H21EOLACvtfcHk0ljVpEa21XccXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXpsFKhug%253D%253D&md5=e03970c3c2c199c764e479c528245692</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0053676&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0053676%26sid%3Dliteratum%253Aachs%26aulast%3DDoppler%26aufirst%3DH.%26aulast%3DLiou%26aufirst%3DG.%2BY.%26aulast%3DStorz%26aufirst%3DP.%26atitle%3DDownregulation%2520of%2520TRAF2%2520mediates%2520NIK-induced%2520pancreatic%2520cancer%2520cell%2520proliferation%2520and%2520tumorigenicity%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26spage%3De53676%26doi%3D10.1371%2Fjournal.pone.0053676" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Liu, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Misquitta, Y. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olland, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelleher, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kriz, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stahl, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mosyak, L.</span><span> </span><span class="NLM_article-title">Crystal Structure of a human IkappaB Kinase beta asymmetric dimer</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">288</span><span class="NLM_x">, </span> <span class="NLM_fpage">22758</span><span class="NLM_x">–</span> <span class="NLM_lpage">22767</span><span class="refDoi"> DOI: 10.1074/jbc.M113.482596</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;key=10.1074%2Fjbc.M113.482596" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;key=23792959" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1Wiu73L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=288&publication_year=2013&pages=22758-22767&author=S.+P.+Liuauthor=Y.+R.+Misquittaauthor=A.+Ollandauthor=M.+A.+Johnsonauthor=K.+S.+Kelleherauthor=R.+Krizauthor=L.+L.+Linauthor=M.+Stahlauthor=L.+Mosyak&title=Crystal+Structure+of+a+human+IkappaB+Kinase+beta+asymmetric+dimer&doi=10.1074%2Fjbc.M113.482596"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal Structure of a Human IκB Kinase β Asymmetric Dimer</span></div><div class="casAuthors">Liu, Shenping; Misquitta, Yohann R.; Olland, Andrea; Johnson, Mark A.; Kelleher, Kerry S.; Kriz, Ron; Lin, Laura L.; Stahl, Mark; Mosyak, Lidia</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">288</span>
        (<span class="NLM_cas:issue">31</span>),
    <span class="NLM_cas:pages">22758-22767</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Phosphorylation of inhibitor of nuclear transcription factor κB (IκB) by IκB kinase (IKK) triggers the degrdn. of IκB and migration of cytoplasmic κB to the nucleus where it promotes the transcription of its target genes.  Activation of IKK is achieved by phosphorylation of its main subunit, IKKβ, at the activation loop sites.  Here, we report the 2.8 Å resoln. crystal structure of human IKKβ (hIKKβ), which is partially phosphorylated and bound to the staurosporine analog K252a.  The hIKKβ protomer adopts a trimodular structure that closely resembles that from Xenopus laevis (xIKKβ): an N-terminal kinase domain (KD), a central ubiquitin-like domain (ULD), and a C-terminal scaffold/dimerization domain (SDD).  Although hIKKβ and xIKKβ utilize a similar dimerization mode, their overall geometries are distinct.  In contrast to the structure resembling closed shears reported previously for xIKKβ, hIKKβ exists as an open asym. dimer in which the two KDs are further apart, with one in an active and the other in an inactive conformation.  Dimer interactions are limited to the C-terminal six-helix bundle that acts as a hinge between the two subunits.  The obsd. domain movements in the structures of IKKβ may represent trans-phosphorylation steps that accompany IKKβ activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGrQPn1lh907Vg90H21EOLACvtfcHk0ljVpEa21XccXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1Wiu73L&md5=7b7c11c3d9c2c3b37ccf40d3093116e1</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M113.482596&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M113.482596%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DS.%2BP.%26aulast%3DMisquitta%26aufirst%3DY.%2BR.%26aulast%3DOlland%26aufirst%3DA.%26aulast%3DJohnson%26aufirst%3DM.%2BA.%26aulast%3DKelleher%26aufirst%3DK.%2BS.%26aulast%3DKriz%26aufirst%3DR.%26aulast%3DLin%26aufirst%3DL.%2BL.%26aulast%3DStahl%26aufirst%3DM.%26aulast%3DMosyak%26aufirst%3DL.%26atitle%3DCrystal%2520Structure%2520of%2520a%2520human%2520IkappaB%2520Kinase%2520beta%2520asymmetric%2520dimer%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2013%26volume%3D288%26spage%3D22758%26epage%3D22767%26doi%3D10.1074%2Fjbc.M113.482596" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Shrestha, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhattarai, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, H.</span><span> </span><span class="NLM_article-title">PTP1B inhibitor ertiprotafib is also a potent inhibitor of IkappaB kinase beta (IKK-beta)</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">2728</span><span class="NLM_x">–</span> <span class="NLM_lpage">2730</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2007.03.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;key=10.1016%2Fj.bmcl.2007.03.001" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=2728-2730&author=S.+Shresthaauthor=B.+R.+Bhattaraiauthor=H.+Choauthor=J.+K.+Choiauthor=H.+Cho&title=PTP1B+inhibitor+ertiprotafib+is+also+a+potent+inhibitor+of+IkappaB+kinase+beta+%28IKK-beta%29&doi=10.1016%2Fj.bmcl.2007.03.001"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2007.03.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2007.03.001%26sid%3Dliteratum%253Aachs%26aulast%3DShrestha%26aufirst%3DS.%26aulast%3DBhattarai%26aufirst%3DB.%2BR.%26aulast%3DCho%26aufirst%3DH.%26aulast%3DChoi%26aufirst%3DJ.%2BK.%26aulast%3DCho%26aufirst%3DH.%26atitle%3DPTP1B%2520inhibitor%2520ertiprotafib%2520is%2520also%2520a%2520potent%2520inhibitor%2520of%2520IkappaB%2520kinase%2520beta%2520%2528IKK-beta%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D2728%26epage%3D2730%26doi%3D10.1016%2Fj.bmcl.2007.03.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Klepper, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polborn, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carell, T.</span><span> </span><span class="NLM_article-title">Robust synthesis and crystal-structure analysis of 7-cyano-7-deazaguanine (PreQ(0) base) and 7-(aminomethyl)-7-deazaguanine (PreQ(1) base)</span> <span class="citation_source-journal">Helv. Chim. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">88</span><span class="NLM_x">, </span> <span class="NLM_fpage">2610</span><span class="NLM_x">–</span> <span class="NLM_lpage">2616</span><span class="refDoi"> DOI: 10.1002/hlca.200590201</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;key=10.1002%2Fhlca.200590201" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=2005&pages=2610-2616&author=F.+Klepperauthor=K.+Polbornauthor=T.+Carell&title=Robust+synthesis+and+crystal-structure+analysis+of+7-cyano-7-deazaguanine+%28PreQ%280%29+base%29+and+7-%28aminomethyl%29-7-deazaguanine+%28PreQ%281%29+base%29&doi=10.1002%2Fhlca.200590201"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1002%2Fhlca.200590201&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fhlca.200590201%26sid%3Dliteratum%253Aachs%26aulast%3DKlepper%26aufirst%3DF.%26aulast%3DPolborn%26aufirst%3DK.%26aulast%3DCarell%26aufirst%3DT.%26atitle%3DRobust%2520synthesis%2520and%2520crystal-structure%2520analysis%2520of%25207-cyano-7-deazaguanine%2520%2528PreQ%25280%2529%2520base%2529%2520and%25207-%2528aminomethyl%2529-7-deazaguanine%2520%2528PreQ%25281%2529%2520base%2529%26jtitle%3DHelv.%2520Chim.%2520Acta%26date%3D2005%26volume%3D88%26spage%3D2610%26epage%3D2616%26doi%3D10.1002%2Fhlca.200590201" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Llona-Minguez, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mackay, S. P.</span><span> </span><span class="NLM_article-title">Stereoselective synthesis of carbocyclic analogues of the nucleoside Q precursor (PreQ(0))</span> <span class="citation_source-journal">Beilstein J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1333</span><span class="NLM_x">–</span> <span class="NLM_lpage">1338</span><span class="refDoi"> DOI: 10.3762/bjoc.10.135</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;key=10.3762%2Fbjoc.10.135" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;key=24991286" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFSrtLbF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2014&pages=1333-1338&author=S.+Llona-Minguezauthor=S.+P.+Mackay&title=Stereoselective+synthesis+of+carbocyclic+analogues+of+the+nucleoside+Q+precursor+%28PreQ%280%29%29&doi=10.3762%2Fbjoc.10.135"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Stereoselective synthesis of carbocyclic analogs of the nucleoside Q precursor (PreQ0)</span></div><div class="casAuthors">Llona-Minguez, Sabin; MacKay, Simon P.</div><div class="citationInfo"><span class="NLM_cas:title">Beilstein Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1333-1338, 6 pp.</span>CODEN:
                <span class="NLM_cas:coden">BJOCBH</span>;
        ISSN:<span class="NLM_cas:issn">1860-5397</span>.
    
            (<span class="NLM_cas:orgname">Beilstein-Institut zur Foerderung der Chemischen Wissenschaften</span>)
        </div><div class="casAbstract">A convergent and stereoselective synthesis of chiral cyclopentyl- and cyclohexyl-amine derivs. of nucleoside Q precursor (PreQ0) has been accomplished.  This synthetic route allows for an efficient prepn. of 4-substituted analogs with interesting three-dimensional character, including chiral cyclopentane-1,2-diol and -1,2,3-triol derivs.  This unusual substitution pattern provides a useful starting point for the discovery of novel bioactive mols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqukdcY9A8n_rVg90H21EOLACvtfcHk0limYLm3VwyQfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFSrtLbF&md5=0c4d4ec27df542f2f424ded6768dfcb4</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.3762%2Fbjoc.10.135&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3762%252Fbjoc.10.135%26sid%3Dliteratum%253Aachs%26aulast%3DLlona-Minguez%26aufirst%3DS.%26aulast%3DMackay%26aufirst%3DS.%2BP.%26atitle%3DStereoselective%2520synthesis%2520of%2520carbocyclic%2520analogues%2520of%2520the%2520nucleoside%2520Q%2520precursor%2520%2528PreQ%25280%2529%2529%26jtitle%3DBeilstein%2520J.%2520Org.%2520Chem.%26date%3D2014%26volume%3D10%26spage%3D1333%26epage%3D1338%26doi%3D10.3762%2Fbjoc.10.135" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Ziegler, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schenck, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krockow, E. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siebert, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wenz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, H.</span><span> </span><span class="NLM_article-title">The synthesis of cantharidin</span> <span class="citation_source-journal">Justus Liebigs Ann. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1942</span><span class="NLM_x">, </span> <span class="NLM_volume">551</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">79</span><span class="refDoi"> DOI: 10.1002/jlac.19425510102</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;key=10.1002%2Fjlac.19425510102" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=551&publication_year=1942&pages=1-79&author=K.+Zieglerauthor=G.+Schenckauthor=E.+W.+Krockowauthor=A.+Siebertauthor=A.+Wenzauthor=H.+Weber&title=The+synthesis+of+cantharidin&doi=10.1002%2Fjlac.19425510102"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1002%2Fjlac.19425510102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjlac.19425510102%26sid%3Dliteratum%253Aachs%26aulast%3DZiegler%26aufirst%3DK.%26aulast%3DSchenck%26aufirst%3DG.%26aulast%3DKrockow%26aufirst%3DE.%2BW.%26aulast%3DSiebert%26aufirst%3DA.%26aulast%3DWenz%26aufirst%3DA.%26aulast%3DWeber%26aufirst%3DH.%26atitle%3DThe%2520synthesis%2520of%2520cantharidin%26jtitle%3DJustus%2520Liebigs%2520Ann.%2520Chem.%26date%3D1942%26volume%3D551%26spage%3D1%26epage%3D79%26doi%3D10.1002%2Fjlac.19425510102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Blades, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donohoe, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winter, J. J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stemp, G.</span><span> </span><span class="NLM_article-title">A <i>syn</i> selective dihydroxylation of cyclic allylic trichloroacetamides using catalytic osmium tetroxide</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">4701</span><span class="NLM_x">–</span> <span class="NLM_lpage">4704</span><span class="refDoi"> DOI: 10.1016/S0040-4039(00)00714-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;key=10.1016%2FS0040-4039%2800%2900714-0" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2000&pages=4701-4704&author=K.+Bladesauthor=T.+J.+Donohoeauthor=J.+J.+G.+Winterauthor=G.+Stemp&title=A+syn+selective+dihydroxylation+of+cyclic+allylic+trichloroacetamides+using+catalytic+osmium+tetroxide&doi=10.1016%2FS0040-4039%2800%2900714-0"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2FS0040-4039%2800%2900714-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4039%252800%252900714-0%26sid%3Dliteratum%253Aachs%26aulast%3DBlades%26aufirst%3DK.%26aulast%3DDonohoe%26aufirst%3DT.%2BJ.%26aulast%3DWinter%26aufirst%3DJ.%2BJ.%2BG.%26aulast%3DStemp%26aufirst%3DG.%26atitle%3DA%2520syn%2520selective%2520dihydroxylation%2520of%2520cyclic%2520allylic%2520trichloroacetamides%2520using%2520catalytic%2520osmium%2520tetroxide%26jtitle%3DTetrahedron%2520Lett.%26date%3D2000%26volume%3D41%26spage%3D4701%26epage%3D4704%26doi%3D10.1016%2FS0040-4039%2800%2900714-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Lam, P. Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinto, D. J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orwat, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galemmo, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fevig, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teleha, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alexander, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smallwood, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rossi, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bai, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luettgen, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knabb, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wexler, R. R.</span><span> </span><span class="NLM_article-title">Structure-based design of novel guanidine/benzamidine mimics: Potent and orally bioavailable factor Xa inhibitors as novel anticoagulants</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">4405</span><span class="NLM_x">–</span> <span class="NLM_lpage">4418</span><span class="refDoi"> DOI: 10.1021/jm020578e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm020578e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;key=1%3ACAS%3A528%3ADC%252BD3sXnvVCjtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=4405-4418&author=P.+Y.+S.+Lamauthor=C.+G.+Clarkauthor=R.+H.+Liauthor=D.+J.+P.+Pintoauthor=M.+J.+Orwatauthor=R.+A.+Galemmoauthor=J.+M.+Fevigauthor=C.+A.+Telehaauthor=R.+S.+Alexanderauthor=A.+M.+Smallwoodauthor=K.+A.+Rossiauthor=M.+R.+Wrightauthor=S.+A.+Baiauthor=K.+Heauthor=J.+M.+Luettgenauthor=P.+C.+Wongauthor=R.+M.+Knabbauthor=R.+R.+Wexler&title=Structure-based+design+of+novel+guanidine%2Fbenzamidine+mimics%3A+Potent+and+orally+bioavailable+factor+Xa+inhibitors+as+novel+anticoagulants&doi=10.1021%2Fjm020578e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-based design of novel guanidine/benzamidine mimics: potent and orally bioavailable factor Xa inhibitors as novel anticoagulants</span></div><div class="casAuthors">Lam, Patrick Y. S.; Clark, Charles G.; Li, Renhua; Pinto, Donald J. P.; Orwat, Michael J.; Galemmo, Robert A.; Fevig, John M.; Teleha, Christopher A.; Alexander, Richard S.; Smallwood, Angela M.; Rossi, Karen A.; Wright, Matthew R.; Bai, Stephen A.; He, Kan; Luettgen, Joseph M.; Wong, Pancras C.; Knabb, Robert M.; Wexler, Ruth R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">4405-4418</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">As part of an ongoing effort to prep. orally active factor Xa inhibitors using structure-based drug design techniques and mol. recognition principles, a systematic study has been performed on the pharmacokinetic profile resulting from replacing the benzamidine in the P1 position with less basic benzamidine mimics or neutral residues.  It is demonstrated that lowering the pKa of the P1 ligand resulted in compds. (3-benzylamine, 15a; 1-aminoisoquinoline, 24a; 3-aminobenzisoxazole, 23a; 3-phenylcarboxamide, 22b; and 4-methoxyphenyl, 22a) with improved pharmacokinetic features mainly as a result of decreased clearance, increased vol. of distribution, and enhanced oral absorption.  This work resulted in a series of potent and orally bioavailable factor Xa inhibitors that ultimately led to the discovery of SQ311, 24a.  SQ311, which utilizes a 1-aminoisoquinoline as the P1 ligand, inhibits factor Xa with a Ki of 0.33 nM and demonstrates both good in vivo antithrombotic efficacy and oral bioavailability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqE6d2DUIccKrVg90H21EOLACvtfcHk0ljWInJh7nywQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXnvVCjtLs%253D&md5=f2c7ea82ae9df29352c9fa74e1563529</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fjm020578e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm020578e%26sid%3Dliteratum%253Aachs%26aulast%3DLam%26aufirst%3DP.%2BY.%2BS.%26aulast%3DClark%26aufirst%3DC.%2BG.%26aulast%3DLi%26aufirst%3DR.%2BH.%26aulast%3DPinto%26aufirst%3DD.%2BJ.%2BP.%26aulast%3DOrwat%26aufirst%3DM.%2BJ.%26aulast%3DGalemmo%26aufirst%3DR.%2BA.%26aulast%3DFevig%26aufirst%3DJ.%2BM.%26aulast%3DTeleha%26aufirst%3DC.%2BA.%26aulast%3DAlexander%26aufirst%3DR.%2BS.%26aulast%3DSmallwood%26aufirst%3DA.%2BM.%26aulast%3DRossi%26aufirst%3DK.%2BA.%26aulast%3DWright%26aufirst%3DM.%2BR.%26aulast%3DBai%26aufirst%3DS.%2BA.%26aulast%3DHe%26aufirst%3DK.%26aulast%3DLuettgen%26aufirst%3DJ.%2BM.%26aulast%3DWong%26aufirst%3DP.%2BC.%26aulast%3DKnabb%26aufirst%3DR.%2BM.%26aulast%3DWexler%26aufirst%3DR.%2BR.%26atitle%3DStructure-based%2520design%2520of%2520novel%2520guanidine%252Fbenzamidine%2520mimics%253A%2520Potent%2520and%2520orally%2520bioavailable%2520factor%2520Xa%2520inhibitors%2520as%2520novel%2520anticoagulants%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D4405%26epage%3D4418%26doi%3D10.1021%2Fjm020578e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Orsini, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menichincheri, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanotti, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panzeri, A.</span><span> </span><span class="NLM_article-title">Highly efficient synthesis of 5-benzyl-3-aminoindazoles</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">3098</span><span class="NLM_x">–</span> <span class="NLM_lpage">3100</span><span class="refDoi"> DOI: 10.1016/j.tetlet.2009.04.024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;key=10.1016%2Fj.tetlet.2009.04.024" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2009&pages=3098-3100&author=P.+Orsiniauthor=M.+Menichincheriauthor=E.+Vanottiauthor=A.+Panzeri&title=Highly+efficient+synthesis+of+5-benzyl-3-aminoindazoles&doi=10.1016%2Fj.tetlet.2009.04.024"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2Fj.tetlet.2009.04.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tetlet.2009.04.024%26sid%3Dliteratum%253Aachs%26aulast%3DOrsini%26aufirst%3DP.%26aulast%3DMenichincheri%26aufirst%3DM.%26aulast%3DVanotti%26aufirst%3DE.%26aulast%3DPanzeri%26aufirst%3DA.%26atitle%3DHighly%2520efficient%2520synthesis%2520of%25205-benzyl-3-aminoindazoles%26jtitle%3DTetrahedron%2520Lett.%26date%3D2009%26volume%3D50%26spage%3D3098%26epage%3D3100%26doi%3D10.1016%2Fj.tetlet.2009.04.024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Jones, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willett, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glen, R. C.</span><span> </span><span class="NLM_article-title">Molecular recognition of receptor-sites using a genetic algorithm with a description of desolvation</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">245</span><span class="NLM_x">, </span> <span class="NLM_fpage">43</span><span class="NLM_x">–</span> <span class="NLM_lpage">53</span><span class="refDoi"> DOI: 10.1016/S0022-2836(95)80037-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;key=10.1016%2FS0022-2836%2895%2980037-9" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=245&publication_year=1995&pages=43-53&author=G.+Jonesauthor=P.+Willettauthor=R.+C.+Glen&title=Molecular+recognition+of+receptor-sites+using+a+genetic+algorithm+with+a+description+of+desolvation&doi=10.1016%2FS0022-2836%2895%2980037-9"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2FS0022-2836%2895%2980037-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0022-2836%252895%252980037-9%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DG.%26aulast%3DWillett%26aufirst%3DP.%26aulast%3DGlen%26aufirst%3DR.%2BC.%26atitle%3DMolecular%2520recognition%2520of%2520receptor-sites%2520using%2520a%2520genetic%2520algorithm%2520with%2520a%2520description%2520of%2520desolvation%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D1995%26volume%3D245%26spage%3D43%26epage%3D53%26doi%3D10.1016%2FS0022-2836%2895%2980037-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Ghose, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herbertz, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pippin, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salvino, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mallamo, J. P.</span><span> </span><span class="NLM_article-title">Knowledge based prediction of ligand binding modes and rational inhibitor design for kinase drug discovery</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">5149</span><span class="NLM_x">–</span> <span class="NLM_lpage">5171</span><span class="refDoi"> DOI: 10.1021/jm800475y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm800475y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVWmurnM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=5149-5171&author=A.+K.+Ghoseauthor=T.+Herbertzauthor=D.+A.+Pippinauthor=J.+M.+Salvinoauthor=J.+P.+Mallamo&title=Knowledge+based+prediction+of+ligand+binding+modes+and+rational+inhibitor+design+for+kinase+drug+discovery&doi=10.1021%2Fjm800475y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Knowledge Based Prediction of Ligand Binding Modes and Rational Inhibitor Design for Kinase Drug Discovery</span></div><div class="casAuthors">Ghose, Arup K.; Herbertz, Torsten; Pippin, Douglas A.; Salvino, Joseph M.; Mallamo, John P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">5149-5171</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review describing the use of Protein Data Bank (PDB) entries specifically for kinase inhibitor drug discovery.  Topics discussed include: the current state of structure-aided ligand design, kinase structure queries and extn. from the PDB, alignment of protein structures, structural classification of ligands, anal. of ligands and binding modes, and ligand design strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDINDYVE15cbVg90H21EOLACvtfcHk0ljWInJh7nywQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVWmurnM&md5=a1afc4d6c7f6fa4dd6aa9da8d78f1ee3</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fjm800475y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800475y%26sid%3Dliteratum%253Aachs%26aulast%3DGhose%26aufirst%3DA.%2BK.%26aulast%3DHerbertz%26aufirst%3DT.%26aulast%3DPippin%26aufirst%3DD.%2BA.%26aulast%3DSalvino%26aufirst%3DJ.%2BM.%26aulast%3DMallamo%26aufirst%3DJ.%2BP.%26atitle%3DKnowledge%2520based%2520prediction%2520of%2520ligand%2520binding%2520modes%2520and%2520rational%2520inhibitor%2520design%2520for%2520kinase%2520drug%2520discovery%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D5149%26epage%3D5171%26doi%3D10.1021%2Fjm800475y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Carbain, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paterson, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anscombe, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cano, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Echalier, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Endicott, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golding, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haggerty, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hardcastle, I. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jewsbury, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newell, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noble, M. E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roche, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffin, R. J.</span><span> </span><span class="NLM_article-title">8-Substituted <i>O</i>-6-Cyclohexylmethylguanine CDK2 inhibitors: Using structure-based inhibitor design to optimize an alternative binding mode</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">56</span><span class="NLM_x">–</span> <span class="NLM_lpage">70</span><span class="refDoi"> DOI: 10.1021/jm401555v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401555v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=56-70&author=B.+Carbainauthor=D.+J.+Patersonauthor=E.+Anscombeauthor=A.+J.+Campbellauthor=C.+Canoauthor=A.+Echalierauthor=J.+A.+Endicottauthor=B.+T.+Goldingauthor=K.+Haggertyauthor=I.+R.+Hardcastleauthor=P.+J.+Jewsburyauthor=D.+R.+Newellauthor=M.+E.+M.+Nobleauthor=C.+Rocheauthor=L.+Z.+Wangauthor=R.+J.+Griffin&title=8-Substituted+O-6-Cyclohexylmethylguanine+CDK2+inhibitors%3A+Using+structure-based+inhibitor+design+to+optimize+an+alternative+binding+mode&doi=10.1021%2Fjm401555v"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Fjm401555v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401555v%26sid%3Dliteratum%253Aachs%26aulast%3DCarbain%26aufirst%3DB.%26aulast%3DPaterson%26aufirst%3DD.%2BJ.%26aulast%3DAnscombe%26aufirst%3DE.%26aulast%3DCampbell%26aufirst%3DA.%2BJ.%26aulast%3DCano%26aufirst%3DC.%26aulast%3DEchalier%26aufirst%3DA.%26aulast%3DEndicott%26aufirst%3DJ.%2BA.%26aulast%3DGolding%26aufirst%3DB.%2BT.%26aulast%3DHaggerty%26aufirst%3DK.%26aulast%3DHardcastle%26aufirst%3DI.%2BR.%26aulast%3DJewsbury%26aufirst%3DP.%2BJ.%26aulast%3DNewell%26aufirst%3DD.%2BR.%26aulast%3DNoble%26aufirst%3DM.%2BE.%2BM.%26aulast%3DRoche%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DL.%2BZ.%26aulast%3DGriffin%26aufirst%3DR.%2BJ.%26atitle%3D8-Substituted%2520O-6-Cyclohexylmethylguanine%2520CDK2%2520inhibitors%253A%2520Using%2520structure-based%2520inhibitor%2520design%2520to%2520optimize%2520an%2520alternative%2520binding%2520mode%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D56%26epage%3D70%26doi%3D10.1021%2Fjm401555v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Huang, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hung, M. C.</span><span> </span><span class="NLM_article-title">Beyond NF-kappa B activation: nuclear functions of IkappaB kinase alpha</span> <span class="citation_source-journal">J. Biomed. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">3</span><span class="refDoi"> DOI: 10.1186/1423-0127-20-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;key=10.1186%2F1423-0127-20-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;key=23343355" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;key=1%3ACAS%3A528%3ADC%252BC3sXivFGksb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2013&pages=3&author=W.+C.+Huangauthor=M.+C.+Hung&title=Beyond+NF-kappa+B+activation%3A+nuclear+functions+of+IkappaB+kinase+alpha&doi=10.1186%2F1423-0127-20-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Beyond NF-κB activation: nuclear functions of IκB kinase α</span></div><div class="casAuthors">Huang, Wei-Chien; Hung, Mien-Chie</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biomedical Science (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">3</span>CODEN:
                <span class="NLM_cas:coden">JBCIEA</span>;
        ISSN:<span class="NLM_cas:issn">1423-0127</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">A review.  IκB kinase (IKK) complex, the master kinase for NF-κB activation, contains two kinase subunits, IKKα and IKKβ.  In addn. to mediating NF-κB signaling by phosphorylating IκB proteins during inflammatory and immune responses, the activation of the IKK complex also responds to various stimuli to regulate diverse functions independently of NF-κB.  Although these two kinases share structural and biochem. similarities, different sub-cellular localization and phosphorylation targets between IKKα and IKKβ account for their distinct physiol. and pathol. roles.  While IKKβ is predominantly cytoplasmic, IKKα has been found to shuttle between the cytoplasm and the nucleus.  The nuclear-specific roles of IKKα have brought increasing complexity to its biol. function.  This review highlights major advances in the studies of the nuclear functions of IKKα and the mechanisms of IKKα nuclear translocation.  Understanding the nuclear activity is essential for targeting IKKα for therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNH6U3apkRf7Vg90H21EOLACvtfcHk0liRa_HR7K18Tw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXivFGksb8%253D&md5=a9015613c1588f7fe87a37bcddc0fc55</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1186%2F1423-0127-20-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1423-0127-20-3%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DW.%2BC.%26aulast%3DHung%26aufirst%3DM.%2BC.%26atitle%3DBeyond%2520NF-kappa%2520B%2520activation%253A%2520nuclear%2520functions%2520of%2520IkappaB%2520kinase%2520alpha%26jtitle%3DJ.%2520Biomed.%2520Sci.%26date%3D2013%26volume%3D20%26spage%3D3%26doi%3D10.1186%2F1423-0127-20-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Leopizzi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cocchiola, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milanetti, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raimondo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Politi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giordano, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scandurra, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scotto d’Abusco, A.</span><span> </span><span class="NLM_article-title">IKKα inibition by a glucosamine derivative enhances Maspin expression in osteosarcoma cell line</span> <span class="citation_source-journal">Chem.-Biol. Interact.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">262</span><span class="NLM_x">, </span> <span class="NLM_fpage">19</span><span class="NLM_x">–</span> <span class="NLM_lpage">28</span><span class="refDoi"> DOI: 10.1016/j.cbi.2016.12.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;key=10.1016%2Fj.cbi.2016.12.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;key=27931795" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;key=1%3ACAS%3A528%3ADC%252BC28XitVOjsrjK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=262&publication_year=2017&pages=19-28&author=M.+Leopizziauthor=R.+Cocchiolaauthor=E.+Milanettiauthor=D.+Raimondoauthor=L.+Politiauthor=C.+Giordanoauthor=R.+Scandurraauthor=A.+Scotto+d%E2%80%99Abusco&title=IKK%CE%B1+inibition+by+a+glucosamine+derivative+enhances+Maspin+expression+in+osteosarcoma+cell+line&doi=10.1016%2Fj.cbi.2016.12.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">IKKα inibition by a glucosamine derivative enhances Maspin expression in osteosarcoma cell line</span></div><div class="casAuthors">Leopizzi, Martina; Cocchiola, Rossana; Milanetti, Edoardo; Raimondo, Domenico; Politi, Laura; Giordano, Cesare; Scandurra, Roberto; Scotto d'Abusco, Anna</div><div class="citationInfo"><span class="NLM_cas:title">Chemico-Biological Interactions</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">262</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">19-28</span>CODEN:
                <span class="NLM_cas:coden">CBINA8</span>;
        ISSN:<span class="NLM_cas:issn">0009-2797</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">Chronic inflammation has been assocd. to cancer development by the alteration of several inflammatory pathways, such as Nuclear Factor-κB pathway.  In particular, IκB kinase α (IKKα), one of two catalytic subunit of IKK complex, has been described to be assocd. to cancer progression and metastasis in a no. of cancers.  The mol. mechanism by which IKKα affects cancer progression is not yet completely clarified, anyway an assocn. between IKKα and the expression of Maspin (Mammary Serine Protease Inhibitor or SerpinB5), a tumor suppressor protein, has been described.  IKKα shuttles between cytoplasm and nucleus, and when is localized into the nuclei, IKKα regulates the expression of several genes, among them Maspin gene, whose expression is repressed by high amt. of nuclear IKKα.  Considering that high levels of Maspin have been assocd. with reduced metastatic progression, it could be hypothesized that the repression of IKKα nuclear translocation could be assocd. with the repression of metastatic phenotype.  The present study is aimed to explore the ability of a glucosamine deriv., 2-(N-Carbobenzyloxy)L-phenylalanylamido-2-deoxy-β-D-glucose (NCPA), synthesized in our lab., to stimulate the prodn. of Maspin in an osteosarcoma cell line, 143B.  Immunofluorescence and Western blotting expts. showed that NCPA is able to inhibit IKKα nuclear translocation, and to stimulate Maspin prodn.  Moreover, in assocn. with stimulation of Maspin prodn. we found the decrease of β1 Integrin expression, the down-regulation of metalloproteases MMP-9 and MMP-13 prodn. and cell migration inhibition.  Taking in account that β1 Integrin and MMP-9 and -13 have been correlated with the invasiveness of osteosarcoma, considering that NCPA affects the invasiveness of 143B cell line, we suggest that this mol. could affect the osteosarcoma metastatic ability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoy_JzFyYCtHrVg90H21EOLACvtfcHk0liRa_HR7K18Tw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitVOjsrjK&md5=679de7ab7445df8b2e8fee818ba526b0</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2Fj.cbi.2016.12.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cbi.2016.12.005%26sid%3Dliteratum%253Aachs%26aulast%3DLeopizzi%26aufirst%3DM.%26aulast%3DCocchiola%26aufirst%3DR.%26aulast%3DMilanetti%26aufirst%3DE.%26aulast%3DRaimondo%26aufirst%3DD.%26aulast%3DPoliti%26aufirst%3DL.%26aulast%3DGiordano%26aufirst%3DC.%26aulast%3DScandurra%26aufirst%3DR.%26aulast%3DScotto%2Bd%25E2%2580%2599Abusco%26aufirst%3DA.%26atitle%3DIKK%25CE%25B1%2520inibition%2520by%2520a%2520glucosamine%2520derivative%2520enhances%2520Maspin%2520expression%2520in%2520osteosarcoma%2520cell%2520line%26jtitle%3DChem.-Biol.%2520Interact.%26date%3D2017%26volume%3D262%26spage%3D19%26epage%3D28%26doi%3D10.1016%2Fj.cbi.2016.12.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Solt, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madge, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orange, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">May, M. J.</span><span> </span><span class="NLM_article-title">Interleukin-1-induced NF-kappa B activation is NEMO-dependent but does not require IKK beta</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">282</span><span class="NLM_x">, </span> <span class="NLM_fpage">8724</span><span class="NLM_x">–</span> <span class="NLM_lpage">8733</span><span class="refDoi"> DOI: 10.1074/jbc.M609613200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;key=10.1074%2Fjbc.M609613200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282&publication_year=2007&pages=8724-8733&author=L.+A.+Soltauthor=L.+A.+Madgeauthor=J.+S.+Orangeauthor=M.+J.+May&title=Interleukin-1-induced+NF-kappa+B+activation+is+NEMO-dependent+but+does+not+require+IKK+beta&doi=10.1074%2Fjbc.M609613200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M609613200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M609613200%26sid%3Dliteratum%253Aachs%26aulast%3DSolt%26aufirst%3DL.%2BA.%26aulast%3DMadge%26aufirst%3DL.%2BA.%26aulast%3DOrange%26aufirst%3DJ.%2BS.%26aulast%3DMay%26aufirst%3DM.%2BJ.%26atitle%3DInterleukin-1-induced%2520NF-kappa%2520B%2520activation%2520is%2520NEMO-dependent%2520but%2520does%2520not%2520require%2520IKK%2520beta%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2007%26volume%3D282%26spage%3D8724%26epage%3D8733%26doi%3D10.1074%2Fjbc.M609613200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Denk, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goebeler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmid, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berberich, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ritz, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindemann, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ludwig, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wirth, T.</span><span> </span><span class="NLM_article-title">Activation of NF-kappa B via the I kappa B kinase complex is both essential and sufficient for proinflammatory gene expression in primary endothelial cells</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">276</span><span class="NLM_x">, </span> <span class="NLM_fpage">28451</span><span class="NLM_x">–</span> <span class="NLM_lpage">28458</span><span class="refDoi"> DOI: 10.1074/jbc.M102698200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;key=10.1074%2Fjbc.M102698200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2001&pages=28451-28458&author=A.+Denkauthor=M.+Goebelerauthor=S.+Schmidauthor=I.+Berberichauthor=O.+Ritzauthor=D.+Lindemannauthor=S.+Ludwigauthor=T.+Wirth&title=Activation+of+NF-kappa+B+via+the+I+kappa+B+kinase+complex+is+both+essential+and+sufficient+for+proinflammatory+gene+expression+in+primary+endothelial+cells&doi=10.1074%2Fjbc.M102698200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M102698200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M102698200%26sid%3Dliteratum%253Aachs%26aulast%3DDenk%26aufirst%3DA.%26aulast%3DGoebeler%26aufirst%3DM.%26aulast%3DSchmid%26aufirst%3DS.%26aulast%3DBerberich%26aufirst%3DI.%26aulast%3DRitz%26aufirst%3DO.%26aulast%3DLindemann%26aufirst%3DD.%26aulast%3DLudwig%26aufirst%3DS.%26aulast%3DWirth%26aufirst%3DT.%26atitle%3DActivation%2520of%2520NF-kappa%2520B%2520via%2520the%2520I%2520kappa%2520B%2520kinase%2520complex%2520is%2520both%2520essential%2520and%2520sufficient%2520for%2520proinflammatory%2520gene%2520expression%2520in%2520primary%2520endothelial%2520cells%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2001%26volume%3D276%26spage%3D28451%26epage%3D28458%26doi%3D10.1074%2Fjbc.M102698200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Craft, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Legge, G. B.</span><span> </span><span class="NLM_article-title">An AMBER/DYANA/MOLMOL phosphorylated amino acid library set and incorporation into NMR structure calculations</span> <span class="citation_source-journal">J. Biomol. NMR</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">15</span><span class="NLM_x">–</span> <span class="NLM_lpage">24</span><span class="refDoi"> DOI: 10.1007/s10858-005-1199-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;key=10.1007%2Fs10858-005-1199-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;key=16222554" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFShsL7O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2005&pages=15-24&author=J.+W.+Craftauthor=G.+B.+Legge&title=An+AMBER%2FDYANA%2FMOLMOL+phosphorylated+amino+acid+library+set+and+incorporation+into+NMR+structure+calculations&doi=10.1007%2Fs10858-005-1199-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">An AMBER/DYANA/MOLMOL Phosphorylated Amino Acid Library Set and Incorporation into NMR Structure Calculations</span></div><div class="casAuthors">Craft, John W., Jr.; Legge, Glen B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biomolecular NMR</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">15-24</span>CODEN:
                <span class="NLM_cas:coden">JBNME9</span>;
        ISSN:<span class="NLM_cas:issn">0925-2738</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Protein structure detn. using NMR requires the use of mol. dynamics programs that incorporate both NMR exptl. and implicit at. data.  At. parameters for each amino acid type are encoded in libraries used by structure calcn. programs such as DYANA and AMBER.  However, only a few non-std. amino acid library sets are included in these programs or the mol. visualization program MOLMOL.  Our lab. is calcg. the phosphorylated and non-phosphorylated states of peptides and proteins using NMR methods.  To calc. chem. correct structures, we have extended the available mol. libraries for these programs to include the modified amino acids phosphoserine, phosphothreonine, and phosphotyrosine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1yJFz3WV4VbVg90H21EOLACvtfcHk0lhqSP3By84Jjg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFShsL7O&md5=1010e86682ceac20c6a114b8d9352ca7</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1007%2Fs10858-005-1199-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10858-005-1199-0%26sid%3Dliteratum%253Aachs%26aulast%3DCraft%26aufirst%3DJ.%2BW.%26aulast%3DLegge%26aufirst%3DG.%2BB.%26atitle%3DAn%2520AMBER%252FDYANA%252FMOLMOL%2520phosphorylated%2520amino%2520acid%2520library%2520set%2520and%2520incorporation%2520into%2520NMR%2520structure%2520calculations%26jtitle%3DJ.%2520Biomol.%2520NMR%26date%3D2005%26volume%3D33%26spage%3D15%26epage%3D24%26doi%3D10.1007%2Fs10858-005-1199-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Talapatra, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anthony, N. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mackay, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kozielski, F.</span><span> </span><span class="NLM_article-title">Mitotic kinesin Eg5 overcomes inhibition to the phase I/II clinical candidate SB743921 by an allosteric resistance mechanism</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">6317</span><span class="NLM_x">–</span> <span class="NLM_lpage">6329</span><span class="refDoi"> DOI: 10.1021/jm4006274</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm4006274" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFeqsbrN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=6317-6329&author=S.+K.+Talapatraauthor=N.+G.+Anthonyauthor=S.+P.+Mackayauthor=F.+Kozielski&title=Mitotic+kinesin+Eg5+overcomes+inhibition+to+the+phase+I%2FII+clinical+candidate+SB743921+by+an+allosteric+resistance+mechanism&doi=10.1021%2Fjm4006274"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Mitotic Kinesin Eg5 Overcomes Inhibition to the Phase I/II Clinical Candidate SB743921 by an Allosteric Resistance Mechanism</span></div><div class="casAuthors">Talapatra, Sandeep K.; Anthony, Nahoum G.; Mackay, Simon P.; Kozielski, Frank</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">6317-6329</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Development of drug resistance during cancer chemotherapy is one of the major causes of chemotherapeutic failure for the majority of clin. agents.  The aim of this study was to investigate the underlying mol. mechanism of resistance developed by the mitotic kinesin Eg5 against the potent second-generation ispinesib analog SB743921 (1), a phase I/II clin. candidate.  Biochem. and biophys. data demonstrate that point mutations in the inhibitor-binding pocket decrease the efficacy of 1 by several 1000-fold.  Surprisingly, the structures of wild-type and mutant Eg5 in complex with 1 display no apparent structural changes in the binding configuration of the drug candidate.  Furthermore, ITC and modeling approaches reveal that resistance to 1 is not through conventional steric effects at the binding site but through reduced flexibility and changes in energy fluctuation pathways through the protein that influence its function.  This is a phenomenon we have called "resistance by allostery".</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqaoYhxRvlbd7Vg90H21EOLACvtfcHk0lhqSP3By84Jjg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFeqsbrN&md5=cff47090a835eb61eada53dd7d8d0343</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1021%2Fjm4006274&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm4006274%26sid%3Dliteratum%253Aachs%26aulast%3DTalapatra%26aufirst%3DS.%2BK.%26aulast%3DAnthony%26aufirst%3DN.%2BG.%26aulast%3DMackay%26aufirst%3DS.%2BP.%26aulast%3DKozielski%26aufirst%3DF.%26atitle%3DMitotic%2520kinesin%2520Eg5%2520overcomes%2520inhibition%2520to%2520the%2520phase%2520I%252FII%2520clinical%2520candidate%2520SB743921%2520by%2520an%2520allosteric%2520resistance%2520mechanism%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D6317%26epage%3D6329%26doi%3D10.1021%2Fjm4006274" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Ryckaert, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciccotti, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berendsen, H. J. C.</span><span> </span><span class="NLM_article-title">Numerical-integration of cartesian equations of motion of a system with constraints - molecular dynamics of <i>N</i>-alkanes</span> <span class="citation_source-journal">J. Comput. Phys.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1977</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">327</span><span class="NLM_x">–</span> <span class="NLM_lpage">341</span><span class="refDoi"> DOI: 10.1016/0021-9991(77)90098-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;key=10.1016%2F0021-9991%2877%2990098-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;key=1%3ACAS%3A528%3ADyaE2sXktVGhsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1977&pages=327-341&author=J.+P.+Ryckaertauthor=G.+Ciccottiauthor=H.+J.+C.+Berendsen&title=Numerical-integration+of+cartesian+equations+of+motion+of+a+system+with+constraints+-+molecular+dynamics+of+N-alkanes&doi=10.1016%2F0021-9991%2877%2990098-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Numerical integration of the Cartesian equations of motion of a system with constraints:  molecular dynamics of n-alkanes</span></div><div class="casAuthors">Ryckaert, Jean Paul; Ciccotti, Giovanni; Berendsen, Herman J. C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computational Physics</span>
        (<span class="NLM_cas:date">1977</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">327-41</span>CODEN:
                <span class="NLM_cas:coden">JCTPAH</span>;
        ISSN:<span class="NLM_cas:issn">0021-9991</span>.
    </div><div class="casAbstract">A numerical algorithm integrating the 3N Cartesian equation of motion of a system of N points subject to holonomic constraints is applied to mol. dynamics simulation of a liq. of 64 butane mols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYPlhG1U3Uw7Vg90H21EOLACvtfcHk0lhTcxXr2gZxkQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE2sXktVGhsL4%253D&md5=b4aecddfde149117813a5ea4f5353ce2</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1016%2F0021-9991%2877%2990098-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0021-9991%252877%252990098-5%26sid%3Dliteratum%253Aachs%26aulast%3DRyckaert%26aufirst%3DJ.%2BP.%26aulast%3DCiccotti%26aufirst%3DG.%26aulast%3DBerendsen%26aufirst%3DH.%2BJ.%2BC.%26atitle%3DNumerical-integration%2520of%2520cartesian%2520equations%2520of%2520motion%2520of%2520a%2520system%2520with%2520constraints%2520-%2520molecular%2520dynamics%2520of%2520N-alkanes%26jtitle%3DJ.%2520Comput.%2520Phys.%26date%3D1977%26volume%3D23%26spage%3D327%26epage%3D341%26doi%3D10.1016%2F0021-9991%2877%2990098-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">MacKenzie, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ritchie, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paul, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plevin, R.</span><span> </span><span class="NLM_article-title">IKK alpha and IKK beta function in TNF alpha-stimulated adhesion molecule expression in human aortic smooth muscle cells</span> <span class="citation_source-journal">Cell. Signalling</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">75</span><span class="NLM_x">–</span> <span class="NLM_lpage">80</span><span class="refDoi"> DOI: 10.1016/j.cellsig.2006.06.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;key=10.1016%2Fj.cellsig.2006.06.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;key=16872805" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;key=1%3ACAS%3A528%3ADC%252BD28Xhtlalt7nI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2007&pages=75-80&author=C.+J.+MacKenzieauthor=E.+Ritchieauthor=A.+Paulauthor=R.+Plevin&title=IKK+alpha+and+IKK+beta+function+in+TNF+alpha-stimulated+adhesion+molecule+expression+in+human+aortic+smooth+muscle+cells&doi=10.1016%2Fj.cellsig.2006.06.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">IKKα and IKKβ function in TNFα-stimulated adhesion molecule expression in human aortic smooth muscle cells</span></div><div class="casAuthors">MacKenzie, Christopher J.; Ritchie, Elwyn; Paul, Andrew; Plevin, Robin</div><div class="citationInfo"><span class="NLM_cas:title">Cellular Signalling</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">75-80</span>CODEN:
                <span class="NLM_cas:coden">CESIEY</span>;
        ISSN:<span class="NLM_cas:issn">0898-6568</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The role of NFκB and it's upstream kinases in regulating adhesion mol. expression in the smooth muscle of the vasculature remains controversial.  We therefore examd. the effect of blocking the NFκB pathway on TNFα-stimulated ICAM-1 and VCAM-1 expression in primary cultures of human aortic smooth muscle cells using an adenoviral wild-type IκBα construct (Ad.IκBα) and dominant-neg. IKKα (Ad.IKKα+/-) and IKKβ (Ad.IKKβ+/-) constructs.  Ad.IκBα treatment was found to block NFκB DNA-binding, and thereby completely prevent TNFα-stimulated ICAM-1 and VCAM-1 expression without influencing IKK activity.  Ad.IKKβ+/- treatment completely inhibited TNFα-stimulated IKK kinase activity, IκBα degrdn. and NFκB DNA-binding in addn. to completely blocking TNFα-stimulated ICAM-1 and VCAM-1 expression.  Ad.IKKα+/- treatment however had no detectable effect on NFκB DNA-binding or ICAM-1 and VCAM-1 expression.  Our results demonstrate that TNFα-stimulated ICAM-1 and VCAM-1 expression in human aortic smooth muscle cells is NFκB-dependent, that IKKβ is a suitable target for drug therapy and Ad.IKKβ+/- an effective inhibitor of TNFα-stimulated ICAM-1 and VCAM-1 expression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZrRgMZkEKsbVg90H21EOLACvtfcHk0lhTcxXr2gZxkQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xhtlalt7nI&md5=6a76d5e67e904b66b66fe2b3c2a9f542</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1016%2Fj.cellsig.2006.06.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cellsig.2006.06.001%26sid%3Dliteratum%253Aachs%26aulast%3DMacKenzie%26aufirst%3DC.%2BJ.%26aulast%3DRitchie%26aufirst%3DE.%26aulast%3DPaul%26aufirst%3DA.%26aulast%3DPlevin%26aufirst%3DR.%26atitle%3DIKK%2520alpha%2520and%2520IKK%2520beta%2520function%2520in%2520TNF%2520alpha-stimulated%2520adhesion%2520molecule%2520expression%2520in%2520human%2520aortic%2520smooth%2520muscle%2520cells%26jtitle%3DCell.%2520Signalling%26date%3D2007%26volume%3D19%26spage%3D75%26epage%3D80%26doi%3D10.1016%2Fj.cellsig.2006.06.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Nicklin, S. A.; Baker, A. H.</span><span> </span><span class="NLM_article-title">Simple methods for preparing recombinant adenoviruses for high-efficiency transduction of vascular cells</span>. In  <span class="citation_source-book">Vascular Disease: Molecular Biology and Gene Therapy Protocols</span>; <span class="NLM_contrib-group">Baker, A. H.</span>, Ed.; <span class="NLM_publisher-name">Humana Press</span>: <span class="NLM_publisher-loc">Totowa, NJ</span>,<span class="NLM_x"> </span><span class="NLM_year">1999</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">271</span><span class="NLM_x">–</span> <span class="NLM_lpage">283</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;key=10.1385%2F1-59259-247-3%3A271" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1999&pages=271-283&author=S.+A.+Nicklin&author=A.+H.+Bakerauthor=A.+H.+Baker&title=Vascular+Disease%3A+Molecular+Biology+and+Gene+Therapy+Protocols"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1385%2F1-59259-247-3%3A271&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1385%252F1-59259-247-3%253A271%26sid%3Dliteratum%253Aachs%26aulast%3DNicklin%26aufirst%3DS.%2BA.%26atitle%3DSimple%2520methods%2520for%2520preparing%2520recombinant%2520adenoviruses%2520for%2520high-efficiency%2520transduction%2520of%2520vascular%2520cells%26btitle%3DVascular%2520Disease%253A%2520Molecular%2520Biology%2520and%2520Gene%2520Therapy%2520Protocols%26aulast%3DBaker%26aufirst%3DA.%2BH.%26pub%3DHumana%2520Press%26date%3D1999%26spage%3D271%26epage%3D283" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4KIK" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4KIK','PDB','4KIK'); return false;">PDB: 4KIK</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i89"><a href="/doi/suppl/10.1021/acs.jmedchem.7b00484">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_87362"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.7b00484">10.1021/acs.jmedchem.7b00484</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">IKKα homology model (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b00484/suppl_file/jm7b00484_si_001.pdb">PDB</a>)</p></li><li><p class="inline">IKKα with compound <b>4</b>(<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b00484/suppl_file/jm7b00484_si_002.pdb">PDB</a>)</p></li><li><p class="inline">IKKα with compound <b>9</b>(<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b00484/suppl_file/jm7b00484_si_003.pdb">PDB</a>)</p></li><li><p class="inline">IKKα with compound <b>43</b>(<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b00484/suppl_file/jm7b00484_si_004.pdb">PDB</a>)</p></li><li><p class="inline">IKKα with compound <b>47</b>(<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b00484/suppl_file/jm7b00484_si_005.pdb">PDB</a>)</p></li><li><p class="inline">IKKα with compound <b>48</b>(<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b00484/suppl_file/jm7b00484_si_006.pdb">PDB</a>)</p></li><li><p class="inline">IKKα with compound <b>50</b>(<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b00484/suppl_file/jm7b00484_si_007.pdb">PDB</a>)</p></li><li><p class="inline">Molecular formula strings with associated IKK biochemical inhibitory data in SMILES format (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b00484/suppl_file/jm7b00484_si_008.csv">CSV</a>)</p></li><li><p class="inline">The inhibitory kinome profile for compound <b>48</b> against 40 kinases (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b00484/suppl_file/jm7b00484_si_009.xls">XLS</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00484/suppl_file/jm7b00484_si_001.pdb">jm7b00484_si_001.pdb (191.46 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00484/suppl_file/jm7b00484_si_002.pdb">jm7b00484_si_002.pdb (390.49 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00484/suppl_file/jm7b00484_si_003.pdb">jm7b00484_si_003.pdb (392.31 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00484/suppl_file/jm7b00484_si_004.pdb">jm7b00484_si_004.pdb (391.5 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00484/suppl_file/jm7b00484_si_005.pdb">jm7b00484_si_005.pdb (397.85 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00484/suppl_file/jm7b00484_si_006.pdb">jm7b00484_si_006.pdb (392.0 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00484/suppl_file/jm7b00484_si_007.pdb">jm7b00484_si_007.pdb (387.97 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00484/suppl_file/jm7b00484_si_008.csv">jm7b00484_si_008.csv (4.29 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00484/suppl_file/jm7b00484_si_009.xls">jm7b00484_si_009.xls (28.5 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.7b00484&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2017.60.issue-16%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.7b00484%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.7b00484" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                9MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679952903daa2428","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
